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Abstract
ABSTRACT
Chromosome abnormalities are observed very frequently in humans. Several types of 
structural chromosome abnormalities have been identified, with chromosome 
translocations, both reciprocal and Robertsonian, being the most common in the 
population. Balanced carriers of such rearrangements could be at risk of generating 
abnormal offspring due to the meiotic segregation of the translocation. Preimplantation 
Genetic Diagnosis (PGD) has allowed the extensive cytogenetic investigation of embryos 
from such patients with the application of Fluorescent in situ hybridisation (FISH). The 
first part of this work involved the development of robust three-colour FISH protocols for 
their clinical application for the PGD for three reciprocal translocations, two different 
Robertsonian translocations and two cases of suspected gonadal mosaicism. Five of these 
patients underwent 1-2 cycles of treatment, and 21 normal/balanced embryos were 
detected and transferred to the maternal uterus. One clinical pregnancy was established 
with a subsequent live birth of a healthy male infant in a case of a female reciprocal 
translocation carrier. Extensive FISH examination of the non-transferred embryos 
showed evidence of post-zygotic mosaicism in 73.4% of them, with chaotic embryos 
predominating. Both meiotic and mitotic mechanisms leading to chromosome gain and/or 
loss were identified in this group of embryos.
Of all types of chromosome anomaly, however, aneuploidy is the most significant 
clinically, occurring in at least 5% of recognised pregnancies. It has been demonstrated 
that the errors taking place during the first meiotic division in females are the main cause 
of aneuploidy. The second part of the project involved the molecular cytogenetic analysis 
of human metaphase II oocytes and corresponding 1st polar bodies (PBs) with the 
application of FISH initially and then with Comparative Genomic Hybridisation (CGH). 
265 unfertilised meiosis II oocytes and their corresponding PBs (when these were 
available) were analysed over three sequential rounds of FISH for the examination of 
chromosomes 1, 4,12,13, 17, 21, 22, and X. CGH was employed during the final part of 
this woik for the potential analysis of 40 meiosis II oocytes and 45 first PBs, 37 of which 
had their corresponding oocyte also investigated. Results were obtained for 11 oocytes 
and 15 PBs, 6 of which were pairs. Several mechanisms leading to aneuploidy were 
identified: 1. Classical whole univalent non-disjunction, 2. Chromatid predivision prior to
5
Abstract
anaphase I, leading to imbalance detected at metaphase II, 3. Germinal/gonadal 
mosaicism for a trisomic cell line and preferential involvement of the smaller 
chromosomes. The CGH investigation led to the detection of oocytes and/or PBs with 
missing chromosome material in a wider range of chromosomes. It was concluded that 
human aneuploidy is caused by a combination of meiotic factors, some of which may not 
be associated with maternal age.
6
Table of Contents
TABLE OF CONTENTS
Title. 1
Dedication. 2
Acknowledgements. 3
Abstract. 5
Table of Contents. 7
List of Tables. 14
List of Figures. 16
List of Abbreviations. 19
Chapter 1: Introduction. 22
1.1 The Origin of Human Chromosomal Defects. 23
1.2 Meiosis in Human Gametogenesis. 25
1.2.1 Spermatogenesis. 26
1.2.2 Oogenesis. 27
1.3 Fertilisation and preimplantation development. 29
1.4 Chromosome Abnormalities. 34
1.4.1 Numerical chromosome abnormalities. 35
1.4.2 Structural chromosome abnormalities. 41
1.4.2.1 Reciprocal translocations. 43
1.4.2.2 Robertsonian translocations. 46
1.5 Preimplantation Genetic Diagnosis. 48
1.5.1 Biopsy methods. 50
1.5.1.1 Polar body biopsy. 50
1.5.1.2 Cleavage stage biopsy. 53
1.5.1.3 Blastocyst biopsy. 54
1.5.2 Diagnosis of single gene defects. 55
1.5.3 Diagnosis of chromosome abnormalities. 58
1.6 Fluorescent in situ hybridisation. 60
7
Table of Contents
1.6.1 Aneuploidy screening. 64
1.6.2 FISH diagnosis of structural abnormalities. 66
1.6.3 FISH limitations. 69
1.7 Comparative Genomic Hybridisation. 71
1.7.1 CGH application in PGD. 74
1.7.2 CGH limitations in clinical PGD application. 76
1.8 Mosaicism in human preimplantation embryos. 77
1.9 Oocyte Studies. 81
1.10 Aims and outline of the study. 86
Chapter 2: Materials and Methods. 88
2.1 Materials. 89
2.1.1 General reagents and equipment. 89
2.1.1.1 Chemicals. 89
2.1.1.2 Enzymes. 89
2.1.1.3 Nucleic Acids. 89
2.1.1.4 Cell culture media and other equipment. 90
2.1.1.5 FISH reagents. 90
2.1.1.6 Microscopy and image analysis. 90
2.1.2 Ethical approval. 91
2.1.3 Pieimplantation Genetic Diagnosis. 91
2.1.3.1 Patient details. 91
2.1.3.2 FISH probe details. 91
2.1.3.3 Preimplantation embryos. 99
2.13.4 Preimplantation embryos grading criteria. 100
2.13 3  Embryo classification according to chromosome abnormalities. 100
2.1.4 Human oocyte and 1st PB analysis with FISH. 101
2.1.4.1 Patients. 101
2.1.4.2 Oocytes. 101
2.1.4.3 FISH probe details. 101
2.1.5 Human oocyte and 151 PB analysis with CGH. 105
8
Table o f Contents
2.1.5.1 Patients. 105
2.1.5.2 Oocytes and 1st PBs. 105
2.1.5.3 Single cell lysis and whole genome amplification. 105
2.1.5.4 Probe labelling, hybridisation, and post-hybridisation washes. 105
2.1.5.5 Image analysis and interpretation. 106
2.2 Methods. 107
2.2.1 IVF and PGD procedures. 107
2.2.1.1 IVF treatment cycles. 107
2.2.12  Embryo manipulation. 107
2.2.1.3 Oocyte recovery. 108
2.2.2 Cell culture. 108
2.2.2.1 Peripheral lymphocyte culture. 108
2.2.2.2 Skin fibroblast cell preparation for FISH. 110
2.2.3 Slide preparation. 110
2.2.3.1 Slide preparation of cultured cells. 110
2.2.3.2 Slide preparation of single blastomeres and embryos. I l l
2.2.3.3 Slide preparation of unfertilised oocytes. 111
2.2.4 Probe preparation. 113
2.2.4.1 Bacterial culture. 113
2.2A2 Maxiprep extraction of plasmid/ cosmid DNA. 113
2.2.4.3 Yeast culture. 114
2.2.4.4 Miniprep extraction of yeast DNA. 114
2.2.4.5 DNA reprecipitation. 114
2.2.4.6 Fluorometry. 115
22A.1  ^ 4/m-PCR. 115
2.2.4.8 Agarose gel electrophoresis. 116
2.2.4.9 Labelling of the FISH probes. 116
2.2.4.9.1 Preparation of the nick translation kit. 116
2.2.4.9.2 Nick translation reaction. 117
2.2.4.9.3 Probe preparation after labelling. 117
2.2.5 FISH for PGD. 118
9
Table of Contents
2.2.5.1 Slide pretreatment. 118
2.2.5.2 Probe preparation. 118
2.2.5.3 Denaturation and hybridisation. 119
2.2.5.4 Post-hybridisation procedures. 119
2.2.5.5 Re-probing of slides. 120
2.2.5.6 Scoring criteria for embryos. 121
2.2.6 FISH for metaphase II oocytes and 1st PBs. 121
2.2.6.1 Slide pretreatment. 121
2.2.6.2 Probe preparation. 121
2.2.6.3 Denaturation and hybridisation. 123
2.2.6.4 Post-hybridisation procedures. 123
2.2.6.5 Re-probing of slides. 123
2.2.6.6 Scoring criteria for oocytes and PBs. 124
2.2.7 CGH of human meiosis II oocytes and corresponding 1st PBs. 124
2.2.7.1 DNA extraction from blood. 124
2.212  DNA extraction from skin fibroblasts. 125
2.212  Single cell collection. 126
2.2.7.3.1 Buccal cells. 126
2 .2132  Skin fibroblasts. 126
2 .2133  Human oocytes and PBs. 127
2.2.7 .4 Isolation and lysis of clumps or single cells. 127
2.21.5 Degenerate Oligonucleotide Primed PCR. 128
2.21.6 Agarose gel electrophoresis. 129
2.211  Amplified product precipitation. 129
2 2 1 .8 Labelling of the amplified products. 130
2.21.9 Comparative Genomic Hybridisation. 130
2.21.9.1 Slide and probe preparation. 130
2.21.9.2 Denaturation and hybridisation. 131
2.21.93  Post-hybridisation procedures. 131
10
Table of Contents
Chapter 3: Results 132
The detection and analysis of chromosomal abnormalities in preimplantation 
embryos from clinical PGD cases. 132
3.1 Development of a FISH protocol for the PGD of chromosomal abnormalities. 133
3.2 PGD for three couples with reciprocal translocations. 135
3.2.1 Case A: Reciprocal translocation 46,XY,t(5;19)(pl2;pl2). 135
3.2.2 Case B: Reciprocal translocation 46,XX,t(l 1 ;22)(q23.3;ql 1.2). 143
3.2.3 Case C: Reciprocal translocation 46,XY,t( 14; 16)(q 13;ql 1.1). 151
3.3 PGD for two couples with Robertsonian translocations. 153
3.3.1 Case D: Robertsonian translocation 45,XY,der(13;21)(qlO;qlO). 153
333. Case E: Robertsonian translocation 45,XY,der(13;14)(qlO;qlO). 160
3.4 PGD for two couples with possible gonadal mosaicism for trisomy 21. 168
3.4.1 Case F: PGD for a couple with ectopic pregnancies and one trisomy 21
conception. 168
3.4.2 Case G: PGD for a couple with recurrent trisomy 21 conceptions. 181
3.5 Summary of the outcome of nine PGD cycles. 184
Chapter 4: Results. 192
The investigation of chromosomal abnormalities in human oocytes and 
corresponding polar bodies using FISH. 192
4.1 Human metaphase II oocytes and corresponding 1st PBs. 193
4.2 Fixation and FISH efficiency. 194
4.3 First Hybridisation Round. 197
4.3.1 FISH with the centromeric probes for chromosomes 1,12, and X. 197
4.3.2 FISH with the centromeric probes for chromosomes 12, 16, and 18. 202
4.33 FISH with the centromeric probes for chromosomes 4 and 17. 202
4.3.4 FISH with the centromeric probes for chromosomes 4,12, and 17. 207
4.4. Second Hybridisation Round. 215
4.4.1 FISH with the centromeric probe for chromosome 16. 215
4.4.2 FISH with the locus-specific probes for chromosomes 13 and 21. 216
4.5 Third Hybridisation Round. 222
11
Table of Contents
4.5.1 FISH with the locus-specific probe for chromosome 22. 222
4.6 Aneuploidy in human metaphase II oocytes and corresponding first polar bodies. 226
Chapter 5: Results. 232
The analysis of human metaphase II oocytes and corresponding polar bodies with 
CGH. 232
5.1 CGH investigation of human metaphase II oocytes and corresponding 1st PBs. 233
5.2 Evaluation of the CGH protocol. 234
5.2.1 CGH analysis of 46,XX genomic DNA against 46,XY genomic DNA. 236
5.2.2 CGH analysis of fibroblast DNA trisomic for chromosome 13 against 46,XY 
genomic DNA. 238
5.2.3 CGH analysis of fibroblast DNA trisomic for chromosome 21 against 46,XX 
genomic DNA. 240
5.2.4 CGH analysis of fibroblast DNA trisomic for chromosome 22 against 46,XY 
genomic DNA. 242
5.2.5 CGH analysis of 46,XX buccal cell clump against 46,XY buccal cell clump. 244
5.2.6 CGH analysis of 46,XX buccal cell clump against 46,XX buccal cell clump. 246 
5.2.7. CGH analysis of a single fibroblast cell trisomic for chromosome 18 against 46,XY 
genomic DNA. 248
5.3 CGH analysis of human metaphase II oocytes. 251
5.4 CGH analysis of 1st Polar Bodies. 265
5.5 Aneuploidy in human metaphase II oocytes and corresponding 1st polar bodies 
analysed by CGH. 277
Chapter 6: Discussion. 283
6.1 The application of PGD for the detection of chromosomal abnormalities. 284
6.2 Analysis of preimplantation embryos from nine cycles for the PGD of chromosome 
abnormalities. 292
6.3 Conclusions. 298
6.4 FISH analysis of human metaphase II oocytes and corresponding first PBs. 302
6.4.1 Processing of oocytes and PBs. 303
12
Table of Contents
6.4.2 Aneuploidy detection in human metaphase II oocytes and first PBs. 304
6.5 CGH analysis of human metaphase II oocytes and corresponding first PBs. 313
6.5.1 Technical aspects of CGH. 313
6.5.2 Chromosome abnormalities in oocytes and PBs investigated with CGH. 317
6.6 Conclusions. 324
6.7 Future Work. 327
Chapter 7: Bibliography. 330
7.1 Publications Arising from Thesis. 331
7.1.1 Articles. 331
7.1J2 Abstracts. 331
7.2 References. 332
Appendices. 362
A: Appendix to Materials and Methods. 363
B: Appendix to Chapter 3. Cytogenetic analysis of embryonic blastomeres using the 
1SCN Nomenclature. 367
C: Appendix to Chapter 4. Cytogenetic analysis of metaphase II oocytes and 1st PBs 
with the ISCN Nomenclature. 381
13
List o f Tables and Figures
LIST OF TABLES
1.1 Different types of chromosomal abnormalities. 34
1.2 Patterns of segregation of a reciprocal translocation and resulting gametes. 42
13 Patterns of segregation of a Robertsonian translocation and resulting gametes. 44
1.4 Some examples of the clinical application of PGD for single gene disorders to 
illustrate different methodologies (from Wells and Delhanty, 2001). 56
2.1 Details of the patients referred for PGD of chromosome abnormalities. 92
2.2 Details of DNA probes employed for the PGD of chromosome abnormalities. 94 
23  Probe combination developed for the PGD of chromosome abnormalities and for
spare embryo re-analysis for the seven cases. 97
2.4 Oocytes collected and embryos biopsied for each of the five PGD cases. 99
2.5 Details of DNA probes employed in the analysis of oocytes and 1st PBs. 102
2.6 Probe combinations during the three sequential FISH rounds applied for oocyte
analysis. 122
3.1 Case A, 46,XY,t(5;19)(pl2;pl2); FISH analysis of biopsied cells and non­
transferred embryos in one PGD cycle. 139
3.2 Case B, 46,XX,t(ll;22)(q23.3;qll.2); FISH analysis of biopsied cells and non­
transferred embryos in two PGD cycles. 147
33  Case D, 45,XY,der(13;21)(qlO;qlO); FISH analysis of biopsied cells and non­
transferred embryos in two PGD cycles. 157
3.4 Case E, 45,XY,der(13;14)(qlO;qlO); FISH analysis of biopsied cells and non­
transferred embryos in two PGD cycles. 164
3.5 Case F, possible gonadal mosaicism for trisomy 21; FISH analysis of biopsied 
cells and non-transferred embryos in two PGD cycles. 
173
3.6 Summary of nine PGD cycles for five couples investigated for a chromosomal 
abnormality. 187
3.7 Summary of embryo classification and segregation patterns observed for three
PGD cycles for two couples carrying reciprocal translocations. 
188
14
List o f Tables and Figures
3.8 Summary of embryo classification and segregation patterns observed for four 
PGD cycles for two couples with Robertsonian translocations.
189
3.9 Summary of embryo classification and segregations observed for two PGD cycles 
for one couple investigated for possible gonadal mosaicism for trisomy 21.
190
3.10 Summary of chromosome constitutions observed in embryos from five couples
treated for chromosome abnormalities with PGD. 191
4.1 FISH results for metaphase II oocytes, investigated for chromosomes 1,12, and X.
200
4.2 FISH results for corresponding 1st PBs, investigated for chromosomes 1, 12 and
X. 201
4 3  FISH results for metaphase II oocytes, investigated for chromosomes 4 and
17. 205
4.4 FISH results for corresponding 1st PBs, investigated for chromosomes 4 and 
17. 206
4.5 FISH results for metaphase II oocytes, investigated for chromosomes 4, 12 and 
17. 211
4.6 FISH results for corresponding 1st PBs, investigated for chromosomes 4, 12 and
17. 214
4.7 FISH results for metaphase II oocytes, investigated for chromosomes 13 and
21. 219
4.8 FISH results for corresponding 1st PBs, investigated for chromosomes 13 and
21. 221
4.9 FISH results for metaphase II oocytes, investigated for chromosome
22. 225
4.10 FISH results for corresponding 1st PBs, investigated for chromosome 22. 225
4.11 Patients with extra chromosomes/chromatids in one or more oocytes and PBs.
Chromosomes investigated are indicated. 229
15
List of Tables and Figures
4.12 Patients showing precocious separation of chromosomes into their sister
chromatids in oocytes and/or PBs. 230
4.13 Hyperploidy frequency identified in oocytes or 1st PBs per chromosome. 231
5.1 CGH analysis of human metaphase II oocytes. 264
5.2 CGH analysis of corresponding 1st PBs. 276
5 3  Summary of CGH analysis of human metaphase II oocytes and their corresponding
1st PBs. Patient details and ART method are indicated. 281
6.1 Summary of the outcome of 17 cycles of PGD for 11 couples carrying a 
chromosomal abnormality (Cases H-M from Simopoulou et al., 2003). 291
6.2 Frequency of anomalies (hyperploidy) found in oocytes or 1st polar bodies per
chromosome (from Cupisti et al, 2003). 306
LIST OF FIGURES
1.1 Mitosis and Meiosis. 24
1.2 The G-banded karyotype. 33
13 The incidence of aneuploidy at various stages of development. 37
1.4 Models of Non-disjunction. 38
13 Configuration of a reciprocal translocation during meiosis. 42
1.6 Configuration of a Robertsonian translocation during meiosis. 45
1.7 Cleavage-stage Embryo Biopsy for PGD. 52
13 Types of DNA probes employed in FISH. 59
1.9 Diagnosis of Biopsied Blastomeres for PGD. 63
1.10 Comparative Genomic Hybridisation. 72
3.1 FISH strategy for the PGD of reciprocal translocalions. 134
33 PGD for Case A, 46,XY,t(5;19)(pl2;pl2). 137
33  PGD for Case B, 46,XX,t(l l;22)(q23.3;ql 1.2). 145
3.4 PGD for Case C, 46,XY,t(14;16)(ql3;ql 1.1). 150
3 3  FISH strategy for the PGD of Robertsonian translocations. 152
3.6 PGD for Case D, 45,XY,der(13;21)(qlO;qlO). 155
3.7 PGD for Case E, 45,XY,der(13;14)(qlO;qlO). 161
16
List o f Tables and Figures
3.8 PGD for Case F, Possible gonadal mosaicism for trisomy 21. 170
3.9 PGD for Case G,Possible gonadal mosaicism for trisomy 21. 182
4.1a Two sets of centromeric probes employed for the first round FISH analysis of
metaphase II oocytes and 1st PBs. 195
4.1b Two sets of locus-specific probes employed for the second and third round FISH
analysis of metaphase II oocytes and 1st PBs. 196
4.2 First hybridisation round- Centromeric probes for 1,12 and X. 198
4 J  First hybridisation round- Centromeric probes for 4 and 17. 203
4.4 First hybridisation round- Centromeric probes for 4, 12 and 17. 208
4.5 Second hybridisation round- Locus-specific probes for 13 and 21. 217
4.6 Third hybridisation round- Locus-specific probe for chromosome 22. 223
5.1 Positive control experiment: CGH analysis of 46,XX genomic DNA against 
46,XY genomic DNA.
237
5.2 Positive control experiment: CGH analysis of 47,XY+13 fibroblast DNA against 
46,XY genomic DNA. 239 
53  Positive control experiment: CGH analysis of 47,XY+21 fibroblast DNA against
46,XX genomic DNA. 241
5.4 Positive control experiment: CGH analysis of 47,XY+22 fibroblast DNA against 
46,XY genomic DNA. 243
5.5 Positive control experiment: CGH analysis of 46,XX buccal cell clump DNA
against 46,XY buccal cell clump DNA. 245
5.6 Positive control experiment: CGH analysis of 46,XX buccal cell clump DNA
against 46,XX buccal cell clump DNA.
247
5.7 Positive control experiment: CGH analysis of 47,XX+18 fibroblast cell DNA
against 46,XY genomic DNA. 249
5.8 Agarose gel analysis demonstrating the DOP PCR amplification of oocyte and PB
no. 1134.3 and two buccal cell clumps. 252
5.9 CGH analysis of oocyte no. 1173.1,23,X against 46,XY buccal cell clump
17
List o f Tables and Figures
DNA. 254
5.10 CGH analysis of oocyte no. 1355.4,23,X against 46,XX buccal cell clump 
DNA. 256
5.11 CGH analysis of oocyte no. 1134.3 against 46,XY buccal cell clump DNA. 258
5.12 CGH analysis of oocyte no. 4412.4 against 46,XX buccal cell clump DNA. 260
5.13 CGH analysis of oocyte no. 4412.5 against 46,XX buccal cell clump DNA. 262
5.14 CGH analysis of PB no. 4125.1, 23,X against 46,XY buccal cell clump DNA. 
266
5.15 CGH analysis of PB no. 4412.6, 23,X against 46,XX buccal cell clump DNA. 268
5.16 CGH analysis of PB no. 4412.5 against 46,XX buccal cell clump DNA. 269
5.17 CGH analysis of PB no. 1143.4 against 46,XY buccal cell clump DNA. 271
5.18 CGH analysis of PB no. 1254.6 against 46,XX buccal cell clump DNA. 273
5.19 CGH analysis of PB no. 1355.1 against 46,XX buccal cell clump DNA. 274
18
List of Abbreviations
Abbreviations
LIST OF ABBREVIATIONS
commonly found in this thesis;
ADO Allele dropout.
^4/w-PCR Alu polymerase chain reaction.
bp Base pair.
CCD Charged coupled device.
CGH Comparative Genomic Hybridisation.
CPM Confined placental mosaicism.
dATP Deoxyadenosine triphosphate.
dCTP Deoxycytidine triphosphate.
dGTP Deoxyguanosine triphosphate.
dNTP Deoxynucleoside triphosphate.
dTTP Deoxythimidine triphosphate.
dUTP Deoxyuridine triphosphate.
DAPI 4’ ,6-diamidino-2-phenylindole.
der Derivative chromosome.
DNA Deoxyribonucleic acid.
DOP-PCR Degenerate oligonucleotide primed- polymerase chain reaction.
ESHRE European Society for Human Reproduction and Embryology.
ET Embryo transfer.
FISH Fluorescent in situ hybridisation.
FSH Follicle stimulating hormone.
G-banding Giemsa banding.
GnRH Gonadotrophin releasing hormone.
GPS Glutamine/Penicillin/Streptomycin.
hCG Human chorionic gonadotrophin.
HCL Hydrochloric acid.
HFEA Human Fertilisation and Embryology Authority.
ICM Inner cell mass.
ICSI Intracytoplasmic sperm injection.
19
List of Abbreviations
ISCN International System for Human Cytogenetic Nomenclature.
IVF In vitro fertilisation.
Kb Kilobase pairs.
KCL Potassium chloride.
LH Luteinising hormone.
Hg Microgram.
Hi Microlitre.
MI First meiotic division.
M il Second meiotic division.
M-FISH Multi-target/Multiplex- fluorescent in situ hybridisation.
mg Milligram.
mm Millimetre
ml Millilitre.
MPF Maturation/M-phase promoting factor.
ng Nanogram.
PB Polar body.
PBS Phosphate-buffered saline.
PCR Polymerase chain reaction.
Pg Picogram.
PGD Preimplantation genetic diagnosis.
PGS Preimplantation genetic screening.
PHA Phytohaemagglutinin.
PK Proteinase K.
PN Pronucleus/ pronuclei.
RNA Ribonucleic acid.
SA Spectrum Aqua.
SDS Sodium dodecyl-sulphate.
SG Spectrum green.
SKY Spectral karyotyping.
SO Spectrum orange.
SR Spectrum red.
20
List of Abbreviations
ssc Standard saline citrate.
SSCP Single strand conformational polymorphism.
TE Trophectoderm.
TOP Termination of pregnancy.
UPD Uniparental disomy.
v/v Volume for volume.
WGA Whole genome amplification.
w/v Weight for volume.
YAC Yeast artificial chromosome.
ZP Zona pellucida.
21
Introduction
Chapter 1 
Introduction
22
Introduction
1.1 The origin of human chromosomal defects
Humans as a species are not as fertile as other mammals, and that flaw becomes more 
pronounced with increasing age. Several studies have shown that the possibility of 
conception ranges between 20-25% per month for young couples with no known fertility 
problems (Bonde et al., 1998; Edwards and Brody, 1995). The implantation rate for 
couples undergoing IVF procedures due to infertility of one of the two partners is also 
approximately 20% for each attempt (Edwards and Beard, 1999). Moreover, even if a 
clinical pregnancy is established, there is a possibility that it will spontaneously abort 
before reaching to term. Various factors have been associated with spontaneous 
pregnancy loss, including viral and bacterial infections of the mother such as rubella, 
cytomegalovirus, herpes simplex virus, syphillis (group STORCH), and infections from 
the Toxoplasma species (Spandidos et al., 1998), and the lifestyle of the mother 
(smoking, alcohol, drug consumption). In addition, DNA alterations in the fetus are 
significantly associated with its rejection. Spandidos and colleagues (1998) examined 
seven microsatellite markers in 35 aborted fetuses and compared them with the 
haplotypes from the corresponding parents. They identified novel mutations in these 
markers in 8 of the 35 fetuses investigated, and postulated that this genetic instability 
could be one of the causes of spontaneous abortions, representing an increase in the 
embryo mutational rate (Spandidos et al., 1998). However, one of the most prevalent 
factors negatively influencing both the establishment and/or maintenance of a clinical 
pregnancy is the high incidence of chromosomal abnormalities.
Studies have shown that an estimated 10-30% of fertilised oocytes tend to be abnormal in 
their chromosome complement (Hassold et al., 1996). The effects of chromosome 
abnormalities are detrimental not only during the early stages of embryo development, 
but in later life as well. Autosomal trisomy, monosomy and triploidy account for over 
50% of spontaneous abortions prior to 15 weeks gestation (Hassold et al, 1980; Pellicer 
et al., 1999). Trisomies 13, 18, and 21 may also result in livebom pregnancies, leading in 
this way to large individual and socio-economic consequences. Carriers of structural 
abnormalities, such as balanced translocations are at increased risk of conceiving 
chromosomally unbalanced offspring, suffering repeated miscarriages, and have frequent 
fertility problems.
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Fig.1.1: M itosis and Meiosis
Mitosis
Meiosis
Chromosomes each 
contain one chromatid
Diploid.
2N
Diploid.
2N
Preparatory phase: DNA doubles
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Chromosomes each 
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Prophase I: chromosomes condense
Prophase: chromosomes condense
Ctnasmata form: crossing over can occur
Metaphase I—anaphase I: double-stranded 
chromosomes pull apart
Metaphase: chromosomes line up on 
mitotic spindle, centromeres replicate
Telophase I: cell division
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chromosomes pull apart
/ < £ * \
Anaphase II: centromeres replicate and each 
double-stranded chromosome pulls apart to form 
two single-stranded chromosomes
Cell divides; each daughter cell 
contains two chromosomes of each type
Cell division yields four gametes
Diploid.
Fig.1.1 : Illustration of mitotic and meiotic divisions. A. Mitosis occurs in 
somatic tissues for their maintenance and regeneration. It results in the 
production of identical daughter cells. B. Meiosis is made up of two divisions, 
MI and MIL During the extended prophase stage of MI the 46 chromosomes (2n) 
condense and form 23 homologous pairs of bivalents. These associate with each 
other via the formation of chiasmata. During metaphase I, these bivalents align 
on the metaphase plate orientated by attachment to the spindle. They then disjoin 
and segregate to the resulting daughter cells at anaphase I and telophase I. MI is 
a reduction division, whereas Mil is a mitotic type division during which 
chromosomes align once again on the metaphase II spindle. Separation and 
segregation of sister chromatids to opposite poles follows at anaphase II and 
telophase II. Cytokinesis produces four haploid products (n). (Reproduced, by 
Larsen, 1997).
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Chromosome defects arise as a consequence of errors in the segregation of chromosomes 
during both the female and male gametogenesis, but also repeatedly arise during 
fertilisation and the first embryonic divisions.
1.2 Meiosis in human gametogenesis
Cellular multiplication is achieved through two different types of division: mitosis and 
meiosis. Mitotic divisions take place for the development and maintenance of somatic 
tissues and organs. Such divisions result in the production of identical daughter cells 
required for different bodily functions and for the replacement of cells that are lost 
throughout an individual’s lifetime (Allshire, 2004). Meiosis is a specialised cellular 
division that occurs only in reproductive tissue and leads to the reduction of the diploid 
chromosome number by half and the generation of haploid gametes. It is subdivided into 
two stages, meiosis I (MI) and meiosis II (Mil). During the first meiotic division the 
sister chromatids of each pair of homologous chromosomes are held together, whilst the 
bivalents separate. In the second meiotic division the sister chromatids are pulled apart. 
The end result is the generation of four haploid cells. Both mitotic and meiotic divisions 
are illustrated in detail in fig. 1.1.
Subsequent union of the male and female gametes during fertilisation restores the diploid 
chromosome complement, ensuring in this way the propagation of the species. Meiotic 
recombination leading to the formation of cross-overs between the non-sister chromatids 
of homologous chromosomes enables their correct segregation during the different stages 
of this process, and enhances genetic variation.
The general mechanism underlying meiosis is the same for both males and females, but 
the details in the gametogenesis process are strikingly different among the two sexes 
(Hunt and Hassold, 2002). This variability will be analysed in the two subsequent 
sections.
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1.2.1 Spermatogenesis
The process of human spermatogenesis is continuous and lasts 64 days. Each cell that 
initiates the meiotic division leads to the generation of four sperm. The latter begins when 
males reach puberty and continues into old age.
The precise regulation of spermatogenesis is essential for male fertility. Among the 
couples facing reproductive problems, 50% are affected by infertility due to male factor 
(Choi et al., 2004). Low sperm numbers in the semen, or production of poor quality 
spermatozoa comprise more than 90% of infertility due to the male partner (Lilford et al., 
1994). Factors contributing to male factor infertility include infection, genital injury, and 
environmental influences. However, such cases are in their majority attributed to genetic 
factors (Lilford et al., 1994). The long arm of the Y chromosome has been identified to 
contain genes that are crucial in the regulation of male fertility. It has been divided into 
three azoospermic factor (AZF) regions: AZFa, AZFb, and AZFc (Choi et al., 2004). 
Deletions of these regions lead to different types of male infertility. Hence, AZFa 
deletions are associated with Sertoli cell-only syndrome and sometimes with 
oligozoospermia (Vogt et al., 1996; Foresta et al., 1998), while AZFb and c deletions 
lead to Sertoli cell-only syndrome combined with mild oligozoosopermia (Pryor et al.,
1997). Investigation of infertile males carrying such deletions led to the detection and 
characterisation of several gene families that regulate spermatogenesis. Out of these DAZ 
and RBM were also mapped on a specific region of the Y chromosome (Reijo et al., 
1995; Ma et al, 1993). Other genetic factors involve chromosomal abnormalities, either 
numerical or structural, and CFTR mutations leading to the congenital absence of the vas 
deferens (Kupker et al., 1999).
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1.2.2 Oogenesis
Contrary to male meiosis, which is a continuous process, the human female is bom with a 
complete set of oocytes and it is thought that there is no subsequent generation of new 
cells after birth. Oogenesis begins at the 6th week of fetal development with a series of 
mitotic divisions that lead to the formation of primordial follicles. The latter contain the 
diploid primary oocytes. These enter MI by 12 weeks of development and arrest at the 
diplotene stage of prophase I. The nuclear size of these arrested oocytes enlarges at this 
stage and becomes watery, leading to the formation of cellular structures known as 
germinal vesicles (GVs) (Larsen, 1997).
The germinal vesicles remain in a dormant state until puberty and the initiation of the 
menstrual cycle, which releases one female gamete each month and prepares the uterus 
for embryo implantation. During the fifth day of this cycle, an increase in the 
gonadotrophin releasing hormone (GnRH) that is secreted by the hypothalamus, affects 
the anterior pituitary which in turn secretes the follicle stimulating hormone (FSH) 
initially, and then the LH. Independently of the secretion of these hormones, the coronal 
cells that surround the oocytes change in their morphology and from flattened, they 
become cuboidal and are called primary follicles. The latter is combined with an increase 
in oocyte diameter and both these events mark the beginning of the preantral period 
(Erikson, 1986) The primary follicles along with the oocyte release a thin layer of 
acellular material that surrounds the oocyte and forms what is known as the zona 
pellucida. Each month, several oocytes are recruited and enter this process of maturation, 
but only one further proceeds, whereas the remaining become atretic and are 
subsequently lost via apoptosis. Completion of MI leads to the extrusion of the first polar 
body (PB), whilst the primary oocyte proceeds to Mil and arrests again, at the metaphase 
stage of this second division. This cell is now called a secondary oocyte (Wassarman and 
Albertini, 1993). Ovulation occurs when the mature follicle ruptures and releases the Mil 
oocyte surrounded by a layer of cumulus cells, the corona radiata, into the uterine tube. 
The secretion of LH regulates the formation of the corpus luteum from the remaining 
follicle. This structure enables the preparation of the uterine cavity for implantation by 
secreting progesterone. If fertilisation does not take place, the levels of oestrogen and
27
Introduction
progesterone decrease and menstruation starts approximately fourteen days later (Moore, 
1988).
All the above stages involving the gradual maturation of the oocyte are controlled by 
several factors. It has been shown that cAMP produced by the granulosa cells and 
transported to the oocyte via gap junctions is responsible for the arrest at prophase I 
(Heikinheimo and Gibbons, 1998). In a study carried out by Downs (1995) it was 
observed that the in vitro decline in cAMP levels led to resumption of meiotic division. 
This decline is caused by the LH surge (Granot and Dekel, 1998) It is thought that cAMP 
kinases phosporylate another protein, called maturation promoting factor (MPF) 
sustaining it in this way inactive. The decline in their concentration results in the 
activation of MPF. The latter has three different functions during oocyte maturation 
(Jones, 2004). Dephosphorylation and activation of the MPF has as an effect the 
breakdown of the nuclear envelope also known as GV breakdown, the resumption of MI 
and progression to Mil and the arrest at metaphase II (Mattioli et al., 1991; Furuno et al., 
1994). The asymmetric cell division that leads to the generation and extrusion of the 1st 
PB and the condensation of chromatin in the oocyte are regulated by a MAP-kinase, 
called c-mos (Verlhac et al., 2000). This kinase is considered to be acting in combination 
with MPF in maintaining the metaphase II arrest, as oocytes produced by c-mos knockout 
mice were capable of completing MI, progressing to Mil and arresting at metaphase II 
(Clarke and Masui, 1983, reviewed in Jones, 2004).
From the several million oogonia with which the female is bom, only a few hundred 
mature, while the rest are lost after birth. Menopause is reached when the ovarian reserve 
is depleted, which renders the woman infertile.
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1.3 Fertilisation and preimplantation development
In humans the meeting of oocyte and sperm and subsequent fertilisation occur in the 
oviduct ampulla. After deposition into and migration up the female reproductive tract, the 
sperm undergo a process known as “capacitation”. This process removes inhibitory 
factors and remodels sperm to prepare them for the acrosome reaction (Wassarman,
1999). Having passed through the cumulus mass of the oocyte the spermatozoon reaches 
the hard zona pellucida, and binds to it (sperm-oocyte interaction). This interaction is 
mediated by the terminal a- and (3-galactose of the ZP3 glycoprotein receptor (Litscher et 
al., 1995). The latter along with ZP1 and ZP2 glycoproteins are the main components of 
the zona pellucida. Once this binding is complete, the sperm acrosome releases its 
degradative enzymes, enabling zona perforation. Fusion of the gamete cell membranes 
results in the release of the small cortical granules ingredients into the perivitelline space, 
located between the oocyte and the zona (Edwards and Beard, 1997).
During syngamy the oocyte resumes and completes the second meiotic division, by 
producing the second polar body, whilst the male and female pronuclei start moving 
towards each other. Chromosome condensation, DNA replication and disintegration of 
pronuclear envelopes follow, and the male and female chromosomes mix with subsequent 
formation of the first mitotic spindle. The fertilised oocyte is now called a zygote. The 
sperm centrosome provides the aster that organizes the first and all following mitotic 
spindles. Hence, the embryo’s potential to divide is of paternal origin (Sathananthan, 
1998).
An important factor throughout both fertilisation and syngamy is calcium (Ca2+). 
Penetration of the sperm causes the first Ca2+ oscillations in the oocyte, inducing the 
release of the hydrolytic enzymes by the cortical granules (Heikinheimo and Gibbons,
1998). These oscillations continue throughout embryogenesis with a spatiotemporal 
manner, possibly crucial in the regulation of embryonic development (Edwards and 
Beard, 1997). Intracellularly, two types of channels are seen as responsible for Ca2+ 
release. The first is called the inositol 1,4,5-triphosphate receptor (IP3R) operated 
channel, while the second is known as the ryanodine receptor (RyR) one (Berridge, 1993, 
Coronado et al, 1994). Goud and colleagues (1999) have shown that the distribution of
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the IP3R operated channel is different during oocyte maturation, zygote formation and 
early embryonic development (6-8 cell stage).
It seems that the IP3R and RyR operated channels have different sensitivities to Ca2+ 
release, and distinct locations within the oocyte. This was concluded in vitro, as Ca2+ 
oscillations after IVF begin at the sperm attachment site, proceed in the periphery of the 
oocyte, and reach its central regions (Nakano et al., 1997). After ICSI however, these 
oscillations are delayed, and when they start they are observed all over the oolemma 
(Nakano et al., 1997).
One day after syngamy the zygote commits itself to a succession of mitotic divisions, 
known as cleavage. These divisions separate the zygote into smaller blastomeres, without 
changing its overall size. During the first few mitotic divisions, the blastomeres are 
spherical and totipotent. This totipotency is progressively lost, whilst the cell divisions 
are asynchronous (Heikinheimo and Gibbons, 1998).
The newly formed blastomeres communicate with each other via two types of 
intercellular junctions: gap junctions and desmosomes. In a study carried out by Hardy et 
al. (1996) it was demonstrated that human preimplantation embryos at the 4-cell stage 
consisted of gap junctions containing the protein connexin-43 that enables the transfer of 
ions and small molecules between blastomeres. As development proceeds, these junctions 
increase in size and organisation. The presence of an ^-sensitive receptor at the gap 
junction sites indicates a possible relationship between Ca2+ and the formation of these 
junctions, as it is believed that the increase of intracellular free Ca2+ establishes a pattern 
of cell-cell communication. Desmosomes are observed at the 16-cell embryos and are 
zonular tight junctions (Edwards and Beard, 1997). They implement the formation of the 
inner cell mass (ICM) and trophectoderm (TE) by attaching blastomeres together. At the 
blastocyst stage they are found exclusively in the TE cells (Hardy et al., 1996).
Genes involved in the regulation of the above processes include Oct-4 and 6. The OCT-4 
protein controls the initiation of transcription, while OCT-6 is important for the cellular 
differentiation of the blastomeres (Woodward et al., 1993). Liu and colleagues (2004) 
examined Oct-4 expression during mouse preimplantation development. They first 
detected transcripts of this gene in the nuclei of 8-16 cell stage morulas, followed by an
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increase in expression in early blastocyts, with subsequent decline in late blastocysts, in 
which most of the OCT-4 protein was confined in the ICM (Liu et al., 2004). The protein 
calmodulin is located in the blastomeres and zona environment only and regulates the 
first embryonic cleavages (Woodward et al., 1993).
All the events that have been reported so far take place under the control of the maternal 
genome, as the embryonic genome is not globally activated until the 4-8 cell stage. This 
transition relies on cAMP-dependent protein kinase-mediated mechanisms and coincides 
with the degradation of the remaining maternal mRNA stores due to the shortening of 
their poly-A tails (Heikinheimo et al., 1995). However, some Y chromosome paternal 
transcripts have been detected during very early stages of embryonic development, 
including the Y-linked genes ZFY, SRY and the myotonic dystrophy associated protein 
kinase DK (Taylor et al., 1997). The paternal effect during the initial cleavages was also 
evident in a more recent study carried out by Tesarik and colleagues (2002) on the quality 
of preimplantation embryos resulting from the fertilisation of sibling oocytes with sperm 
from different donors. It was established that paternally derived problems become 
obvious even before the initial cleavage division, and that the quality of the fertilising 
sperm is crucial for the further development of the embryo (Tesarik et al., 2002).
The morula is formed by the 32-cell stage and the individual blastomeres can no longer 
be visualised due to compaction. This process begins at the 8-cell stage and leads to the 
flattening, polarisation and increase of blastomere adherence, enabling in this way the 
maximisation of cellular communication. Near the end of compaction and due to 
polarisation, two different cell types develop: the ICM consisting of apolar and totipotent 
cells, and the TE consisting of polar ones. The cellular polarisation is dependent on Ca2+, 
the intercellular contacts via the desmosomes, and the apical accumulation of the 
cytoskeleton, clathrin and actin (Houliston and Maro, 1989, reviewed in Edwards and 
Beard, 1997). An embryonic clock regulates compaction, which is independent of 
cleavage times and DNA synthesis (Edwards and Beard, 1997). The ICM and TE 
differentiation is regulated by the leptin and STAT3 oocyte proteins (Antczack and 
VanBlerkom, 1997). Leptin is a cytokine able to activate the STAT3 signal transducer 
(Baumann et al, 1996; Vaissee et al, 1996). The spatial localisation of these proteins is 
polarised in the mature oocyte (Antczack and VanBlerkom, 1997). At the morula stage,
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inner blastomeres are poor in their content of leptin/STAT3, while outer ones are both 
reach and poor. By the blastocyst stage, these two proteins are only located in the TE 
(Antczack and VanBlerkom, 1997).
Morula cavitation leads to the formation of the blastocyst. This takes place on day 5 post­
fertilisation, when the embryo arrives at the uterus. Cavitation involves the liquid 
accumulation among ICM cells, which leads to the formation of the blastocoel cavity. 
The TE cells construct a thin epithelial layer surrounding this cavity. Two models have 
been proposed to explain the development of the blastocyst. According to the inside- 
outside hypothesis the blastomeres located in the morula are destined to form the ICM 
cells, while the exposed ones will form the TE cells (Tarkowski and Wroblewska, 1967, 
reviewed in Edwards and Beard, 1997). According to the polarisation hypothesis, the 
ICM cells are to be formed by apolar blastomeres, while the TE cells from polar ones, 
depending on whether the division will be parallel or perpendicular to the axis of polarity. 
Due to the increase of cell-cell contact, the apolar cells are internalized and give rise to 
the ICM, while the polar ones stay exposed and form the TE (Mottla et al., 1995). 
Evidence for this hypothesis was obtained in a study by Mottla and co-workers (1995). 
By injecting a fluorescent dye into blastomeres of 2-8 cell stage human embryos and then 
culturing them to the blastocyst stage, it was demonstrated that the dye was distributed 
evenly prior to differentiation, while afterwards it was visible in both the ICM and TE 
(Mottla et al., 1995).
The final stage prior to implantation is the hatching of the blastocyst by the release of 
enzymes that penetrate and open a hole in the zona. The blastocyst is now ready to 
initiate communication with the maternal tissues and implant in the endometrium.
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Fig. 1.2 : The G-banded Karyotype
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Fig. 1.2 : G-banded metaphase chromosomes from male peripheral 
lymphocytes, which were treated with trypsin prior to Giemsa staining. The 
normal diploid complement is comprised by 46 chromosomes. Out of these, 
22 are pairs of autosomes and one is the pair of sex chromosomes (XY in 
males, XX in females). Each chromosome is divided by the centromere into 
a short (p) and a long (q) arm, each of which terminates to a telomere. 
Chromosome classification is standardised through the International System 
for Human Cytogenetic Nomenclature (ISCN, 1995) according to size, 
centromere position and banding pattern. Normal variable regions have 
been identified near the centromeres of chromosomes 1, 9, and 16, the p 
arm and satellites of the acrocentric chromosomes and Yq.
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1.4 Chromosome abnormalities
Initial estimates on the frequency of chromosome anomaly came from several 
cytogenetic studies of consecutive series of livebirths carried out during the 1960s and 
1970s. Results were obtained on approximately 60,000 newborns (Hassold and Jacobs,
1984). Out of these 0.3% of liveboms were characterised to be chromosomally abnormal, 
with trisomy of chromosome 21 or trisomy for a sex chromosome being the most 
common (Hassold and Jacobs, 1984). The advent of IVF and the rapid development of 
cytogenetic methods to investigate chromosomes of embryos in the context of 
preimplantation genetic diagnosis (PGD) resulted in the accumulation of data about such 
abnormalities prior to implantation. Chromosome abnormalities can be classified into
three groups and are shown in Table 1.1 below. The G-banded karyotype of a normal 
male, 46,XY, is shown in fig. 1.2.
Table 1.1: Different types of chromosomal abnormalities
Type o f  chromosome abnormality Category
Numerical Aneuploidy: monosomy, trisomy, and 
tetrasomy.
Polyploidy: triploidy and tetraploidy
Structural Translocations: reciprocal and 
Robertsonian 
Deletions 
Insertions 
Inversions: paracentric and pericentric 
Rings 
Isochromosomes
Different cell lines (mixoploidy) Mosaicism
Chimaerism
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1.4.1 Numerical chromosome abnormalities
Aneuploidy is the commonest of all chromosome abnormalities and the most significant 
clinically (Hassold et al., 1996). It can be defined as the loss or gain of one or more 
chromosomes, and its mainly caused by an error during chromosome segregation, called 
“non-disjunction”. During non-disjunction, homologous chromosomes and/or sister 
chromatids do not segregate against one another in a balanced manner, but in a way that 
leads to unequal chromosome numbers in daughter cells (Griffin, 1996). This error can 
occur during meiosis I, II, and mitosis. Trisomy is one of the most frequent types of 
aneuploidy, being observed in 0.3% of all newborns (Bond and Chandley, 1983), and 
25% of spontaneously aborted fetuses (Hassold et al., 1980). Trisomies that could lead to 
viable pregnancies include those for chromosomes 13, 18 and 21. Of the monosomies, the 
one for chromosome X (45 X, Turner’s syndrome) with a fetal survival rate of 1 in 
20,000 is the only one to survive implantation to any degree (Griffin, 1996).
The incidence of aneuploidy is estimated by studies carried out on live births, stillbirths, 
spontaneous abortions, human preimplantation embryos, human oocytes and sperm 
(Griffin, 1996). Such studies indicate that in our species aneuploidy is observed to be an 
order of magnitude higher, compared with that of other mammals (Bond and Chandley, 
1983). Hassold and colleagues (1996) estimated that at least 5% of all human conceptions 
are aneuploid. These studies also attempted to establish the parental origin of aneuploidy. 
It has been demonstrated that the majority of autosomal trisomies are due to maternal 
meiotic errors (Hassold et al, 1996), while most sex chromosome abnormalities are 
paternally derived (Griffin, 1996). Fig. 1.3 demonstrates the aneuploidy incidence at 
different developmental stages.
Non-disjunction can be characterised as a de novo event, whose frequency is associated 
with two major factors: advancing parental age and aberrant genetic recombination. 
Several models attempted to describe the mechanisms of this process, but two are 
generally accepted:
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(i) The classical model which involves the segregation of homologous chromosomes 
to the same pole, instead of segregating to opposite poles during meiosis I. This 
produces disomic and nullisomic daughter cells (Griffin, 1996).
(ii) This model was proposed by Angell and co-workers (1991; 1994) who in their 
analyses of 179 meiosis II oocytes, observed either cells with 22 or 23 
chromosomes and an extra chromatid, or others with 22 chromosomes and two 
extra chromatids. This observation led them to suggest that non-disjunction is 
caused by premature division (predivision) of the chromosome centromere, 
instead of the wrong segregation of two homologous chromosomes to the same 
pole, as proposed by the classical model (Angell et al, 1991; 1994). Fig. 1.4 
illustrates the two different models of non-disjunction.
Subsequent studies supported both the above models. One such example is a report on the 
analysis of 383 oocytes that failed to fertilise with the application of FISH carried out by 
Dailey and co-workers (1996). The authors examined chromosomes 13, 18, 21, and X 
and identified cells containing both extra chromosomes, but also extra single chromatids. 
The results obtained also indicated that non-disjunction of whole chromosomes increased 
with advancing maternal age. (Dailey et al, 1996). In a more recent study, Mahmood and 
colleagues (2000) investigated 127 oocytes that had failed to fertilise and 57 
corresponding 1st polar bodies (PBs) using three sequential rounds of FISH, targeting a 
wider range of chromosomes, including 1,9, 13, 16, 18, 21, and X. They too identified 
six oocytes and three PBs with additional signals, with half the anomalies involving extra 
single chromatids and the remaining extra chromosomes (Mahmood et al, 2000). These 
observations provided evidence that both the above mentioned mechanisms lead to 
maternal aneuploidy.
The various types of trisomy originate from errors that take place in meiosis I or II. Thus, 
75% of trisomy 21 cases and 100% of trisomy 16 cases arise from maternal meiosis I 
errors (Antonarakis et al, 1993; Hassold et al, 1995), while maternal meiosis II errors 
account for most trisomy 18 cases (Fisher et al, 1995).
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Fig. 1.3: The incidence of aneuploidy at various stages of 
development
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Fig.1.3 : Numerical chromosome abnormalities take place during gametogenesis, 
fertilisation, and postzygotically with different frequencies. (From Griffin, 1996)
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Fig.1.4: Models of Non-disjunction
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Model 2: Premature division of a chromosome into its sister chromatids and 
random segregation during Anaphase I
Fig.1.4: Two models of meiotic chromosome malsegregation have been proposed. 
Model 1 involves the segregation of homologous chromosomes (MI) or chromatids 
(Mil) to the same pole, which leads to the formation of disomic and nullisomic 
gametes. Model 2 involves the premature separation of a chromosome into its sister 
chromatids. These are subsequently distributed at random during Anaphase I. This 
predivision has been observed in Mil oocytes, and could have as an effect the 
formation of gametes that either have an extra or a missing chromatid.
38
Introduction
Studies on trisomy 21 have demonstrated an association between non-disjunction in 
maternal meiosis I with reduced recombination of the two non-disjoined chromosomes 21 
(Warren et al, 1987; Sherman et al., 1991). This suggests that the failure of 
pairing/recombination could play a primary role in the causation of Down’s syndrome 
(Nicolaidis and Petersen, 1998). Conversely, it has been reported that non-disjunction 
during meiosis II is related to increased recombination, taking place in the first meiosis, 
something which implies that all errors arise in this stage (Lamb et al, 1996). From these 
studies it was concluded that specific chiasma configurations which take place in meiosis 
I, and can mal-segregate either during the first, the second or both divisions determine the 
increased risk of non-disjunction (Lamb et al, 1997). Another example is sex 
chromosome trisomy 47 XXY (Klinefelter’s syndrome), which in 50% of cases is due to 
paternal meiotic errors (Hassold et al., 1991). This trisomy is due to reduced 
recombination leading to the prevention of the formation of the single obligatory chiasma 
between the X and Y bivalent, with subsequent non-disjunction at anaphase I (Hassold et 
al., 1991). A recent investigation in the sperm of a non-mosaic patient with Klinefelter’s 
syndrome, being treated with ICSI, demonstrated an increased number of spermatozoa 
with 24,XX or 24,XY chromosome complements (Hennebicq et al., 2001). Results from 
this study also indicated a much higher frequency of disomy 21 in this patient’s 
spermatozoa compared with those from normal individuals (6.2 vs 0.4%) (Hennebicq et 
al., 2001). Furthermore, it has been suggested that male factor infertility is closely 
associated with the presence of chromosome abnormalities in the sperm of such patients. 
The latter was identified during the prenatal diagnosis of offspring generated by ICSI, 
which detected an increased incidence of de novo sex chromosome abnormalities in these 
fetuses (Bonduelle et al., 2002). This was confirmed in a study carried out by Rodrigo 
and colleagues (2004). They applied FISH for the investigation of chromosomes 13, 18, 
21, X in sperm from patients with obstructive and non-obstructive azoospermia. High 
rates of sex chromosome abnormalities were scored in testicular spermatozoa from these 
patients, especially in the non-obstructive cases (Rodrigo et al., 2004). This study also 
provided evidence for the paternal origin of sex chromosome aneuploidy.
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Polyploidy involves the generation of cells that consist of multiples of the haploid 
chromosome number, i.e., 69- triploidy or 92- tetraploidy. Triploidy is observed in about 
16% of chromosomally abnormal spontaneous abortions (Tharapel et al, 1985). In the 
majority of cases triploidy arises due dispermy or due to failure of the first or second 
meiotic division of oocytes or spermatocytes, or less commonly through participation of 
the second polar body in fertilisation, or by defective segregation of one haploid set of 
chromosomes during the first zygotic division (Niebuhr, 1974; Niikawa and Kajii, 1974; 
Kaji and Nikawa, 1977). The risk of triploidy is not increased with advancing maternal 
age, and usually such conceptions are not recurrent. A case, however, of recurrent triploid 
conceptions was described by Pergament and co-workers (2000). The origin of the extra 
set of chromosomes was established to be maternal, and was the result of an error during 
the second meiotic division leading to the generation of diploid oocytes (Pergament et al, 
2000). Tetraploidy originates from first cleavage division suppression of a zygote after 
the duplication of chromosomes has taken place (Jacobs and Hassold, 1980). The fusion 
of two diploid gametes is also possible. It has been identified in approximately 6% of 
chromosomally abnormal fetuses (Tharapel et al, 1985).
Mitotic errors taking place during the first embryonic cleavage divisions are another 
cause of non-disjunction, having as an effect the formation of embryos consisting of 
mosaic or even chaotic chromosome complements (Delhanty et al, 1997). These errors, 
their effects and the underlying mechanisms will be described in a subsequent section.
40
Introduction
1.4.2 Structural chromosome abnormalities
Structural chromosome abnormalities are formed due to chromosome breakage followed 
by reunion in a different configuration. The latter could have as an effect the 
development of numerically or structurally abnormal gametes and embryos. There are 
different types of such abnormalities and these are the following:
• Translocations, grouped as reciprocal and Robertsonian
• Deletions
• Insertions
• Inversions, grouped as pericentric and paracentric
• Ring chromosomes
• Isochromosomes
These abnormalities can either be balanced, i.e. with no loss or gain of genetic material, 
or unbalanced, where there is a loss or gain of genetic material. Carriers of such 
abnormalities are phenotypically normal. However, they may produce abnormal 
offspring, due to the way the normal and derivative chromosomes segregate during 
meiosis. In addition, they frequently experience problems of reproductive fitness, such as 
infertility, subfertility, or continuous unexplained pregnancy losses (Tharapel et al.,
1985).
The most commonly met structural chromosomal abnormalities in the general population 
are reciprocal and Robertsonian translocations. Both types of translocations, their patterns 
of segregation and their genetic risks for carriers and embryos, will be described below.
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Fig.1.5: Configuration of a reciprocal translocation during meiosis
Pachytene quadrivalent
A derA B derB
Fig.1.5 : Meiosis in a balanced reciprocal translocation carrier. The 
process of meiotic pairing is different, compared to karyotypically 
normal individuals. The two normal and two derivative chromosomes 
align with homologous material. The latter results in the formation of a 
structure called the pachytene quadrivalent. One of five possible modes 
of segregation follows, to resolve this structure. These modes of 
segregation and the resulting gametes are analysed in Table 1.2 below.
Table 1.2: Patterns of segregation of a reciprocal translocation and resulting gametes
Alternate A,B Normal
derA,derB Balanced
Adjacent-1 A,derB Partial disomy and partial nullisomy for
B,derA translocated segments
Adjacent-2 A,derA Partial disomy and partial nullisomy for centric
B,derB segments
3:1 Interchange derA,derB,A Interchange disomy for A
B Nullisomy for A
3:1 Interchange derA,derB,B Interchange disomy for B
A Nullisomy B
3:1 Tertiary A,B,derA Tertiary disomy for transl. B and centric A
derB Nullisomy for transl. B and centric A
3:1 Tertiary A,B,derB Tertiary disomy for transl.A and centric B
derA Nullisomy for transl. A and centric B
4:0 A,B,derA,derB, 0 Disomy A,B, nullisomy A,B
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1.4.2.1 Reciprocal translocations
A reciprocal translocation is generated when a break occurs in each of two chromosomes 
with the segments being exchanged to form two new derivative chromosomes. These can 
be either both monocentric, or one of them dicentric and the other acentric. This type of 
structural abnormality is very common in humans, being present in approximately 1 in 
500 live births (Hook and Hamerton, 1977).
Reciprocal translocations may involve any combination of two non-homologous 
chromosomes. An exception to this rule is the reciprocal translocation t(l l;22)(q23;ql 1), 
which is repeatedly occurring in the general population (Armstrong et al., 2000), and has 
been identified in many unrelated families (Estop et al, 1999).
The process of homologous chromosome pairing and recombination during meiosis I is 
somewhat different for balanced carriers of reciprocal translocations, compared to normal 
individuals. Thus, the two normal and two derivative chromosomes align with 
homologous material and form a structure termed the pachytene quadrivalent. One of five 
possible modes of segregation follows. These include the alternate mode, adjacent-1, 
adjacent-2, 3:1 or 4:0 and result in gametes that are either balanced or unbalanced. 
Fertilisation of these gametes leads to the generation of 32 possible zygotes, out of which 
only two are genetically balanced, one carrying a normal chromosome complement 
whilst the other carries the reciprocal translocation in the balanced form. The pachytene 
quadrivalent, the possible modes of segregation and the gametes that result from those are 
shown in fig.1.5 and Table 1.2.
Data obtained from the study of both balanced and unbalanced carriers of reciprocal 
translocations suggest that only one mode of segregation leading to the generation of 
unbalanced gametes is likely to result in the attainment of a viable pregnancy. This 
segregation mode is dependent on the reciprocal translocation and the sex of the carrier 
(Gardner and Sutherland, 1996). Jalbert and colleagues (1980) described several 
pachytene shape algorithms, produced by comparing the length of the translocated and 
non-translocated segments, and suggested this as a way to predict the most likely 
segregation pattern leading to imbalance for any translocation. Ogilvie and Scriven 
(2002) analyzed the meiotic outcomes of a total of 16 different reciprocal translocations,
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12 of which were identified in females and 4 in males, by examining the embryos 
generated from these patients with the application of FISH. They identified that the 
alternate and adjacent-1 segregation modes were occurring with the same frequency for 
both males and females, whilst the 3:1 mode was observed more often in females, rather 
than in males. The authors attributed the latter, to the generation of a large spectrum of 
gametes during spermatogenesis and the possible negative selection of highly abnormal 
ones. This negative selection is not feasible in the female meiosis, which could 
predispose to specific segregation modes depending on the size of the translocated and 
centric segments of the chromosomes that participate in the translocation (Ogilvie and 
Scriven, 2002).
Balanced carriers of reciprocal translocations are usually phenotypically normal, as there 
is no loss of genetic material. However, there have been cases of such carriers suffering 
from mental retardation (Funderburck et al, 1977), or some types of cancer when the 
transfer of chromosome segments is accompanied with gene disruption (Therman and 
Susman, 1993). This type of structural abnormality is often identified in cases where it 
affects the reproductive fitness of the carrier, leading to subfertility, infertility, 
unexplained spontaneous abortions, or the birth of an abnormal child. The risk for such 
births ranges between 10-15% (Midro et al, 1992) and is associated with the 
translocation involved. Viable offspring that are carriers of unbalanced reciprocal 
translocations run a high risk of being mentally retarded, have serious congenital 
abnormalities or a combination of both. This is dependent on how large the duplications 
and deletions are on the two derivative chromosomes. The latter can be predicted by 
constructing a pachytene diagram and measuring the sizes of the centric and translocated 
segments, as mentioned above. In most cases, however, fetuses with unbalanced 
reciprocal translocations fail to proceed past mid-pregnancy.
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Fig-1.6: Configuration of a Robertsonian translocation during meiosis
DerA/B
Pachytene trivalent
DerA/B
Fig. 1.6: Meiosis in a balanced Robertsonian translocation carrier. As with reciprocal 
translocations, the process of meiotic pairing is different, than that observed in normal 
individuals. The two normal and the derivative chromosomes align with homologous 
material. The latter, in this case, results in the formation of a structure called the pachytene 
trivalent. One of four possible modes of segregation follows. These modes of segregation 
and the resulting gametes are analysed in Table 1.3 below.
Table 1.3: Patterns of segregation of a Robertsonian translocation and resulting gametes
Alternate A, B Normal
DerA/B Balanced
Adjacent DerA/B, A Disomy for A
B Nullisomy for A
Adjacent DerA/B, B Disomy for B
A Nullisomy for B
3:0 A, B, DerA/B Disomy A, B
0 Nullisomy A, B
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1.4.2.2 Robertsonian translocations
Robertsonian translocations are formed when two acrocentric chromosomes (13, 14, 15, 
21, and 22) break at a position on or close to their centromeres with subsequent fusion of 
their long arms. In this way, a single metacentric derivative chromosome is produced and 
the diploid number is reduced by one. These translocations are identified in humans with 
a frequency of approximately 1 in 1000 livebirths. Of all the possible chromosome 
combinations, two Robertsonian translocations are observed more often in the general 
population. These are 45,XX or XY, t( 13; 14)(q 10;q 10) and 45,XX or XY, 
t(14;21)(ql0;ql0), leading to 73% and 8% of all newborn Robertsonian translocation 
carriers (Therman and Susman, 1993).
As with reciprocal translocations, the meiotic segregation patterns of the chromosomes 
involved in a Robertsonian translocation are crucial, as far as the production of aneuploid 
gametes and embryos is concerned. During the first meiotic division the normal 
homologues and the derivative chromosome synapse together and behave as a trivalent 
(Munne et al., 2000a; Morel et al., 2001). The subsequent segregation modes are not as 
complicated as is the case for the reciprocal translocations. Hence, the alternate mode is 
most commonly observed and results in normal or balanced gametes, while the adjacent 
mode is also sometimes identified leading to the generation of two disomic and two 
nullisomic gametes (Munne et al., 2000a). This trivalent association of chromosomes, 
patterns of segregation and resulting gametes can be seen in fig. 1.6, and Table 1.3.
Studies that were carried out on spermatozoa of balanced (13; 14) Robertsonian 
translocation carriers identified the alternate mode of segregation as being the most 
prevalent one, found in 73.5% out of 117 spermatozoa (Martin, 1988). A similar 
observation was made in a much larger study on the sperm of two (13; 14) Robertsonian 
translocation carriers by the application of FISH (Escudero et al., 2000). Out of an 
average of 1000 gametes scored for each of these carriers, approximately 77% had either 
a normal or balanced complement, as far as the chromosomes that were involved in the 
rearrangement were concerned (Escudero et al., 2000). Investigation of embryos 
generated from Robertsonian translocation carriers confirmed the above. Scriven and 
colleagues (2001) applied FISH for the PGD of embryos coming from five couples in
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which one of the partners was a carrier of such a translocation. The data obtained led to 
the conclusion that the segregation of a Robertsonian translocation predisposes mostly to 
the production of normal or balanced gametes, and subsequent generation of embryos 
consisting of the expected chromosome complement.
The phenotype of balanced carriers of Robertsonian translocations is usually normal, but 
this rearrangement may again affect their fertility. Many male Robertsonian translocation 
carriers have been shown to be infertile, whilst the reproductive capacity of others is not 
affected at all. In a research letter Daniel (2002) attempts to explain this phenomenon by 
describing a model proposed by Henikoff and colleagues (2001). In this model, the 
infertility of the male carriers of such rearrangements is connected to the dicentric 
derivative chromosome, which leads to the formation of more spindle attachment sites. 
This in turn affects the normal chromosome segregation during meiosis, and thus male 
fertility (Henikoff et al., 2001). Female carriers of such translocations may experience 
recurrent spontaneous abortions. Moreover, the offspring of Robertsonian translocation 
carriers have a high risk of being bom genetically handicapped, suffering from Down’s 
syndrome (4% of all trisomies 21), rarely Patau’s syndrome (trisomy 13) and sometimes 
of uniparental disomy for chromosome 14 (Boue and Galiano, 1984; Mutton et al., 1996; 
Tomkins et al, 1996).
Carriers of both reciprocal and Robertsonian translocations that have experienced 
infertility or repeated miscarriages and are at a high reproductive risk are becoming 
increasingly interested in PGD in order to improve their chances of a viable healthy 
pregnancy.
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1.5 Preimplantation Genetic Diagnosis
Preimplantation genetic diagnosis (PGD) was developed in 1989 and it was initially 
utilised in sexing and identifying healthy embryos for couples that were at risk of 
transmitting X-linked recessive disorders with the application of the polymerase chain 
reaction (PCR) (Handyside et al., 1990). In brief, the procedure involves the generation 
of embryos by IVF, the biopsy of either one or two blastomeres on day 3 post fertilisation 
(cleavage stage of development), their genetic analysis either by PCR or by FISH, and the 
transfer of healthy embryos on day 4 of preimplantation development (Handyside and 
Delhanty, 1997). At present, PGD can be considered as an alternative to prenatal 
diagnosis of certain single gene disorders and chromosome abnormalities (Harper and 
Delhanty, 2000). This identification of genetic anomalies in the embryo prior to 
implantation is advantageous as it enables parents who have had affected children or have 
suffered repeated miscarriages to initiate an unaffected pregnancy, avoid considering 
termination, and possibly even eradicate a disorder from the family.
Patients that turn to PGD to achieve a healthy pregnancy can be divided in the following 
groups:
(i) Patients at risk of transmitting an X-linked disorder for which the development of 
a specific molecular diagnosis is not feasible.
(ii) Carriers of single gene disorders, dominant and recessive, autosomal or X-linked. 
PGD enables them to have a healthy child, but also to remove the inherited 
disease from the family, in the case of dominant disorders.
(iii) Carriers of structural chromosome abnormalities. These chromosome 
abnormalities could be affecting their fertility, as mentioned above, or they could 
have undergone recurrent spontaneous abortions as a result of these abnormalities.
(iv) Women over the age of 35 that undergo IVF could use PGD to screen for age- 
related aneuploidy to improve their chance of an embryo implanting.
(v) Male patients that are infertile and require ICSI. In such cases PGD can be 
applied for the detection of cystic fibrosis, Y chromosome deletions and/or 
chromosome imbalance where appropriate.
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(vi) Couples who are against the termination of an affected pregnancy due to moral or 
religious reasons. PGD offers the ability to select for embryos prior to 
implantation and reduce or even eliminate the necessity for a termination.
From the above one could conclude that PGD is the ideal solution for patients belonging 
to one of the listed categories. However, this procedure is not as widespread as prenatal 
diagnosis with only a small number of centres providing it worldwide, and less than 2000 
cycles being carried out in fifteen years (Harper and Bui, 2002). This could be attributed 
to the fact that the process of selecting and transferring healthy embryos whereas the 
remaining are discarded still remains controversial. There have been quite a few studies 
and surveys about the attitudes towards PGD. Possible advantages offered by PGD 
include the following (Viville and Pergament, 1998):
(i) Avoiding the elective termination of pregnancy, especially for couples that have 
had to undergo this procedure repeatedly or are against it due to moral or religious 
reasons.
(ii) Preventing severe and disabling inherited disorders prior to embryonic 
implantation.
There have been however, some ethical considerations. More specifically, people against 
PGD have expressed worries about eugenics and the creation of embryos whose 
characteristics such as sex, height, and intelligence are selected by the parents (Harper 
and Delhanty, 2000). However, such characteristics are multifactorial, and their diagnosis 
would be very complicated, if not impossible (Harper and Delhanty, 2000). In the UK all 
centres that offer PGD are under the control of the Human Fertilisation and Embryology 
Authority (HFEA), and the diagnosis of every new disease must first be approved before 
application. Other problems challenging the efficiency of PGD include the possibility of 
misdiagnosis either by PCR due to allele dropout (ADO) or contamination, and by FISH 
due to embryo mosaicism (Handyside, 1998). For this reason the ESHRE PGD 
Consortium was established in 1997. This Consortium collects prospective and 
retrospective data on the accuracy, reliability, and effectiveness of PGD and has the 
following aims (ESHRE PGD Consortium Steering Committee, 2000):
(i) Perform surveys on the availability of PGD for the different disorders
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(ii) Begin follow-up studies of pregnancies achieved and children bom
(iii) Develop guidelines and recommended PGD protocols to assist the best practice 
possible
(iv) Formulate a consensus on the use of PGD
The various stages of PGD will be discussed in the sections to follow.
1.5.1 Biopsy methods
There are two stages involved in the PGD of a genetic disorder, the biopsy and the 
diagnosis (Harper and Delhanty, 2000). Biopsy can be performed on three types of cells: 
first and second PBs (Verlinsky et al, 1992), blastomeres from cleavage stage embryos 
(Tarin and Handyside, 1993; Inzunza et al, 1998), and trophectoderm cells from 
blastocysts (Veiga et al, 1997).
1.5.1.1 Polar body biopsy
Polar body biopsy involves the examination of oocytes prior to fertilisation by 
investigating the first and/or second PBs. Neither of these cells are required during 
fertilisation and subsequent embryonic development, and hence their removal should not 
have any adverse effects on the embryo.
Before the application of this type of biopsy on human oocytes, the method was 
evaluated on those from the mouse (Gordon and Talansky, 1986). The PBs were removed 
through an opening on the zona pellucida that was achieved with the use of Acid 
Tyrode’s solution. Mouse oocytes that were treated this way resulted in the production of 
live offspring after their subsequent fertilisation (Gordon and Talansky, 1986). This was 
not the case, however, with human oocytes when they were treated with acidified 
Tyrode’s prior to their fertilisation. This solution posed an inhibitory effect on embryonic 
development, even though a normal fertilisation was observed (Malter and Cohen, 1989). 
Now mechanical means or a laser are used in order to create an opening in the zona of 
human oocytes to (Montag et al, 1998).
50
Introduction
The actual process is as follows: the aspiration of the first PB usually takes place within 
six hours after oocyte retrieval to avoid its degeneration in culture, whilst the second one 
is removed after formation of the zygote (Kuliev et al, 1998; Strom et al, 1997). It is 
also possible to biopsy both the first and second PBs at the same time from the zygote 
(Verlinsky et al, 1995; 1996).
PB biopsy was developed by two groups in the United States (Munne et al, 1995; 
Verlinsky et al, 1996) and has been applied mostly for the detection of chromosome 
abnormalities with the application of FISH, in the context of aneuploidy screening. The 
rationale behind this approach is that chromosome loss or gain taking place in the oocyte 
has the reciprocal effect of gain or loss in the PB (Munne and Wells, 2002). PBs have 
also been aspirated for the PGD of both reciprocal and Robertsonian translocations 
(Munne et al, 1998d; Durban et al, 2001), and single gene disorders (Strom et al, 1997; 
Kuliev et al, 1998).
There are several advantages in this PGD approach, including the fact that there is no 
intervention with the actual embryo, the origin of aneuploidy is predominantly maternal 
and thus detectable in PBs, and the fact that no abnormal embryos are being discarded 
(Munne and Wells, 2002). However disadvantages do exist and involve the decrease in 
the accuracy of the FISH procedure due to the chromatid predivision that takes place if 
PBs are cultured for prolonged periods, and the inability to score for paternally-derived 
abnormalities (Munne and Wells, 2002). For these reasons, this approach is not as 
widespread as cleavage stage biopsy.
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Fig.1.7: Cleavage-stage Embryo Biopsy for PGD
(c) (d)
Fig.1.7 : Illustration of a cleavage-stage embryo biopsy, (a) The day 3 post-insemination 
embryo is immobilised by gentle suction, imposed through a holding pipette, (b) A 
localised stream of acidified Tyrode’s solution is directed at the zona pellucida through a 
tapered micropipette (diameter 5-7 pm), (c) The stream of Acid Tyrode’s solution has as 
an effect the opening of a hole in the zona pellucida. (d) Blastomere aspiration follows 
with the use of a second sampling pipette (diameter 30-40 pm). The aspiration of 
embryonic cells requires great care to avoid their lysis. Once the blastomere is removed 
from the embryo, it is placed and washed in handling medium for several times. It is then 
further processed for genetic analysis. In the meantime the remainder of the embryo is 
returned to normal culture conditions to await the diagnosis results. (Courtesy of W. 
Piyamongkol).
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1.5.1.2 Cleavage stage biopsy
Cleavage stage biopsy is the method of preference for the majority of the 50 centres 
currently offering PGD worldwide (J. Haprer, personal communication). It is based on 
the fact that all the blastomeres of an embryo are totipotent at this early stage of 
development (Mottla et al, 1995). As with PB removal, this method of biopsy was 
initially applied to the mouse to evaluate its feasibility, and embryonic survival rates after 
blastomere removal (Nijs et al, 1988; Wilton et al, 1989; Krzyminska et al, 1990; Kola 
and Wilton, 1991). Its subsequent evaluation on human embryos demonstrated that two 
cells could be aspirated from 8-cell embryos at day 3 after fertilisation, without 
significantly affecting further development and blastulation (Hardy et al, 1990)
Hence, cleavage stage biopsy takes place on day 3 post insemination when the embryo 
consists of 6-8 blastomeres, whereas the actual procedure has practically remained 
unmodified, compared to the original (Handyside et al, 1989; 1990; Van de Velde, 
2000). The biopsy begins by making a hole in the zona pellucida that still surrounds the 
embryo with localized application of acidified Tyrode’s solution (Hardy et al, 1990). 
This procedure is illustrated in fig. 1.7. Partial zona dissection achieving a hole on the 
zona by mechanical means has been reported for PB biopsy, but also for cleavage stage 
biopsy (Malter and Cohen, 1989). Cieslak and colleague (1999) have improved this 
method and achieved a three-dimensional partial zona dissection for the same purpose. In 
addition, more recently there have been reports on the application of a laser for the 
drilling of the zona pellucida (Veiga et al, 1997; Boada et al, 1998; Montag et al, 1998) 
Blastomere aspiration usually takes place with a 30pm pipette that is inserted into the 
hole. Alternatives to this approach include the use of direct mechanical pressure (Anver 
et al, 1996) or a flow of medium to displace cells (Pierce et al, 1997). The removal of 
blastomeres is directly dependent on how compact are the embryos at the time of biopsy. 
Medium without calcium and magnesium has been employed by several groups to 
overcome the problem of compaction. The latter disrupts intracellular contacts, enabling 
the easier aspiration of blastomeres and the prevention of lysis during biopsy (Dumoulin 
etal, 1998).
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Soussis and colleagues (1996a,b) assessed the safety and efficacy of embryo biopsy by 
examining established pregnancies and subsequent births from biopsied embryos. 
Biochemical and ultrasound measurements of these fetuses did not demonstrate any 
significant developmental differences compared to pregnancies that were achieved after 
routine IVF. Deliveries, including birth weight and apghar scores were considered normal 
in both categories (Soussis et al, 1996a,b).
Blastomere biopsy has the advantage that errors that are maternally-, paternally-, and 
postzygotically-derived can be detected and eliminated. However, especially in the cases 
of chromosomal abnormalities, embryo mosaicism poses a significant misdiagnosis risk. 
In a recent report, Munne and colleagues (2002a) detected a 7.2% misdiagnosis rate, of 
which 5.6% was attributed to mosaicism. Therefore, it has become routine practice to 
remove two cells from embryos consisting of six blastomeres or more in cases of 
chromosome abnormalities such as reciprocal translocations and dominant disorders 
(Delhanty, 1994; Delhanty and Handyside, 1995; Kuo et al, 1998; Van de Velde et al,
2000). One cell is usually taken for aneuploidy screening (PGS), where the aim is to 
maximise implantation rates.
1.5.1.3 Blastocyst biopsy
This type of biopsy was developed as an alternative to cleavage stage biopsy, and 
involves the removal and examination of TE cells from the blastocyst, taking place on 
days 5-6 post-insemination. This approach has the advantage that it enables the sampling 
of a larger number of cells, reducing in this way the risk of misdiagnosis and providing 
more data about the embryonic DNA constitution (Wells and Delhanty, 2001). Moreover, 
blastocyst biopsy does not interfere with the embryonic ICM. As before, the procedure 
involves making a hole in the zona pellucida and then replacing the blastocyst in culture. 
TE cells herniate from this opening and are removed for further investigation 
(Muggleton-Harris et al., 1993).
The drawback of this method is the possibility that the TE cells are genetically and 
chromosomally diverged from the ICM cells, which could pose a risk of misdiagnosis if 
the former were use for PGD. The phenomenon of different chromosome complements of
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the embryo proper and the placental tissues is known as confined placental mosaicism 
(CPM), and is observed in approximately 1-2% of conceptions (Kalousek and Dill, 
1983). Moreover, the TE cells are required for embryo implantation, and their reduction 
could adversely affect the latter. Another disadvantage, is that only about 40% of 
embryos reach the blastocyst stage in vitro, while the remainder tend to arrest beforehand 
(Harper and Delhanty, 2000). This has the effect of testing only a few embryos. Even 
though embryo survival to the blastocyst stage has improved in recent years, currently the 
most widespread method of acquiring embryonic cells is the cleavage stage biopsy 
(ESHRE PGD Consortium, 2000, 2002).
1.5.2 Diagnosis of single gene defects
PCR has the ability to increase the quantity of a specific fragment in a DNA sample to a 
level that it can undergo further genetic testing. It was the first technique to be applied for 
the PGD of X-linked disorders (Handyside et al., 1990). This method was used for sexing 
embryos by amplifying a repeat sequence on the long arm of chromosome Y. However, 
after a misdiagnosis, FISH has largely replaced PCR for this purpose (Griffin et al., 
1994). Since then, PCR has been used almost solely for the diagnosis of single gene 
disorders that can be dominant, recessive or X-linked.
The first single gene disorder to be diagnosed at the preimplantation stage with the 
application of PCR was cystic fibrosis, caused by the AF508 mutation. The diagnosis 
took place with the use of heteroduplex analysis to detect unaffected homozygous normal 
and heterozygous embryos for transfer (Handyside et al, 1992). As time progressed, the 
PCR strategies became more sophisticated and this was accompanied by an increase in 
the number of diseases for which PGD could be applied and a subsequent increase in 
patient demand (Wells and Sherlock, 1998). The diseases currently diagnosed in this 
way, are more than 20 and some of them can be seen in Table 1.4 below.
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Table 1.4: Some examples of the clinical application of PGD for single gene disorders to
illustrate different methodologies (from Wells and Delhanty, 2001).
Disease diagnosed Method used for mutation analysis
Cystic fibrosis Heteroduplex formation; analysis of allelic size differences; restriction 
enzyme digestion (Handyside et al, 1992; Goossens et al.., 2000)
p-thalassaemia Restriction enzyme digestion and use of linked marker; denaturing 
gradient gel electrophoresis (Kuliev et al., 1998; Kanavakis et al.,
1999)
Sickle cell anaemia Restriction enzyme digestion and use of linked marker (Xu et al.,
1999)
Lesch-Nyhan syndrome Restriction enzyme digestion (Ray et al., 1999)
Tay-Sachs disease Heteroduplex formation (Gibbons et al, 1995)
RhD blood typing Allele specific amplification (Anver et al., 1996)
Medium chain acyl CoA 
dehydrogenase deficiency
SSCP and use of linked marker (Ioulianos et al, 2000)
Spinal muscular atrophy Mutant allele is refractory to PCR (Dreesen et al., 1998)
Marfan syndrome Use of linked markers; restriction enzyme digestion (Blaszyk et al., 
1998; Sermon et al., 1999)
Myotonic dystrophy Mutant allele is refractory to PCR (fluorescent PCR) (Sermon et al,
1998)
Familial adenomatous SSCP, heteroduplex formation and use of linked marker (Ao et al.,
polyposis coli 1998)
Retinitis pigmentosum Site specific mutagenesis and allele dependent length polymorphism
(Strom et al, 1998)
Huntington’s chorea Analysis of allelic differences (fluorescent PCR) (Sermon et al., 1998)
Fragile X Mutant allele is refractory to PCR (Sermon et al., 1999)
Congenital adrenal Fluorescent PCR and restriction enzyme digestion (Van de Velde et al.,
hyperplasia 1999)
Duchenne muscular Mutant allele is refractory to PCR (priming sites deleted); use of linked
dystrophy markers (Lee et al., 1998)
56
Introduction
Charcot-Marie-T ooth 
disease
Duplication detected by a linked marker (De Vos et al, 1998)
Osteogenesis imperfecta Fluorescent PCR and restriction enzyme digestion (De Vos et al,
2000)
Herlitz junctional 
epidermolysis bullosa
Restriction enzyme digestion (Cserhalmi-Friedman et al, 2000)
The development of PGD protocols for the detection of single gene disorders is 
technically very demanding as there is only of 5-10pg of DNA in a single cell, and hence 
requires quite a few cycles of amplification in order for the possible mutation to be 
visualised. Moreover, the evaluation of the PCR protocols prior to clinical application can 
turn out to take longer than expected and be very labour intensive. Additional problems 
could be caused due to failure of amplification, contamination and a phenomenon known 
as allele dropout (ADO), all of which increase the risk of misdiagnosis (Navidii and 
Amheim, 1991). ADO can be defined as the amplification of only one of the parental 
alleles present in the single cell (Handyside and Delhanty, 1997). The latter is thought to 
be due to suboptimal PCR conditions and rapid degradation of the target DNA during 
thermocycling (Ray and Handyside, 1996). Thus, ADO could lead to a misdiagnosis of a 
heterozygous cell as homozygous. This would pose a problem especially in the case of a 
dominant disorder, in which the heterozygous embryo would be affected. In order to 
avoid this potential risk of misdiagnosis, Ao and co-workers (1998) suggested the 
inclusion of a polymorphic marker, which is located on the same chromosome and near 
the disease-causing gene (multiplex PCR). As far as the possibility of contamination is 
concerned, it can be caused by an extra sperm, cumulus cells, culture media, or the build 
up of PCR products in the laboratory (Wells and Sherlock, 1998). These can be overcome 
by using ICSI for the fertilisation procedure, washing the blastomere after the biopsy, and 
applying nested PCR, which involves two separate sets of cycles using two different sets 
of primers.
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As can be seen in Table 1.4 a variety of mutation analysis methods are currently being 
applied in PGD protocols. These include heteroduplex analysis, restriction endonuclease 
digestion, and single-strand conformational polymorphism (SSCP). Incorporation of the 
highly accurate fluorescent-PCR is also widely used, and preferred to the more 
conventional methods (Wells and Sherlock, 1998). The best PCR PGD protocols employ 
multiplex PCR so as for the amplification of the DNA fragment encompassing the 
mutation to be achieved, another fragment onto which a linked polymorphism is located 
to avoid ADO, and at least one more highly polymorphic marker to detect possible 
contamination (Wells and Delhanty, 2001). Ideally the primers to be used are 
fluorescently tagged, as this type of PCR is much more sensitive and requires a lower 
number of amplification cycles, making the whole procedure much quicker and more 
robust.
1.5.3 Diagnosis of chromosome abnormalities
Cytogenetic analysis of chromosome abnormalities involves the visualisation of 
chromosomes at the metaphase stage. Embryonic blastomeres, however, do not in most 
cases contain analysable metaphases, and even if a metaphase is identified, the spreading 
of the blastomere would be very difficult, due to potential chromosome loss (Handyside 
and Delhanty, 1997). FISH therefore is an ideal method for the investigation of the 
chromosome complement of blastomeres, as it enables the analysis of interphase nuclei 
by using fluorescently tagged DNA probes, specific for the chromosomes in question 
(Harper et al, 1995). The principles of FISH along with its applications for the PGD of 
chromosome abnormalities will be discussed in the subsequent sections.
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Fig.1.8 : Types of DNA Probes employed in FISH
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Fig.1.8: Illustration of four different types of FISH probes hybridised onto lymphocyte 
chromosomes that are counterstained with DAPI (blue), giving a G-band pattern when 
inverted, (a) Whole chromosome paint probe hybridised onto chromosome 16 (green). 
Such probes are only employed for the analysis of metaphase chromosomes, due to their 
large signal domains, (b) Repeat-sequence alpha-satellite probe hybridised onto the 
centromeric region of chromosome 1 (orange). Such probes give large signals, and can be 
used for both metaphase and interphase analysis, (c) Locus-specific probe hybridised 
onto the long arm of chromosome 13 (green, position 13q33). Such probes give smaller 
signals, compared to repeat-sequence probes, which sometimes can be split. They can be 
employed for the analysis of both interphase and metaphase nuclei, (d) Sub-telomeric 
probes hybridised onto the short (green) and long (red) arm telomeres of chromosome 6. 
Similarly with the locus-specific probes, they give small signals, which sometimes appear 
as split. They too are employed for both metaphase and interphase examination.
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1.6 Fluorescent in situ hybridisation
The basis of the FISH method is the ability of DNA single strands to bind onto 
complementary target sequences and form a stable DNA hybrid complex. In other words, 
this technique employs fluorescently tagged DNA probes that are specific for different 
chromosomal regions. Three types of probes are used in FISH and these are the 
following:
(i) Repeat sequence or centromeric probes- These hybridise to the repeat alpha- 
satellite sequences of the centromeres of all chromosomes, apart from 1,9, 16 and 
Y. The centromeric heterochromatin for these four chromosomes includes alpha- 
satellite repeats, but also consists of repeats of different nature, such as beta- 
satellites. The required hybridisation time for probes of this type is approximately 
1-2 hours, while visualisation is feasible both on metaphase and interphase nuclei.
(ii) Locus-specific probes- These bind to specific regions located either on the short 
or long arms of chromosomes, corresponding to genes and surrounding 
sequences. The required hybridisation time ranges between 6-16 hours, and these 
probes can be visualised both on interphase and metaphase nuclei.
(iii) Subtelomere probes- These hybridise to the short and long arm telomeric regions 
of chromosomes, and are a relatively recent addition to the various FISH probe 
categories. The required hybridisation time is 16 hours, and they can be applied 
for the analysis of both interphase and metaphase nuclei.
(iv) Whole chromosome paints- These bind onto the whole of the chromosome and 
they are visualised after approximately 16 hours of hybridisation. They can be 
employed only for metaphase nuclei. The different types of probes are shown in 
fig. 1.8.
During the first applications of FISH the probes used were obtained from cloned 
fragments of cDNA or genomic DNA. These fragments were usually inserted into 
vectors, such as plasmids, cosmids, Pis, PI derived artificial chromosomes (PACs), 
bacterial artificial chromosomes (BACs), and yeast artificial chromosomes (YACs). 
Probe preparation took place in the laboratory and involved the amplification of the DNA 
either directly with the application of the Alu-PCR or by growing bacterial or yeast
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cultures that were carrying these vectors. Extraction and fluorescent labelling of the DNA 
followed. This procedure was very time consuming and labour intensive and meant that 
the FISH could not be as widely applied as required according to patient demand. The 
extended commercial availability of directly labelled probes belonging to all categories, 
and especially the development of subtelomere probes complementary for telomeric 
regions of the p and q arms of almost all chromosomes (Knight and Flint, 2000), led to 
the adaptation of this method for several diverse biological investigations. (Heng et al,
1997). These range from clinical genetic diagnosis to purely research purposes.
The speed and accuracy of FISH has made it the ideal technique for the screening of 
aneuploidy in the context of prenatal diagnosis to complement standard karyotyping. 
Ward and colleagues (1993) employed this method for the chromosomal analysis of 
4,500 uncultured amniotic fluid samples, and reported an overall detection rate of 
aneuploidies of 73.3%, with an accuracy as high as 93.9%. FISH has the advantage that it 
can be applied for the examination of interphase nuclei and hence enables a more rapid 
result, since it omits the culturing of chorionic villi or amniotic fluid samples (Klinger et 
al, 1992). Moreover, FISH has been used in the mapping of single or clusters of genes or 
even whole chromosomal regions, in the context of positional cloning. This data is 
crucial in the integration of physical and genetic mapping information and the 
construction of high resolution cytogenetic chromosome maps (Heng et al, 1997).
FISH was also the basis for the development of three similar methods that enable the 
labelling of all 24 chromosomes. These include a method called spectral karyotyping 
(SKY) (Schrock et al, 1996), and another called multifluorochrome karyotyping (M- 
FISH) (Speicher et al., 1996). These two methods employ 24 chromosome specific paint 
probes labelled with different combinations of fluorochromes, something which allows 
the simultaneous analysis of all chromosomes in the human complement (Harper and 
Wells, 1999). Comparative genomic hybridisation (CGH) is also associated with FISH, 
but its principles and applications will be analysed in a following section.
At the single cell level, FISH has been used in the detection of individual chromosomes 
coming from samples for which good metaphases are difficult or impossible to obtain,
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such as oocytes (Dailey et al, 1996; Mahmood et al., 2000; Cupisti et al., 2003), 
embryonic nuclei (Munne et al., 1993; Harper et al., 1994;) and sperm nuclei (Spriggs et 
al, 1996; Van Hummelen etal, 1997).
As with PCR, the first application of FISH for PGD was for the sexing of embryos to 
avoid X-linked disorders. The latter became the preferred method after a diagnostic error 
had taken place in one of the pregnancies that were achieved with the use of PCR to 
identify embryos free of cystic fibrosis (Griffin et al. 1994). At the same time, several 
groups were attempting to evaluate the FISH procedure with the aim of possibly 
employing it for the PGD of chromosome abnormalities. These studies revealed the high 
efficiency and reliability of this technique. An example of such a study was that carried 
out by Griffin and colleagues (1994) who reported on seven clinical pregnancies achieved 
after selecting embryos for sex with the application of dual-colour FISH, in a 2-year 
period. Hence FISH became the method of choice for the detection of chromosome 
associated abnormalities.
As far as the sexing of embryos is concerned, initially two repetitive sequence probes 
were used to detect chromosomes X and Y. These probes were labelled with digoxygenin 
and biotin, in a way that a detection step was required so as for the fluorescent tag to be 
acquired. This process was also known as indirect labelling (Griffin et al., 1994). Later 
apart from the probes for the sex chromosomes, one or more autosome probes were 
added, to also establish ploidy of the embryo for these specific chromosomes (Staessen et 
al., 1999). Embryos identified to be normal female for the examined chromosomes, i.e. 
showing two signals for X and two signals for the autosome under investigation are 
transferred in sexing cases. All male embryos are excluded due to the possibility of being 
affected, even though 50% of them should be normal unaffected. The distinction between 
affected and unaffected male embryos can be achieved with the application of a PCR 
strategy enabling the identification of the exact mutation. Such tests, however, are not 
feasible for all X-linked diseases, as mentioned previously.
At present, different FISH strategies have been devised for the PGD of a variety of 
chromosome abnormalities, both numerical and structural, as will be discussed below.
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Fig.1.9 : Diagnosis of Biopsied Blastomeres for PGD
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Fig.l.9a: Mutation analysis using a PCR-based method. Diagnosis of single gene disorders 
occurs by initially transferring the biopsied blastomere to a PCR tube containing lysis 
buffer, with subsequent amplification of its DNA, using specific oligonucleotide primers. 
The figure illustrates the results obtained from multiplex PCR using fluorescent primers 
for the identification of the DM alleles (PGD for myotonic dystrophy) and a contamination 
marker (D21S11). Analysis in such cases takes place with electrophoretic fragment 
separation achieved with a laser analysis system. Lanes 1 and 3 show the peaks resulting 
from the amplification of the contamination marker. Lanes 2 and 4 demonstrate the peaks 
resulting from the amplification of the DM alleles from two cells. According to these 
results, the embryo was characterised as not being affected with DM and recommended for 
transfer. (Courtesy of W. Piyiamongkol)
(i)
Fig.l.9b: Chromosome analysis using a FISH-based method. Diagnosis of chromosome defects 
occurs by spreading the biopsied blastomeres onto microscope slides using one of three 
methods (see 1.6.4). Such methods remove most of the cell cytoplasm, making in this way the 
nucleus accessible to the FISH probes. Both the above nuclei were analysed with three 
repetitive sequence probes for chromosomes X (green), Y (red) and 1 (orange). Such probes are 
employed during the PGD for embryo sexing to avoid X-linked disease. Nucleus (i) was 
diagnosed as female (XX; 1,1). Nucleus (ii) was diagnosed as male (XY; 1,1). Both embryos 
were recommended for transfer.
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Fig. 1.9 illustrates examples for the PGD of myotonic dystrophy with the application of 
PCR and the diagnosis of sex in two embryos, with the application of FISH.
1.6.1 Aneuploidy screening
In recent years FISH has been applied for the screening of aneuploidy in embryos from 
women of advanced age that are undergoing IVF, due to fertility problems (Handyside 
and Delhanty, 1997). This procedure is termed PGD for aneuploidy screening or PGS (J. 
Harper, personal communication). Studies have shown that the aneuploidy frequency in 
oocytes and embryos of women aged 35 years or older is relatively high (30-40%) (Strom 
et al, 2000). It has also been shown that there is a correlation between aneuploidy and a 
decline in implantation rates (Bahce et al, 2000). For this reason, it was assumed that by 
applying PGD and FISH to negatively select chromosomally abnormal embryos, and 
transfer only the normal ones, the implantation rates for older women with such problems 
would improve (Munne et al., 1993).
Most PGD centres offer this type of diagnosis to couples with the following indications: 
female age 35 years or more, 3 or more previous unsuccessful embryo transfers with 
regular IVF procedures, or repeated spontaneous loss of pregnancies when parents have a 
normal karyotype.
Currently there is at least one FISH probe commercially available for every human 
chromosome, but a limited number can be hybridised to embryonic nuclei at any one 
time, to avoid the occurrence of overlapping signals, that could pose a misdiagnosis risk. 
The hybridisation efficiency is also reduced with each extra probe added. Two different 
approaches have been employed for PGS. In the first one, FISH analysis takes place on 
the first and/or second PBs. Verlinsky and colleagues (1999) applied this strategy for the 
examination of 1st and 2nd PBs of women with an average age of more than 34 years. The 
DNA probes used for this analysis were specific for chromosomes 13, 18, and 21. Out of 
the 3943 oocytes tested, 43% were identified as abnormal (Verlinsky et al, 1999). This 
aneuploidy rate was relatively high, as the group was examining only 3 chromosomes. 
Out of the abnormalities detected, 35.7% were attributed to errors taking place during the
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1st meiotic division and most of them were due to chromatid malsegregation. The 
resulting pregnancy rate after transfer of embryos for which the oocytes were considered 
to be normal was approximately 22% (Verlinsky et al., 1999). However, no comparison 
with control data took place during this study, to ascertain the efficacy of PB analysis for 
PGS (Wilton, 2002). PB investigation for the identification of aneuploidy is hampered 
by two critical problems. First of all, only maternally derived aneuploidies can be 
detected, and the possibility of fertilisation of an oocyte with an aneuploid sperm cannot 
be investigated. Second, identification of post-zygotic chromosome abnormalities is not 
feasible (Wilton, 2002).
The second approach involves the direct FISH testing of biopsied blastomeres and this is 
more widely applied. The most extensive FISH screen to date has been employed by the 
group at St Barnabas, USA, and involved the examination of blastomeres for 
chromosomes X, Y, 13, 14, 15, 16, 18,21, and 22 in two sequential rounds (Munne et al., 
1998b). This probe set would detect 70% of the aneuploidies identified in spontaneous 
abortions. Out of a total of 25 cycles carried out and analysis of 247 embryos, 42% of 
them were classified as karyotypically normal with the remaining being trisomic, 
monosomic or carrying complex abnormalities for the chromosomes tested. Ten 
pregnancies were achieved after embryo transfer, while the FISH misdiagnosis risk was 
reported to be about 15% (Munne et al., 1998b). A different set of probes was applied for 
the analysis of 194 embryos in a similar study carried out by Bahce et al., (1999). 
Chromosomes 1, 4, 6, 7, 14, 15, 17, 18, and 22 were investigated in an attempt to 
establish whether chromosome abnormalities that are associated with implantation failure 
were distinct from those observed in spontaneous abortions. The chromosomes most 
frequently affected by aneuploidy events were identified to be 22, 15, 1, and 17. The 
authors concluded that chromosomes X, Y, 13, 18, and 21 should be examined in case of 
repeated trisomic conceptions, whereas chromosomes 1, 15, 16, 17, and 22 in cases of 
recurrent miscarriages and implantation failure (Bahce et al., 1999).
Gianaroli and colleagues (1997a,b) compared the implantation rate between two groups 
of poor-prognosis patients. The first group had their embryos examined for chromosomes
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X., Y, 13, 18, and 21, whilst the second acted as a control and the generated embryos 
were transferred after having the zona pellucida opened, but without the subsequent 
removal of blastomeres. The implantation rate for the first group of patients was 
estimated to be 28%, which was much higher compared to the 12% identified for the 
second group. A similar implantation rate of 30% was reported in a more recent study by 
Kahraman and co-workers (2000) after transfer of embryos that were investigated for the 
same set of chromosomes. These rates seemed to be encouraging, especially in cases of 
patients with IVF implantation failure as reviewed by Wilton (2002). A similar 
conclusion was drawn by Munne and colleagues (2002a), who advocated an increase in 
implantation rates and a decrease in recurrent miscarriages and trisomic offspring for 
women over the age of 37 with at least six good quality embryos. Hence, from the data 
obtained so far, PGS appears to be fulfilling its purpose.
1.6.2 FISH diagnosis of structural abnormalities
The reproductive history of couples in which one of the partners is a carrier of a structural 
chromosome abnormality is often complex. The incidence of subfertility or complete 
infertility, multiple spontaneous miscarriages, or the birth of abnormal children may be 
frequent in this group. Such couples can either attempt to conceive naturally or via IVF 
procedures if necessary and then have prenatal diagnosis and a possible termination of an 
affected pregnancy, or can choose to have their embryos investigated via a PGD FISH 
protocol specific for their abnormality and ensure that if a pregnancy ensues, it will be 
normal. Increasing numbers of couples who are experiencing difficulties due to structural 
rearrangements opt for the PGD choice, now.
Various FISH strategies have been devised for the diagnosis of reciprocal and 
Robertsonian translocations and for other structural abnormalities such as inversions. 
These strategies will be outlined in the paragraphs that follow.
PGD FISH protocols for reciprocal translocations are not straightforward to develop, due 
to the fact that the breakpoints can arise at any position of any chromosome. Thus, each 
reciprocal translocation case is normally unique to a carrier or a family. Both PB and
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cleavage stage analysis strategies have been devised for the identification and transfer of 
normal/balanced embryos.
PB analysis strategies for the identification of reciprocal translocations of maternal origin 
were developed by Munne and colleagues (1998d). The FISH approach involved the use 
of whole chromosome painting probes for the analysis of 1st PBs, biopsied just after 
oocyte retrieval. In this way, the detection of normal, balanced and unbalanced oocytes 
was feasible (Munne et al, 1998d). The first application of this strategy was during the 
PGD for a female carrier of a reciprocal translocation involving chromosomes 4 and 14. 
Identification of three unbalanced and two normal PBs (oocytes balanced) was feasible 
with subsequent transfer of two balanced embryos. A clinical pregnancy was established, 
but spontaneously aborted after 7 weeks. Cytogenetic analysis of the fetus confirmed the 
balanced karyotype (Munne et al, 1998d). Similar PGD strategies have been used by 
several centres (Verlinsky and Evsikov, 1999; Durban et al, 2001; Pujol et al, 2003b). 
PB analysis has the advantage that the actual detection of both normal and balanced 
embryos is attainable. However, the possibility of crossing-over taking place within the 
translocated segments, chromatid predivision occurring in the oocyte, and poor 
chromosome morphology of the PB, could lead to a potential misdiagnosis. Therefore 
this approach should be followed by analysis of the 2nd PB and/or of embryonic 
blastomeres (Munne, 2002).
Two different FISH schemes have been used for blastomere analysis. The first involves 
the design and application of locus-specific probes that span the breakpoints of the 
translocation (Munne et al, 1998a), while the second one uses FISH probes that flank the 
breakpoints of a translocation (Conn et al, 1999). The first type of probes are designed to 
span the breakpoints of a translocation, leading in this way to the visualisation of two 
distinct signals on the normal chromosomes and two signals that are the result of the 
combination of the 2 probes on the derivative chromosomes. The latter has as an effect 
the distinction between normal and balanced embryos, as different signal patterns are 
obtained in each case (Munne et al, 1998a), which is also the advantage of this strategy. 
The drawback in this case, is that such probes could require a longer period for their 
optimisation, and as they are entirely patient-specific, the whole PGD procedure may not 
be as cost-effective. Hence, this approach is not as widely applied.
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The second strategy ideally involves the application of four probes that flank the 
breakpoints on each of the two chromosomes that form the translocation. As however 
there is a limited availability of fluorochromes with which the DNA probes could be 
tagged, a three-colour FISH strategy is used instead (Conn et al, 1999). Hence, a 
pachytene diagram is drawn and the probes that are selected in this way will enable the 
detection of all possible segregations during meiosis (Delhanty, 1998). Distinction 
between normal and balanced embryos is not feasible with this strategy, as the signal 
pattern is identical for both types. This FISH strategy is much simpler compared to the 
first one, and the wide range of commercially available probes, both centromeric and 
locus specific, means that the diagnosis of practically any translocation is possible. This 
strategy was first developed by Conn and colleagues in 1995 at the UCL centre for PGD 
and it has been used ever since. Its relative simplicity made it the main strategy for the 
preimplantation diagnosis of reciprocal translocations and currently most PGD centres 
(Scriven et al, 1998; Coonen et al, 2000; Iwarsson et al, 2000; Fridstrom et al, 2001; 
Simopoulou et al, 2003) use either the original or slightly modified protocols, applying 
the newly available subtelomere probes (Munne et al, 2000c), for the detection of such 
structural rearrangements.
Analysis of first PBs and embryonic blastomeres has also taken place for the PGD of 
Robertsonian translocations. The FISH strategies applied are not as complicated as the 
ones for reciprocal translocations. However, in cases of Robertsonian translocations, 
centromeric probes cannot be used due to the sequence homology of the satellite regions 
between chromosomes 13 and 21 and 14 and 22. The general PGD FISH strategy devised 
for these translocations involves the application of two probes, each one hybridising on 
one of the two chromosomes that form this rearrangement. In cases where one of the 
chromosomes involved in the rearrangement could result to the generation of a viable 
trisomic pregnancy, such as chromosome 21, then two probes are ideally applied for that 
chromosome, to ensure its visualisation during diagnosis (Conn et al, 1998). PGD for 
Robertsonian translocations was initially carried out with the application of YAC probes, 
due to the lack of commercial locus specific probes for the acrocentric chromosomes. 
However, more recently locus-specific probes for these chromosomes have become
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commercially obtainable, and thus the development of PGD FISH protocols for the 
detection of these rearrangements in blastomeres is relatively easy (Harper and Delhanty,
2000). As Robertsonian translocation breakpoints are the same for each carrier, once a 
FISH protocol is optimised it can be applied for any similar case without any further 
modifications.
First PB analysis of female Robertsonian translocation carriers has also been employed 
(Munne et al, 2000b; Durban et al, 2001). In a study carried out by Munne and 
colleagues (2000b) on female Robertsonian translocation carriers for both the t(13; 14) 
and t(14;21), whole chromosome paint probes for chromosomes 13, 14, and 21, plus a 
locus-specific probe for either 13 or 21 were used to screen their 1st PBs for chromosomal 
imbalance due to these translocations. In both cases, the oocytes that were normal 
outnumbered the abnormal ones (Munne et al, 2000b).
FISH strategies have been developed for other less frequently occurring chromosome 
abnormalities, such as pericentric inversions (Iwarsson et al, 1998b; Escudero et al.,
2001), deletion of part of chromosome 22 leading to Di George syndrome (Iwarsson et 
al, 1998a) and for patients that are gonadal mosaic for a trisomic cell line (Conn et al,
1999). In all, the wider availability of commercial probes increased the number of 
chromosome cases feasible, and hence the number of patients that could be treated.
A limitation to the PGD of chromosome abnormalities is the presence of mosaicism in 
the resulting embryos (Conn et al, 1998; Conn et al, 1999; Malmgrem et al, 2002). 
There have been reports demonstrating the presence of highly abnormal chromosome 
complements in 70-100% of embryos generated from some patients with poor histories, 
and could result in the reduction in the success rates of PGD (Harper and Bui, 2002). 
However, as such couples may be unable to establish or maintain a pregnancy naturally, 
PGD still is the most attractive option.
1.63 FISH limitations
FISH is in general a very efficient technique that enables the chromosomal constitution to 
be analysed in all the nuclei in an embryo. Problems, however, may arise in the 
application of this method in the PGD of chromosome abnormalities, leading to a 
potential misdiagnosis. These include the reduction of FISH efficiency with the addition
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of every extra probe, the loss of micronuclei or even whole nuclei during fixation, signal 
overlaps and, most importantly, mosaicism (Magli et al., 2001b).
The decrease in multicolour FISH efficiency with the addition of every extra probe, 
especially on interphases was demonstrated in a study carried out by Ruangvutilert and 
colleagues (2000a). In their investigation on metaphase and interphase nuclei from non­
mosaic trisomic fibroblast cultures it was revealed that multicolour FISH was 100% 
efficient on metaphases, whereas the efficiency dropped to as low as 80% for interphases. 
Probe combinations for autosomes and sex chromosomes were used in this study, and 
both centromeric and locus-specific probes were tested (Ruangvutilert et al, 2000a). 
Thus, it is essential to assess the efficiency of probe combinations for each PGD case on 
lymphocytes and spare embryos (Harper and Wells, 1999).
The method with which the embryonic nucleus is fixed on the microscope slide is crucial 
and it must ensure both the minimal loss of material and the best nuclear morphology. 
Three methods are currently being applied. The first involves the use of a combination of 
HCL and Tween 20 solution (Coonen et al, 1994), which leads to nuclei that are compact 
and with a small surface area. The latter could have as an effect the higher incidence of 
signal overlap if more than three probes are used at a time (Munne et al, 1996). The 
second one is based on the method suggested by Tarkowski and colleagues (1966) and 
uses the Camoy solution (methanol/acetic acid) to ensure fixation of the cells on slides. 
The resulting nuclei have a much larger surface area due to the hypotonic pretreatment, 
but the FISH error rate for this method is still relatively high (10-15%) (Munne and 
Weier, 1996). The third fixation method is a combination of the two above (Dozortsev 
and McGinnis, 2001). Evaluation of all three fixation methods took place in a study 
carried out by Velilla (2002). It was reported that the first fixation method resulted in 
inferior nuclear quality and had a higher rate of FISH signal overlaps compared to the 
other two (Velilla, 2002). In practice, however, the decision of which fixation method to 
be used for the spreading of cells depends on the actual handler, while the FISH protocol 
should be adjusted accordingly.
The greatest risk of misdiagnosis, however, during the application of FISH for the PGD 
of chromosome abnormalities is attributed to the presence of embryonic mosaicism 
(presence of two different cell lines). This phenomenon has been observed in almost all
70
Introduction
studies of human preimplantation embryos (covered in section 1.8) (e.g. Delhanty et al, 
1997; Iwarsson et al., 2000). These were carried out on both normal and abnormal 
embryos, and all of them revealed a high rate of complex abnormalities in their 
chromosome complement. The misdiagnosis risk in PGD involves examining a 
blastomere that could be scored as normal or balanced, whilst the majority of cells of the 
embryo are abnormal. This risk increases when diagnosis is carried out on only one 
blastomere (Iwarsson et al, 2000). Therefore, in most PGD centres it is considered 
routine practice to obtain two blastomeres from embryos consisting of 6 cells or more in 
cases of structural chromosome abnormalities. Biopsy of one blastomere only takes place 
for aneuploidy screening cases, as for these the aim is to optimise implantation rates.
1.7 Comparative Genomic Hybridisation
Comparative genomic hybridisation (CGH) is another method closely related to FISH, 
which allows the copy number of every chromosome to be assessed in a single 
hybridisation by reference to a normal DNA sample. In principle, a green fluorescent 
molecule is incorporated in the “test” DNA, while a DNA sample coming from a 
karyotypically normal individual (46,XY, or 46,XX) is labelled in red, and serves as 
reference. The two are then mixed together and hybridized to normal male (46,XY) 
metaphase spreads on a microscope slide. Test and reference DNAs compete for 
hybridisation sites on each of the 23 chromosomes. In the case that the test DNA is 
karyotypically normal, i.e., as the reference DNA, no difference in fluorescence 
intensities would be observed and the chromosomes would have a yellow/orange 
colouration. If however, the test DNA carried a trisomy for a specific chromosome, then 
this chromosome would appear to be greener. The opposite would happen if the test DNA 
was monosomic for a chromosome, which would then appear more red rather than green. 
Such differences in the intensities of the two fluorochromes are identified with the aid of 
specialised computer software, which is able to identify chromosome areas that are either 
over- (gain) or under- (loss) represented in the test DNA sample. CGH sensitivity 
involves the detection of gains and/or losses in the range of 3-5 Mb (Ghaffari et al., 1998; 
Kirchoff et al., 1999; 2001). Hence, this method is very accurate and robust in detecting
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Fig.1.10 : Comparative Genomic Hybridization
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Fig.1.10: The principle of CGH. (a) The DNA of unknown karyotype (test) is labelled with 
a green fluorescent molecule and is mixed with DNA from a karyotipically normal 
individual (46,XX or 46,XY). The latter is labelled with a red fluorescent molecule and 
serves as the reference, with which the test is compared. The mixture is hybridised onto 
normal male (46,XY) metaphase chromosomes on a microscope slide, (b) If the test DNA 
is normal, then there is no difference in fluorescence intensities and the chromosomes have 
an even orange colouration, (c) If the test DNA is trisomic for a specific chromosome, then 
the latter would be more green rather than red. (d) In the case that the test DNA is 
monosomic for a specific chromosome, then the latter would be redder. The differences in 
fluorescence intensities between the red and the green are detected by employing 
specialised computer software. This software has the ability to identify chromosome areas 
that are either over- (gain) or under- (loss) represented in the test DNA sample.
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whole chromosome aneuploidy, but also duplications or deletions of noticeable size 
(Wells and Levy, 2003). The principle of this technique is illustrated in fig. 1.10.
CGH was initially developed by Kallioniemi and colleagues (1992) as a means of 
identifying previously unknown amplification regions in the DNA from primary bladder 
tumours. Since this initial application, CGH became an essential tool in cancer research, 
for the cytogenetic analysis of solid tumours, as it is technically very demanding to obtain 
analysable metaphases from such material. The chromosome constitution of several types 
of tumours has been investigated this way, such as breast cancer (Kallioniemi et al, 
1994), uveal melanomas (Gordon et al, 1994), small-cell lung carcinoma (Ried et al, 
1994; Levin et al., 1995), gliomas (Schrock et al., 1994), sarcomas (Forus et al., 1995), 
and head, neck and pancreatic carcinomas (Speicher et al., 1995; Solinas-Toldo et al., 
1996). Various unrecorded areas of presumed tumour suppressor gene deletion and 
oncogene amplification in cell lines from these solid tumours were discovered in this 
way.
Moreover, CGH has found wide application in clinical cytogenetics, as it provides an 
analysable karyotype from a DNA sample without having to culture cells with the 
conventional methods. In one of the initial studies, the accuracy of CGH was compared 
with those of conventional karyotyping and FISH, in the analysis of material coming 
from 27 fetuses that spontaneously aborted. This evaluation led to the conclusion that the 
CGH method was sensitive enough to even detect a case of 50% mosaicism for trisomy, 
18, which was also identified by conventional cytogenetics (Daniely et al., 1998). 
Identification of marker chromosomes, cryptic deletions, and even confined placental 
mosaicism was feasible with the use of CGH (Bryndorf et al., 1995; Ghaffari et al, 1998; 
Daniely et al., 1999; Amiel et al., 2002).
In recent years, its ability to screen the whole genome made it an attractive alternative for 
the chromosomal analysis of gametes and embryos, in the context of PGD.
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1.7.1 CGH application in PGP
The ability of CGH to provide information for all 23 chromosomes led several different 
research groups to attempt to modify this method so that it can be applied in PGD for the 
analysis of embryonic blastomeres. The difficulty in this case was that the DNA content 
of a single cell was in the range of 5-10 pg (Vendrely et al, 1955, reviewed in Wells and 
Levy, 2003), and thus required amplification, prior to its use. Wells and colleagues 
(1999) were the first to identify an efficient way of amplifying the DNA of a single cell 
with a type of PCR that uses a primer that anneals at many sites throughout the genome 
and results to an approximately 40,000 fold increase in the DNA concentration. This 
whole genome amplification (WGA) method was called degenerate oligonucleotide 
primed (DOP) PCR. It was used for the amplification of the DNA from normal and 
trisomic single cells, which were then further analysed with CGH. In all cases the 
expected karyotype was confirmed (Wells et al, 1999). A similar study was carried out 
by another group in Australia leading to comparable results (Voullaire et al., 1999). 
Subsequently, both these groups used the DOP-PCR method followed by CGH analysis 
for the examination of blastomeres from 12 cleavage-stage embryos (Wells and Delhanty, 
2000; Voullaire et al, 2000). In both investigations, the findings confirmed and extended 
the data obtained from FISH studies into the chromosome constitution of embryos at this 
stage of development. Specifically, mosaicism and chaotic chromosome complements 
were determined, but also some extreme abnormalities, including monosomies of the 
larger chromosomes and also nullisomy (Wells and Delhanty, 2000; Voullaire et al, 
2000).
The first clinical application of CGH in the context of PGD, came from the Australian 
group (Wilton et al, 2001). They used this method in a case of PGS for a 38-year old 
patient with seven years of unexplained infertility. Out of the eleven generated embryos, 
a single blastomere from six was analysed with FISH using probes for chromosomes 13, 
16, 18, 21, and 22, while a single cell from the remaining five was examined with CGH, 
after the DNA was amplified with the use of DOP-PCR. Since, however, the CGH 
required a hybridisation period of about 72 hours which was longer than the embryos 
could survive in culture, they had to be cryopreserved. Analysis of these embryos 
revealed several chromosome abnormalities including a blastomere with monosomy 14, a
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second one with monosomy 4 and another with trisomy 16. One blastomere was 
characterised as normal female (46,XX), the corresponding embryo was thawed and 
transferred, resulting in the establishment of a pregnancy and the birth of a healthy 
female baby (Wilton et al., 2001). One year later, CGH was applied by another group 
(Wells et al., 2002) in the context of PGS for the analysis of eleven 1st PBs biopsied from 
the oocytes of a 40-year old woman, just after their retrieval. Nine of these PBs were 
characterised as aneuploid, and abnormalities affecting the larger chromosomes 2 and 5 
were detected among them. These results were confirmed by FISH analysis of 
blastomeres that were biopsied on day 3. The chromosomes analysed by FISH included 
X, Y, 13, 15, 16, 17, 18, 21, and 22, and also those that were highlighted as potentially 
abnormal after the PB CGH analysis. One embryo was characterised as normal, but its 
transfer did not result in a clinical pregnancy. The extremely high aneuploidy rate found, 
is interesting in view of the history of repetitive IVF failure of this patient (Wells et al., 
2002).
The Australian group continues to employ CGH for the cytogenetic analysis of embryos 
generated from women undergoing PGS (Voullaire et al., 2002; Wilton et al., 2003). In 
one of their more recent reports, they have used a combination of FISH for chromosomes 
13, 16, 18,21, and 22 and CGH for the analysis of single biopsied cells of 110 out of 198 
embryos from 20 patients, in an attempt to compare the two techniques (Wilton et al., 
2003). From the obtained data they concluded that if these blastomeres were examined 
solely with FISH, 38% of the aneuploidies would have been missed, and if the 
chromosomes X, Y, 14, 15, and 19 were also investigated, then 25% of abnormalities 
would not have been scored. Furthermore, they observed that the clinical pregnancy rate 
was higher in the group of patients who had had their embryos analysed with CGH, 
though the difference was not statistically significant.
Hence, CGH seems to be a very promising method, as far as PGD is concerned, as it is 
capable of providing data for all 23 chromosomes, even at the single cell level. As with 
FISH though, there are some limitations involved.
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1.7.2 CGH limitations in clinical PGD application
The CGH protocol used by Wilton and colleagues in all of their reports (Wilton et al, 
2001; Voullaire et al., 2002; Wilton et al, 2003), involves the cryopreservation of 
embryos, and their transfer in subsequent cycles, as this procedure requires 5 days to 
yield results. In general, embryo cryopreservation does not adversely affect viability to a 
great extent, but this not the case for biopsied embryos (Wells and Levy, 2003). One of 
the aims, however, of PGS is to improve implantation rates, and this may not be best 
achieved by freezing biopsied embryos (Munne and Wells, 2003). First PB analysis may 
be a more acceptable alternative for the application of CGH in the context of PGS for 
women in the older age group. However, further FISH analysis of blastomeres is 
advisable since chromatid anomalies detected in meiosis I have only a 50% chance of 
leading to an aneuploid embryo. There is also the potential for misdiagnosis due to a 
meiosis II error or a chromosome abnormality of paternal origin. Moreover, CGH is 
unable to identify ploidy abnormalities and may not be significantly sensitive to detect 
embryonic aneuploidies caused by parental translocations, especially if the latter involve 
exchange of very small chromosomal segments (Malmgerm et al., 2002; M. Simopoulou, 
personal communication). Hence, this method would be less likely to be applied for the 
PGD of structural chromosome rearrangements.
The most limiting factor, however, is the complexity of the actual technique. The whole 
protocol is very labour intensive and necessitates good knowledge of both molecular and 
cytogenetic methods, including expertise in recognising individual chromosomes. In 
addition, there is always the possibility of the failure to yield results, due to poor DNA 
quality of the sample. Hence a simplified approach would be required for the wider 
clinical application of CGH. The latter could come in the form of array CGH. This 
modified method involves the hybridisation of test and reference samples onto DNA 
microarrays, instead of metaphase slides, something which would significantly reduce 
hybridisation time and increase the accuracy and sensitivity of the method (Wells and 
Levy, 2003). Array CGH has been applied for the detection of amplifications in tumour 
DNA samples (Albertson et al., 2000; Cai et al, 2002; Pollack et al., 2002). In a recent 
report, Hu and colleagues (2004) described the application of this type of CGH for the
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examination of single lymphocytes that were either 46,XX or 46,XY, or were trisomic for 
13, 15, or 18. The slides used were arrayed with chromosome-specific DNA libraries. 
The expected karyotype of all the cells analysed was confirmed, whilst hybridisation took 
place for just 30 hours. The authors of this report suggested that this modified method 
could be the most appropriate alternative for the wider application of CGH for the 
blastomere analysis in the context of PGS (Hu et al, 2004).
1.8 Mosaicism in human preimplantation embryos
The advent of IVF and the continuously evolving molecular cytogenetic techniques that 
are employed in PGD have both enabled the extensive chromosome investigation of 
embryos that were not selected to be transferred back to the maternal womb. Such studies 
led to the detection of mosaicism in these embryos. The latter can be defined as the 
presence of two or more different cell lines in an individual derived from a single zygote. 
Initial studies into the extent of chromosome abnormality observed at this very early 
stage of human development, involved the karyotyping of small groups of embryos 
(Plachot et al, 1987; Papadopoulos et al, 1989; Wimmers and van der Merve, 1988; 
Angell, 1989; Jamieson et al, 1994). Among them 16-40% were characterised as 
chromosomally abnormal with mosaicism being frequent. Mosaicism was first 
demonstrated by FISH analysis by Delhanty and colleagues (1993), during the 
investigation of eight embryos from one patient that was undergoing PGD for sex 
selection to avoid an X-linked disorder.
Harper and colleagues (1995) and Delhanty and colleagues (1997) were among the first 
to examine the full extent of chromosome abnormalities in human preimplantation 
embryos with the use of FISH. During the first investigation, 69 cleavage stage embryos 
underwent FISH for chromosomes X, Y, 1, and 17 in an attempt to determine the extent 
of sex chromosome and autosome 1 and 17 abnormality in normally developing, 
monospermic human preimplantation embryos (Harper et al., 1995). The results for the 
chromosomes examined were very similar to the karyotyping studies. On the contrary, 
when abnormally developing embryos, or those generated from older IVF patients were 
tested for chromosomes X, Y, 18, and 16 in a similar investigation the rate of 
abnormalities increased to 70% (Munne et al, 1993). Delhanty and colleagues (1997),
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analysed a larger cohort of 93 morphologically normal embryos with FISH for 
chromosomes X, Y, and 1, and according to the chromosomal patterns that were 
observed, they classified them into the following categories:
(i) Uniformly normal with a diploid chromosome complement.
(ii) Uniformly abnormal having trisomies or monosomies of autosomal or sex 
chromosomes.
(iii) Mosaic having diploid cell lines and aneuploid, haploid or polyploid nuclei.
(iv) Chaotic having each cell with a different chromosome complement.
The authors also attempted to establish the actual origin of mosaicism, and attributed it to 
the loss or gain of a chromosome from some cells during post-zygotic development. Two 
mechanisms were thought to be causing this phenomenon, namely mitotic non­
disjunction and anaphase lag the latter leading to chromosome loss alone. They 
determined the second cleavage division as the onset for aneuploid or ploidy 
abnormalities, while haploid nuclei were attributed to the production of binucleate cells 
(Delhanty et al, 1997).
A slightly different classification was given in a review by Munne and Cohen (1998). 
They considered the chaotic embryos to be mosaic, and they grouped the mosaic 
abnormalities into different categories, according to ploidy (haploid, diploid, polyploid 
mosaics), and also according to the developmental stage in which they arose. Hence, they 
postulated that the mosaic chromosome abnormalities affecting a small proportion of the 
cells led to the generation of diploid/tetraploid embryos, which were also normally 
developing. If the chromosome abnormalities, scored were affecting the whole of the 
embryo then they would classify it as a chaotic mosaic, and such abnormalities would 
usually be noted in arrested or abnormally developing embryos (Munne and Cohen,
1998).
Numerous other studies were subsequently carried out, applying both conventional 
cytogenetic methods (Clouston et al, 1997; 2000) but more frequently FISH with an 
increasing number of probes for the analysis of both normally and abnormally developing 
spare cleavage-stage embryos or even blastocysts (Munne et al, 1998c; Evsikov and 
Verlinsky, 1998; Ruangvutilert et al, 2000b; Sandalinas et al, 2001; Magli et al, 
2001a,b; Bielanska et al, 2003; Coonen et al, 2004). The level of mosaicism observed in
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these studies was in the range of 50% or over. Furthermore, it was concluded that certain 
patients had the tendency of generating chaotic embryos more frequently than others 
(Delhanty et al., 1997). An association of mitotic non-disjunction with advanced maternal 
age was also demonstrated from the examination of embryos coming from patients 
undergoing PGS (Munne et al, 2002a). These conclusions were drawn from the 
investigation of a limited number of chromosomes and led to the question of whether any 
embryo was uniformly chromosomally normal at this early stage of development 
(Delhanty, 2001).
The application of CGH for the analysis of two sets of cleavage-stage embryos carried 
out by two different groups (Wells and Delhanty, 2000; Voullaire et al., 2000) gave the 
answer to this question. Wells and Delhanty (2000) analysed 64 blastomeres from 12 
good quality embryos, with the use of the DOP PCR, followed by CGH. Among them, 
three embryos were classified as uniformly euploid for all 23 chromosomes. As would be 
expected, from the FISH results, many abnormalities were also detected, including a 
uniformly double aneuploid (trisomy 21 and monosomy X) embryo, another with 
monosomy for chromosome 1 in most of its cells, and one with a deletion of part of 
chromosome 1. In total, eight were mosaic, two of which were chaotic, and several 
abnormalities of meiotic origin were also detected (Wells and Delhanty, 2000). 
Comparable results were obtained from the other CGH study (Voullaire et al., 2000). 
More recently, Malmgrem and colleagues (2002) employed CGH for the analysis of 28 
cleavage-stage embryos, from 13 couples with structural chromosome abnormalities, 
including both reciprocal and Robertsonian translocations. Analysis revealed that all 
examined embryos were either highly mosaic, or even chaotic (Malmgrem et al., 2002).
An effect of this high degree of chromosomal mosaicism, which is negatively associated 
with embryo survival is a phenomenon known as confined placental mosaicism (CPM). 
The latter can be defined as a dichotomy between the chromosomal constitution of the 
placental and embryonic/fetal tissues. This is observed in approximately 1-2% of all 
tested pregnancies, and in its most common type it involves a trisomic clone confined to 
the placenta (Kalousek et al., 1989; Kalousek, 1990). In zygotes that are diploid, a
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mitotic duplication of a specific chromosome taking place in a cell that could end up in 
the trophectoderm results in the generation of type I or II CPM (either trophoblast or 
chorionic stroma). Trisomic zygote rescue due to chromosome loss occurring in the 
embryonic progenitor cells has as an effect the formation of type III CPM (trisomy 
present in both the trophoblast and the chorionic stroma). (Kalousek et al, 1993; 
Robinson et al., 1997). The opposite is also feasible, i.e. the generation of a trisomic 
embryo with a diploid placenta. It has been shown that diploid placentas maintain fetuses 
that are trisomic for chromosomes 13 or 18 (Kalousek et al, 1989).
As far as the general survival is concerned, embryos with extensive abnormalities, 
including more than one extra or missing chromosome in the majority or even a few cells 
have a very limited developmental potential. It is very likely that such embryos would 
either arrest prior to implantation, or if they do not, they will fail to implant (Wells and 
Delhanty, 2000). Data related to embryo survival, depending on which chromosomes 
show anomalies and their extent has been obtained by studies of embryos that were left to 
reach the blastocyst stage of development (Ruangvutilert et al, 2000b; Clouston et al, 
2000; Sandalinas et al, 2001). Analysis of 50 chromosomally abnormal embryos, 
diagnosed at the cleavage stage on a single cell that survived to the blastocyst stage, with 
probes for chromosomes X, Y, 1, 13, 15, 16, 18, 21, and 22 revealed that 17 of them were 
aneuploid, with 14 being trisomic and the other monosomic for 21 or X. None of these 
embryos were classified as highly mosaic or chaotic, whilst the majority of them were 
mosaic diploid/tetraploid. The latter is thought to be a normal part of TE development 
(Sandalinas et al 2001). Similar results were obtained in the karyotyping study of 438 
human blastocysts carried out by Clouston and colleagues (2000). The survival of the 
monosomic embryos, was confined to chromosomes 21 or X, as the one is relatively 
small and hence the deletion of genes is minimal, whilst the other one could be possibly 
inactivated in female embryos. Monosomies of larger chromosomes would not be 
compatible with survival, due to the loss of essential housekeeping genes, required for 
vital cellular functions (Wells and Delhanty, 2000).
The chromosomal mosaicism observed at this early stage of human development 
resembles the chromosome instability observed in cells coming from cancerous tumours.
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The latter led to the suggestion that the normal cell cycle checkpoints may not be 
operating during the initial cleavage divisions (Delhanty and Handyside, 1995). A study 
carried out on mouse oocytes demonstrated the absence of the metaphase-anaphase 
checkpoint in these cells (Le Maire-Adkins et al, 1997). This checkpoint is responsible 
for the correct alignment of chromosome onto the mitotic spindle, and the situation could 
be similar for the human oocytes as well. Since the first cleavage divisions are supported 
by the maternal genome with the embryonic genome being globally activated after the 4- 
cell stage (Braude et al, 1988), it is possible that the absence of this checkpoint could be 
one cause of the complex chromosome abnormalities described above (Wells and 
Delhanty, 2000). Moreover, maternal genome support could result in the survival of 
embryos with multiple aneuploidy up until the blastocyst stage. Elimination of maternal 
mRNAs could lead to the arrest that is frequently observed prior to blastocyst formation 
for highly abnormal embryos (Wells and Delhanty, 2000).
IVF culture conditions could also be responsible for the high frequency of mosaicism. An 
example is a sudden decrease in temperature that could in turn affect cytokinesis, leading 
to the generation of diploid/polyploid embryos (Munne and Cohen, 1998). In addition, it 
has been shown that embryos produced by different stimulation protocols and cultured 
under different conditions have very diverse mosaicism rates (Munne et al, 1997).
The factors regulating and causing post-zygotic chromosome abnormalities will be 
elucidated only by gene expression studies, which are very difficult to carry out in vitro. 
However, the incidence of such extensive anomalies in the chromosome complement is 
surely the main reason of the relatively low fertility observed in humans.
1.9 Oocyte studies
Cytogenetic analysis of preimplantation embryos has revealed that quite a few 
chromosome anomalies have their origin in meiosis. As was mentioned previously, 
female meiosis is a more complex process, compared to its male counterpart. The latter is 
confirmed by FISH studies carried out on sperm that demonstrated a chromosome- 
specific aneuploidy rate of 0.1-0.2% (Hassold, 1998). Extrapolation of this data to the full 
chromosome count, would result in a total of 2% of sperm with additional or missing 
chromosomes (Delhanty, 2001). Meiotic investigation of female gametes is more difficult
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due to the inaccessibility of these cells. Such material is only obtained after IVF, and the 
oocytes that are available for examination are in their majority the ones that failed to 
fertilise after exposure to sperm. Moreover, they come from a selected group of patients 
that are being treated for infertility, which is not however necessarily of female origin 
(Delhanty, 2001).
These cells are arrested at metaphase II, and the latter has enabled their cytogenetic 
analysis, either via conventional karyotyping or FISH. Karyotyping of metaphase II 
oocytes demonstrated the gain or loss of whole chromosomes (Zenzes and Casper, 1992), 
or chromatids due to their premature division during meiosis I (Angell et a l, 1994; 
Angell, 1995; 1997). Both these mechanisms of aneuploidy have been described in 
section 1.4.1.
More recent studies on metaphase II oocytes have employed FISH or associated methods 
to establish the involvement of specific chromosomes in oocyte aneuploidy. The majority 
of these studies have used oocytes that failed to fertilise after their exposure to sperm. 
The polar body chromosomes were also investigated either separately, or in combination 
with the oocyte. Different fixation protocols have been employed including the ones 
suggested by Tarkowski (1966) or Kamiguchi and colleagues (1993) that allow the 
visualisation of whole chromosomes and chromatids.
One such study investigated the association of non-disjunction in meiosis II oocytes and 
1st PBs with maternal age, and was carried out by Dailey and co-workers (1996). They 
examined 338 oocytes and corresponding 1st PBs from 107 patients using FISH, applying 
probes for chromosomes 13, 18, 21, and X in a single hybridisation round. Their results 
demonstrated both mechanisms of non-disjunction for the examined chromosomes and 
led to the conclusion that whole chromosome non-disjunction is age-related, with the 
aneuploidy rate increasing from 1.5% for women aged 25-34 to 24.2% for women over 
the age of 40. Chromatid predivision did not seem to increase with maternal age (Dailey 
et al, 1996). In a subsequent study by the same group, that employed SKY for the 
analysis of 47 fresh metaphase II oocytes, an increase of balanced chromatid predivision 
was observed with advancing maternal age, from 6.5% for women of 34 years or less to 
75% for women over the age of 40 (Sandalinas et al, 2002). It has been shown that
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balanced chromatid predivision could be caused by the oocyte ageing in culture (Dailey 
et al., 1996). However, this was not the case with this study, as the oocytes were analysed 
just after retrieval (Sandalinas et al., 2002).
Mahmood and colleagues (2000) and Cupisti and colleagues (2003) investigated spare 
meiosis II oocytes and 1st PBs using 3 sequential rounds of FISH employing probes for 
chromosomes 1,9, 12, 13, 16, 18, 21 and X. Data was obtained for a total of 236 eggs 
(oocyte+PB), generated from 124 patients with an average age of 32.5 years (22-44). A 
total of 14 anomalies were scored, involving the presence of extra chromosomes and/or 
chromatids with chromosomes 13, 16, 18, and 21 being mostly affected. Both these 
studies were considering as abnormal oocytes and PBs with extra chromosomes only, as 
their absence could have been an artefact of the spreading process (Mahmood et al., 
2000; Cupisti et al, 2003). The estimated hyperploidy rate was in the range of 4% for 
both oocytes and PBs, while both studies confirmed the presence of the above-mentioned 
non-disjunction mechanisms, and identified a third one, involving the presence of a 
trisomic cell line in the gonads of some patients (gonadal/germinal mosaicism). They also 
showed that the smaller chromosomes were more frequently participating in non­
disjunction events, compared to larger ones (Mahmood et al., 2000; Cupisti et al., 2003). 
Anahory and colleagues (2003) examined 104 unfertilised oocytes and 56 corresponding 
PBs by employing a double-label FISH procedure. In this study, centromeric or locus- 
specific probes were used in combination with whole painting probes for the examination 
of chromosomes 9, 13, 16, 18, 21, and X, taking place in 3 sequential rounds. These cells 
came from 45 women of average age 31.6 (21-42 years). The overall aneuploidy rate in 
this study was estimated to be 11.5%, and abnormalities involving extra chromosomes 
and/or chromatids were again observed (Anahory et al, 2003).
A slightly increased aneuploidy rate of 22.1% was observed in the study of Pellestor and 
colleagues (2003) that employed an R-banding method for the examination of the whole 
chromosome complement of 3,042 oocytes coming from 792 women with an average age 
of about 34 years (19-46). This study was scoring as abnormal both the presence, but also 
the absence of chromosomes, as it used the gradual fixation method that is said not to be 
hampered by the artefactual loss of chromosomes, as is the Tarkowski one (Kamiguchi 
et al., 1993). As with the previous studies, both whole chromosome and extra chromatids
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were involved in the scored anomalies, and smaller chromosomes were preferentially 
participating (Pellestor et al, 2003).
The average age of all the oocyte donors from the above studies was lower than that at 
which the aneuploidy risk becomes significant enough for prenatal diagnosis to be used. 
The latter suggests that age-independent factors could be operating to increase the risk of 
trisomic conceptions. Such factors could be causing the high rate of meiotic errors 
observed during oocyte maturation. As with post-zygotic cleavage divisions and the 
associated mosaicism, absent or malfunctioning checkpoint genes that regulate meiosis 
could lead to the frequent incidence of chromosome malsegregation. Examples of genes 
that have been identified as regulators of oogenesis include MAP kinases that increase in 
the GV stage and remain at high levels during the two meiotic processes and even after 
fertilisation (Sagata, 1997). The c-mos protooncogene and its corresponding protein 
regulate meiosis II arrest in oocytes (Sagata, 1997) and mask an epitope of the 
motorprotein CENP E at meiotic kinetochores (Duesbery et al, 1997). CENP E itself 
regulates chromatid separation by delaying the anaphase onset until all centromeres are 
correctly attached to the spindle during mitosis (Abrieu et al, 2000). Its role in oogenesis 
is not known yet, but it could be similar. Studies on mouse oocytes having the c-mos gene 
knocked out showed failure of arrest in metaphase II, and possession of aberrant spinldes 
(Araki et al, 1996; Colledge et al, 1994). Thus, the masking of the CENP E epitope by 
the C-MOS protein, is most likely involved in the regulation of these processes during 
oogenesis.
Another gene, Rec8 is thought to be responsible for the maintenance of the cohesion of 
two sister chromatids at the centromere. Its removal is observed at anaphase I, enabling 
the termination of the chiasmata and the separation of the homologues. This is mediated 
by two other proteins, securin and separin whose mutations could lead to chromatid 
predivision (Cohen-Fix, 2000; Van Heemst and Heyting, 2000). Maml has also been 
shown to enhance monopolar attachment of microtubules to sister chromatid 
kinetochores, ensuring in this way their correct segregation to different poles (Toth et al,
2000). Finally, Steuerwald and colleagues (2001) observed that the transcripts of spindle 
attachment checkpoint genes, such as MAD2 and BUB1, are detected in lower
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concentrations in oocytes of older women, who are more likely to generate aneuploid 
gametes. This observation provided direct evidence that disturbances in the gene 
expression of meiosis specific genes may be directly associated with aneuploidy 
(Steuerwald et al, 2001).
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1.10 Aims and outline of the study
This study involved the investigation of chromosome abnormalities in preimplantation 
embryos, meiosis II oocytes and their corresponding first PBs with the application of two 
different molecular cytogenetic methods. It was divided into three parts, the last two 
being associated with each other. The aims and objectives of this study were the 
following:
• The first objective of this study was the development of reliable FISH-based 
protocols for their application in the PGD of chromosome anomalies and in the 
follow-up analysis of abnormal embryos. The aim was to extensively investigate 
the hypothesis that various types of chromosomal errors both meiotic and post- 
zygotic lead to the generation of highly mosaic and chaotic embryos that can be 
patient specific. Robust 3-colour FISH protocols were devised for seven patients 
and were applied clinically for five, with detailed follow-up analysis.
• The second objective of this study involved the in-depth investigation into the 
causal mechanisms of maternal aneuploidy, in an attempt to answer questions 
associated with chromosome size and participation in oocyte aneuploidy, 
frequency of whole chromosome versus single chromatid anomalies, the presence 
of gonadal/ germinal mosaicism, and an accurate estimation of both 
hyperhaploidy and hypohaploidy. Spare unfertilised oocytes and their 
corresponding first PBs were initially analysed with three sequential rounds of 
FISH for chromosomes of different sizes, and then by the application of CGH. 
This DNA-based technique was used to examine the whole of the maternal 
genome and would provide data about the participation of larger chromosomes in 
meiotic errors and the manner with which meiosis II oocytes were affected by 
hypohaploidy.
The main results of this investigation are described in three Chapters (3, 4, and 5). 
Chapter 3 describes the development and application of the FISH protocols for the 
diagnosis of five different chromosome abnormalities over nine PGD cycles, the 
chromosome complements seen in all generated embryos and an overall analysis of the 
levels of chromosomal mosaicism found in these embryos. Chapter 4 describes the
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sequential FISH analysis of the unfertilised meiosis II oocytes and corresponding 1st PBs, 
including the probes used, and the conclusions drawn from this part of the study 
concerning the mechanisms underlying maternal aneuploidy. Chapter 5 describes the 
optimisation of the CGH protocol via some positive control experiments, with the aim of 
employing this in the extensive analysis of meiosis II oocytes and first PBs. The data 
obtained from its application for the examination of these cells is illustrated along with 
conclusions. A detailed discussion of this work with review of similar studies, both for 
the PGD of chromosome abnormalities and the cytogenetic analysis of female gametes, 
along with the general conclusions is presented in Chapter 6.
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Materials and Methods
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2.1 Materials
The composition of reagents and solutions is described in detail in Appendix A
2.1.1 General reagents and equipment
2.1.1.1 Chemicals
The chemicals and reagents used in the laboratory were obtained from BDH 
Chemicals, Sigma Chemical Company or Gibco BRL, unless declared differently. 
They were all of Analar or biochemical grade. Preparation of solutions and buffers is 
described in Appendix 2A.1.
2.1.1.2 Enzymes
Details about the constitution of enzymes used for the nick translation for both FISH 
probes and CGH probes are shown in Appendix 2A.5.3 and came as part of the nick 
translation kit from Vysis/Abbott, UK. Pepsin (Sigma,UK) (lOmg/ml) was applied for 
the pre-treatment of slides during the FISH procedure. Proteinase K (Roche,UK) 
(lOOpg/ml) was used for single cell lysis. Pronase (Sigma, UK) was used for the 
separation of oocytes and PBs. Finally, the Super Taq Plus DNA polymerase (5 
units/pl), used during the Alu and DOP-PCR reactions was obtained from HT 
Biotechnologies.
2.1.13 Nucleic Acids
Oligonucleotide primers for the Alu, and the DOP-PCR reactions were supplied by 
Pharmacia and Oswel respectively (details seen in Appendix 2A.3.3 and 2A.4.3). 
DNA size standards (lkb Hypperladder IV) were from Bioline. Sonicated Herring 
Sperm DNA (lOmg/ml) and human Cof1 DNA (lpg/ml) were obtained from Sigma, 
UK, while the latter was also ordered from Gibco BRL. Deoxynucleotide 
triphosphates (dNTPs dATP, dCTP, dGTP, dTTP) for the DOP-PCR already mixed 
(lOmM), were supplied by Promega. dNTPs were also used during the nick translation 
of FISH and CGH probes and came as part of the Vysis/Abbott nick translation kit 
(dATP, dCTP, dGTP, dTTP, each 0.3mM). Finally, labelled deoxynulceotide 
triphosphates (dUTPs, Spectrum Green, Spectrum Orange, Spectrum Red) also came 
from Vysis/Abbott.
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2.1.1.4 Cell culture media and other equipment
Flasks for the culture of lymphocytes and fibroblasts, plastic pipettes, and microscope 
slides were all from BDH. Glass and plastic microcapillaries (internal diameter 75- 
100 mm) for embryo and oocyte manipulation and for single cell isolation and tubing 
were obtained from Laser. Iscoves modified Dulbeccos medium and Roswell Park 
Memorial Institute 1640 medium, both used for lymphocyte culture, were obtained 
from Sigma and Gibco BRL, respectively. Colcemid (lOOpg/ml) and fetal calf serum, 
used for lymphocyte culture, were both ordered from Gibco BRL. The former was 
stored at 4°C, whereas tbe latter at -20°C. Methotrexate (Sigma, UK) was used for 
lymphocyte culture. Hanks’s medium and Versene medium, both used for skin 
fibroblast culture, were obtained from Gibco BRL. Other reagents for media 
preparation, antibiotics and growth supplements were from Sigma Chemical 
Company, Difco Bacto, Gibco BRL, and BDH. If any of the above were in desiccated 
form, they were made up to stock concentrations, filtered, and stored at -20°C.
2.1.1.5 FISH reagents
The chemical solutions and buffers used during the FISH procedure are shown in 
Appendix 2A.6. The detergent polyoxyethylene sorbitan monolaurate or Tween 20, 
the Poly-L-lysine adhesive reagent, along with the 4’,6-diamidino-2-phenylindole 
(DAPI) solution, which counterstains DNA and enables the detection of nuclei under 
the fluorescence microscope, were all from Sigma Chemical Company. DAPI was 
mixed with the anti-fade mounting medium Vectarshield (Vector Laboratories). The 
first two solutions were stored at room temperature, whereas the other two at 4°C.
2.1.1.6 Microscopy and image analysis
Embryo and oocyte manipulation, as well as lymphocyte slide preparation took place 
with the use of dissecting and inverted microscopes, from Nikon and Olympus, 
respectively. Images were captured and analysed with the Olympus BX40 fluorescent 
microscope, equipped with a cooled charge-coupled device (CCD) camera, controlled 
by SmartCapture (Digital Scientific UK).
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2.1.2 Ethical approval
Patient referrals for PGD came from different clinical genetics centres mostly in the 
UK, but overseas, as well. The IVF and PGD treatments were carried out exclusively 
at the Assisted Conception Unit (ACU), University College Hospital (UCH), London. 
Unfertilised oocytes were donated for research by patients undergoing routine IVF or 
ICSI treatments at both the ACU, UCH, London and the ACU at Tayside University 
Hospitals NHS Trust, Dundee, Scotland. The preliminary work on surplus embryos, 
the clinical application of PGD, and the research work carried out on human oocytes 
were all carried out under licence from the Human Fertilisation and Embryology 
Authority and were also approved by the Research Ethics Committees of University 
College London Hospital and Tayside Trusts. Donation of embryos and oocytes from 
patients occurred only after their informed consent.
2.1.3 PreimplaDtation Genetic Diagnosis
2.13.1 Patient Details
Seven couples were investigated, all of them being at risk of unbalanced pregnancy or 
offspring due to a chromosomal abnormality. In three of the seven, one of the two 
partners was a balanced carrier of a reciprocal translocation, in two cases one of the 
partners was carrying a Robertsonian translocation, whereas the remaining two were 
referred for suspected gonadal mosaicism for a trisomic cell line. The maternal age 
varied between 25-39 (average age: 32.6) The details of these patients including their 
reproductive histories are shown in Table 2.1.
2.13.2 FISH probe details
All the probes that were used in this part of the study were directly labelled and most 
of them were of commercial origin. Laboratory-prepared probes were also employed. 
The latter were provided in the form of agar stabs from various resource centres. DNA 
extraction for the plasmid and cosmid DNA probes took place with the application of 
the Wizard maxiprep kit from Promega, whereas yeast DNA was extracted with the 
Nucleon extraction and purification kit for yeast minipreps, obtained from Amersham. 
These probes were labelled via nick translation, using the Vysis nick translation kit. 
Details of the probes are shown in Table 2.2.
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The various probe strategies employed for the PGD of these seven cases, along with 
the different probe combinations applied for spare embryo re-analysis are shown in 
Table 2.3.
Table 2.1: Details of the patients referred for PGD of chromosome abnormalities.
Case Female partner details Male partner details Reproductive history
A Karvotvpe: Normal 
46, XX 
Age: 25
Karvotvpe: Balanced 
reciprocal translocation, 
46XY,t(5;19Xpl2;pl2) 
Age:25
Primary infertility, due to severe 
oligospermia
B Karvotvpe: Balanced 
reciprocal translocation 
46,XX,t(ll;22)(q23.3;q 
11.2)
Age: 28
Karyotype: Normal 
46XY 
Age: 39
Four spontaneous abortions
C Karvotvpe: Norma/ 
46XX 
Age: 28
Karvotvoe: Balanced 
reciprocal translocation, 
46^CY,t(14;I6)(ql3;qll. 
1)
Age; 32
Primary infertility, due to severe 
oligospermia
D Karvotvoe: Normal. 
46, XX  
Age: 34
Karvotvoe: Balanced 
Robertsonian 
translocation, 
45,XY,der(13;21XqlO;ql 
0)
Age: 49
Primary infertility due to 
oligoasthenoteratozoospemiia
E Karyotype: Normal. 
46,XX 
Age: 37
Karvotvpe: Balanced 
Robertsonian 
translocation, 
45,XY,der(13;14XqlO;ql
Primaiy infertility due to 
oligospermia, Male partner 
fathered a pregnancy with previous 
partner after IVF, but ended in first
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1 0> 
Age: 45
trimester spontaneous abortion. 
Male partner's sister is also a 
balanced carrier of the 
translocation and has experienced 
early spontaneous abortions
F* Karvotvoe: Normal. Karvotvoe: Normal. Female partner experienced two
46,XX. 46, XY ectopic pregnancies, which led to
Age: 39 Age: 36 her having a bilateral 
salpingectomy. One pregnancy 
was achieved after IW , which was 
affected by trisomy 21 and was 
terminated at 20 weeks.
G* Karvotvoe: Normal. 1 Karvotvoe: Norma/. Recurrent trisomy 21 pregnancies.
46JCX. 46,XY Two Down’s syndrome children
Age: 37 Age: 35 and a termination of a Down’s 
syndrome pregnancy
*Couples F and G were referred for possible gonadal mosaicism for trisomy 21 in one of the 
two partners. FISH analysis on 400 lymphocyte interphase nuclei coming from each of the 
two partners did not reveal any sign of mosaicism, in these somatic cells.
93
Materials and Methods
Table 2.2: Details of DNA probes employed for the PGD of chromosome 
abnormalities.
Probe name Probe details Location of 
hybridisation
Origin
Centromeric for 
chromosome 4
Alpha-satellite.
Laboratory 
prepared probe. 
Labelled in SG, 
using the Vysis 
nick translation kit
4pl 1.1-ql 1.1 p4nl/4 
D’Aiuto et al, 1993
LSI EGR1 or “Cri 
du Chat” for 
chromosome 5
Locus-specific 
D57S21, D5S23. 
Dual coloured, SO 
andSG
5q31-SO
5pl5.2-SG
Vysis/Abbott, UK
CEP 11 
Centromeric
Alpha-satellite, 
DNA D11Z1. 
Labelled in SO
1 lp l 1.1-ql 1.1 Vysis/Abbott, UK
CEP 11 
Centromeric
Alpha-satellite, 
DNA D11Z1. 
Labelled in SG
1 Ipl 1.1-ql 1.1 Vysis/Abbott, UK
LSI 13 Locus-specific.
Spans the 
retinoblastoma 
gene (RBI). 
Labelled in SG
13ql4 Vysis/Abbott, UK
TelVysion 14q Subtelomeric, 
D14S308. 
Labelled in SO
14qter Vysis/Abbott, UK
CEP 15 
Centromeric
Alpha-satellite.
D15Z1. 
Labelled in SO
15pl 1.1-ql 1.1 Vysis/Abbott, UK
Centromeric for Satellite HI. 15ql 1.2 pMC15
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chromosome 15 D15Z3 
Laboratory- 
prepared. Labelled 
in SO, using the 
Vysis nick 
translation kit
Archidiacono et al., 
1995
Centromeric for 
chromosome 16
Beta-satellite.
D16Z2. 
Laboratory- 
prepared. Labelled 
in SG, using the 
Vysis nick 
translation k it
16ql 1.1 pZ16A 
Archidiacono et al., 
1995
CEP 16.
1 Heterochrvnmtic 
legion
Satellite H. 
DNAD16Z3 
Labelled in SA
I6qll.2 Vysis/Abbott, UK
TelVysion 16p Subtelomeric 
D16S3400. 
Labelled in SG
16pter Vysis/Abbott, UK
CEP18.
Centromeric
Alpha-satellite, 
D18ZI. Labelled in 
SA
1 8 p lU - q lU Vysis/Abbott, UK
YAC probe for 
chromosome 19
Locus-specific. 
Laboratory- 
prepared. Labelled 
in SO and SG, 
using the Vysis 
nick translation kit
19ql3.2 S.cerevisiae strain. 
Frcngen etui., 
1999
LSI 21
.
Locus-specific
D21S529,
D21S341,
21ql3.2-q22.2
...............................................L
Vysis/Abbott, UK
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D21S342. Labelled 
in SO
Chromosome 21 
specific DNA 
probe
Band-specific. 
Labelled in red
21q22.2 Oncor, UK
TEL21q Subtelomeric. 
Labelled in red
21qter Oncor, UK
TEL21q Subtelomeric. 
Labelled in red
21qter Oncor, UK
LDIVCFS, or “Di 
George” for 
chromosome 22
Locus-specific
D22S75.
Dual coloured, 
labelled in SO and 
SG
22ql 1/TUPLE1 
(HIRA)-SO 
22q 13/Arylsulphata 
se A (ARSA)-SG
Vysis/Abbott, UK
LSI 22 Locus-specific. 
Spans the bcr gene. 
Labelled in SG
22qll.2 Vysis/Abbott, UK
CEPX.
Centromeric
Alpha-satellite 
DXZ1. Labelled in 
SO
X p ll.l-q ll.l Vysis/Abbott, UK
CEPY.
Centromeric
Alpha-satellite 
DYZ3. Labelled in 
SO
Y p ll.l-q ll.l Vysis/Abbott, UK
SA: Spectrum Aqua 
SG: Spectrum Green 
SO: Spectrum Orange- appeared red
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Table 23: Probe combination developed for the PGD of chromosome abnormalities 
and for spare embryo re-analysis for the seven cases.
Case Probe combination for diagnosis Probe combination for re-analysis
A LSI “Cri du chat” probe for chromosome 
5
YAC probe for chromosome 19
B LSI “Di George” dual probe for 22 
CEP 11 a-satellite for chromosome 11
Cvcle 1: 16 centromeric 6-satellite for 
chromosome 16 
15 centromeric satellite m for 
chromosome 15 
CEP 18 centromeric a-satellite for 
chromosome 18
Cvcle 2: CEP 18 centromeric a-satellite 
for chromosome 18 
CEP X centromeric a-satellite for 
chromosome X 
CEP Y a-satellite for chromosome Y
C TelVysion 14q for chromosome 14 
CEP 16 centromeric satellite D for 
chromosome 16 
TelVysion 16p for chromosome 16
D LSI 13 for chromosome 13 
LSI 21 for chromosome 21 
TEL 21q for chromosome 21
Cvcle 1: CEP 18 centromeric a-satellite 
for chromosome 18 
CEP X centromeric a-satellite for 
chromosome X 
CEP Y a-satellite for chromosome Y
E LSI 13 for chromosome 13 
TelVysion 14q for chromosome 14
Cvcle 1: 4 centromeric a-satellite for 
chromosome 4 
15 centromeric satellite IE for 
chromosome 15 
CEP 18 centromeric a-satellite satellite 
for chromosome 18
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Cvcle 2: CEP 18 centromeric a-satellite 
satellite for chromosome 18 
CEP X centromeric a-satellite for 
chromosome X 
CEP Y a-satellite for chromosome Y
F LSI 13 for chromosome 13 
LSI 21 for chromosome 21
Cvcle 2: CEP 15 centromeric a-satellite 
for chromosome 15 
CEP 18 centromeric a-satellite for 
chromosome 18 
LSI 22 for chromosome 22
G Band-specific for chromosome 21 
TEL 21q for chromosome 21
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2.133 Preimplantation embryos
The patients involved in this part of the study all underwent routine IVF procedures, 
as described in Ranieri et al., 2001 and summarised in the Methods section 2.2.1. 
Diagnostic chromosome analysis with the application of FISH was carried out on 
eighty-nine embryos (147 blastomeres). Of the embryos biopsied, only three showed 
abnormal fertilisation, i.e. one or three pronuclei. The remaining were all normally 
fertilised, as indicated by the presence of two pronuclei 18 hours post-insemination. 
Two blastomeres were obtained from embryos having 6 cells or more, whereas one 
blastomere was obtained from embryos having 5 cells or less. Details of the oocytes 
collected and fertilised in each of the five PGD cases, along with the number of 
embryos biopsied and blastomeres obtained are shown in Table 2.4.
Table 2.4: Oocytes collected and embryos biopsied for each of the five PGD cases.
Case No. of oocytes 
collected
No. of oocytes 
fertilised
No. of embryos 
biopsied
No. of 
blastomeres 
obtained
A
Cvcle 1 20 15 13 24
B
Cvcle 1 12 5 3 6
Cvcle 2 14 9 8 11
D
Cvcle 1 9 7 6 11
Cvcle 2 13 10 9 12
E
Cvcle 1 12 8 8 16
Cvcle 2 13 13 8 + 1 with 3PN 13
F
Cvcle 1 19 17 17 24
Cvcle 2 24 20 16 30
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2.13.4 Preimplantation embryos grading criteria
Embryos produced via IVF procedures were divided into three categories, according 
to grading criteria set by Dawson et al, 1995. These categories are the following: 
Grade I  Embryos at the correct stage of in vitro development with regular- 
shaped and even-sized blastomeres with no fragmentation.
Grade II Embryos show an intermediate morphology between grades I and HI
Grade III Embryos show retarded development with unequally sized blastomeres
with at least one degenerated blastomere and/or high level of fragmentation
2.133 Embryo classification according to chromosome abnormalities observed
Depending to the chromosome abnormalities observed during PGD analysis, embryos 
were classified into four groups: normal, abnormal, mosaic (diploid mosaic and 
aneuploid mosaic) and chaotic. Classification took place according to criteria set by 
Delhanty et al, 1997 and designation to one of the four categories was based on the 
chromosome complement observed in majority of blastomeres constituting each 
embryo. Thus:
Normal Embryos which are uniformly normal for all tested chromosomes.
Abnormal Embryos which are uniformly abnormal for all tested chromosomes.
Mosaic
Diploid mosaic Embryos that are in the main euploid, but contain one or more 
cells that are aneuploid, polyploid or haploid.
Abnormal mosaic Embryos that are in the main aneuploid, polyploid or haploid, 
but also contain one or more cells that differ.
Chaotic Embryos showing a random chromosome complement, varying among 
different blastomeres. Chromosome status of initial zygote cannot be identified.
At least two cells with the same chromosome loss were required to demonstrate 
monosomy.
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2.1.4 Human oocyte and 1st PB analysts with FISH
2.1.4.1 Patients
Meiosis II oocytes and corresponding first PBs were donated for research from women 
with no known chromosome abnormalities, whose age varied between 22 and 44 years 
(average age 32.5 years). These patients were undergoing routine IVF or ICSI 
procedures at the time, and the duration of infertility ranged between 1.5 to 10 years. 
The causes of infertility were the following:
• Male factor- 25%
• Tubal factor- 20%
• Endometriosis- 22%
• Polycystic ovaries- 11%
• Anovulation- 6%
• Low response to stimulation regimes- 6%
Two centres collaborated in this part of the study: the Assisted Conception Unit at 
Tayside University Hospitals NHS Trust, Dundee, Scotland, and the Assisted 
Conception Unit at the University College London Hospitals Trust. Fully informed 
consent was given.
The ovarian stimulation regime was the same in both centres and is described in the 
Methods section 2.2.1.
2.1.4.2 Oocytes
The majority of oocytes investigated in this part of the study had not demonstrated any 
signs of fertilisation, after either being incubated (IVF), or injected (ICSI) with sperm. 
Oocytes that were not fertilised either due to lack of sperm from the male partner, or 
because they were classified as immature were also studied. Culture time ranged 
between 24 to 48 hours. All oocytes were at the metaphase II stage of meiosis and had 
extruded the first PB, prior to them being spread on slides.
2.1.43 FISH probe details
All the probes that were used in this part of the study were directly labelled. Various 
commercial and lab-prepared probes were employed. The latter were all repetitive
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sequence probes, initially cloned in plasmids or cosmids. Their treatment was exactly 
the same as described in 2.1.3.2. Details of the probes are shown in Table 2.5
Table 2.5: Details of DNA probes employed in the analysis of oocytes and 1st PBs.
Probe name Probe details I Location if 
hybridisation
1 Origin
Repeat-sequence 
probe for 
chromosome 1 
(heterochromatic 
region)
Satellite III. I^b- 
prepared probe. 
Labelled in SG 
using the Vysis 
nick translation 
k it
lq l2 pUC1.77 Cooke 
and Hindley, 1979
Centromeric for 
chromosome 4
Afpha-satelfite. 
Lab-prepared 
probe. Labelled 
in SO using the 
Vysis nick 
translation kit
4 p ll.I-q I 1.1 | p4nl/4 
D’Aiuto et 
at.,1993
Centromeric for 
chromosome 4
Alpha-satellite. 
Lab-prepared 
probe. Labelled 
in SG using the 
Vysis nick 
translation kit
4p! L l-ql 1.1 p4nl/4 
D’Aiuto et 
aJ.,1993
Centromeric for 
chromosome 9
Alpha-satelhte , 
Lab-prepared 1 
probe. Labelled 
in SO usiqg the 
Vysis nick 
translation kit
CCMP 9.27, 9qh;
N. Carter 
Cambridge, UK
Centromeric for
chromosome 12 
........ . _ ... ! ,
Alpha satellite. 
Lab-prepared
1 2 p ll.l-q ll.l Baldini et al., 
1990
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probe. Labelled 
in SO using the 
Vysis nick 
translation k it
Centromeric for 
chromosome 12
Alpha satellite.
Lab-prepared 
probe. Labelled 
in SG using the 
Vysis nick 
translation k it
12pl 1.1-ql 1.1 Baldini et al, 
1990
LSI 13 Locus-specific 
probe. Spans the 
retinoblastoma 
gene (RBI). 
Labelled in SG
13ql4 Vysis/Abbott, UK
Centromeric for , 
chromosome 16
Alpha-satellite. < 
Lab-prepared 
probe. Labelled 
in SO, using the 
Vysis nick 
translation k it
16pl2.1-qll.l pSE16, Greig ei i 
al, 1989 1
CEP 16
1
Satellite U. DNA 
D16Z3. Labelled 
inSA
16qll. Vysis/Abbott, UK 1
Centromeric for 1 
chromosome 17
Alpha-satellite. 
Lab-prepared 
probe. Labelled 
in SG using the 
Vysis nick
1 7 p ll.l-q ll.l
1
pZ17-1.6A 
Archidiacono et 
al, 1995
.......... . .. 1
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translation kit
Centromeric for 
chromosome 17
Alpha-satellite. 
Lab-prepared 
probe. Labelled 
in SO using the 
Vysis nick 
translation k it
1 7 p ll.l-q ll.l pZ17-1.6A 
Archidiacono et 
al., 1995
Centromeric for 
chromosome 18
Alpha-satellite. 
Lab-prepared 
probe. Labelled 
in SG using the 
Vysis nick 
translation kit
18pl 1.1-ql 1.1 L1.84 
Devilee et al., 
1986
LSI 21 Locus-specific 
probe. D21S529, 
D21S341, 
D21S342. 
Labelled in SO
21q22.2 Vysis/Abbott, UK
LSI 22 Locus-specific 
probe. Spans the 
bcr gene. 
Labelled in SG.
22ql 1.1 Vysis/Abbott, UK
Centromeric for 
chromosome X
Alpha-satellite. 
Lab-prepared 
probe. Labelled 
in SO using the 
Vysis nick 
translation kit
X p ll.l-q ll.l pBAMX5 Willard 
etal, 1983
SA: Spectrum Aqua 
SG: Spectrum Green 
SO: Spectrum Orange- appeared red
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2.1.5 Human oocyte and 1st PB analysis with CGH
2.1.5.1 Patients
The genomic content of oocytes at the metaphase II stage of development and their 
corresponding first PBs were investigated. These came from routine IVF patients with 
no known karyotype abnormalities. Maternal age varied between 22 and 39 years 
(average age 31.9 years). The causes of infertility were broadly as described in 
2.1.4.1. The Assisted Conception Unit at Tayside University Hospitals NHS Trust, 
Dundee, Scotland, provided material. Ovarian stimulation protocols were as described 
in 2.2.1.
2.1.5.2 Oocvtes and 1st PBs
Similarly as before, the oocytes examined, had failed to fertilise after either IVF, or 
ICSI, or were unexposed to sperm. All of them however, had extruded the 1st PB. 
Culture time ranged between 24 to 48 hours. Oocyte and corresponding 1st PBs were 
separated and placed into tubes individually, as described in the Methods section 
22.133.
2.1.53 Single cell Ivsis. and whole genome amplification
Single cells were lysed with the use of the enzyme Proteinase K (PK), provided by 
Roche and Sodium Dodecyl Sulphate (SDS), obtained from Sigma Chemical 
Company. Whole genome amplification was achieved with the application of the 
DOP- PCR reaction. The DOP primer was supplied by Oswel (details as seen in 
Appendix 2A.4.3).
2.1.5.4 Probe labelling, hybridisation and post-hvbridisation washes
Amplified DNA was labelled with the application of the Vysis nick translation kit. 
Details of its components are given in section 2.1.1.3. Probes were hybridised onto 
CGH metaphase target slides, which were supplied by Vysis/Abbot UK. Sigma 
Chemical Company supplied Triton used during the post-hybridisation washes as a 
detergent.
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2.1.5.5.Image analysis and interpretation
Image capturing took place with the use of a Zeiss Axioskop microscope, equipped 
with a Photometries KAF 1400 cooled CCD (charged coupled device) camera, 
controlled by Path Vysion software (Vysis, UK). The captured images were then 
analysed in order for a comparison between the amplified test DNA (oocyte or PB), 
labelled in green and the amplified control DNA (normal male or female), labelled in 
red, along the length of each of the chromosomes to be achieved. Analysis and 
interpretation of the captured images was enabled by special computer software 
(Digital Scientific), that converted fluorescent intensities into a red-green ratio for 
each chromosome. Loss or gain of chromosome material was identified by the 
presence of deviation from a 1:1 ratio.
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2.1 Methods
2.2.1 IVF and PGD procedures
2.2.1.1 IVF treatment cycles
All patients undergoing PGD followed a long IVF protocol, as described in Ranieri et 
a l , 2001. More specifically, initial pituitary suppression took place with 
administration of a luteinising hormone agonist in the form of buserelin nasal spay 
(Suprefact; Hoechst, Hounslow, Middlesex, UK). Ovarian stimulation began after 12 
days, by providing patients with purified FSH (Metrodin HP; Serono, Welwyn Garden 
City, Hertfordshire, UK). The follicular development and growth was observed by 
transvaginal ultasonography, which started on day 6 of stimulation. Patients that had 
at least one follicle of 17 mm in diameter and two or more of 15 mm in diameter, 
between days 12 and 14 were administered with 10,000 IU of human chorionic 
gonadotrophin (hCG, Profasi; Serono, UK). Collection of oocytes took place 36 hours 
later by ultrasound guided transvaginal aspiration. These were inseminated with 
prepared spermatozoa, approximately four hours after retrieval, and fertilisation was 
evaluated 24 hours later, by the presence of two pronuclei. Intracytoplasmic sperm 
injection (ICSI) was carried out for patients with sperm problems, such as 
oligospermia. In such cases the protocol followed is as described in Van Steirteghem 
etal., 1993.
Oocytes and embryos were cultured in IVF medium (Cook, Australia), while embryo 
suitability for biopsy was evaluated in the morning of day 3. Embryos that were 
assessed as normal following PGD were transferred to the uterus on day four post­
insemination, and a pregnancy test (p-hCG assay) took place on day 15.
2.2.1.2 Embryo manipulation
Embryos that were considered to be normally fertilised were graded as far as 
morphology was concerned, as described in 2.1.3.4 on the morning of day 3, and 
subsequently biopsied. The protocol followed was as described by Piyiamongkol et 
al, 2001. All embryo manipulation procedures were performed at 37°C in order to 
avoid embryo cooling. Prior to biopsy, embryos were immobilised by gentle suction 
with a holding pipette, controlled by a Leitz micromanipulator. Acid Tyrodes solution
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(pH 2.4) was applied to the zona pellucida, using a fine pipette until a hole of around 
30pm was made. The blastomere was aspirated from the embryo with a fine pipette, 
and was then transferred to the same medium droplet in the petri dish. The second 
blastomere was removed in the same way. If the blastomere lysed, during spreading or 
was anucleate, an extra blastomere was aspirated if the embryo cell number permitted. 
The remainder of the embryo was returned back to normal culture conditions 
immediately after the biopsy was completed. Two blastomeres were aspirated only 
from embryos whose cell number was six and above, so that die embryo mass was not 
drastically reduced.
2.2.13 Oocvte recovery
Oocytes that were investigated with application of FISH were obtained using the same 
IVF protocol as in 2. 2.1. Their culture conditions are described in 2.1.4.2
2.2.2 Cell culture
2.2.2.1 Peripheral lymphocyte culture
Two different protocols were used in order to obtain lymphocyte suspensions from 
normal individuals (controls), patients and their partners, that were then used for FISH 
investigations. Both of them involved a synchronised culture method, which would 
yield extended chromosomes from peripheral lymphocytes. Whole blood was 
collected in sterile lithium heparinised tubes.
Protocol 1
The blood culture was set up as soon as possible after whole blood collection. Firstly, 
under aseptic conditions, a 20ml culture was prepared using lml of peripheral venous 
blood. The culture was prepared in a 50ml culture flask by adding 17ml Iscoves 
modified Dulbeccos medium, (Appendix 1A.1) supplemented with 2ml (10%) GPS, 
2ml FCS, and 200pl PHA. The culture was mixed by shaking and incubated at 37°C 
for 48 hours. On the third day 200pl of thymidine (30mg/ml stock) were added to the 
culture, which was then further incubated for 18 hours. On the following day 200pl of 
deoxycytosine (0.227mg/ml stock) were added to the culture and incubated for four
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hours. After incubation, 200pl of colcemid (lOpg/ml) were added and the culture was 
incubated for another 20 minutes. Colcemid arrests the cells at metaphase, by 
preventing the formation of the mitotic spindle. The cells were harvested employing 
standard methods, using 0.075M KC1 hypotonic solution and methanol/ acetic acid 
fixative. The lymphocyte suspensions were stored at -20°C.
Protocol 2
The blood used to prepare the culture for this protocol was stored at 4°C for 3-4 days 
after being drawn. The medium used to set up the blood in this protocol was the RPMI 
1640 medium (Appendix 1A.2). The latter was prepared in the following way. To 
80ml of RPMI medium 15ml of FCS, 3ml of NaHCC>3,1m l PS and 1ml L-Glutamine 
were added and the pH adjusted by adding up to 1ml of NaOH. The latter was 
indicated by the colour of the medium, which should be salmon pink. When this 
colour was achieved, 18.5ml of the medium were added to 50ml cell culture flasks, 
along with 0.4ml PHA and 1ml of whole blood. All the components were mixed 
gently, and the cultures were incubated at 37°C for 65-72 hours. When this period had 
passed, 200pl of methotrexate (lx l 0'5 stock) were incorporated in each of the flasks, 
and the cultures were further incubated for 17 hours. The following day RPMI 
medium was prepared, as previously and warmed to 37°C. The cultures were again 
decanted into 10ml centrifuge tubes (two per flask) and they were then centrifuged at 
1 lOOrpm for 10 minutes. The supernatant was removed and 0.5ml were left above the 
cell pellets. Five ml of RPMI medium were added and the pellets were resuspended. 
Another centrifugation followed, die supernatant was removed and 5 ml of RPMI 
medium were added, as before, along with 50pl of BrdU (1 mg/ml stock). The cultures 
were incubated for 4 hours and 40 minutes. When this period had passed, 50pl of 
colcemid (lOpg/ml stock) were added and another 20-minute incubation followed. 
Harvest of the cell culture took place subsequently, as before. The cell suspensions 
were left at 4°C overnight and were then stored in the -20°C freezer.
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2.2.2J2 Skin fibroblast cell preparation for FISH
As part of the preliminary work for some PGD cases, the probes were tested on 
trisomic fibroblast cells, apart from lymphocytes and spare preimplantation embryos. 
The aim was to assess the efficiency of detection of trisomies, compared with 
disomies. Skin fibroblast cultures were obtained from frozen cell stocks from fetuses 
with trisomy 13 or trisomy 14. The cells were provided as growing monolayer 
cultures. The cell culture medium was poured off, and the cells were washed by first 
adding 3-5ml of Hank’s medium (2.1.1.4), and then by adding 3-5ml of 0.25% 
trypsin/Versene solution (Appendix 1A.3). At that point they were left at room 
temperature for 1 minute, after which most of the trypsin/Versene solution was 
discarded, and only a thin layer was left. The cells were placed in the 37°C incubator 
for 3-5 minutes and then they were observed under the microscope to check if they 
were loose. They were washed with 5ml of PBS (Appendix 2A. 1.1) and transferred to 
conical centrifuge tubes. Centrifugation at lOOOrpm for 5 minutes followed, the 
supernatant was discarded and another wash with 5ml of PBS took place in exactly 
the same way as previously. The cells were fixed in exactly the same way as for the 
lymphocyte culture and were left at room temperature for 30 minutes. The fix was 
removed, and fresh fixative solution was added. The cell suspensions were then stored 
in -20°C.
2.2.3 Slide preparation
2.23.1 Slide preparation of cultured cells
Before preparing the slides, 20ml of fresh fix solution (Appendix 2A.1.6) and 10ml of 
70% acetic acid (Appendix 2A.1.7) were prepared. Most of the old fix was removed 
and discarded from the lymphocyte or fibroblast suspension, and fresh fix was added 
to resuspend the cells. A small amount of cells was dropped onto a clean moist slide 
and the nuclei were spread by warming the slide on the back of the hand. With the use 
of a diamond marker a circle was drawn on the underside of the slide to mark where 
the nuclei were located. Once the slide was totally dry it was flooded with fix for 10 
seconds. The latter was poured off, the slide was dried and flooded with 70% acetic 
acid for another 10 seconds. The slide was dried once again and observed under the
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microscope to ensure that the nuclei were present. The slide was dehydrated through 
an ethanol series (70%, 90% and 100%), (5 minutes in each) and air-dried. Finally the 
initial cell suspension was topped up with fresh fix and stored in the -20°C.
2.23.2 Slide preparation of single blastomeres and embryos
Human embryos or blastomeres were spread on poly-l-lysine coated slides. These 
were prepared by firstly washing the standard microscope slides in methanol/HCl and 
then drying them with a cloth. The poly-l-lysine was diluted 1:10 with water, and 
poured into a coplin jar in which the slides were incubated for 5 minutes. They were 
then left overnight to dry at room temperature and then stored at 4°C.
The spreading solution (Appendix 2A.8.3) was made fresh each time. A small circle 
was drawn on the underside of the poly-l-lysine slide using a diamond marker, a small 
drop of spreading solution was placed on the side of the circle, and a small drop of 
PBS was placed on the comer of the slide. Under a dissecting microscope, a pulled 
capillary was primed with PBS and the blastomere or embryo was moved from the 
petti dish into the PBS on the slide. The capillary was then primed with spreading 
solution and the blastomere or embryo was transferred to the drop of spreading 
solution within the circle, ensuring at the same time minimum transfer of PBS, as this 
would prevent the cell(s) from lysing. The blastomere or embryo was located under an 
inverted microscope, and the spreading solution was gently removed and replaced 
until the cell membrane started to lyse, the cytoplasm was washed away and the nuclei 
were clear. The spreading solution was not allowed to dry before the cell lysed. The 
spreading of the nucleus took approximately 5 minutes, and once it had finished the 
slide was left to air dry. It was incubated in PBS for 5 minutes, and dehydrated 
through an ethanol series. Nuclei were located under the microscope and co-ordinates 
taken using an England Finder (Optech, UK). The embryo slides were stored for up to 
2 weeks at room temperature.
2 3 3 3  Slide preparation of unfertilised oocvtes
Generally, oocytes were spread on normal marked microscope slides and were fixed 
using the Tarkowski (1966) protocol with modifications (Mahmood et al, 2000). 
More specifically, they were first treated with freshly made hypotonic solution (1% 
sodium citrate) for 6-7 minutes, and placed in fixative I (Appendix 2A.8.4) for 1
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minute, during which the zona pellucida dissolved. The oocyte was transferred to the 
marked slide and 13pl fixative II (Appendix 2A.8.5) was gently dropped onto the 
oocyte. When the edge of the drying fixative reached the oocyte, another drop of 
fixative II was added and allowed to dry, and this process was repeated 2-3 times. The 
slide was dehydrated through an ethanol series, and air-dried. In some cases oocytes 
and 1st PBs were spread with an alternative protocol that used three fixative solutions 
instead of two. More specifically, initially oocytes were transferred to 0.9% sodium 
citrate in a culture dish and were left in this hypotonic solution for 10-15 minutes at 
room temperature. The oocytes were transferred very gently to the bottom of another 
culture dish, containing fixative solution I (Appendix 2A.8.6). This fixative gradually 
dissolved the zona pellucida. After about 2-3 minutes the oocytes showed signs of 
movement, indicating that this fixation step was complete. The oocytes were 
transferred to the centre of cleaned slides that were marked with a diamond pen. The 
oocytes were re-fixed by expelling a drop of fixative solution II (Appendix 2A.1.6) 
on top of them. The slides were then immediately immersed into a coplin jar 
containing fixative solution II and were incubated for 5 minutes. The slides were 
moved to another coplin jar containing fixative solution III (Appendix 2A.8.7), and 
were further incubated for 1 minute. This last step enabled the softening of the 
cytoplasm. Each slide was pulled out from the coplin jar very slowly and was wiped at 
the back. This protocol was suggested by Kamiguchi et al. (1993). Some oocyte 
groups were subsequently stained with either DAPI or Giemsa to check for the 
presence, the location and the morphology of the chromosomes. Other oocyte 
preparations were not stained at all and were identified under the phase microscope. 
Initially some oocytes were also spread on charged slides and in some cases the zona 
pellucida was removed with the use of Acid Tyrode’s solution, prior to spreading. The 
slides were aged at room temperature for up to a month and then stored either at 4°C 
or at -20°C prior to FISH
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2.2.4 Probe preparation
2.2.4.1 Bacterial culture
Repetitive sequence probes used mainly to examine the chromosome complement of 
unfertilised oocytes were isolated from E. coli strains carrying plasmid or cosmid 
vectors containing the DNA insert of interest. DNA was extracted with the application 
of maxiprep techniques. Bacterial culture started by inoculating E.coli cells into small 
cultures of 4ml of 2xTY medium (Appendix 1 A.5), also containing 4pl of ampicillin 
(lOOmg/ml stock) or other antibiotic for which the bacterial strains were resistant. The 
cultures were left overnight in a shaking incubator at 37°C. The following day these 
small cultures were re-inoculated into larger cultures, containing 200ml of 2xTY 
medium, plus 200pl of ampicillin, and were again incubated overnight as above.
2.2.4.2 Maxiprep extraction of plasmid/cosmid DNA
The DNA was extracted using a commercial maxiprep kit (Wizard; Promega, USA). 
The procedure was the following: Firstly the cells were pelleted by centrifugation at 
4,000 rpm for 10 minutes. The supernatant was discarded and the cells resuspended 
into 15ml of Cell Resuspension Solution (Appendix 2A.2.1). Subsequently, 15ml of 
Cell Lysis Solution (Appendix 2A.2.2) were added and mixed gently but thoroughly, 
by stirring or inverting. When the cellular mixture became clear, 15ml of 
Neutralisation Solution (Appendix 2A.2.3) were added, and immediately mixed by 
gently inverting the centrifuge bottles several times. The suspensions were centrifuged 
at 9,000rpm for 15 minutes at 22-25°C in a room temperature rotor. The supernatants 
were filtered through blotting paper and transferred into a 100ml graduated cylinder. 
After their volumes were measured, the supernatants were transferred to new 
centrifuge bottles. Half a volume of isopropanol was added to these supernatants, 
which was mixed by inversion. The suspensions were centrifuged at 9,000rpm for 15 
minutes as above. The supernatants were discarded and the DNA pellets resuspended 
in 2ml TE buffer (Appendix 2A.1.4). The DNA purification was achieved with the use 
of the Wizard resin and vacuum pump. Finally, the DNA concentrations were 
measured by a fluorometer, as described in 2.2.4.5 below and were then stored at - 
20°C.
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2.2.43 Yeast culture
The YAC probe for chromosome 19 (probe details in Table 2.2) was prepared by 
extracting total genomic DNA from yeast strains (S.cerevisiae). Initially six different 
yeast liquid cultures were set up from three frozen glycerol stocks of S.cerevisiae cells 
(Appendix 1A.7). A sterile needle was used to scrape some of the frozen stock and 
inoculate it into 10ml of S.D. medium (Appendix 1A.4), supplemented with 5pl 
ampicillin (lOOmg/ml, stock). The liquid cultures were incubated in a shaker at 30°C 
for three days.
23.4.4 Miniprep extraction of yeast DNA
The DNA extraction took place with the use of the “Nucleon extraction and 
purification kit” for yeast DNA extraction (Amersham). The protocol was as follows. 
Each of the 10ml cultures was divided into 1.5ml microcentrifuge tubes, which were 
then spun for 30 seconds at 13,000rpm. The supernatant was discarded and as much 
medium as possible was removed. The cells were completely resuspended by mixing 
in 540pl of Solution A. When each of the pellets was completely diluted, 60pi of 
Solution B were added and mixed thoroughly by rapid inversion. This mixture was 
incubated at 70°C for 10 minutes. 300pl of Solution C were added into each of the 
microcentrifuge tubes, which were mixed by shaking and were left to cool into ice for 
3-5 minutes. The samples were centrifuged at 13,000rpm for 5 minutes. The 
supernatant was collected and 600pl of isopropanol were added to precipitate the 
DNA. Again the samples were centrifuged at 13,000 rpm for 5 minutes, the 
supernatant was discarded, and 200pl of cold 70% ethanol were added. The samples 
were again centrifuged at 13,000rpm for 5 minutes, and each tube was drained and 
allowed to dry by placing them at 70°C for 3 minutes. Finally, 50pl of Solution D 
were added and the tubes were placed at 70°C. The samples were mixed periodically, 
until the DNA was completely resuspended. These DNAs were stored at 4°C.
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2.2.4.5 DNA reprecipitation
The miniprep procedure described above gave DNA yields of about 7pg/ml of original 
yeast culture. Thus, these DNAs were reprecipitated to increase the final 
concentration. The procedure was as follows. One tenth of the final volume, i.e. 5pi of 
3M sodium acetate were added into each of the different samples, along with two 
volumes, i.e. 1 lOpl of 100% ice-cold ethanol. The samples were either left overnight 
at -20°C or at -80°C for 1 hour. They were centrifuged at 13,000rpm for 20 minutes, 
the supernatant was removed and the pellets were left to dry at room temperature. 
They were resuspended in lxTE (Appendix 2A. 1.4) (50pl or less). The DNA 
concentrations were measured with the use of a flurometer, and varied between 350- 
565ng/pl. Each of the samples was stored at 4°C.
2.2.4.6 Fluorometrv
Concentrations of plasmid, cosmid and yeast DNA were measured with the use of a 
Hoefer Scientific Instruments TKO fluorometer. Initially, the fluorometer was 
calibrated with a solution containing an intercalating DNA dye (O.lpg/ml Hoechst 
33258 dye in lxTNE buffer). The standard used was lOOng/ml calf thymus DNA. 
Readings obtained for the concentrations of the DNA samples were converted to 
ng/pl.
2.2.4.7 Alu-PCK
Alu-PCR was performed to amplify specifically the human sequences in the YAC 
DNA, in order to generate probes for the PGD case A. The ^ /w-PCR was performed as 
described by Romana et a l , (1993), with some modifications. The amplification was 
carried out with the use of two Alu primers: ALU1F and ALU1R (both Appendix 
2A.3.3). Each were used in the PCR assay, along with lOOng DNA, 5pi of lOx PCR 
buffer (Appendix 2A.3.1), 2mM dNTPs (Appendix 2A.3.2), 0.125pl Super Taq 
enzyme and water to a volume of 50pl.
Two different sets of cycles were used for the amplification and these were the 
following: Initial denaturation at 95°C for 5 minutes, and then 30 cycles of PCR with 
denaturation at 95°C for 1 minute, annealing at 65°C for 1 minute, and extension at
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72°C for 4 minutes. At the end of the last cycle a 10-minute extension took place at 
72°C. The second set of PCR cycles involved an initial denaturation at 96°C for 1 
minute, and then 30 cycles of PCR with denaturation at 96°C for 1 minute, annealing 
at 40°C for 30 seconds, and extension at 72°C for 6 minutes. At the end of the last 
cycle a 10-minute extension at 72°C took place. PCR products were analysed on 2% 
agarose gels, as described below.
2.2.4.8 Agarose gel electrophoresis
Products that were amplified via Alu-PCR were analysed on agarose gels, in order for 
the PCR efficiency to be assessed. These gels were made as follows: 2% agarose was 
melted in lxTBE buffer (Appendix 2A.1.3) and lpg/ml ethidium bromide was also 
added to enable visualisation of the gels. The melted agarose was poured into an 
electrophoresis tank, containing gel-slot formers and left to dry at room temperature. 
In the meantime, the DNA samples were prepared for the analysis, by mixing lOpl of 
sample with lpl of loading buffer. When the agarose gel had set, it was immersed into 
lxTBE buffer and the DNA samples were also loaded into the formed wells. 
Electrophoresis took place at 100V for 30 minutes. Visualisation of the gel occurred 
via ultra-violet trans-illumination.
2.2.4.9 Labelling of the FISH probes
FISH probes that were prepared in the lab acquired their fluorescent label via nick 
translation. The latter involves the introduction of random nicks in the DNA with the 
use of a DNAase I, specific for this process. These nicks act as priming sites for the 
synthesis of new DNA, that is enabled by DNA polymerase I. The labelled nucleotides 
are incorporated as the old strand is being degraded. A commercial kit was used for 
this purpose (Nick translation kit Vysis/Abbott, UK). This kit enables the substitution 
of half the amount of the dTTP with spectrum green or spectrum orange-labelled 
dUTP. The latter dilutes the label incorporation, and increases the DNA polymerase I 
efficiency. The procedure permits the incorporation of about 20% of the fluorescent- 
labelled nucleotide into the DNA, generating in this way a clear bright signal during 
hybridisation. Ethanol precipitation removes the unincorporated nucleotides.
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2.2.4.9.1 Preparation of the nick translation kit
Initially spectrum green dUTP (Appendix 2A.5.1) 50nmol and spectrum orange dUTP 
(Appendix 2A.5.1) 50nmol concentrations were prepared at 0.2mM by adding lOpl of 
0.1 mM dUTP to 40pl nuclease-free water. d'lTP was prepared in a concentration of 
O.lmM with the addition of lOpl of 0.3mM d'lTP (Appendix 2A.5.1) to 20pi 
nuclease-free water. A concentration of O.lmM dNTP mix was achieved by mixing 
together lOpl of each of 0.3mM dATP, 0.3mM dCTP, 0.3mM dGTP (Appendix 
2A.5.1).
In order to make sure that the added DNA was 1 pg in a 50pl reaction mix, its volume 
had to be calculated in relation to the concentration of the DNA. The volume of 
nuclease-free water that was added was calculated using the formula 17.5-x, where x 
is the DNA volume.
2.2.4.9.2 Nick translation reaction
The components added in a microcentrifuge tube in order to begin the nick translation 
reaction were the following: 17.5-x nuclease-free water mixed with lpg of DNA, 
2.5pl of 0.2mM spectrum green or spectrum orange, 5pi of O.lmM dTTP, lOpl of 
dNTP mix, 5pi of lOx nick translation buffer (Appendix 2A.5.2) and lOpl of nick 
translation enzyme (Appendix 2A.5.3).
The micocentrifuge tubes were briefly centrifuged and vortexed to mix the reaction 
components and incubated for 2 hours at 16°C. This temperature was crucial for probe 
efficiency and the success of the labelling method.
The nick translation reaction was stopped with the addition of 5pl of 0.5mM EDTA 
pH 8 (BDH, UK).
2.2.4.9.3 Probe preparation after labelling
Probe precipitation took place once the nick translation reaction was stopped. 
Different components were added in the microcentrifuge tubes, depending whether the 
labelled probes were locus-specific or hybridised onto the heterochromatic regions of 
chromosomes.
Thus, the following reagents were added for locus-specific probes: lOOpl of human 
COT-1 DNA (Sigma, UK), 5pl herring sperm DNA (Sigma, UK), 16pl of 3M sodium
117
Materials and Methods
acetate and 1ml of 100% of ice-cold ethanol. For repetitive sequence probes the 
following components were mixed: 5pi of herring sperm DNA, 16pl of 3M sodium 
acetate, and 1ml of 100% ice-cold ethanol.
Precipitation took place by leaving the probes at -80°C for 1 hour. Once this period of 
time had passed, the probes were centrifuged for 10 minutes at 13,000rpm. The 
supernatant was discarded, and the resulting pellets were air-dried by leaving the tubes 
open in the dark. Finally, the repetitive sequence probes were resuspended in 100 pi of 
hybridisation buffer (Appendix 2A.6.6), whereas the locus-specific probes were 
resuspended in 20pl of COSMIX buffer (Appendix 2.A.6.5).
2.2.5 FISH for PGD
2.2.5.1 Slide pretreatment
When all slides were prepared (control lymphocytes, blastomeres and embryos), they 
were incubated in IN HC1 and pepsin (lOmg/ml, Sigma, UK) (Appendix 2A.6.1) at 
37°C for 20 minutes. This incubation enabled the removal of the remaining protein 
from the cells, making in this way the DNA accessible to the probes. When the 
incubation period finished, the slides were washed briefly in double-distilled de­
ionised water and PBS. Subsequently the slides were fixed by a 10-minute incubation 
in 1% paraformaldehyde (Sigma, UK) (Appendix 2A.6.2), in PBS at 4°C. Another 
wash in PBS and two washes in double-distilled de-ionised water followed, and the 
slides were dehydrated through an ethanol series and left to dry. All the above were 
carried out in 50ml volume coplin jars, unless otherwise stated. This method was 
described previously by Harper et al. (1994).
2.2.5.2 Probe preparation
The hybridisation mix for single-colour FISH consisted of the probes, different 
hybridisation buffers depending on the probes used and sometimes different volumes 
of water. The total volume of hybridisation mix used was in most cases 5pl. The 
hybridisation buffers used for commercial probes were the LSI, and CEP buffers 
(Vysis/Abbott, UK), and Hybridisation solution (Oncor, UK). The hybridisation 
buffer used for the YAC probes was the lab-prepared COSMIX buffer, whereas the
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band-specific probe for chromosome 21 came already mixed with hybridisation 
solution.
The hybridisation mixes for the combination of different probes were made to a total 
volume of 5-6.5pl. Thus, the amounts of buffer and water were divided to 
accommodate the volume of each of the probes.
When blastomeres were tested during a PGD case, the hybridisation mix volume was 
always 3 pi. Similarly with above, the amounts of probes and buffer were converted 
accordingly.
2.2.53 Denaturation and hybridisation
The probes and slides were denatured separately for all the PGD cases. More 
specifically, denaturation of nuclear DNA took place by covering the slides in 
denaturation mix (70% formamide in 2xSSC) and then placing them in an incubator 
set between 73-75°C for 5 minutes. Coverslips were removed and the slides immersed 
into ice-cold 70% ethanol for 5 minutes. Subsequently, slides were dehydrated 
through an ethanol series and left to dry, preserving the single-stranded DNA 
conformation. Locus-specific probes were mixed, denatured in an incubator set 
between 73-75°C for 5 minutes and then left to pre-anneal at 37°C with the COT1 
DNA for a period o f30-60 minutes. In the case that the probe mix contained repetitive 
sequence probes as well, the latter were denatured in the same way in a separate 
microcentrifuge tube, but without the pre-annealing step. Once the denaturation was 
complete they were placed on ice. Probes were mixed prior to them being placed on 
the slides, under a 13mm coverlsip. Slides and probes were left to hybridise in a moist 
chamber at 37°C. Hybridisation varied according to the probes used. Thus, repetitive 
sequence probes required 45 minutes to 1 hour, whereas locus-specific probes 
required 16 hours on average. Combinations of locus-specific and repetitive sequence 
probes were left to hybridise overnight. In such cases, the coverslips were sealed with 
rubber cement to prevent probe evaporation.
2.2.5.4 Post-hybridisation procedures
The washes following the hybridisation of the probes controlled the stringency with 
which the latter bound onto the DNA. This was achieved by the adjustment of 
formamide and salt concentrations and also the temperature at which the post­
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hybridisation washes took place. The stringency conditions were dependent on the 
probe type, i.e. whether these were locus-specific or centromeric. The post­
hybridisation washes were all carried out in the dark to avoid possible bleaching of the 
fluorochromes. The coplin jars used were 50ml in volume and the washes that used 
formamide took place in a laminar flow cabinet. Once the hybridisation period was 
complete, any rubber cement was removed and the coverslips gently floated off by 
immersing the slides in the first wash solution for a brief period. When the probe mix 
included locus-specific probes, slides were washed at 45°C for 3x3 minutes in 50% 
formamide in 2xSSC and then 3x3 minutes in 2xSSC, with two subsequent 5 minute 
washes in 4xSSC/0.05% Tween at room temperature. In the case of repetitive 
sequence probes, there was an increase of formamide concentration to 60%, whereas 
the rest of the washes remained the same. The slides were finally dehydrated through 
an ethanol series and were left to air-dry.
A different set of washes was carried out for the PGD case E. Locus-specific probes 
were used for the diagnosis. The slides were initially washed at 46°C for 3x10 minutes 
in 50% formamide in 2xSSC, once for 10 minutes in 2xSSC, pH5.3 and then once for 
5 minutes in 2xSSC/0.1% NP 40. They were left to dry in the dark.
The slides were mounted in Vectorshield antifade medium containing 1.25ng/ml 4’,6- 
diaminidino 2 phenylindole (DAPI) counterstain and stored covered at 4°C.
2.2.5.5 Re-probing of slides
Embryos that were considered abnormal after PGD were not transferred and were 
analysed with the same probe mix to confirm the diagnosis. Re-analysis with other 
probes was often performed to further investigate chromosome status for these 
embryos. Re-probing of these embryos took place in the following way: The slides 
were immersed in a coplin jar containing 4xSSC/0.05% Tween and the coverslips 
were removed. Two 5-minute washes in 4xSSC/0.05% Tween and one 10 minute 
wash in PBS, all taking place at room temperature, followed. During these washes the 
slides were exposed to light, so the old probe mix faded. The slides were then 
dehydrated through an ethanol series and air-dried. The new probe mix was placed 
and the slides were denatured as before. The rest of the FISH steps remained as 
previously.
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2.2.5.6 Scoring criteria for embryos
Embryo analysis took place with the use of a fluorescent microscope. The guidelines 
suggested by Hopman et a l (1988) were followed for signal scoring in embryonic 
interphase nuclei. Specifically, two signals closer than a signal diameter apart, were 
considered a single split signal. Two signals that were further apart than a signal 
diameter were considered as two separate signals.
2.2.6 FISH for metaphase n  oocytes and 1st PBs
2.2.6.1 Slide pre-treatment
Material loss was experienced during the sequential rounds of FISH. To reduce the 
latter, the slides were handled in different ways prior to FISH. These included, an 
overnight incubation at 37°C or 65°C, or a combination of both and in all cases their 
ageing at room temperature for up to a month. Their pre-treatment, in order to make 
the chromosomes accessible to the probes was similar to that described in 2.2.5.1 with 
the following modifications. Incubation in IN HCL and pepsin at 37°C took place for 
only 5 minutes, instead of the standard 20 minutes. It was thought that the longer the 
slides were left in pepsin the more likely it was for oocyte chromosomes to be lost 
afterwards. The remaining of the pre-treatment was exactly the same as for the 
lymphocytes and the blastomeres.
2.2.6.2 Probe preparation
Depending on whether the oocyte and PB chromosomes remained on the slides, a 
two- or three- stage FISH was carried out. Chromosomes were initially hybridised 
with repetitive sequence probes (Table 2.5), whereas the second and third rounds were 
carried out with the use of locus-specific probes The volume of the hybridisation mix 
applied on the slides was 4pl. The LSI hybridisation buffer (Vysis/Abbott, UK) was 
used in combination with locus-specific probes for chromosomes 13, 21 and 22. The 
latter were all commercial (Vysis/Abbott, UK, Table 2.5). Probe combinations applied 
during the three subsequent rounds of FISH are shown in Table 2.6.
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Table 2.6: Probe combinations during the three sequential FISH rounds applied for 
oocyte analysis.
FISH Round Probe combination
1st • Satellite HI for chromosome 1- SO 
Alpha-satellite for chromosome 12- SO+SG 
Alpha-satellite for chromosome X- SG
• Alpha satellite for chromosome 12- SO+SG 
CEP 16 (Satellite II) for chromosome 16- SA
Alpha-satellite for chromosome 18- SG
• Alpha-satellite for chromosome 4- SG 
Alpha-satellite for chromosome 17- SO
• Alpha-satellite for chromosome 4- SG or SO 
Alpha-satellite for chromosome £2- SO+SG
Afpha-satellite for chromosome £ 7- SG or SO
2nd • Satellite III for chromosome £- SG 
CEP 16 (Satellite II) for chromosome 16- SA
• LSI 13 locus-specific probe for chromosome 13- SG 
LSI 21 locus specific probe for chromosome 21- SO
3rd • LSI 22 locus specific probe for chromosome 22- SG
S A- Spectrum aqua 
SG- Spectrum green 
SO- Spectrum orange- appeared as red
122
Materials and Methods
2.2.63 Denaturation and hybridisation
Oocytes and controls were denatured simultaneously. Thus, the probes were mixed in 
a microcentrifuge tube and placed on 13mm coverslips, onto which the oocytes were 
inverted. Denaturation took place in an incubator at 75°C, whereas the time the slides 
and probes were left varied between 3 and 5 minutes, depending on the probe set used 
for analysis. Hybridisation occurred at 37°C. Locus-specific probes were left to 
hybridise overnight. Repetitive sequence probes were left to hybridise either for 1-2 
hours or overnight, according to resulting signal intensities, and as detailed in 
Mahmood et al., 2000. In the case of overnight hybridisation, the coverslips were 
sealed with rubber cement to prevent probe evaporation.
23.6.4 Post-hybridisation procedures
The washes following the hybridisation of the probes controlled the stringency with 
which the latter bound onto the DNA, as mentioned in 2.2.S.4. Similarly with the 
FISH for the PGD cases, the post-hybridisation washes for the oocyte FISH were all 
carried out in the dark to avoid possible bleaching of the fluorochromes. The coplin 
jars used were of 50ml in volume and the washes that used formamide took place in a 
laminar flow cabinet. Once the required hybridisation period had passed, the 
coverslips were removed as described in 2.2.5.4. For locus-specific probes, slides 
were washed at 45°C once for 5 minutes in 50% formamide in 2xSSC and then once 
for 5 minutes in 2xSSC, with two subsequent 5 minute washes in 4xSSC/0.05% 
Tween at room temperature. For repetitive sequence probes, the formamide 
concentration increased to 60%, with the remaining washes staying as described 
above. The slides were finally dehydrated through an ethanol series, were left to air- 
dry in the dark and were mounted in Vectorshield antifade medium containing 
1.25ng/ml 4’,6-diaminidino 2 phenylindole (DAPI) counterstain. They were stored 
covered at 4°C.
2.2.63 Re-probing of slides
Analysis of the different oocyte and PB chromosomes was achieved in three 
sequential rounds of FISH. Re-probing of oocyte slides occurred as described in
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2.2.5.5 (re-probing of embryo slides). Similar to the embryo slides, no further 
treatment or fixation took place on the oocytes that were spread on these slides. It was 
not possible to successfully re-FISH all of the oocytes and PBs due to some 
chromosome loss that was experienced during their processing.
22.6.6 Scoring criteria for oocytes and PBs
Analysis of oocytes was achieved with the use of a fluorescent microscope (Olympus 
BX 40). The guidelines suggested by Cupisti et a l (2003) were followed for signal 
scoring. More specifically, the morphology of oocyte and PB chromosomes varied, 
with the oocyte chromosomes being more distinct, and the PB chromosomes being 
more compact, less well spread and beginning to degenerate. It was not possible to 
confuse sperm and PB chromosomes, as the former tend to be very extended, whereas 
the sperm head itself had a typical compact shape.
Each oocyte and PB chromosome consists of two chromatids joined together on the 
centromere. Thus, repetitive sequence probes, which hybridised onto centromeric 
regions, were visualised either as one large signal or a doublet if chromatids were 
close to each other. Premature separation of chromatids would result to two distinct 
signals for the repetitive sequence probes. The locus-specific probes used in this study 
hybridised onto long arm regions of chromosomes 13, 21, and 22. Thus, they always 
demonstrated some degree of separation.
During this study, only the presence of extra signals indicating the gain of either a 
whole chromosome or a chromatid was scored. Absence of signals was not considered 
as a true abnormality, as it could be influenced by the artifactual loss of chromosomes 
that could have taken place either during the spreading of the cells or the FISH 
procedure.
2.2.7 CGH of human meiosis II oocytes and corresponding 1st PBs
2.2.7.1 PNA extraction from blood
DNA extraction from whole blood was carried out according to a protocol suggested 
by Lahiri et a l (1991). The blood was initially collected in tubes containing 15% 
EDTA. The procedure was as follows: 5ml of whole blood were placed in centrifuge
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tubes and 5ml of low salt solution (TKM1, Appendix 2A.9.1), and 125 pi of Nonident- 
40 (NP40, Sigma) were also added, in order for the cells to be lysed. The contents of 
the tubes were mixed well by inversion and were spun at 1000 rpm for 10 minutes in a 
Centaur™ centrifuge. The resulting supernatant was discarded and each of the pellets 
washed in 5 ml of TKM1. NP40 was added again and another centrifugation followed, 
similarly with above. The TKM1 and NP40 washes were repeated for three more 
times, or until the pellet became white, something which indicated that all the red 
blood cells were removed.
The pellets were resuspended in 50pl of TKM1. Lysis of the white blood cells was 
achieved by addition of 800pl of high salt solution (TKM2, Appendix 2A.9.2) and 
50pl of 10% (w/v) SDS. After mixing thoroughly, the suspension was incubated at 
55°C, with occasional agitation, for a minimum of 30 minutes, or until it became 
clear. Once the latter took place, 300pl of 6M NaCl were added into each of the tubes, 
and the suspensions were mixed thoroughly so as to ensure that all cells had lysed.
A centrifugation followed at 10,000 rpm for 5 minutes and the resulting supernatants 
were transferred to new tubes, into which 2 volumes of ice-cold 100% ethanol were 
added. Inversion of each of the tubes was carried out for several times until the DNA 
had precipitated. The DNA strands were transferred to microcentrifuge tubes that 
contained 1ml of ice-cold 70% ethanol with the use of sterile inoculation loops. 
Another centrifugation at 10,000 rpm for 5 minutes took place, the supernatants were 
removed and the DNA pellets were air-dried. Each of the pellets was dissolved in an 
appropriate volume of TE solution (Appendix 2A.1.4) and stored at 4°C.
2.2.1.2 DNA extraction from skin fibroblasts
DNA from skin fibroblast cultures carrying trisomies for different chromosomes (e.g. 
trisomy 18, trisomy 22) was used during initial positive control experiments to 
demonstrate that the CGH technique was able to detect these trisomies, during 
analysis and interpretation of the captured images. The extraction procedure started by 
removing the cell culture medium and washing the cells with Hank’s balanced salt 
solution, pre-warmed at 37°C. This solution was discarded after a few seconds and 
5ml of Versene, containing 2.5% trypsin (Appendix 1A.3) were added into the tissue 
culture flasks, which were then incubated at 37°C for 5 minutes. The Versene/trypsin
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solution was also pre-warmed at 37°C. Incubation of the cells at 37°C resulted in their 
detachment from the flasks, something, which was confirmed by observing the cells 
under an inverted microscope. The trypsin was inactivated with the addition of a few 
drops of fetal calf serum. The cell suspensions were placed into centrifuge tubes and 
were spun at 1000 rpm for 5 minutes. Most of the supernatant was removed and a 
small amount was left in order for the pellets to be resuspended in it. Addition of 2ml 
of sterile PBS followed and the cells were again centrifuged at 1000 rpm for 5 
minutes. The cells were lysed with the addition of 2.5ml of lysis buffer (Appendix 
2A.10.1) and a 30 minute incubation at 37°C. After this period of time had passed, 
equal volumes of isopropanol were added into the tubes, in order for the DNA to be 
precipitated. Similar to the extraction of DNA from whole blood, the DNA was 
transferred into microcentrifuge tubes with the use of sterile inoculation loops, which 
were spun at 10,000 rpm for 5 minutes. Removal of the supernatants followed and the 
DNA pellets were left to dry at room temperature. They were finally resuspended into 
appropriate volumes of TE and stored at 4°C.
2.2.73 Single cell collection
2.2.7.3.1 Buccal cells
Buccal cells were collected from both male and female individuals with a normal 
karyotype (46,XY or 46rXX) by gently scraping the inside of the cheek with a sterile 
mouth swab. These cells served as the reference DNA against which the test DNA 
was hybridised. The buccal cells were transferred into 1.5ml of sterile PBS containing 
1% polyvinyl alcohol (PVA).
2.2.7.3.2 Skin fibroblasts
Single fibroblasts from cell cultures that were carrying trisomies for different 
chromosomes were used in initial positive control experiments for the same purpose 
as the DNA. The collection of these cells took place in the following way. Initially, 
the culture medium and any dead cells were removed from the tissue culture flasks. 
Live cells that were attached to the flasks were washed for a few seconds with Hank’s 
balanced salt solution that was pre-warmed at 37°C. The latter was then removed, and 
the cells covered with Versene, containing 2.5% trypsin and incubated at 37°C for 5 
minutes. The Versene/trypsin solution was also pre-warmed at 37°C. Incubation of the
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cells at 37°C resulted in their detachment from the flasks. Once the latter was 
achieved the cells were removed and spun at 3,000 rpm for 5 minutes.
The supernatants were discarded and the pellets were resuspended in 2-5ml PBS 
containing 1% PVA.
2.2.133  Human oocvtes and PBs
The meiosis II oocytes and corresponding first PBs were separated either with the use 
of acid Tyrodes solution or with pronase (Appendix 2A.7.1).
The acid Tyrode’s solution was used for the first two groups of oocytes and PBs. The 
procedure was as follows. The oocyte was placed in a drop of acid Tyrode’s solution 
in a small petri dish. The oocyte was observed continuously under a dissecting 
microscope. Gentle aspiration with a mouth pipette also took place in order to enable 
the lysis of the zona pellucida. Once the latter was achieved, both oocyte and 
corresponding PB were placed in different drops of PBS/PVA.
The pronase separation was applied for the third group of oocytes and PBs. Similar to 
above, the oocyte was placed in a drop of pronase in a small petri dish. The petri dish 
was covered, and put in an incubator set at 37°C for 5-10 minutes. Once this period of 
time had passed, the petri dish was removed from the incubator and the oocyte 
observed under a dissecting microscope. If the zona pellucida had disappeared 
completely the oocyte and PB were recovered and placed in different drops of 
PBS/PVA. If the zona was still there, the oocyte was gently aspirated and released 
using a mouth pipette until the zona lysed. Both cells were again transferred in 
different drops of PBS/PVA.
2.2.1 A Isolation and Ivsis of clumps or single cells
Once the cells were collected in PBS/PVA, an aliquot was placed on a petri dish and 
observed under a dissecting microscope. Another petri dish containing 10pl droplets 
of PBS/PVA was also prepared and the cells from the initial aliquot were passed 
through at least three different droplets of PBS/PVA. In this way, either clumps (3-5 
cells) or single cells were isolated and washed. In the case of buccal cells that during 
the CGH were used as the reference DNA with which the test DNA was compared 
only clumps were isolated, in order to ensure that there would be at least one cell that 
would yield hybridisation results. Fibroblasts were isolated either as single cells or in
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clumps, whereas all oocytes and corresponding PBs were washed individually in four 
droplets of PBS/PVA.
Once the above procedure of isolation and washing was complete, the buccal cells and 
fibroblasts were transferred individually to microcentrifuge tubes containing 2p.l of 
proteinase K (PK, 125pg/ml) and lpl of SDS (17p.M) and overlaid with oil. Lysis of 
the cells followed, to allow their DNA to be released. This was achieved by 
incubation at 37°C for 1 hour. After this, the PK was inactivated by another incubation 
at 95°C for 15 minutes. All cells were stored at -80°C until they were used.
Three differently prepared groups of oocytes and corresponding PBs were investigated 
with CGH during this study. All of them were lysed on the day that the whole genome 
amplification reaction was set up. More specifically, the cells of the first group were 
placed in microcentrifuge tubes containing 100p.l of sterile PBS and were stored at - 
80°C. In this case, when they were to be tested, they were first centrifuged at 6,000 
rpm for 10 minutes, 98pl of the PBS removed, and 2pi of PK and lpl of SDS (lysis 
mixture) were added to the tubes. They were covered with oil and lysed as described 
above. For the second group of oocytes and PBs, all cells were placed in 
microcentrifuge tubes, suspended in 2pl of sterile PBS, and they were stored at -80°C. 
In this way, the initial centrifugation at 6,000 rpm was avoided. Lysis mixture was 
added to each of the tubes, which were then covered with oil and lysed. Similarly, in 
the third group, all cells were suspended in 2pl of sterile PBS but were also overlaid 
with oil, prior to their storage at -80°C. They were lysed as above.
2.2.7.5 Degenerate Oligonucleotide Primed PCR
The Degenerate Oligonucleotide Primed (DOP) PCR was applied for the whole 
genome amplification of the buccal cells, fibroblasts, oocytes, and PBs and for the 
genomic and fibroblast DNAs for all the CGH experiments. The protocol was carried 
out as suggested by Wells et a l (1999) with some modifications. Thus, the reactions 
were performed in a total volume of 50pl and consisted of the following reagents: lOx 
SuperTaq Plus buffer (Appendix 2A.4.1); lOmM dNTPs (Appendix 2A.4.2); 83 pM 
degenerate oligonucleotide primer (CCGACTCGANNNNNNATGTGG) (Appendix 
2A.4.3); 2.5 U SuperTaq Plus polymerase and nuclease-free H2O.
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Thermal cycling was carried out as follows: 94°C for 4.5 minutes; 10 cycles of 95°C 
for 30 seconds, 30°C for 1 minute, a l°C/second ramp to 68°C, and 68°C for 3 
minutes; 40 cycles of 95°C for 30 seconds, 56°C for 1 minute, and 68°C for 3 minutes; 
and finally, 68°C for 8 minutes. Once the amplification was complete 5-10pl of each 
of the samples were taken and stored at 4°C for further analysis. The DOP-PCR was 
carried out in an Omnigene thermal cycler.
Strict precautions were taken against contamination, as suggested by Wells and 
Sherlock (1998) and Wells et a l (2002). More specifically, all equipment and reagents 
used to set up the DOP-PCRs were reserved only for single cell use. In addition, all 
reactions were set up in a room that was designated for single cell work only, was 
separate from the main laboratory and was kept under constant positive pressure, to 
avoid the entry of dust and amplified DNA products. All reagents, equipment, gowns, 
gloves and overshoes remained in this room.
The possible incidence of contamination was investigated by the presence of negative 
control tubes, which contained all DOP reagents apart from DNA. These were 
subjected to the entire DOP-PCR and the remaining of the CGH protocol. Absence of 
DNA in these tubes was demonstrated as absence of fluorescence during the analysis 
of the samples.
2.2.7.6 Agarose gel electrophoresis
DOP-PCR amplification and efficiency were assessed by analysing the DOP products 
on 1% agarose gels. These gels were prepared by mixing 1% agarose in lxTBE. 
Ethidium bromide (lpg/ml) was also added, so as for the gels to be visualised under 
UV illumination. As far as sample preparation was concerned, 5 pi of each of the DOP 
products was mixed with lpl loading buffer. The remaining of the procedure was as 
described in 2.2.4.8.
2.2.1.1 Amplified product precipitation
All DOP-PCR products were precipitated prior to their fluorescent labelling. This was 
achieved by mixing the 40-45pl of the samples with 4.5pl of 3M Sodium Acetate 
(Sigma) and 125 of ice-cold 100% ethanol. They were then placed at -80°C for 24 
hours. Once this period of time had passed, the samples were centrifuged at 13,000
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rpm for 30 minutes, their supernatants were discarded and their pellets were left to dry 
at room temperature for 5 minutes.
2.2.7.8 Labelling of the amplified products.
A nick translation reaction was applied in order for the DOP PCR products to be 
fluorescently labelled. The reaction took place with the use of a commercial kit (Nick 
translation kit Vysis/ Abbott, UK). The process was similar to the labelling of FISH 
probes (described in 2.2.4.9) with some modifications to accommodate for the nature 
of the CGH probes. More specifically, and for all experiments, the test DNA (i.e. 
fibroblasts, oocytes and PBs) was labelled in spectrum green (SG), whereas the 
reference DNA (buccal cell clumps, genomic) was labelled in spectrum red (SR). The 
preparation of the nick translation kit is described in 2.2.4.9.1, whereas the nick 
translation reaction is described in 2.2.4.9.2. The modifications were the following: all 
DOP-PCR product pellets were resuspended in 17.5pi of nuclease-free H2O, and the 
nick translation reaction took place at 15°C for up to 2 hours. The incubation period at 
15°C was directly associated with the size of the labelled DNA fragments. The desired 
sizes ranged between 500bp-lKb, and were assessed by agarose gel electrophoresis of 
a lOpl sample from the labelled products. The reaction was stopped by incubating all 
samples in a water-bath set at 70°C for 10 minutes. Test and control DNAs were 
mixed and then 30pg of COT 1 DNA, 13pl of 3M Sodium Acetate, and 360pl of ice- 
cold 100% ethanol were also added. The samples were left to precipitate at -80°C. The 
duration of the precipitation varied between 2-24 hours. Similar with above and after 
this period was complete, all samples were centrifuged at 13,000 rpm for 40 minutes, 
their supernatants were removed, and the pellets were covered and left to dry at room 
temperature for 5 minutes.
2.2.7.9 Comparative Genomic Hybridisation
2.2.7.9.1 Slide and probe preparation
The fluorescent DNA pellets were resuspended in 6pl of COSMIX buffer and were 
left to dissolve for 20 minutes in a water-bath set at 37°C. In the meantime, the slides 
that were used as templates onto which the CGH probes were to be hybridised were 
prepared. These were normal 46,XY metaphase slides and were provided by 
Vysis/Abbott, UK. The slides were observed under a phase microscope and
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hybridisation areas were marked, using a diamond pen. They were dehydrated by 
passing them through an ethanol series (70%, 90%, and 100%, 3 minutes in each), and 
were left to air-dry. They were then placed onto a hot-plate set at 42-45°C.
2.2.7.9.2 Denaturation and hybridisation
Denaturation of the slides was carried out by placing them in a 50ml coplin jar 
containing 70% formamide, 2xSSC in a water-bath set at 75°C, for 5 minutes. The 
denaturation process was stopped by immersing the slides in an ice-cold ethanol series 
(70%, 85% and 100%) and incubating them 3 minutes in each. The slides were left to 
air-dry and were again placed on the hot plate as above.
Denaturation of the probes was performed in an incubator set at 75°C and it lasted for 
10 minutes. After this period of time had passed, the probes were left covered at room 
temperature for 2 minutes. They were transferred on 22mm round glass coverslips, 
placed over the marked areas on the slides and sealed with rubber cement. Probes and 
slides were placed in a humidified chamber, and were left to hybridise in an incubator 
set at 37°C for 72 hours.
2.2.7.9.3 Post-hvbridisation procedures
Similar to the post-hybridisation washes during FISH, stringency conditions were 
critical for CGH. In this case formamide was avoided, while the slides were 
sequentially washed in decreasing temperatures. The protocol followed was described 
in Wells et al. (2002). All washes were carried out in 50ml coplin jars and in the dark 
to avoid possible bleaching of the fluorochromes. Thus, after the hybridisation period 
had passed, the rubber cement was removed from the slides, which were then 
immersed briefly in a coplin jar containing 2x SSC at 73°C. Coverisips were gently 
floated off and the slides incubated in this solution for 5 minutes. Three 5 minute 
washes at 37°C followed, the first and third in 4x SSC, while the second was in 4x 
SSC+ 0.1% Triton-X. The slides were finally washed in 2x SSC at room temperature, 
for another 5 minutes, they were briefly immersed in double-distilled deionised H2O, 
and were dehydrated through an ethanol series as before. Once they were dry, they 
were mounted in DAPI/Vectorshield and stored at 4°C until they were observed. 
Image analysis and interpretation are described in 2.1.5.5.
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3.1 Development of a FISH protocol for the PGD of chromosomal 
abnormalities
FISH protocols were devised for seven couples, and three different types of chromosomal 
abnormalities. Patient details are shown in 2.1.3.1 and Table 2.1. The abnormalities 
investigated included three different reciprocal translocations, two different Robertsonian 
translocations, and two cases of possible gonadal mosaicism for a trisomic cell line. 
Maternal age varied between 25-39 years (average age 32.6 years). The reproductive 
histories of these patients are shown individually in Table 2.1.
Characterisation of the patient karyotype had already taken place by the clinical 
cytogenetic centre from which these couples were referred. The development of each 
individual PGD protocol initially involved the prediction of the possible behaviour of the 
normal and derivative chromosomes during meiosis. Note was taken of all modes of 
segregation, depending on the type of chromosomal abnormality. Probe combinations 
were selected that would distinguish all abnormal chromosome compliments. Each of the 
chosen probes was tested individually and in combination on control (46, XY) and patient 
lymphocytes. In this way, confirmation of the binding position of the selected probe 
combination on the patient metaphases and evaluation of the efficiency of the FISH 
protocol were both achieved.
The aims of this part of the study were the following:
• To develop robust and reliable FISH protocols for their clinical implementation in 
the PGD of chromosomal abnormalities.
• To extensively analyse all untransferred embryos so as to investigate the 
hypothesis that different types of errors both meiotic and mitotic result in the 
generation of highly mosaic embryos that could also be patient specific.
Description of each of these PGD cases and their outcome will follow.
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Fig.3.1: FISH strategy for the PGD of reciprocal translocations
meiosis
Pachytene quadrivalent
A
a
b Mode of segregation Segregating Signals visible Embryo outcome
chromosomes
2:2 Alternate A,B Or derA, derB 2 0 ,  2 9 ,  2<0 Normal or balanced
2:2 Adjacent-1 A, derB 2 0 ,  IO . i m Partial monosomy B
B, derA 2 0 ,  3 9 ,  2m Partial trisomy B
2:2 Adjacent-2 A, derA 3®> Partial trisomy A
B, derB i o ,  2 m , 3 m Partial monosomy A
3:1 Tertiary aneuploidy A, B, derA 3 m , 3 m , i m Tertiary trisomy A
derB i o ,  \m , 2m Tertiary monosomy A
3:1 Tertiary aneuploidy A, B, derB 2 0 , 2 m , 3 m Tertiary trisomy B
derA 2 0 ,  2m , I O Tertiary monosomy B
3:1 Interchange A, derA, derB 3 m , 2 m , 2 m Interchange trisomy A
aneuploidy
B i o ,  2m , 2m Interchange monosomy A
3:1 Interchange B, derA, derB 2 0 , 3 m , 3 m Interchange trisomy B
aneuploidy
A 2 0 ,  1^^, I O Interchange monosomy B
4:0 Double aneuploidy A, B, derA, derB 3 0 ,  3 m Trisomy A, B
0 i o ,  \m  i o Monosomy A, B
Fig.3.1: a. Triple-colour FISH strategy developed for the PGD of reciprocal translocations. Out 
of the three probes, two (red, green) flank the breakpoint on one of the two chromosomes 
involved in the translocation, and one probe (orange 50:50 redrgreen) is located on the other 
chromosome. The homologous segments of the two normal and the two derivative 
chromosomes pair-up during meiosis and form the pachytene quadrivalent, b. The pachytene 
quadrivalent theoretically segregates in 8 different ways: three 2:2, four 3:1 and one 4:0. These 
generate 16 different gamete types. The signal patterns are different for each of the different 
modes of segregation. Identification of all unbalanced segregations is feasible with this probe 
strategy. The signal pattern is identical for the normal and balanced segregants.
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3.2 PGD for three couples with reciprocal translocations
During the first meiotic division in the gametes of balanced reciprocal translocation 
carriers, the two normal and two derivative chromosomes align with homologous 
material and form a structure called the pachytene quadrivalent. The FISH strategy 
employed in our centre for the detection of all possible modes of segregation of this 
structure was initially developed by Conn and colleagues (1999) and involves the use of 
two probes that flank the breakpoint on one chromosome and a third probe specific for 
the other chromosome. The “flanking” probes can hybridise at any distance apart, as long 
as one is proximal and the other distal to the breakpoint on that chromosome. With the 
application of this strategy a different combination of signals is achieved for all 
unbalanced chromosome constitutions and all imbalances due to both 2:2 and 3:1 
segregations are detected. However, this strategy cannot distinguish between a normal 
and a balanced chromosome complement (Fig. 3.1).
FISH protocols were devised for three couples that were referred to our centre because 
one of the partners was a carrier of a reciprocal translocation. Out of these, two cases 
reached the biopsy stage, whereas the third couple is was treated after completion of this 
thesis. The patient karyotypes were the following: 46,XY, t(5;19)(pl2;pl2), 46,XX, 
t(l 1 ;22)(q23.3;ql 1.2), and 46,XY, t(14;16)(ql 3;ql 1.1). A combination of locus-specific, 
subtelomeric and centromeric probes was employed for all cases. All probes used were 
commercial, apart from one locus-specific probe for chromosome 19 that was developed 
from a YAC clone.
3.2.1 Case A: Reciprocal translocation 46.XY, t(5:19Kpl2;pl2)
This couple was referred for PGD due to a paternal balanced reciprocal translocation 
46,XY, t(5; 19)(p 12;p 12). The couple had experienced several years of infertility due to 
severe oligospermia. Maternal age was 25 at the time of treatment.
The FISH protocol devised for this case employed only locus-specific probes, as the 
centromeric probes for chromosomes 5 and 19 cross-hybridised. Thus, the probe 
combination used consisted of the commercial LSI EGR1 or “Cri du chat” dual probe that 
flanked the breakpoint on chromosome 5 (binding positions: 5q31-SO, seen as red and
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5pl5.2-SG, seen as green) and a locus-specific probe for chromosome 19 that was 
developed from a YAC clone, due to lack of a commercially available probe at the time 
of treatment. The latter mapped on 19ql3.2 and was labelled in SO, red +SG, green to 
give orange fluorescence. This combination was tested on both control (46,XY) and 
patient lymphocytes giving a FISH efficiency of 96.75%. Signal appearance was 
evaluated on lymphocytes and a spare embryonic nucleus. In both cases the commercial 
probe for chromosome 5 gave intense and clearly visible signals. The YAC probe for 19 
was also clearly seen, but its signals were diffuse.
One PGD cycle was carried out for this couple, and ICSI was used, due to the severe 
oligospermia of the male partner. Twenty oocytes were recovered, and fifteen fertilised 
(fertilisation rate 75%). On day 2 all fifteen embryos consisted of 4-5 cells, whereas on 
day 3 all of them were at the 6-8 cell stage. Out these 15 embryos, 13 were considered 
suitable for biopsy, and two cells were taken from each of them.
Of the 26 blastomeres investigated, results were obtained from 19, as some of them lysed 
during spreading, or were lost during the FISH procedure. Unfortunately, only one of 
these blastomeres showed the expected signals for the “Cri du chat” and YAC probes to 
be considered normal or balanced, i.e. two SO and two SG signals for chromosome 5 and 
two orange signals (red+green) for chromosome 19. The second blastomere from this 
embryo had the same signals for the probe hybridising to the two positions on 
chromosome 5, and two additional red signals, but no green signals. The latter was 
explained as possible failure of hybridisation for the labelled in green YAC probe, as 
during preliminary work, its signals were fainter compared to the red YAC probe and the 
“Cri du chat” probe. The other possible explanation was that the chromosome 
complement of this blastomere included two chromosomes 5, two derivatives of 5 and no 
chromosome 19. The latter however, would not result in a viable pregnancy. This embryo 
was transferred, but pregnancy did not follow. The blastomeres from the remaining 
embryos were all considered as abnormal. All remaining non-transferred embryos were 
analysed after the embryo transfer took place, in order to confirm the initial diagnosis. As 
the yeast strain carrying the YAC insert failed to grow after further culturing, and all the 
DNA had been labelled for the blastomere diagnosis, the non-transferred embryos were 
analysed only with the “Cri du chat” probe for chromosome 5.
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Fig. 3.2: PGD for Case A, 46,XY,t(5;19)(pl2;pl2)
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a:FISH Analysis of Patient 
Lymphocyte Metaphase
Dual locus specific probe-5p 15.2 (SG), 5q31 (SO) 
O YAC probe- 19 q 13.1 (SG & SO)
b: FISH Analysis of Biopised Blastomeres for PGD
Fig.3.2: a (i) PGD triple probe strategy selected for Case A, 46,XY,t(5;19) 
(pl2;pl2).
(ii) Triple-colour FISH using the probes from (i) on patient chro­
mosomes.
b The same probe combination applied to blastomeres coming from 
preimplantation embryos during the PGD cycle for this couple.
(i) Blastomere with normal or balanced chromosome complement 
(2 green, 2 red, 2 orange).
(ii) Blastomere with monosomy 5q31->qter (lred, 2 green).
(iii) Blastomere with monosomy 5(1 red , 1 green).
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The latter meant that information was obtained for chromosome 5 and the two 
derivatives, but not for chromosome 19 alone. Of the 12 spare embryos, eight were 
categorised as chaotic (66.66%) and 4 as aneuploid or aneuploid mosaic (33.3%). Due to 
the high incidence of chaotic embryos, the meiotic segregation was determined only for 
two and was in one case alternate and the other adjacent-2. Table 3.1 shows the results 
obtained from the biopsied cells, the non-transferred embryos, their classification and the 
possible segregation in the sperm. Detailed analysis of the non-transferred embryos using 
the ISCN nomenclature is shown in Appendix B. FISH analysis of a patient metaphase 
along with a normal/balanced and two unbalanced blastomeres can be seen in Fig. 3.2.
Sperm analysis (carried out by B. Smith) demonstrated that alternate segregation was 
observed in 54% of the gametes, while the rest were as follows: 18% adjacent-1, 11% 
adjacent-2, and 13% 3:1 disjunction.
This couple did not come through for a second cycle, as the female partner was able to 
conceive naturally one year later.
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Table 3.1:Case A, 46,XY,t(5;19)(pl2;pl2); FISH analysis of biopsied cells and non-transferred embryos in one PGD cycle.
Embryo Biopsied cell(s) Cells from remainder of embryo Embryo classification Possible segregation 
(paternal gamete type)
1 A: Monosomy 5ql 1 ->qter, 
monosomy 19 
B: Lost during FISH procedure
1: Trisomy 5pl2->pter 
nullisomy 19pl2->pter.
2: normal/balanced for 5 
3: Monosomy 5ql l->qter and monosomy 
19qll->qter 
4: Trisomy 5pl2->pter, nullisomy 19pl2- 
>pter
Chaotic Unknown
2 A: Failure of hybridisation 
B: Monosomy 19
1: Balanced for chromosome 5 
2: Trisomy 5pl2->pter, monosomy 19ql 1- 
>qter, nullisomy 19pl2->pter 
3: Monosomy 5 
4: Nullisomy 19 
5: Trisomy 5qll->qter, monosomy 19pl2- 
>pter
6: Monosomy 5ql l->qter 
monosomy 19qll->qter, nullisomy 19pl2- 
>pter
Chaotic Unknown
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Embryo
5
Biopsied cell(s)
No results as cells lysed during 
spreading
Cells from remainder of embryo
1: Tetrasomy 5pl2->pter, nullisomy 19pl2- 
>pter 
2: Tetrasomy 5 
3: Tetrasomy 5pl2->pter, nullisomy 19pl2- 
>pter
4: Tetrasomy 5pl2->pter, nullisomy 19pl2- 
>pter
5: Trisomy 5, monosomy 19ql l->qter 
6: Trisomy 5pl2->pter, monosomy 19ql 1- 
>qter, nullisomy 19pl2->pter
Embryo classification
Chaotic
Possible segregation 
(paternal gamete type) 
Unknown
7 A: Failure of hybridisation of SG 
YAC probe, possibly 
normal/balanced 
B: Normal/balanced
Transferred Normal or balanced Alternate
8 A (binucleate)
Al: Trisomy 5pl2->pter, 
nullisomy 19pl2->pter 
A2: Trisomy 5pl2->pter, 
monosomy 19qll->qter, 
nullisomy 19pl2->pter
1: Trisomy 5pl2->pter, monosomy 19ql 1- 
>qter, nullisomy 19pl2->pter 
2: Trisomy 5 
3: Trisomy 5 
4: Trisomy 5pl2->pter, monosomy 19ql 1- 
>qter, nullisomy 19pl2->pter
Chaotic Unknown
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Embryo
9
Biopsied cell(i)
A: Lost during FISH procedure 
B: Monosomy 5, monosomy 19
Cells from remainder of embryo
Embryo lost during spreading
Embryo classification
Abnormal
Possible segregation 
(paternal gamete type) 
Inconclusive
10 A: Monosomy 5ql l->qter, 
monosomy 19pl2->pter 
B: Monosomy 19
1: Trisomy 5ql 1 ->qter 
2: Trisomy 5qll->qter 
3: Trisomy 5, monosomy 19 
4: Trisomy 5, monosomy 19
Mosaic aneuploid 
chaotic
Unknown
11 Both cells lost during the FISH 
procedure
1,2 ,3 ,4 : Monosomy 19 
5,6: Monosomy 5
Mosaic aneuploid Unknown
13 A (binucleate)
A l, A2: Monosomy 5pl2->pter, 
trisomy 19pl2->pter 
B: Lost during the FISH 
procedure
1: Monosomy 5 
2: Monosomy 19 
3: Monosomy 5pl2->pter, monosomy 19pl2- 
>pter, nullisomy 19ql l->qter
Chaotic Unknown
14 A: Monosomy 5qll->qter, 
monosomy 19qll->qter, 
nullisomy 19pl2->pter 
B: Monosomy 5
1,2 ,3 ,4 : Monosomy 5ql l->qter, 
monosomy 19qll->qter, nullisomy 19pl2- 
>pter
4: Monosomy 5pl2->pter, monosomy 19pl2- 
>pter 
5: Monosomy 5
Chaotic Unknown
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Embryo
15
Biopsied cell(s)
No results, as cells lysed during 
spreading
Cells from remainder of embryo
1,2, 3,4: Tetrasomy 5pl2->pter, monosomy 
5q 11 ->qter, trisomy 19q 11 ->qter
Embryo classification
Uniformly abnormal
Possible segregation 
(paternal gamete type) 
Does not fit any 
standard segregation 
pattern
17 Both cells lost during FISH 
procedure
1: Trisomy 5ql l->qter, monosomy 5pl2- 
>pter
2-6: Monosomy 5pl2->pter, and monosomy 
19pl2->pter
Mosaic aneuploid 2:2 Adjacent-2
18 A: Trisomy 5, nullisomy 19 
B: Lost during FISH procedure
1: Trisomy 5pl2->pter, monosomy 19ql 1- 
>qter
2: Trisomy 5ql l->qter, monosomy 19pl2- 
>pter 
3,4: Trisomy 5
Chaotic Unknown
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3.2.2 Case B: Reciprocal translocation 46.XX. tdl:22)(q23.3:qll.2)
The balanced reciprocal translocation carrier in this case was the female partner, whose 
karyotype was 46,XX, t(ll;22)(q23.3;qll.2). The couple had experienced four early 
spontaneous abortions in the 12 months preceding treatment. Maternal age was 28 at the 
time of the two PGD cycles.
The FISH protocol devised for this case employed one dual locus-specific probe for 
chromosome 22 and one centromeric probe for the heterochromatic region of 
chromosome 11. More specifically, the probe combination applied during both PGD 
cycles involved the commercial LSI VCFS or “Di George” dual probe (Vysis/Abbot) 
flanking the breakpoint on chromosome 22 (binding positions: 22qll/TUPLEl-SO, seen 
as red and 22ql3/ARSA-SG, seen as green) and another commercial centromeric probe, 
the CEP11 (Vysis/Abbott) for chromosome 11 hybridising on the alpha-satellite region of 
this chromosome. An orange colour was achieved for this probe by mixing SO and SG 
probes together. This combination was tested on both control (46,XY) and patient 
lymphocytes giving a FISH efficiency of 98%. Signal appearance was evaluated on 
lymphocytes only. Both probes gave signals that were bright and clear on metaphase and 
interphase nuclei. The signals for the locus-specific probe would sometimes appear as 
split. The latter was an expected observation on the lymphocyte cells as the probe 
hybridised to unique sequences on the two chromatids of chromosome 22. Embryonic 
nuclei are much more compact compared to lymphocyte interphases, and thus locus- 
specific probe signals are much more discreet.
Two IVF cycles were carried out for this couple. In the first standard IVF cycle, twelve 
oocytes were collected, but only five of these fertilised, leading to a fertilisation rate of 
41.6%. Three embryos consisted of 6-8 cells on day 3, all of which were biopsied and 
had two blastomeres taken from each. FISH analysis of the biopsied blastomeres was 
carried out by A. Mantzouratou. During diagnosis, FISH results were obtained for all 
cells, which showed a chaotic chromosome complement with nuclei coming from the 
same embryo not agreeing as far as the observed signal patterns, were concerned. Thus, 
no embryo was considered suitable for transfer in this first PGD cycle.
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The three biopsied embryos, along with the remaining two that were not considered fit 
for biopsy on day 3 of development, were analysed with the probe combination used for 
the PGD diagnosis, in order to confirm the latter. These embryos were re-analysed with 
another probe set including a lab-prepared centromeric probe for chromosome 15 labelled 
in SO, another lab-prepared centromeric probe for chromosome 16 labelled in SG and a 
commercial centromeric probe for chromosome 18 (CEP 18, Vysis/Abbott) labelled in 
SA, in order to further investigate their chromosome complement. Details of these probes 
are shown in Table 2.2. Out of these five embryos, the three that were biopsied were 
classified as fully chaotic (60%), showing a different signal pattern and thus, 
chromosome complement, in almost each of their nuclei. The remaining two gave 
inconclusive results, due to their nuclei either appearing as fragments or being very faint 
without any signals. Details of these results are seen in Table 3.2. Because of the chaotic 
nature of these embryos, segregation patterns could not be determined, and the 
unfertilised oocytes were not provided for analysis.
ICSI was used for the second treatment cycle for this couple, due to the low fertilisation 
rate during the first cycle. Fourteen oocytes were recovered, nine were fertilised 
(fertilisation rate 64.3%), and eight embryos were considered suitable for biopsy on day 3 
of preimplantation development. Out of these, two blastomeres were obtained from only 
two embryos, which also had the best morphology. One blastomere was obtained from 
the rest, as they consisted of less than 6 cells and were of poorer morphology on the day 
of the biopsy. FISH results were obtained from 8 of the biopsied cells, as some of them 
were either covered with cytoplasm or were lost during the FISH procedure. The same 
probe combination used for the 1st PGD cycle was employed this time as well. However, 
this batch of probes was not initially tested on lymphocytes, as they had arrived the day 
previous to the actual biopsy. During diagnosis, it was observed that the SG CEP11 probe 
had almost completely failed to hybridise on the embryonic nuclei, and had hybridised 
poorly on the control lymphocyte slide. Even so, with considered judgement, two 
embryos were identified as normal or balanced and were transferred on day 4. Diagnosis 
was based on two blastomeres from the first and on one blastomere from the second. 
Both were at the morula stage of preimplantation development. All the remaining 
embryonic nuclei were considered as abnormal.
Fig.3.3: PGD for Case B, 46,XX,t(ll;22)(q23.3;qll.2)
der
/  *
11 der 
22
(ii)
d e r ll
15 5
a: FISH Analysis of Patient 
Lymphocyte metaphase
w  (i)
CEP 11 probe- alpha satellite (SO&SG)
Dual locus specific probe- 22ql3 (SG), 22ql 1 (SO)
(i) I  d o  I  (iii)
b: FISH Analysis of Biopsied Blastomeres for PGD
Fig.3.3: a (i) PGD triple probe strategy selected for Case B 46,XX,t(l 1;22) 
(q23.3;ql 1.2).
(ii) Triple-colour FISH combination using the probes from (i) on a 
patient metaphase, 
b The same probe combination applied to blastomeres from the 
embryos generated by this couple during 2 PGD cycles.
(i) Blastomere with normal or balanced chromosome complement 
(2 red, 2 green, 2 orange).
(ii) Blastomere with monosomy 11(1 orange) and monosomy 22 (1 
red, 1 green).
(iii) Blastomere with one derl 1 (1 orange, 1 green) and trisomy 22 (3 
red, 3 green).
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This double embryo transfer resulted in a clinical pregnancy and a normal live birth.
The non-transferred embryos were analysed with the probe combination applied 
during the 2nd PGD cycle, in order to confirm the initial diagnosis. However, an older 
batch of SG CEP11 probe was used, to obtain more accurate results. They were also 
re-analysed with another commercial (Vysis/Abbott) probe set, including the 
centromeric probe for chromosome 18 labelled in SA, the centromeric probe for 
chromosome X labelled in SG and the centromeric probe for chromosome Y labelled 
in SO. Details of these probes are shown in Table 2.2. This re-analysis took place in 
order to further investigate the chromosome complement of the non-transferred 
embryos. Out of the six non-transferred embryos, one was lost after the 1st round of 
FISH, whereas three more were lost sifter the second round of FISH. According to the 
signal patterns after both rounds of FISH, the embryos were classified in the 
following categories: one aneuploid mosaic and chaotic for the sex chromosomes, one 
balanced aneuploid mosaic, one balanced chaotic mosaic, one uniformly abnormal, 
and two fully chaotic. The segregation could be determined as follows: Alternate for 
the two transferred embryos, 3:1 interchange combined with mitotic non-disjunction 
for the mosaic aneuploid and the mosaic aneuploid balanced embryos, and 2:2 
adjacent-1 for the uniformly abnormal embryo (results based on biopsied cell). 
Similarly to the 1st PGD cycle, unfertilised oocytes were not provided for FISH 
analysis.
Details of the chromosome constitutions of these embryos are shown in Table 3.2. A 
patient metaphase demonstrating the binding positions of the probes used for 
diagnosis and pictures of a normal and two abnormal blastomeres are shown in 
Fig.3.3. Detailed cytogenetic analysis of all embryonic nuclei is described in 
Appendix B.
In summary, during both PGD cycles, twenty-six oocytes were collected, fourteen 
fertilised, and eleven embryos were considered suitable for biopsy on day 3. Out of 
these, 2 were considered as normal or balanced (18.2%), 5 as fully chaotic (45.4%), 
while the remaining of the abnormal chromosome complements observed varied. 
Even though this couple produced a relatively low number of embryos during both 
cycles and the majority were considered as abnormal a healthy pregnancy was 
achieved, which resulted in the birth of a normal male.
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Case B Results
Table 3.2; Case B, 46,XX,t(l l;22)(q23.3;ql 1.2); FISH analysis of biopsied cells and non-transferred embryos in two PGD cycles.
Embryo 
l gt cycle
Biopsied cell(s)
FISH probes for 11 and 22
Cells from remainder of embryo 
FISH probes for 11,22,15,16,18
Classification Possible segregation 
(maternal gamete type)
1 Not biopsied Fragmented nuclei 
1: Nullisomy 11, nullisomy 18 
2: Nullisomy 11, nullisomy 16
Inconclusive Unknown
2 Not biopsied 1: Monosomy 22ql 1.2->qter 
2: Monosomy 11, nullisomy 22 
No signals visible upon re-FISH
Inconclusive Unknown
10 A: Apoptotic, no signals 
B: Monosomy 11
1: Monosomy 11, monosomy 16, nullisomy 15 and 18, 
inconclusive for 22 
2: Monosomy 1 lq22.3->pter, trisomy 22ql 1.2->qter, 
monosomy 16, nullisomy 15 and 18
Chaotic Unknown
11 A: nullisomy 11, tetrasomy 
22ql 1.1 ->pl 3, monosomy 
22ql 1,2->qter 
B (binucleate)
Bl: nullisomy llq22.3- 
>pter, nullisomy 22ql 1.2- 
>qter
1: Nullisomy 1 lq22.3->pter, monosomy 22ql 1.2->qter, 
nullisomy 15, monosomy 18 
2: Nullisomy 1 lq22.3->pter, monosomy 22ql 1.2->qter 
3: Nullisomy 11, monosomy 22ql 1.2->qter, monosomy 15 
and 16, nullisomy 18 
4: Nullisomy 22ql l->pl3, nullisomy 1 lq23.3->qter, 
monosomy 15 and 16 
5: Tetrasomy 1 lq23.3->qter, monosomy 15, nullisomy 16
and 18
Chaotic Unknown
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Embryo 
1st cycle
12
Biopsied cell(s)
FISH probes for 11 and 22
Both nuclei gave
inconclusive results
Cells from remainder of embryo 
FISH probes for 11,22,15,16,18
1: Nullisomy 11, trisomy 16
2: Nullisomy 11, monosomy 16
Classification
Chaotic
Possible segregation 
(maternal gamete type)
Unknown
Embryo 
2nd cycle
Biopsied cell(s)
FISH probes for 11 and 22
Cells from remainder of embryo 
FISH probes for 11,22,18, X, Y
Classification Possible segregation 
(maternal gamete type)
1 A: No signals, as nucleus 
covered with cytoplasm
1: Monosomy 11, trisomy X 
2: Monosomy 11, trisomy X, disomy Y 
3: Monosomy 11, trisomy 22, disomy Y
Mosaic 
aneuploid, 
chaotic for 
sex
chromosomes
3:1 Interchange, oocyte 
with chromosome 22 
only
2 A: Monosomy 22 
B: Lost during FISH process
1: Trisomy 22 
2: Balanced for both 11 and 22 
Both nuclei lost after 2nd round of FISH
Mosaic
balanced
aneuploid
Alternate, combined 
with mitotic non­
disjunction
3 A: Normal or balanced Transferred Normal or 
balanced
Alternate
5 A: Lost during FISH 
process 
B: Inconclusive
1: Trisomy 22ql 1.1 ->pl3 
2: Monosomy 11 and 22 
Both nuclei lost after 2nd round of FISH
Chaotic Unknown
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Embryo 
2nd cycle
Biopsied cell(s)
FISH probes for 11 and 22
Cells from remainder of embryo 
FISH probes for 11,22,18, X, Y
Classification Possible segregation 
(maternal gamete type)
6 A: Normal or balanced 
B: Normal or balanced
Transferred Normal or 
balanced
Alternate
7 A: Tetrasomy llq23.3- 
>qter, nullisomy 22ql 1.2- 
>qter
1: Monosomy 11 
2: Balanced for both 11 and 22 
3: Monosomy 11, trisomy 22 
Nuclei lost after 2nd round of FISH
Mosaic
balanced
chaotic
Unknown
8 A (binucleate)
Al, A2: Monosomy 
1 lq23.3->qter, trisomy 
22ql 1.2->qter
Lost during FISH process Uniformly
abnormal
2:2 Adjacent-1
9 A: Fragments, no signals 1: Nullisomy 11 and 18, monosomy 22ql 1.1 ->pl 3 
2: Nullisomy 11, and 18, monosomy 22ql 1.2->qter 
3: Nullisomy 1 lq22.3->pter, monosomy 18, trisomy 
22qll.l->pl3
4: Trisomy 1 lq22.3->pter, trisomy 18, monosomy 22ql 1.1- 
>pl3, disomy X, trisomy Y
Chaotic Unknown
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Fig 3.4: PGD for Case C, 46,XY,t(14;16)(ql3;qll.l)
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b: FISH Analysis of Spare embryonic blastomeres
Fig. 3.4: a (i) Triple-colour FISH strategy selected for Case C, 
46,XY,t(14;16Xql3;qlU).
(ii) Three-colour FISH using the probes from (i) on 
patient chromosomes. The derl4 was missing 
from this metaphase, 
b (i), (ii) Application of the same three probes on spare 
embryonic nuclei. Both were identified to have a 
normal complement for the examined chromosomes 
(2 green, 2 aqua, 2 red).
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3.2.3 Case C: Reciprocal translocation 46JY. t(14:16)(al3:all.l)
This couple was referred for PGD because of a balanced reciprocal translocation 
identified in the male partner, whose karyotype was 46,XY, t(14;16)(ql3;qll). At the 
time the couple had experienced two years of infertility due to severe oligospermia. This 
was followed by further three years of infertility before treatment commenced. The 
maternal age was 28 at the time of referral.
The FISH protocol devised for this case employed one commercial subtelomeric probe 
for the long arm of chromosome 14, and two commercial probes flanking the breakpoint 
on chromosome 16, all from Vysis/Abbott. Thus, the probe combination involved the 
centromeric CEP 16 probe, labelled in SA and mapping on the beta-satellite region of this 
chromosome, the subtelomere probe for the short arm of chromosome 16 labelled in SG, 
and the subtelomere probe for chromosome 14 labelled in SO. Evaluation of the FISH 
efficiency of this combination took place on control (46,XY) and patient lymphocytes 
giving a FISH efficiency of 95.7%. Signal appearance was evaluated initially on 
lymphocyte metaphases and interphases. All probes gave bright and clear signals. 
However, there was some interference of the SA fluorochrome with the DAPI used to 
stain the nuclei, and both subtelomere probes gave split signals. The latter made the 
testing of this probe combination on a spare embryo essential for reasons mentioned in 
the previous section. One normally fertilised spare embryo was tested. The signals for all 
three probes were much more intense and sharp, and the embryo was considered normal 
for the chromosomes tested. Fig.3.4 demonstrates a patient metaphase showing the 
binding positions of the probe, and two spare embryonic nuclei showing signal 
appearance. The couple were finally treated in May 2004, after preparation of this thesis.
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Fig.3.5: FISH strategy for the PGD of Robertsonian translocations
Meiosis
Pachytene trivalent
DerA/B
a
b Mode of segregation Segregating
chromosomes
Signals visible Embryo outcome
Alternate A, B 2 0 , i m Normal
Adjacent
DerA/B 
A, derA/B 2m ,  i m ,  s m
Balanced 
Trisomy A
Adjacent
B
B, derA/B 3 »  3 *  2X
Monosomy A 
Trisomy B
3:0 Double aneuploidy
A
A, B, derA/B 3 0  3 * ’ 3 *
Monosomy B 
Trisomy A, B
0 I O ,  l«», I O Monosomy A, B
Fig.3.5: a. Triple-colour FISH strategy developed for the PGD of Robertsonian 
translocations. Two probes are used for the detection of the chromosome that is most likely 
to result in a viable trisomy, e.g. 21. In this case one probe (green) hybridises on A and two 
probes (red, orange obtained by combining 50:50 red:green) on B. During meiosis 
chromosomes A and B pair-up with homologous regions from the derA/B. This results in the 
formation of the pachytene trivalent. b. This arrangement theoretically segregates in four 
different ways generating eight different gamete types. Hence, the alternate mode of 
segregation leads to the formation of either normal or balanced gametes, the adjacent 
produces interchange aneuploidy and the 3:0 leads to aneuploidy for both chromosomes 
involved in the rearrangement. The embryo outcome for PGD is represented for each type, 
assuming that the other parent has a normal karyotype. The application of this FISH strategy 
enables the detection of all unbalanced chromosome constitutions, due to the resulting signal 
patterns being different, depending on the segregation. As with the FISH approach for the 
PGD of reciprocal translocations, this FISH strategy cannot distinguish between normal and 
balanced chromosome constitutions.
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3.3 PGD for two couples with Robertsonian translocations
The first meiotic division in the gametes of balanced Robertsonian translocation carriers 
is somewhat different from reciprocal translocation carriers. More specifically, the 
derivative metacentric chromosome and the two normal homologues synapse together 
and behave as a trivalent.
In such cases, centromeric probes cannot be used, due to sequence homology between 
chromosomes 13 and 21 and 14 and 22. Thus, the FISH strategy used involved two or 
three locus-specific probes, labelled in different colours, which hybridised to a position 
on the long arm of each of the two acrocentric chromosomes that formed the derivative 
chromosome (Fig. 3.5).
FISH strategies were devised for two couples that were referred in our centre, as one of 
the two partners was a balanced carrier of a Robertsonian translocation. Two PGD cycles 
were carried out for both cases. The patient karyotypes were as follows: 45,XY, 
t(13;21)(ql0;ql0), 45,XY, t( 13; 14)(q 10;q 10). A three-colour FISH protocol was applied 
in the first case, with two probes hybridising on chromosome 21 and one on chromosome
13, whereas two locus-specific probes were used for the second case, one mapping on the 
long arm of chromosome 13 and the other on the long arm subtelomere of chromosome
14. All probes were commercially available.
3.3.1 Case D: Robertsonian transiocation 45.XY. t(13:21t(qlO:alOI
This couple was referred to our centre after having experienced four years of primary 
infertility, due to severe oligoasthenoteratozoospermia. Cytogenetic investigations of the 
male partner revealed that he was a balanced carrier of a Robertsonian transiocation. His 
karyotype was identified to be: 45,XY, t(13;21)(ql0;ql0). The maternal age was 34 at the 
time of treatment.
The FISH protocol used for this case involved the application of two locus-specific 
probes and one subtelomeric probe. Thus, one probe was used for the detection of 
chromosome 13. The latter hybridised on position 13ql4, was labelled in SG and was 
commercially available (Vysis/Abbott, UK). Two probes were used to identify 
chromosome 21, as this chromosome was associated with the more viable trisomy. Out of 
these, the first mapped on positions 21q22.13-q22.2, was labelled in SO and was
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provided by Vysis/Abbott. The second mapped on the telomere of the long arm of 
chromosome 21, was provided by Oncor, UK and was labelled in orange by mixing red 
and green together. This triple probe combination was initially tested on control (46,XY) 
and patient lymphocytes, resulting in a FISH efficiency of 94%. Observation of 
metaphase chromosomes and interphase nuclei showed that all probes gave clear signals. 
However, the two locus-specific probes were relatively more intense compared to the 
subtelomeric probe. Split signals were also seen on some nuclei.
Two treatment cycles were carried out for this couple. ICSI was used both times, in order 
for fertilisation of the oocytes to be achieved. During the first PGD cycle nine oocytes 
were collected, and seven fertilised, resulting in a fertilisation rate of 77.7%. Out of the 
seven embryos created, six were considered fit for biopsy on day 3. Eleven blastomeres 
were obtained in total, but FISH results were acquired only from seven. The rest were 
either lost during spreading, or they were too faint to be detected under the phase 
microscope. Diagnosis led to the identification of three normal or balanced embryos. The 
latter were all transferred, but no clinical pregnancy was achieved.
The non-transferred embryos from this first cycle were biopsied for a second time on day 
4, and the blastomeres that were taken were to be analysed with the application of CGH. 
These embryos were then placed on slides and analysed with the same probes used on 
the day of the diagnosis, to confirm the latter. Further investigations of their chromosome 
constitution took place with the use of another commercial centromeric probe set for 
chromosomes 18 labelled in SA, X labelled in SG, and Y labelled in SO (Vysis/Abbott, 
UK). Details of all probes and combinations are shown in Tables 2.2 and 2.3. Out of the 
three spare embryos, FISH results were obtained for two, as one was lost during 
spreading. Thus, one was identified as fully chaotic, while the other one gave 
inconclusive results after both rounds of FISH. CGH analysis (carried out by M. 
Simopoulou) revealed a mosaic balanced aneuploid chromosome complement.
During the second treatment cycle, thirteen oocytes were collected, twelve were injected, 
and ten were fertilised (fertilisation rate: 83.3%). Nine embryos were biopsied, leading to 
FISH analysis of twelve blastomeres (two were obtained from 4 embryos and 1 from the
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Fig. 3.6: PGD for Case D, 45,XY,der(13;21)(qlO;qlO)
13 21 der 13/21
3 der13/21
t 21
a: FISH Analysis of Patient Lymphocyte 
metaphase
LSI 13 probe-13q 14 (SG)
LSI 21 probe-2 Iq22.13-q22.2 (SO) 
iTEL 21 q probe- 21qter (green/red- orange)
b: FISH Analysis of Biopsied Blastomeres for PGD
Fig. 3.6: a (i) Triple probe strategy devised for the PGD for Case D, 
45,XY,der(13;21XqlO;qlO).
(ii) The same probe combination applied on a patient metaphase, 
b Blastomeres from embryos generated by this couple during two PGD 
cycles:
(i) Blastomere with a normal or balanced chromosome complement (2 
green, 2 red, 2 orange).
(ii) Blastomere trisomic for 13 (3 green), and monosomic for 21 (1 red, 
1 orange).
(iii) Blastomere monosomic for 21 (1 red, 1 orange) and normal for 13 
(2 green). The red and one of the two green signals appeared to be 
very close together.
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remaining five. Results were obtained from all cells, apart from one that was lost 
during the FISH procedure. The same probe combination used in the first cycle was 
also employed for this second cycle. Similarly to the first cycle, three embryos were 
identified as normal or balanced and were transferred, but no clinical pregnancy 
ensued.
The six non-transferred embryos were analysed only with the probes used for 
diagnosis, to confirm the latter and investigate their chromosome status. No further 
analysis took place, as all nuclei were of very poor morphology, being very faint and 
fragmented in some cases. All were classified as chaotic, showing different 
chromosome complements in almost all their cells. Details of the chromosome 
constitutions observed in embryos from both cycles are shown in Table 3.3. 
Cytogenetic analysis of all nuclei according to the ISCN nomenclature is described in 
Appendix B. Fig. 3.6 demonstrates a patient metaphase with the probes used for the 
FISH diagnosis, along with pictures of a normal and two abnormal blastomeres.
Sperm was available for FISH analysis (carried out by B.Smith) in this case. From the 
results, it was evident that 89% of the male gamete chromosomes were segregating in 
an alternate mode. This agreed with the identification of six normal or balanced
embryos out of the fifteen that were analysed in both cycles.
In summary, in the two treatment cycles that took place for this couple, twenty-two 
oocytes were collected, seventeen fertilised, and fifteen embryos were considered of 
appropriate morphology and cell number to be biopsied on day 3 of preimplantation 
development. Six embryos were classified as normal or balanced (40%), one was 
classified as mosaic balanced/aneuploid (6.6%), one as aneuploid (6.6%), based on 
the biopsied cell results, and seven were characterised as chaotic (46.6%). Conn and 
colleagues (1998) observed that the high incidence of chaotic embryos is patient- 
specific and tends to lead to a poor PGD outcome. The latter, along with the fact that 
all embryos from this couple were of relatively poor morphology, could explain their
failure to achieve pregnancy in either of the two PGD cycles.
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Table 3.3: Case D, 45,XY,der(13;21)(qlO;qlO); FISH analysis of biopsied cells and non-transferred embryos in two PGD cycles.
Embryo 
l 8t cycle
Biopsied cell(s)
FISH probes for 13 and 21
Cells from remainder of embryo 
FISH probes for 13,21,18, X, and Y
Embryo classification Possible 
segregation 
(paternal gamete type)
2 A: Lost during spreading 
B: Trisomy 13
Lost during spreading Aneuploid 
Results obtained from 1 
cell only
Inconclusive, 
possibly adjacent-1
3 A: Normal Transferred Normal or balanced Alternate
4 A: Trisomy 21, no information on 
13
B: Lost during spreading
1: Trisomy 21, normal for 13,18, X, and 
Y
2: Monosomy 13, 21, nullisomy 18, X 
and Y
3: Trisomy 21, lost after 2nd round of 
FISH
4: Monosomy 13,21, nullisomy 18 and 
X
Chaotic Unknown
5 A, B: Normal Transferred Normal or balanced Alternate
7 A: Lost during FISH 
B: Normal
Transferred Normal or balanced Alternate
9 A, B: Lost during spreading or FISH 1: Nullisomy 13 Inconclusive from FISH 
Mosaic balanced aneuploid 
after CGH analysis
Unknown
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Embryo 
2nd cycle
Biopsied cell(s)
FISH probes for 13 and 21
Cells from remainder of embryo 
FISH probes for 13 and 21
Embryo classification Possible 
segregation 
(paternal gamete type)
1 A,B: Normal Transferred Normal or balanced Alternate
2 A: Trisomy 13 Nuclei of poor morphology 
1: No signals 
2: Monosomy 21 
3: Monosomy 13 and 21 
4: No signals
Chaotic Unknown
3 A: Monosomy 21 1: Trisomy 13 
2: Normal/balanced 
3: Trisomy 13 
4: Trisomy 13, monosomy 21
Chaotic Unknown
4 A: Trisomy 13, monosomy 21 1: Monosomy 13, nullisomy 21 
2: Monosomy 21 
3: Monosomy 13, nullisomy 21 
4: Trisomy 13, monosomy 21
Chaotic Unknown
5 A: Lost during FISH 
B: Normal
Transferred Normal or balanced Alternate
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Embryo 
2nd cycle
Biopsied cell(s)
FISH probes for 13 and 21
Cells from remainder of embryo 
FISH probes for 13 and 21
Embryo classification Possible 
segregation 
(paternal gamete type)
6 A: Normal Transferred Normal or balanced Alternate
7 A: Trisomy 13 1: Trisomy 13,
2: Trisomy 13 
3: Six copies of 13 
4: Trisomy 13 
5: Monosomy 13 
6: Monosomy 21
Chaotic Unknown
8 A: Trisomy 21 1: Monosomy 21 
2: Trisomy 21,5 copies of 13 
3: Trisomy 21,5 copes of 13 
4: Trisomy 13 
5: Trisomy 13, 21 
6: Trisomy 13, 21
Chaotic Unknown
9 A: Normal 
B: Tetrasomy 13, trisomy 21
1: Trisomy 21 
2: Monosomy 21, nullisomy 13 
3: Normal/balanced
Chaotic Unknown
159
Case E Results
3.3.2 Case E: Robertsonian transiocation 45.XY. t(13:14)(al0:al0)
This couple had experienced many years of infertility, as the male partner was 
oligospermic. He had had IVF treatment in the past with a previous partner. This 
treatment resulted in a clinical pregnancy, which aborted spontaneously during the first 
trimester. Cytogenetic analysis revealed that he was a balanced carrier of a Robertsonian 
transiocation, his karyotype being: 45,XY, t(13;14)(ql0;ql0). His sister was identified to 
be carrying the balanced form of this transiocation and had also experienced early 
spontaneous abortions. The maternal age was 37 at the time of both PGD cycles.
A dual colour FISH protocol was developed for this case. The probes used included the 
locus-specific probe for chromosome 13, hybridising on region 13ql4 and labelled in SG 
and the subtelomere probe for the long arm of chromosome 14, mapping on 14qter and 
labelled in SO. Both probes were commercially available (Vysis/Abbott, UK). As with all 
the previous cases, this probe combination was tested on lymphocytes from both control 
individuals (46,XY) and from the patient as well. FISH efficiency was calculated to be 
98%, and the probes gave intense and clearly visible signals on both metaphase and 
interphase nuclei. The subtelomere probe would sometimes appear as a split signal for 
reasons already mentioned above (3.2.1).
Two PGD cycles were carried out for this couple and ICSI was used in both in order for 
fertilisation to be achieved. During the first treatment twelve oocytes were collected from 
the female partner and eight of them fertilised, resulting in a fertilisation rate of 66.66%. 
All eight resulting embryos were biopsied giving a total of sixteen blastomeres (two from 
six embryos with 6-8 cells, 3 from an embryo with 10 cells and 1 from an embryo with 5 
cells). FISH analysis was carried out by A. Mantzouratou. Results were obtained from 10 
blastomeres, as the remainder were either fragmented, or had no signals due to being too 
cytoplasmic, or apoptotic. According to the observed signal patterns, three embryos were 
identified as normal and were transferred. Unfortunately no clinical pregnancy followed; 
the female partner suffered a kidney infection and this could have prevented 
implantation.
The remaining five non-transferred embryos were initially examined with the probe 
combination used on the day of the diagnosis, in order to confirm the latter. They were
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Fig. 3.7: PGD for Case E, 45,XY,der(13;14)(qlO;qlO)
der 13/14
;ii
der13/14
► LSI 13 probe-13q 14 (SG) a
TelVysion 14q probe- 14qter(SO)3i
a: FISH analysis of Patient 
Lymphocyte Metaphase
b: FISH Analysis of Biopsied Blastomeres for PGD
Fig. 3.7: a (i) Probe strategy devised for the PGD of Case E, 45rKY,der(13;14XqlO;qlO) 
(ii) The same probe combination applied on a patient metaphase, 
b Blastomeres coming from preimplantation embryos, generated by this couple 
during two PGD cycles:
(i) Blastomere showing a normal or balanced complement for the examined 
chromosomes (2 green, 2 red).
(ii) Blastomere monosomic for 13 (1 green) and normal for 14 (2 red).
(iii) Blastomere monosomic for both 13 and 14(1 red, 1 green).
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further investigated with the use of another probe combination, consisting of the lab- 
prepared centromeric probe for chromosome 4 labelled in SG, the lab-prepared 
centromeric probe for chromosome 15 labelled in SO and the commercial 
(Vysis/Abbott, UK) centromeric probe for chromosome 18 labelled in SA. These five 
embryos were classified as follows: one normal or balanced (20%), one aneuploid 
mosaic (20%), and three fully chaotic embryos (60%). Details of the results of the 
biopsied cells and the spare embryos are shown in Table 3.4, and detailed cytogenetic 
analysis of all embryos with the use of ISCN nomenclature is shown in Appendix B.
During the second treatment cycle thirteen oocytes were collected and all of them 
fertilised after ICSI (fertilisation rate 100%). Eight normally fertilised embryos along 
with one that showed three pronuclei (3 PN) were biopsied in day 3, resulting in a 
total of thirteen blastomeres for FISH analysis (two from six embryos consisting of 6- 
9 cells and one from the remaining two that had 4-5 cells). Results were obtained 
from nine cells, as the rest were either fragmented and did not have any signals, or 
they were lost during spreading or FISH. Two embryos were characterised as normal 
and were transferred to the female partner, but no clinical pregnancy was achieved.
The chromosome constitution of the six non-transferred embryos was examined with 
the application of two sets of probes. The first included the two probes used on the 
day of the diagnosis, while the second involved three commercial (Vysis/Abbott, UK) 
centromeric probes for chromosomes 18 labelled in SA, X labelled in SG and Y 
labelled in SO. Embryo classification for this second PGD cycle was as follows: two 
embryos were classified as mosaic balanced/aneuploid (33.3%), one was mosaic 
aneuploid (16.6%), and three were classified as fully chaotic (50%). Details of these 
results, along with those from the biopsied cells are shown in Table 3.4, and 
cytogenetic analysis of all embryos with the use of ISCN nomenclature is shown in 
Appendix B. Fig. 3.7 demonstrates a patient metaphase showing the exact position of 
the probes on the chromosomes involved in the transiocation. One normal and two 
abnormal blastomeres are also illustrated.
Segregation modes in the sperm of the male partner were established as alternate for 
the embryos that were classified as normal or balanced and were transferred. The 
chromosome complements identified for the remaining embryos were attributed to
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post-zygotic errors such as mitotic non-disjunction. Sperm was not available for 
analysis in this case.
Thus, during both PGD cycles for this Robertsonian transiocation twenty-five oocytes 
were collected, twenty-one fertilised and sixteen embryos reached the biopsy stage. 
Both cycles led to the detection of six normal or balanced embryos in total (37.5%), 
five of which were transferred. Three embryos were classified as balanced aneuploid 
mosaic (18.75%), one as aneuploid mosaic (6.25%), and six as fully chaotic (37.5%). 
No clinical pregnancy was achieved in any of the two cycles. The relatively high 
incidence of abnormal embryos, combined with the advanced maternal age and the 
kidney infection of the female partner could be attributing factors.
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Table 3.4: Case E, 45,XY,der(13;14)(qlO;qlO); FISH analysis of biopsied cells and non-transferred embryos in two PGD cycles.
Embryo 
l rt cycle
Biopsied cell(s)
FISH probes for 13 and 14
Cells from remainder of embryo 
FISH probes for 13,14,4,15, and 18
Classification Possible segregation 
(paternal gamete type)
1 A: Fragmented, no signals 
B: Monosomy 14, normal for 
13
1,2,3: Normal for 13 and 14, nullisomy
4.15.18
4,5,6,7: Normal for 13, nullisomy 14,
4.15.18
8: Normal for 13,4, nullisomy 14,15,18 
9: Normal for 14,18, trisomy 13, 
monosomy 15, nullisomy 4
Chaotic Unknown
2 A: Covered with cytoplasm, no 
signals 
B: Normal
Transferred Normal or balanced Alternate
3 A,B: Normal Transferred Normal or balanced Alternate
4 A,B: Normal 1,2,3: Normal for 13,14,4,15,18 
4 (fragment): Monosomy 13,14,4,18, 
nullisomy 15 
5 (fragment): Monosomy 13,14,4, 
normal for 15,18
Normal or balanced 
Fragments could be part of 
the same nucleus, but 
cannot conclude from 
signal patterns
Alternate
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Embryo 
1st cycle
5
Biopsied cell(s)
FISH probes for 13 and 14
A,B: Fragmented, no signals 
C: Normal
Cells from remainder of embryo 
FISH probes for 13,14, 4,15, and 18
Transferred
Classification
Normal or balanced
Possible segregation 
(paternal gamete type)
Alternate
6 A: Faint and apoptotic, no 
signals 
B: Normal
1: Normal for 13,14,4,15,18 
2: Normal for 13,4, monosomy 14,15, 
trisomy 18 
3: Nullisomy for 13,14,4,15,18
Mosaic
balanced/aneuploid
Alternate combined with 
post-zygotic errors
7 A,B: Monosomy 13, nullicomy 
14
1,2: Monosomy 13,14, normal for 
4,15,18
3: Monosomy 13,14, nullisomy 4,15,18 
4: Trisomy 13, monosomy 14, 
nullisomy 4,15,18 
5: Trisomy 13, monosomy 14,4,15, 
nullisomy 18 
6: Normal for 13,14,4,15,18 
7: Monosomy 14, normal for 13, 
trisomy 4,15,18 
8: Nullisomy 13,14, lost after 2nd FISH 
round
Chaotic Unknown
8 A,B: Trisomy 13,14 1,2: Normal for 13,14, nullisomy 
4,15,18
3: Normal for 13,14, monosomy 15, 
nullisomy 4,18 
4: Monosomy 13,14,15, nullisomy 4,18
Chaotic Unknown
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Embryo 
1st cycle
8 cont.
Cells from remainder of embryo 
FISH probes forl3 ,14,4,15, and 18
5: Monosomy 13,14,4,15, nullisomy 18 
6,7: Nullisomy 13,14, normal for 4, 
monosomy 15,18 
8: Trisomy 13,4, monosomy 14, normal 
for 15,18
9: Normal for 13, monosomy 14,4,15,18 
10: Nullisomy 14, monosomy 15, 
normal 13,4,18 
11: Trisomy 13, normal 14,4,15,18
Embryo 
2nd cycle
Biopsied cell(s)
FISH probes for 13 and 14
Cells from remainder of embryo 
FISH probes for 13,14,18, X, and Y
Classification Possible segregation 
(paternal gamete type)
1 A: Monosomy 13, and 14 
B: Lost during FISH
1: Normal for 13,18, tetrasomy 14, 
disomy X, Y 
2: Normal for 13,14, trisomy 18, disomy 
X,Y
3: Normal for 13, tetrasomy 14, 
monosomy 18, trisomy X, disomy Y
Chaotic Unknown
2 A: Monosomy 13 1: Monosomy 13 
2: Monosomy 14 
3: Monosomy 14 
4: Normal for 13,14 
5: Trisomy 13, monosomy 14 
Nuclei lost after 2nd FISH round
Chaotic Unknown
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Embryo 
2nd cycle
Biopsied cell(s)
FISH probes for 13 and 14
Cells from remainder of embryo 
FISH probes for 13,14,18, X, and Y
Classification Possible segregation 
(paternal gamete type)
3 A: Lost during FISH 
B: Normal
Transferred Normal or balanced Alternate
5 A(fragmented): Monosomy 14 
B: Fragments, no signals
1: Trisomy 14 
2,5,6: Normal for 13 and 14 
3: Monosomy 14 
4: Monosomy 13 
Nuclei lost after 2nd FISH round
Mosaic
balanced/aneuploid
Alternate combined with 
post-zygotic errors
6 A,B: Normal Transferred Normal or balanced Alternate
7 A: Lost during FISH 1: Monosomy 13,14 
2: Normal for 13,14 
Nuclei lost after 2nd FISH round
Mosaic
balanced/aneuploid
Alternate combined with 
post-zygotic errors
8 A: Monosomy 14, normal for 
13
B: Monosomy 13,14
Lost during spreading Chaotic Unknown
9 A: Monosomy 13, trisomy 14 1: Normal for 13,18,Y, trisomy 14, 
disomy X 
2: Monosomy 13, trisomy 14, normal 
for 18, Y, disomy X 
3: Normal for 13,18, trisomy 14, 
tetrasomy X, disomy Y 
4: Normal for 13,18,Y, trisomy 14, 
disomy X
Mosaic aneuploid Adjacent-1 combined with 
post-zygotic errors
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3.4 PGD for two couples with possible gonadal mosaicism for trisomy 21
Two couples that were phenotypically normal were referred to our centre in order for 
PGD for trisomy 21 to be carried out. Both couples had trisomy 21 conceptions in the 
past, and both had experienced terminations of affected pregnancies. Cytogenetic 
investigation of lymphocytes took place for both partners in each of the two cases, and all 
karyotypes appeared to be normal 46,XX and 46,XY. Maternal ages were 39 and 37, 
respectively.
Two different strategies were applied for these two couples. In both protocols dual FISH 
probe combinations were employed. More specifically, in the first case two locus-specific 
probes were used for the detection of chromosomes 13 and 21. In the second case one 
locus-specific and one telomeric probe, both mapping on chromosome 21 were used.
3.4.1 Case F: PGD for a couple with ectopic pregnancies and one trisomy 21 
conception
The female partner had experienced two ectopic pregnancies, which led to a bilateral 
salpingectomy. These pregnancies were not karyotyped. Another pregnancy was 
achieved after an IVF cycle, but was terminated at 20 weeks gestation, as the fetus was 
prenatally diagnosed to have Down’s syndrome. The karyotypes of both partners were 
normal 46,XY and 46,XX. Two PGD cycles and a frozen embryo transfer were carried 
out for this couple. Maternal age was 39 at the time of treatment.
The FISH protocol devised for this couple employed two probes, one hybridising on 
chromosome 13 and the other on chromosome 21. Both probes were locus-specific and 
commercially available (Vysis/Abbott, UK). Chromosome 13 was investigated for two 
reasons. The first was the two ectopic pregnancies that the female partner had 
experienced in the past. These were not karyotyped, but it has been suggested that 
chromosomal abnormalities are more frequent in ectopic pregnancies (Karikoski et ah, 
1993). Moreover, the second probe would act as an additional indicator of chromosome 
status. Thus, the probe for chromosome 13 mapped on 13ql4 and was labelled in SG, 
whereas the probe for chromosome 21 hybridised on 21ql3.2-q22.2 and was labelled in 
SO. This probe combination was tested on control (46,XY) lymphocytes, resulting in a 
FISH efficiency of 98%. Signals for both probes were intense and clearly visible on both
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metaphase chromosomes and interphase nuclei. This probe combination was 
subsequently tested on lymphocytes of both the male and the female partner. Four 
hundred interphase nuclei were scored, in order to identify if either of the two partners 
was mosaic for trisomy 21. The results obtained were comparable to those seen on 
lymphocyte controls, i.e. 95% of nuclei had the expected number of signals for both 
probes. Thus, neither of the two partners appeared to be a trisomy 21 mosaic in these 
somatic cells.
Standard IVF was used for fertilisation during the first PGD cycle. Nineteen oocytes were 
collected from the female partner and 17 fertilised normally (fertilisation rate 89.5%). All 
seventeen embryos were considered suitable for biopsy on day 3 of preimplantation 
development. Two blastomeres were taken from twelve embryos consisting of 6-8 cells, 
whereas one blastomere was biopsied from the remaining 5, as they contained 4-5 cells. 
In total 24 blastomeres were spread and FISH results were obtained from ten. The 
remaining fourteen were either lost during spreading or FISH, or no signals were visible 
for various reasons. According to these results, six embryos were characterised as 
chromosomally balanced. Out of these, two were transferred to the female partner, while 
the rest were frozen. No clinical pregnancy was established after this first cycle.
The ten non-transferred embryos along with one that had showed three pronuclei and 
another one that was of poor quality, both of which were not biopsied, were spread onto 
slides. FISH analysis took place with the application of the same probe combination that 
was used on the day of the diagnosis, so as for the latter to be confirmed. These embryos 
were not investigated by further FISH analysis, as their nuclei were of very poor 
morphology. FISH results were obtained for eight of these embryos, which were 
classified as follows: one mosaic diploid/aneuploid (12.5%), one mosaic balanced/chaotic 
(12.5%), one mosaic aneuploid/chaotic (12.5%), and five fully chaotic (62.5%). Another 
embryo transfer followed this first PGD cycle, using two of the embryos that were 
identified as normal and were frozen at the time, but again no pregnancy ensued.
169
PGD Results
Fig. 3.8: PGD for Case F, Possible Gonadal Mosaicism for trisomy 21
21
13
12
11.2
1L1
11
12.1
12.2
12.3
13
14.1
14.2
14.3 
21.1 
21.2
21.3
22
31
32
33
34
(i)
LSI 13 probe-13q 14 (SG) 
LSI 21 probe-2Iq22.13-q22.2 (SO)
a: FISH Analysis of Patient 
Lymphocyte Meta phase
»
(i)
•  •*
(ii) (iii)
b: FISH Analysis of Biopsied Blastomeres for PGD
Fig. 3.8: a (i) Dual-colour probe combination devised for the PGD for Case F.
(ii) The same probes applied on a metaphase from the female partner 
of this couple.
b Blastomeres from preimplantation embryos generated by this couple 
during two PGD cycles:
(i) Blastomere with a normal complement for the chromosomes exami­
ned (2 green, 2 red).
(ii) Blastomere monosomic for 13 (1 green), normal for 21 (2 red).
(iii) Blastomere monosomic for 21 (1 red), nullisomic for 13 (0 green).
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In the second PGD cycle, twenty-four oocytes were collected, and twenty fertilised 
(fertilisation rate 83.3%). Fourteen normally fertilised embryos, one of which initially 
showed 0 pronuclei (0 PN), and one that showed three pronuclei (3 PN) were 
considered fit for biopsy. Two blastomeres were obtained from the fourteen normally 
fertilised embryos, all of which consisted of 6-9 cells, whereas one blastomere was 
obtained for the 0 PN and the 3 PN embryos. FISH results were obtained from 
twenty-one blastomeres, and three embryos were identified as chromosomally normal 
for the chromosomes tested. These were transferred to the female partner. Similarly 
with the other two transfers, no clinical pregnancy was achieved.
The non-transferred embryos were analysed with the same probe combination used on 
the day of the diagnosis. These embryos and the biopsied blastomeres from the 
embryos that were transferred were also examined further with a probe set, including 
the centromeric probe for chromosome 15 labelled in SO, the centromeric probe for 
chromosome 18 labelled in SA and the locus-specific probe for chromosome 22 
labelled in SG. All probes were commercial (Vysis/Abbott, UK) and are shown in 
Tables 2.2 and 2.3. From the results obtained after the two rounds of FISH the 
embryos were classified as follows: five were characterised as mosaic
aneuploid/diploid (41.66%), five as mosaic aneuploid (41.66%), one as chaotic 
(8.3%%) and one as normal for all the chromosomes examined (8.3%). The biopsied 
blastomere from this embryo was lost during the FISH procedure, and hence no 
results were obtained during diagnosis. Details of chromosome constitutions for 
biopsied cells and non-transferred embryos for both cycles are shown in Table 3.5. 
Cytogenetic analysis of all nuclei according to the ISCN nomenclature is described in 
Appendix B. Fig. 3.8 demonstrates a patient metaphase with the probes employed 
during diagnosis, along with pictures of a normal and two abnormal blastomeres.
In summary, during two PGD cycles that took place for this couple, fourty-three 
oocytes were collected and thirty-seven fertilised, resulting in a fertilisation rate of 
86%. Out of the thirty-three embryos that were biopsied, conclusive FISH results 
were obtained from twenty-nine. Ten (34.5%) of those were classified as normal, six 
(20.7%) as mosaic diploid/aneuploid, five (17.24%) as mosaic aneuploid, one (3.45%) 
as mosaic aneuploid/chaotic, one as mosaic balanced/chaotic (3.45%) and six (20.7%) 
as fully chaotic. Oocytes and sperm from the couple were not available for FISH 
analysis, and thus the possibility of one of them being a gonadal mosaic for trisomy
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21 was not investigated directly. However, examination of the spare embryos 
especially from the second PGD cycle, revealed abnormal numbers for chromosomes 
other than those that were investigated during the diagnosis, combined with 
chromosome 21. The inability of this couple to establish a clinical pregnancy could be 
attributed to various factors, including the advanced maternal age (39 years at the time 
of treatment), and the high number of abnormal or mosaic embryos that were 
produced in both cycles. The origin of the abnormalities scored in the non-transferred 
embryos was different between the two cycles. Hence, in the first cycle all 8 spare 
embryos were highly mosaic, chaotic in their majority (5). In the second cycle, 
however, most of the non-transferred embryos (12) were either mosaic aneuploid (5) 
or mosaic diploid/aneuploid (5), and only one was characterised as frilly chaotic. Of 
all the embryos showing aneuploidy, only two were deduced to be of meiotic origin. 
Both (14, 20) were monosomic for 21, and embryo 14 was also trisomic for 13. 
Taking into account the three embryos that were transferred to the mother, the latter 
results in an aneuploidy rate of 2 in 16 for chromosome 21 in the second cycle. The 
mosaicism observed during this second cycle was mostly due to mitotic non­
disjunction, contrary to the chaotics observed during the first PGD cycle. It is 
possible, that the advanced maternal age was the factor leading to both the meiotic 
abnormalities, but to the post-zygotic as well. Evidence for the latter has also been 
provided by Munne and colleagues (2002b) in their study of mosaicism at the 
cleavage-stage of embryo development and the effect of maternal age.
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Table 3.5: Case F, possible gonadal mosaicism for trisomy 21; FISH analysis of biopsied cells and non-transferred embryos in two PGD cycles.
Embryo 
1st cycle
Biopsied cell(s)
FISH probes for 13 and 21
Cells from remainder of embryo 
FISH probes for 13 and 21
Embryo classification
1 Nucleus lost during spreading 1,2,3,4,5: Normal for 13 and 21 
6,7,8,9,10,11,12: Tetrasomy 13 and 21
13,14: Trisomy 13, normal 21
Mosaic diploid/aneuploid
2 A: Normal for 13 and 21 
B: Lost during spreading
Frozen Normal for chromosomes 13 and 21
3 A: Lost during FISH 
B: Normal for 13 and 21
Frozen Normal for chromosomes 13 and 21
4 A: No signals visible Fragmented nuclei with no signals Inconclusive
5 A,B: Normal for 13 and 21 Transferred Normal for chromosomes 13 and 21
6 A: Normal for 13 and 21 Frozen Normal for chromosomes 13 and 21
7 A,B: Normal for 13 and 21 Frozen Normal for chromosomes 13 and 21
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Embryo 
1st cycle
Biopsied cell(s)
FISH probes for 13 and 21
Cells from remainder of embryo 
FISH probes for 13 and 21
Embryo classification
8 Both nuclei lost during spreading 1,2: Tetrasomy 13, normal 21 
3,4: Nullisomy 13, normal 21 
5,6: Nullisomy 13, monosomy 21 
7,8,9: Tetrasomy 13,21 
10: Normal 13,21 
11: Tetrasomy 13, five copies for 21 
12: Nullisomy 13, tetrasomy 21
Chaotic
9 A: Signals not visible clearly during initial 
diagnosis. Nucleus was re-investigated, 
whilst embryo was frozen. Signals were 
not clear during re-investigation 
B: Lost during FISH
Frozen due to required re-investigation Inconclusive
10 A: Inconclusive, due to background 
fluorescence
Very faint nuclei, inconclusive results Inconclusive
11 Not biopsied due to poor quality 1: Normal for 13, tetrasomy 21 
2: Nullisomy 13,21
Chaotic
12 A: Normal for 13, trisomy 21 1,2: Tetrasomy 13,21 
3,4: Nullisomy 13,21
Chaotic
174
Case F  Results
Embryo 
1st cycle
Biopsied cell(s)
FISH probes for 13 and 21
Cells from remainder of embryo 
FISH probes for 13 and 21
Embryo classification
13 A: Normal for 13, monosomy 21 
B: Lost during FISH
Fragmented nuclei with no signals Inconclusive
14 A,B: Lost during FISH 
C: Trisomy 13,21
1,2,3: Nullisomy 13, tetrasomy 21 Chaotic
15 A: Normal for 13 and 21 
B: Large hole in middle of nucleus, one 
signal for 13
Frozen Inconclusive
16 A,B: Normal for 13 and 21 Transferred Normal for chromosomes 13 and 21
17 A: Lost during FISH 
B: Normal for 13, trisomy 21
1: Normal for 13, tetrasomy 21 
2,3: Tetrasomy 13,21 
4: Normal for 13 and 21
Chaotic
18 A: Normal for 13,21 and one 
micronucleus with monosomy 21 
B: Lost during spreading
1,2,3,4: Tetrasomy 13, trisomy 21 
5,6,7,8,9,10,11,12,13,14,15,16,17: 
Normal for 13,21 
18,19,20,21,22,23: Tetrasomy 13,21 
24,25,26,27: Nullisomy 13,21 
28: Eight copies of 13,21 
Two binucleatejcells: Normal 13,21 in 
each of the nuclei
Mosaic balanced/chaotic
3PN Not biopsied 1,2,3,4,5,6,7,8,9,10,11: Trisomy 13,21 
12: Normal for 13, trisomy 21 
13: Trisomy 13, normal for 21 
14: Monosomy 13, trisomy 21 
15,16: Normal for 13,21
Mosaic aneuploid/chaotic
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Embryo 
2nd cycle
Biopsied cell(s)
FISH probes for 13, 21,15,18, and 22
Cells from remainder of embryo 
FISH probes for 13, 21,15,18, and 22
Classification
1 Not biopsied due to poor quality 1,4: Normal for 13,21,15.18.22 
2: Normal for 13,21, monosomy 15,18,22 
3: Monosomy for 13,21, lost after 2nd 
round of FISH 
5: Nullisomy 13,21,18,22, monosomy 15 
6: Normal for 13,21,18,22, monosomy 15
Mosaic diploid/aneuploid
2 A: Lost during FISH 1,2,3,4,5,6: Normal for 13,15,18,21,22 Normal for all chromosomes tested
3 A: Nucleus covered with cytoplasm, two 
signals for 21 visible, no signals visible 
for 13 
B: Normal for 13,21 
Nuclei lost after 2nd round of FISH
Transferred Normal for 13 and 21
4 A: Normal for 13,21,15,18,22 
B: Lost during FISH
Transferred Normal for chromosomes tested
5 A: Monosomy 13, normal for 21 
B: Normal for 13 and 21
1: Monosomy 13,15,18,22, normal for 21 
2: normal for 13,15,18,21,22,
3: Normal for 13,21,15,22, trisomy 18 
4: Monosomy 13,21, trisomy 18, normal 
for 15,22
Mosaic aneuploid
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Embryo 
2nd cycle
Biopsied cell(s)
FISH probes for 13, 21,15,18, and 22
Cells from remainder of embryo 
FISH probes for 13, 21,15,18, and 22
Classification
6 A: Normal for 13 and 21 
B: Normal for 13, trisomy 21
1: normal for 13,21, trisomy 22, 
nullisomy 15,18 
2: monosomy 13, normal for 15,18,21,22 
3: Trisomy 13,21, lost after 2nd round of 
FISH
4,6: Normal for 13,21,15,18,22 
5: Trisomy 13, normal for 21, lost after 
2nd round of FISH 
7: Normal for 13,21,15,22, monosomy 18 
8: Normal for 13, monosomy 21, lost 
after 2nd round of FISH 
9: Normal for 13,21,15,22, trisomy 18
Mosaic diploid/aneuploid
7 A: Normal for 13 and 21 
B: Normal for 13, monosomy 21
1: trisomy 13, normal for 21,22, 
monosomy 15,18 
2: normal for 13,21,15,18, trisomy 22 
3,4,5: Normal for 13,15,18,22, 
monosomy 21 
6: Trisomy 13, normal for 21,15,18,22 
7: Normal for 13,21, lost after 2nd round 
of FISH
Mosaic aneuploid
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Embryo 
2nd cycle
Biopsied cell(s)
FISH probes for 13, 21,15,18, and 22
Cells from remainder of embryo 
FISH probes for 13, 21,15,18, and 22
Classification
9 A: Trisomy 13, normal for 21 
B: Lost during FISH
1: Monosomy 13,21, normal for 15,18,22 
2: Normal for 13,21,15,18,22 
3: Monosomy 13,21,15,18,21 
4: Normal for 13,21,18,22, trisomy 15 
5: Monosomy 13, normal for 21,18, 
trisomy 15,22 
6: Monosomy 13, normal for 21,15,22, 
five copies of 18
Mosaic diploid/aneuploid
10 A: Very faint nucleus, no signals visible 
B: Lost during FISH
All nuclei were fragmented and no 
signals were visible
Inconclusive
11 A: Nullisomy 13, monosomy 21 
B: Anucleate
1,6,9: Normal for 13,21,18,22, 
monosomy 15 
2: Normal for 13,15,18,22, monosomy 
21
3,4: Normal for 13,21,15,18, trisomy 22 
5: Monosomy 13, normal for 21,15,18,22 
7: Normal for 13,21,15, trisomy 18, 
monosomy 22 
8: Normal for 13,21, lost after 2nd round 
of FISH 
10: Normal for 13,21,15,18,22
Mosaic diploid/aneuploid
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Embryo 
2nd cycle
Biopsied cell(s)
FISH probes for 13, 21,15,18, and 22
Ceils from remainder of embryo 
FISH probes for 13, 21,15,18, and 22
Classification
12 A: Trisomy 13,21 
B: Trisomy 13, normal for 21
1: Nullisomy 13,21, trisomy 22, normal 
for 15,18 
2: Monosomy 13,21,15, trisomy 22, 
normal for 18 
3: Nullisomy 13,21,22, trisomy 15, 
monosomy 18 
4: Normal for 13,18, monosomy 21,15, 
trisomy 22 
5: Trisomy 13,21, normal for 15,18,22 
6: Trisomy 13, normal for 21, lost after 
2nd round of FISH
Mosaic aneuploid
13 A: Normal for 13,21 
B: Nullisomy 13,21
Nuclei lost during 1st round of FISH Inconclusive
14 A: Trisomy 13, monosomy 21 
B: Nucleus covered with cytoplasm, no 
signals visible
1,2,3: Trisomy 13, monosomy 21, lost 
after 2nd round 
4: Trisomy 13,22, monosomy 21, normal 
for 15,18
5: Trisomy 13, monosomy 21, normal for 
15,18,22
Mosaic aneuploid
15 A,B: Normal for 13,15,18,21,22 Transferred Normal for all chromosomes tested
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Embryo 
2nd cycle
Biopsied cell(s)
FISH probes for 13, 21,15,18, and 22
Cells from remainder of embryo 
FISH probes for 13, 21,15,18, and 22
Classification
16 A: Normal for 13,21 
B: Normal for 13, monosomy 21
1: Monosomy 13, trisomy 22, normal for 
21,15,18
2: Normal for 13,15,18,22 monosomy 21 
3: Normal for 13,18, trisomy 21,15, 
monosomy 22 
4: Normal for 13,21,18,22, trisomy 15 
5: Normal for 13,21, trisomy 15, 
monosomy 18,22 
6: Trisomy 13, normal for 21, monosomy 
15,22, tetrasomy 18
Mosaic aneuploid
19 Not biopsied 1: Five copies of 13, trisomy 21, four 
copies of 15, monosomy 18,22 
2: Lost during 1st round of FISH
Inconclusive, due to lack of information, 
possibly chaotic (results of 1 nucleus)
20 (0 PN) A: Normal for 13, monosomy 21 1: Normal for 13, monosomy 21,18,22, 
nullisomy 15
Mosaic diploid/aneuploid 
(results of 2 nuclei)
21 (3 PN) A: Lost during FISH 1: Monosomy 13, normal for 21,15,18,22 
2: Tetrasomy 13, trisomy 21,18,22, 
normal for 15
Chaotic 
(results of 3 nuclei)
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3.4.2 Case G: PGP for a couple with recurrent trisomy 21 conceptions
This couple was referred for PGD because of recurrent trisomy 21 conceptions. More 
specifically, the female partner had given birth to two children with Down’s syndrome, 
and one more pregnancy was terminated after being prenatally diagnosed to be trisomic 
for chromosome 21. The karyotypes of both partners appeared to be normal 46,XY and 
46,XX, and maternal age was 37 at the time of referral.
A dual colour FISH strategy was developed for this case, involving the use of a band- 
specific probe for chromosome 21 labelled in red, and the subtelomere probe for the same 
chromosome, labelled in green. Both probes were commercially available (Oncor, UK). 
Testing of this probe combination on control lymphocytes revealed that both hybridised 
to the expected regions of chromosome 21 and gave clear signals, which were sometimes 
split. When observing a metaphase spread, both probes hybridised very close together. 
This was not the case for interphases, though, and as embryonic blastomeres are at the 
interphase stage, the latter would not pose a problem during diagnosis. Scoring of control 
interphases (n=200) resulted to an efficiency of 94.5% for this probe combination.
This probe combination was then evaluated on lymphocytes of both the male and the 
female partner. The signals observed for both probes were equally good as those 
observed on control lymphocytes. In order to identify if either of the two partners was 
mosaic for trisomy 21 or had a structural rearrangement involving this chromosome, 400 
interphase nuclei were scored for both the male and the female partner. Thus, for the 
female partner the two probes showed the expected number of signals in 93.4% of nuclei. 
The latter was comparable to the probe combination efficiency observed in the control 
lymphocytes. Different results were obtained from the scoring of the lymphocytes of the 
male partner. In his case, approximately 10 (25%) cells of the 400 scored consisted of 
three signals for both probes, resulting in an efficiency of detection of disomy of 91.25%. 
The detection of 25% of cells as trisomic for chromosome 21 is a significant finding in 
view of the family history. From the above it was suspected that the male partner could 
be a gonadal mosaic for trisomy 21. However, to confirm this, FISH analysis of his sperm 
would have to take
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Fig. 3.9: PGD for Case G, Possible Gonadal Mosaicism for trisomy 21
21
(i)
Band-specific probe for chromosome 21- 21q22.1 (Red) 
Subtelomere probe for chromosome 21- 21qter (Green)
a: FISH Analysis of a Patient b. FISH Analysis of a Patient
Lymphocyte metaphase interphase
Fig, 3.9: (i) The two different probes targeting chromosome 21. This strategy was 
devised for the PGD of Case G. 
a This probe combination applied on a metaphase from the female partner 
of this couple.
b The same probe combination applied on a lymphocyte interphase from the 
male partner.
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place. This couple decided not to proceed with treatment, because of family problems. 
Thus, no further investigations were carried out. Fig. 3.9 demonstrates a metaphase 
spread showing the positions of hybridisation for both probes, and also an interphase 
nucleus after FISH with these probes.
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3.4 Summary of the outcome of nine PGD cycles
FISH protocols were devised for seven couples, all of who were referred to our centre, 
as one of the two partners was a carrier of a chromosomal abnormality. Out of these, 
five were treated, whereas from the remaining two, one couple came through in 2004, 
and the other decided against PGD treatment due to family problems.
The optimisation of different 3-probe combinations and the extensive chromosomal 
examination of all embryos characterised as abnormal during diagnosis in order to 
establish parental segregation patterns and elucidate the underlying mechanisms 
leading to the generation of highly mosaic and chaotic embryos in this patient group 
were addressed in this part of the project.
Nine cycles (TVF or ICSI) took place and PGD was carried for two balanced 
reciprocal translocations (3 cycles), two balanced Robertsonian translocations (4 
cycles), and one couple with possible gonadal mosaicism for trisomy 21 (2 cycles plus 
one frozen embryo transfer). Maternal ages ranged from 25 to 39 years with a mean 
age of 32.6 years.
During these nine PGD cycles 136 oocytes were retrieved and 104 were fertilised 
successfully (76.5%). Eighty-eight (84.6%) of the embryos created were considered 
suitable for biopsy on day 3 of preimplantation development. Results of FISH analysis 
of the blastomeres obtained revealed that only 21 (23.8%) of these embryos were 
characterised as normal or balanced and were transferred to the female partners. 
Ideally the identification of the balanced embryos was based on FISH results being 
acquired from two biopsied cells. The latter was not feasible in every case, as nuclei 
were either lysed or lost during spreading or the FISH procedure, or were covered 
with cytoplasm, or were of poor morphology or quality without any signals. Eight 
cycles led to the transfer of embryos, one of which resulted in a clinical pregnancy and 
subsequently a normal live birth. Table 3.6 demonstrates the summary outcome of 
these nine PGD cycles.
The remaining non-transferred embryos and some others that were not biopsied due to 
abnormal fertilisation (0 PN or 3 PN) were analysed with the same probe combination
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that was applied on the day of the diagnosis. In two of the five couples being treated, 
two non-transferred embryos were identified as balanced during this re-analysis. In the 
first case, the biopsied cell, had also given a normal result, but this embryo was not 
selected for transfer, as three more were discovered to have a balanced chromosome 
complement and for these, diagnosis was based on two embryonic nuclei. In the 
second case, the biopsied nucleus was covered with cytoplasm, making the 
visualisation of signals impossible. Re-analysis of this embryo showed a normal 
complement for the chromosomes in question, but also for another set of probes that 
were applied to investigate its chromosome constitution further. In six out of the nine 
cycles, the spare embryos were further examined for chromosomes not involved in the 
initial diagnosis. Poor morphology and the DNA quality of embryonic nuclei did not 
permit this for the three remaining cycles. The purpose of this second FISH analysis 
was to gain more information on embryonic chromosomes, leading in this way to an 
accurate classification of abnormalities, but also identification of specific segregation 
modes in the parental gametes, or different types of mitotic errors at the post-zygotic 
stages of embryonic development. Tables 3.7-3.9 show the different groups of 
embryos for two patients with reciprocal translocations, two with Robertsonian 
translocations, and one with possible gonadal mosaicism for trisomy 21.
In total 94 embryos were investigated, some of which being characterised as 0 PN or 3 
PN initially. Out of these, twenty-five (26.6%) were grouped as normal or balanced, 
while 69 (73.4%) were characterised as abnormal. The latter category consisted of the 
following:
1. Embryos that were uniformly abnormal or with inconclusive result (13.8%)
2. Embryos classified as diploid mosaic (10.6%)
3. Embryos classified as aneuploid mosaic (10.6%)
4. Embryos classified as chaotic (38.3%).
A summary of these results is seen in Table 3.10.
It is obvious from the above percentages that chaotic embryos predominate among the 
abnormal ones, and were produced by all couples in this study in different 
frequencies. It has been postulated that the generation of highly mosaic or even 
chaotic embryos is largely patient specific and can be used as a predictor of PGD
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outcome (Delhanty et al., 1997). The latter hypothesis was confirmed in this study. 
Hence, the couple in case B produced the second lowest number of chaotic embryos in 
both cycles, and they were able to achieve a clinical pregnancy and a normal live birth 
after the second PGD cycle. The female partner was the second youngest in this group 
of patients. On the contrary, the couples in cases A and F both produced a high 
number of chaotic embryos and failed to establish a clinical pregnancy. The female 
partner in this case A was the youngest in the group, whilst the female partner in case 
F was the oldest. Maternal ages and number of mosaic and chaotic embryos were 
similar for the remaining cases. Hence, even though all the rest of the couples had 
embryos transferred in all cycles, no pregnancies ensued. Attributing factors, apart 
from the frequent generation of highly abnormal embryos, could include the advanced 
maternal age, embryo morphology and their general developmental potential. These 
will be discussed in a subsequent section.
To conclude, the frequent observation of highly abnormal embryos being produced 
from couples investigated for chromosomal abnormalities, illustrates the necessity of 
the biopsy of two blastomeres, where possible. In this way, the risk of misdiagnosing 
an abnormal embryo as normal is significantly reduced.
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Table 3.6: Summary of nine PGD cycles for five couples investigated for a chromosomal abnormality.
Case Parental karyotype PGD cycles Oocytes
collected
Oocytes
fertilised
Embryos
Biopsied/Not
biopsied
Normal or 
Balanced
Abnormal Embryos
transferred
A 46,XY,t(5; 19)(p 12;p 12) 1 20 15 13/2 1 12 1
B 46,XX,t(l 1 ;22)(q23.3;ql 1.2) 2 26 14 11/2 2 11 2
D 45,XY,der( 13 ;21 )(q 10;q 10) 2 22 17 15/0 6 9 6
E 45,XY,der(13;14)(qlO;qlO) 2 25 21 16/0 6 10 5
F 46,X X , 46,XY, suspected 
gonadal mosaicism for trisomy 
21
2 + 1 frozen 
embryo 
transfer
43 37 33/4 10 27 7
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Table 3.7: Summary of embryo classification and segregation patterns observed for three PGD cycles for two couples carrying reciprocal 
translocations.
Case Parental karyotype PGD
cycles
Normal Uniformly 
abnormal or 
inconclusive FISH 
result
Diploid
mosaic
Aneuploid
mosaic
Chaotic* Segregation 
patterns in 
parental gametes: 
no. of embryos
A 46,XY ,t(5; 19)(p 12 ;p 12) 1 1 2 0 2 8 Alternate: 1 
2:2 Adjacent 2: 1 
Unknown: 8 
Inconclusive: 2
B 46,XX,t(l l;22)(q23.3;ql 1.2) 2 2 3 0 1 7 Alternate: 3 
3:1 Interchange: 2 
2:2 Adjacent 1: 1 
Unknown: 3
*Also includes mosaic aneuploid/chaotic and mosaic balanced/chaotic
188
PGD Results Summary Tables
Table 3.8: Summary of embryo classification and segregation patterns observed for four PGD cycles for two couples with Robertsonian 
translocations.
Case Parental karyotype PGD
cycles
Normal Uniformly 
abnormal or 
inconclusive 
FISH result
Diploid
mosaic
Aneuploid
mosaic
Chaotic* Segregation patterns in 
parental gametes: no. 
of embryos
D 45,XY,der( 13 ;21 )(q 10;q 10) 2 6 1 0 1 7 Alternate: 6 
Adjacent 1:1 
Unknown: 8
E 45,XY,der(13;14)(qlO;qlO) 2 6 0 3 1 6 Alternate: 6 
Alternate with post- 
zygotic errors: 5 
Adjacent 1 with post- 
zygotic errors: 1 
Unknown: 4
*Also includes mosaic aneuploid/chaotic and mosaic balanced/chaotic
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Table 3.9: Summary of embryo classification and segregations observed for two PGD cycles for one couple investigated for possible gonadal 
mosaicism for trisomy 21.
Case Parental karyotype PGD cycles Norma
1
Uniformly abnormal 
or inconclusive FISH 
result
Diploid
mosaic
Aneuploid
mosaic
Chaotic* Segregation in 
embryos
F 46,X X , 46,XY 2 + 1 frozen 
embryo 
transfer
10 7 7 5 8 Diploid zygote 
status with post- 
zygotic errors: 5 
Mitotic non- 
disjunction^ 
Meiotic errors: 2 
Unknown: 7
'Includes mosaic aneuploid/chaotic
190
PGD Results Summary Tables
Table 3.10: Summary of chromosome constitutions observed in embryos from five couples treated for chromosome abnormalities with PGD.
Case Parental karyotype PGD cycles Normal Uniformly 
abnormal or 
inconclusive
Diploid
mosaic
Aneuploid
mosaic
Chaotic*
A 46,XY,t(5; 19)(p 12 ;p 12) 1 1 2 0 2 8
B 46,XX,t( 11 ;22)(q23.3 ;q 11.2) 2 2 3 0 1 7
D 45 ,X Y,der( 13 ;21 )(q 10;q 10) 2 6 1 0 1 7
E 45 ,X Y,der( 13; 14)(q 10;q 10) 2 6 0 3 1 6
F 46,XX, 46,XY, possible 
gonadal mosaicism for 
trisomy 21
2 +1 frozen 
embryo 
transfer
10 7 7 5 8
Combined
totals
Total 
embryos: 94 
(100%)
25
(26.6%)
13 (13.8%) 10(10.6%) 10(10.6%) 36
(38.3%)
'Includes mosaic aneuploid/chaotic, and mosaic balanced/chaotic
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Chapter 4-Results
The investigation of chromosomal abnormalities in human 
oocvtes and corresponding polar bodies using FISH
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4.1 Human metaphase II oocytes and corresponding 1st PBs
This part of the study involved the analysis of human oocytes, arrested at the 
metaphase stage of the second meiotic division and their corresponding 1st PBs, when 
these were available, with the application of FISH. 453 oocytes and 51 PBs were 
spread on slides, obtained from a total o f 168 patients, undergoing routine IVF or ICSI 
treatments. All had either failed to fertilise after exposure to sperm or were 
unexposed. Time in culture varied between 24-48 hours.
Of the 453 oocytes, 265 were considered suitable for FISH analysis. The remaining 
were discarded because they did not contain any chromosomes, were of too 
degenerate morphology, had too few chromosomes due to over spreading, or were 
immature, being arrested at meiosis I. The fact that the majority of the analysed 
oocytes did not have PBs, could be attributed either to the latter degenerating during 
culture, or being lost during the spreading process.
The patients participating in the study were not known to have abnormal karyotypes 
with maternal ages ranging between 22-44 years (mean 32.5). Most of the couples 
were being treated for infertility due to a male factor. Some of these patients came 
from the Assisted Conception Unit at the University College London Hospitals Trust, 
but the great majority of them were treated at the Assisted Conception Unit at Tayside 
University Hospitals NHS Trust, Dundee, Scotland. In the latter case, all eggs 
(oocyte+PB) were spread on slides in Scotland and were received by post.
The aim of this part of the study was to investigate the variety of anomalies arising 
during the first maternal meiosis. Two hypotheses were being tested:
1. Several mechanisms are involved in maternal aneuploidy.
2. Chromosomes of all sizes could be participating. The latter was evident from 
molecular cytogenetic investigations of cleavage stage embryos.
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4.2 Fixation and FISH efficiency
Oocytes and PBs were fixed together and the protocol followed for most of them was 
as suggested by Tarkowski (Tarkowski, 1966), with some modifications described by 
Mahmood et al. (2000). An alternative spreading protocol was also applied for some 
cells, involving their gradual fixation on the slides (Kamiguchi et al, 1993). Details of 
both protocols are described in 2.2.3.4.
It was not possible to successfully subject all 265 cells to three sequential rounds of 
FISH, since some chromosome loss occurred during processing. Thus, after the first 
round, results were obtained for 51 preparations, after the second round for 29, while 
after the third round only seven oocytes could be detected and scored. In total 180 
cells were lost during this study either prior or after the different rounds of FISH 
analysis. Different pre-treatments of the slides were used before FISH, in an attempt 
to reduce this high chromosome loss. The protocol identified as the most effective 
involved not staining the cells with either DAPI or Giemsa, locating them under the 
phase microscope, and reducing both time of incubation in HCL/pepsin during the 
FISH procedure (5 minutes instead of 20), but also the actual pepsin concentration 
from lOmg/ml to 5mg/ml, as suggested by Clyde et al. (2001).
The details of the probes used for the investigation of all oocytes and PBs during the 
three consecutive FISH rounds are shown in Table 2.5 whereas the actual probe 
combinations applied are described in Table 2.6. Lymphocyte control slides were 
employed for every FISH procedure, in order to evaluate signal morphology and 
efficiency of the different probe combinations. All probes, either centromeric or locus- 
specific, gave clear and intense signals on both metaphase and interphase nuclei as 
FISH efficiency was calculated by scoring 200 interphase nuclei and ranged between 
85-95%, depending on which probes were used for the investigation. Fig. 4.1a and b 
shows pictures of lymphocyte metaphases demonstrating the various probe 
combinations employed during the three consecutive rounds of FISH.
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Fig. 4.1a: Two sets of centromeric probes employed for the first round 
FISH analysis of metaphase II oocytes and 1st PBs
1 X
*  12m
36.1
31.1
II1
13.3
11.2
ft-1
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13.1m
14
15
m
22
23
241
21.3
m
41
m
§9
(i)
V  28
Chromosome 1- satellite III (SO) m H  of 46>xy contro, lymphocyte
Chromosome 12- alpha-satellite (orange) metaphase with centromeric probes for
chromosomes 1 (green), 12 (orange), and X 
Chromosome X- alpha-satellite (SO) (re(j)
(Hi)
Chromosome 4- alpha-satellite (SG) FISH of 46,XY control lymphocyte
Chromosome 12- alpha-satellite (orange) metaphase with centromeric probes
for chromosomes 4 (green), 12
(orange), and 17 (red).Chromosome 17- alpha-satellite (SO)
Fig. 4.1a: (i) Triple probe combination employed for the FISH analysis of 
oocytes and 1st PBs in Section 4.3.1. (ii) Three-colour FISH analysis of a 
metaphase spread coming from a 46,XY individual, using the probes from 
(i). (iii) Triple probe combination used for the FISH analysis of oocytes and 
1st PBs in Section 4.3.4. The centromeric probes for 4 and 17 were also 
used for the examination of cells in Section 4.3.3. (iv) Three-colour FISH 
analysis of a metaphase spread coming from a 46,XY individual, with the 
probes from (iii).
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Fig. 4.1b: Two sets o f locus-specific probes em ployed fo r the  second and  
th ird  round  FISH  analysis o f m etaphase II oocytes and  1st 
PBs
13
13 CZD
11.2
11.1
1L2
11.1
11.1
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14.1
14.2
14.3 
21.1 
21.2
21.3
22.1
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34
LSI 13 probe-13q 14 (SG) FISH of 46,XX control
LSI 21 probe-2 Iq22.13-q22.2 (SO) ^ P ^ y t e  metaphase spread
with locus-specific probes for
chromosomes 13 (green) and
21 (red). |R
(iii)
LSI 22 probe- 22qll.2(SG)
FISH of46,XY control lymphocyte 
metaphase spread with locus- 
specific probe for chromosome 22 
(green).
Fig. 4.1b: (i) Details of the two locus-specific probes employed for the FISH analysis 
of oocytes and 1st PBs during the second round (Section 4.4.2). (ii) Dual-colour FISH 
analysis of a metaphase spread coming from a 46,XX individual using the probes from 
(i). (iii) Details of the locus-specific probe employed for the FISH analysis of oocytes 
and 1st PBs during the third round (Section 4.5.1). (iv) FISH analysis of a metaphase 
spread from a 46,XY individual with the probe for 22.
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4.3 First hybridisation round
Seven different chromosomes were assessed during this first round of FISH. More 
specifically, oocytes and corresponding 1st PBs were examined for chromosomes 1,4, 12, 
16, 17, 18, and X in different two or three-colour FISH combinations. All probes were 
centromeric, and were prepared in the laboratory, apart from the probe for chromosome 
16, that was commercially available (Vysis, UK). These chromosomes were investigated 
in different combinations (Table 2.6).
An attempt to examine all 265 eggs, (124 patients), took place during this first round of 
FISH. Out of these, results were obtained for 51 oocytes and 11 PBs. The remaining 214 
were lost during the FISH procedure. The results obtained during the first hybridisation 
round will be discussed below.
4.3.1 FISH with the centromeric probes for chromosomes 1.12. and X
A total of 128 oocytes, some of which consisted of the 1st PB as well, underwent FISH 
with the centromeric probes for chromosomes 1,12 and X. All cells were fixed on slides, 
normal or charged, using the modified Tarkowski protocol. Some were immersed in Acid 
Tyrodes prior to fixing to remove the zona pellucida. Ageing of cells occurred either by 
leaving them at room temperature for up to one month, or by placing them at 65°C for 12 
hours, as was suggested in a report by Sandalinas and colleagues (2002). The oocytes 
and PBs were stained with DAPI after fixation, and identification took place under the 
fluorescent microscope. Some of the cells were also captured prior to FISH, with the use 
of the CCD camera.
The FISH procedure followed involved the standard initial incubation of cells in 
HCL/pepsin for 20 minutes, for cytoplasm removal. The probes used were the satellite III 
for chromosome 1 labelled in SG, the a-satellite for chromosome 12 labelled in orange 
(mix of SO+SG) and the a-satellite for chromosome X labelled in SO. Hybridisation time 
varied between 2-12 hours.
Analysis was feasible for eleven oocytes and two 1st PBs, from eight patients. All the 
remaining cells could not be detected after the FISH procedure. As all probes were 
complementary for centromeric regions of the chromosomes being investigated, they 
would either give rise to one large signal, or one doublet if sister chromatids were close 
to each other. Thus, premature division of chromatids would be seen as two distinct 
signals.
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Fig.4.2: F irs t hybrid isation  round - C en trom eric  probes fo r 1 ,12 , 
and  X
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(i) FISH analysis of oocyte 3782.1. 
The cell was classified as haploid 
normal for all examined chromoso­
mes. One large signal was scored for
1 (green), and for X (red). The probe 
Chromosome 12- alpha-satellite (orange) f()r 12 gave a douWet (orange)
Chromosome X- alpha-satellite (SO)
Chromosome 1- satellite III (SG)
\
(ii) (iii)
(ii) FISH analysis of oocyte 3416.11. 
Premature division of chromosome X 
into its sister chromatids was apparent 
for this cell (2 separate red signals). No other 
signals were visible for chromosomes 1 and 
12.
(iii) FISH analysis of PB 968.1.
Two separate orange signals demonstrate 
the premature division of 12 to its sister 
chromatids. One large signal was scored 
for 1 (green) and a doublet for X (red), 
which also showed some degree of 
separation.
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In the case of PBs, signal separation was sometimes attributed to their rapid 
degeneration. Oocytes and/or PBs were scored as abnormal only in the presence of 
extra signals, representing either a whole chromosome or a single chromatid. The 
absence of signals was either attributed to loss of chromosomes because of the 
spreading of cells or the FISH procedure or due to hybridisation failure.
Three oocytes (3782.1, 3783.2, 971.3) were characterised as being normal for 
chromosomes 1, 12 and X, showing clear and distinct signals for all probes. Three 
(5coll(t), 6col2(b), 1009.4) were normal for chromosomes 12 and X, having lost 
chromosome 1, two (968.1, 968.2) were normal for chromosomes 1 and X, having 
lost 12, and two (3855.1, 3416.12) were normal for chromosome X, having lost 
chromosomes 1 and 12.
Premature division of chromatids was observed in one oocyte and one PB, from two 
different patients. In the case of the oocyte no. 3416.11, two separate signals were 
visible for chromosome X only. Its corresponding 1st PB was also available, and was 
classified as normal for chromosome X. No other signals were observed in this pair 
of cells. In the case of the PB no. 968.1PB, two distinct signals were visible for 
chromosome 12, whereas one large signal was observed for chromosomes 1 and X. 
The corresponding oocyte was normal for chromosomes 1 and X, but had lost 
chromosome 12.
Tables 4.1 and 4.2 show the results obtained during this hybridisation round for 
metaphase II oocytes and corresponding 1st PBs respectively. FISH analysis of a 
normal oocyte, the oocyte showing the premature division of chromatids for X and the 
PB with the division of chromatids for 12 are seen in fig.4.2. Detailed cytogenetic 
analysis of all cells, using the ISCN nomenclature is given in Appendix C.
Abnormalities of either extra whole chromosomes or single chromatids were not 
observed in this group of cells. The high rate of chromosome loss (91.4%) that was 
experienced during this hybridisation round was notable. Affecting factors included 
the staining of the cells with DAPI, their extended exposure to fluorescent light prior 
to FISH and their extended incubation in pepsin during slide pre-treatment.
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Table 4.1: FISH results for metaphase II oocytes investigated for chromosomes 1,12
and X
Oocyte/patient
no.
Chromosomes scored and further 
observations
Oocyte characterisation
5coll(t) Two chromosomes scored 
Doublet for 12 
Doublet for X
Normal for 12 and X
6col2(b) Two chromosomes scored 
Doublet for 12 
Doublet for X
Normal for 12 and X
3782.1 Three chromosomes 
Large signal for 1 
Doublet for 12 
Large signal for X
Normal for 1,12 and X
3783.2 Three chromosomes 
Large signal for 1 
Doublet for 12 
Large signal for X
Normal for 1, 12 and X
3855.1 One chromosome 
Doublet for X
Normal for X
1009.4 Two chromosomes 
Doublet for 12 
Doublet for X
Normal for 12 and X
971.3 Three chromosomes 
Large signal for 1 
Large signal for 12 
Large signal for X
Normal for 1, 12 and X
968.1 Two chromosomes 
Doublet for 1 
Doublet for X
Normal for 1 and X
968.2 Two chromosomes 
Doublet for 1 
Doublet for X
Normal for 1 and X
200
Oocyte and PB FISH Results
3416.11 One chromosome 
Two separate signals for X
Premature division of 
chromatids for X
3416.12 One chromosome 
Doublet for X
Normal for X
Table 4.2: FISH results for corresponding 1st PBs, investigated for chromosomes 1,
12,and X
PB/patient no. Chromosomes scored and further 
observations
PB characterisation
968.1 PB Three chromosomes 
Large signal for 1 
Two separate signals for 12 
Doublet for X
Separation of chromatids 
for chromosome X
3416.11 PB Two chromosomes 
Doublet for 12 
Doublet for X
Normal
Triple-colour FISH efficiency on lymphocytes: 90%
201
Oocyte and PB FISH Results
4.3.2 FISH with the centromeric probes for chromosomes 12.16 and 18
Ten oocytes were investigated for chromosomes 12, 16 and 18, none of which contained 
a 1st PB. They came from a total of four patients. All cells were treated in exactly the 
same way as those in 4.3.1. The FISH procedure was also as described in 4.3.1, with the 
only difference being that the hybridisation time was just over one hour. Out of the three 
probes used in this round, the a-satellites for chromosomes 12 and 18 were prepared in 
the laboratory, labelled in orange (mix of SG+SO) and SG respectively. The centromeric 
probe for chromosome 16 was commercial (Vysis/Abbot, UK), mapped on satellite II of 
this chromosome and was labelled in SA.
A total of four oocytes were detected on slides after this FISH round, while the remaining 
were all lost. No signals were visible for any of these oocytes, even though their 
chromosome numbers ranged between 18-20. The lymphocyte slide used as a positive 
control for this hybridisation round did not show signals on either metaphases or 
interphase nuclei for any of the probes. This observation led to the conclusion that the 
absence of signals was due to failure of the FISH, possibly because of the short 
hybridisation period.
4.33 FISH with the centromeric probes for chromosomes 4 and 17
Analysis of eleven eggs from three patients was attempted with the two centromeric 
probes for chromosomes 4 and 17. Cells were spread on slides according to either the 
modified Tarkowski protocol, or the gradual fixation protocol, and all were left to age at 
room temperature for up to 30 days. As it was suspected that prolonged exposure to 
fluorescent light could possibly affect the DNA quality of the oocytes and lead to them 
becoming loose from the slides and being lost after FISH, all cells in this group were 
stained with Giemsa and their identification occurred under the light microscope.
The FISH protocol was also modified and was carried out as suggested in a report by 
Clyde and colleagues (2001). More specifically, the time of slide incubation in 
HCL/pepsin was decreased to 5-8 minutes, and the concentration of pepsin was reduced 
from being lOmg/ml to 5mg/ml. Both probes employed in this round were prepared in the 
laboratory. The a-satellite for chromosome 4 was labelled in SG, whereas the one for
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Fig.4.3: First hybridisation round- Centromeric probes for 4 
and 17
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(i) FISH analysis of oocyte 3969.2. 
The cell showed a doublet for chro­
mosome 17 (red), and no signals for 
chromosome 4.
17
(ii) (iii)
(ii) FISH analysis of oocyte 3967.9. 
Premature division of chromosome 17 
into its sister chromatids was observed 
for this cell (2 separate red signals).
No signals were visible for chromosome
4.
(iii) FISH analysis of PB 3967.9.
As with the corresponding oocyte, 
two separate red signals were visible, 
demonstrating the predivision of 
chromosome 17. Again, no signals 
were observed for chromosome 4.
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chromosome 17 was labelled in SO. Hybridisation took place for 12 hours.
From the eleven cells being examined, FISH results were obtained for nine oocytes 
and four corresponding 1st PBs. Five oocytes (3969.2, 3967.8, 1084.4, 1084.6, 
1084.8) from all three patients were characterised as being normal for chromosome 
17, but no signals were visible for chromosome 4. Two oocytes (3969.3, 3967.3) did 
not show signals for any of the two probes. In both the above cases, oocyte 
chromosome number ranged between 10-12, the remaining possibly being lost during 
processing. The expected large signals for chromosome 17 were also visible for two 
PBs, while there was one that did not have signals for either 4 or 17.
Premature separation of chromatids was observed in two oocytes and one PB 
originating from two different patients. In the first case, the oocyte (3969.4) showed 
the expected doublet for chromosome 17 and two slightly separated signals for 
chromosome 4. In the second case, both oocyte (3967.9) and 1st PB were detected 
after FISH. Two separate signals corresponding to chromosome 17 were visible for 
the oocyte that did not show any signals for chromosome 4. The exact same signal 
pattern was observed for its 1st PB, i.e. the cell showed separation of sister chromatids 
for chromosome 17 and loss of chromosome 4. Two more oocytes (3967.3, 3967.8) 
were analysed from this patient, one of which did not show any signals, and the other 
was scored as normal for chromosome 17, having lost chromosome 4.
Tables 4.3 and 4.4 demonstrate the above results. FISH analysis of a normal oocyte, 
the oocyte and the PB showing the premature division of chromatids for chromosome 
17 are seen in fig.4.3. Detailed cytogenetic analysis of all cells, using the ISCN 
nomenclature is given in Appendix C.
The rate of cell loss was significantly reduced in this hybridisation round, as out of the 
11 oocytes examined only two (18%) could not be detected after FISH. The latter was 
attributed to the alterations made both in the staining and identification of the cells 
and the actual FISH procedure itself.
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Table 43: FISH results for metaphase II oocytes, investigated for chromosomes 4
and 17
Oocyte/patient
no.
Chromosomes scored and 
further observations
Oocyte characterisation
3969.2 One chromosome 
Doublet for 17
Normal for 17
3969.3 No signals
3969.4 Two chromosomes 
Two separate signals for 4 
Large signal for 17
Premature division of 
chromatids for 4, normal 
for 17
3967.3 No signals
3967.8 One chromosome 
Doublet for 17
Normal for 17
3967.9 One chromosome 
Two separate signals for 17
Premature division of 
chromatids for 17
1084.4 One chromosome 
Doublet for 17
Normal for 17
1084.6 One chromosome 
Doublet for 17
Normal for 17
1084.8 One chromosome 
Doublet for 17
Normal for 17
i
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Table 4.4: FISH results for corresponding 1st PBs, investigated for chromosomes 4
and 17
PB/patient
no.
Chromosomes scored and further 
observations
PB characterisation
3969.4 PB No signals
3967.3 PB One chromosome 
Large signal for 17
Normal for 17
3967.9 PB One chromosome 
Two separate signals for 17
Separation of chromatids for 
17
1084.8 PB One chromosome 
Doublet for 17
Normal for 17
Dual-colour FISH efficiency on lymphocytes: 85%
I
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43.4 FISH with the centromeric probes for chromosomes 4.12. and 17
The combination consisting of the three centromeric probes for the examination of 
chromosomes 4, 12, and 17 was employed for the analysis of 115 oocytes, for some of 
which the corresponding PBs were also available. Cells were donated from sixty-one 
patients. All cells were fixed on slides using the modified Tarkowski protocol only, and 
were aged at room temperature for up to one month. Detection of oocytes took place 
under the light microscope. However, the chromosomes of eighty of them were stained 
with Giemsa, whereas the remaining thirty-five oocytes were not. The staining of the 
chromosomes was omitted towards the end, as it was observed that the Giemsa was 
affecting DNA quality in a similar way to the DAPI, leading to chromosomes either 
being of poor morphology, or being frequently lost after FISH. The FISH protocol itself 
was as described in 4.3.3 with no other modifications. The probes used were as for 
previous rounds, the a-satellite for chromosome 4 labelled in either SG or SO, the a- 
satellite for chromosome 12 labelled in orange (mix of SO+SG) and the a-satellite for 
chromosome 17 labelled in either SO or SG.
FISH analysis was feasible for 31 oocytes and 5 corresponding 1st PBs from a total of 
fourteen patients. All the remaining cells were lost during processing. Identification of 
either large signals or doublets for all three chromosome occurred for eight oocytes 
(3892.2, 4176.5, 4176.8, 4181.1, 4181.2, 4181.3, 4181.4, 4257.2), which were 
characterised as normal after this first hybridisation round. Two oocytes (4257.3,4264.3) 
had signals for chromosomes 4 and 12 only, two (4077.1, 4292.9) for 4 and 17, two 
(3892.5, 4292.7) for 12 and 17, two (4091.2, 1152.1) for chromosome 4 only, five 
(1033.4, 3847.1, 3839.1, 4257.1, 4264.2) for chromosome 12 and two (1118.5, 1118.6) 
for chromosome 17 only. Absence of signals was attributed to chromosome loss during 
spreading or FISH.
Out of the five PBs that were identified after the first hybridisation round, one 
(3892.1PB) showed the expected signals for chromosomes 4 and 12 and was 
characterised as normal for these chromosomes, and another (4181.4PB) showed the 
expected doublet for chromosome 4 only.
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Fig.4.4: First hybridisation round- Centromeric probes for 4,
12, and 17
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(i) FISH analysis of oocyte 4264.4. 
Premature division of chromosome 
4 into its sister chromatids was obser­
ved for this cell (2 separate red signals). 
A double orange signal was visible for 
chromosome 12 and a double green 
signal was scored for 17. No separa­
tion was scored for the latter two.
(ii) FISH analysis of oocyte 4264.1. This cell 
was identified to contain an extra copy of chro­
mosome 17 (two different double green signals). 
A double red signal was scored for chromosome 
4, whereas chromosome 12 was absent.
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Premature division of chromatids was observed in two oocytes originating from 
different patients, for one of which the corresponding PB was also available. For the 
first oocyte (4264.4), two distinct and separate signals were observed for chromosome 
4, demonstrating its premature division to the two sister chromatids. This oocyte also 
showed the expected doublets for chromosomes 12 and 17. As far as the latter oocyte 
and 1st PB were concerned (1243.6), their chromosomes were clearly visible, but were 
mixed together. Some of the PB chromosomes could be distinguished due to their 
degenerate morphology. A doublet and an extra single signal were observed for 
chromosome 4, three distinctly separate signals were observed for chromosome 12 
and four separate signals were observed for chromosome 17. Thus, for this oocyte/1st 
PB pair, premature division took place for one of the two chromosomes 4 with 
subsequent loss of the one sister chromatid, for both chromosomes 12 with similar 
loss of one of the chromatids and for both chromosomes 17. Division of chromatids 
for 4 and 17 were also observed in two different PBs.
An additional whole chromosome 17 was observed for another two oocytes, for which 
however, the PB was not available for analysis. In the first case (4264.1), the oocyte 
showed one doublet for chromosome 4, no signal for chromosome 12 and two 
doublets for chromosome 17, one of which demonstrated the presence of the extra 
chromosome. The other oocyte (1209.2) consisted of the expected doublets for 
chromosomes 4 and 12, but also had two doublets for chromosome 17.
These observations are shown in Tables 4.5 and 4.6. FISH analyses of an oocyte with 
premature division of chromatids of 4, an oocyte with an extra chromosome 17 and a 
PB are seen in fig.4.4. Detailed cytogenetic analysis of all cells is described in 
Appendix C.
The rate of chromosome loss for this hybridisation round was high, as out of 115 cells 
results were obtained for 31 only, while the remaining 84 (73%) could not be detected 
after FISH. Most of these cells had been initially stained with Giemsa, to aid in their 
identification under the microscope. Omitting this step meant that more cells 
remained on slides and were available for analysis.
Out of all the chromosomes investigated during the different first hybridisation 
rounds, chromosome 17 was the second smallest after 18. It was also the only 
chromosome from this group that appeared as an extra copy in two of the oocytes
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examined, originating from two different patients. Even though the sample size is 
very small to draw any conclusions it is consistent with the observation of the 
preferential involvement of smaller chromosomes in maternally derived aneuploidy, 
as suggested by Cupisti and colleagues (2003). Premature division of chromatids was 
also observed for chromosome 4 in oocyte 4264.4 and for all the investigated 
chromosomes, in oocyte 1243.6 which, was spread with the corresponding 1st PB. In 
the latter case, the degenerate morphology of both the oocyte, and corresponding 1st 
PB, along with the fact that premature division was visible for all three chromosomes, 
could be attributed to cellular degeneration due to extended culture time.
Am.
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Table 4.5: FISH results for metaphase II oocytes, investigated for chromosomes 4,
12, and 17
Oocytc/patient bo. C hnm osoncs scored and 
farther observations
Oocyte characterisation
3892.1 Two chromosomes 
Large signal for 12 
Large signal for 17
Normal for 12 and 17
3892.2 Three chromosomes 
Large signal for 4 
Large signal for 12 
Large signal for 17
Normal for 4,12 and 17
3892.5 Two chromosomes 
Large signal for 12 
Large signal for 17
Normal for 12 and 17
1033.4 One chromosome 
Doublet for 12
Normal for 12
1118.5 One chromosome 
Doublet for 17
Normal for 17
1118.6 One chromosome 
Doublet for 17
Normal for 17
3847.1 One chromosome 
Large signal for 12
Normal for 12
1054.1 Two chromosomes 
Doublet for 4 
Doublet for 17
Normal for 4 and 17
3839.1 One chromosome 
Doublet for 12
Normal for 12
4077.1 Two chromosomes 
Doublet for 4 
Large signal for 17
Normal for 4 and 17
4091.2 One chromosome 
Large signal for 4
Normal for 4
1169.3 Two chromosomes Normal for 4 and 17
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Large signal for 4 
Doublet for 17
4130.6 Two chromosomes 
Doublet for 4 
Doublet for 17
Normal for 4 and 17
1152.1 One chromosome 
Doublet for 4
Normal for 4
4176.5 Three chromosomes 
Doublets for 4 ,12 ,17
Normal for 4,12, and 17
4176.8 Three chromosomes 
Doublets for 4 ,12 ,17
Normal for 4,12, and 17
4181.1 Three chromosomes 
Doublets for 4 ,12 ,17
Normal for 4,12, and 17
4181.3 Three chromosomes 
Doublets for 4, 12,17
Normal for 4,12 and 17
4181.4 Three chromosomes 
Doublets for 4 ,12 ,17
Normal for 4,12 and 17
4184.2 Three chromosomes 
Doublets for 4 ,12 ,17
Normal for 4,12 and 17
1209.2 Three chromosomes 
Doublet for 4 
Doublet for 12 
Two doublets for 17
Disomic for 17 
No PB result
1243.6 
oocyte and PB 
chromosomes were 
mixed
Three chromosomes 
Doublet for 4 or one signal for 4 
Doublet for 12 or one signal for 
12
Two separate signals for 17
Premature division of 
chromatids for 17 and either 
for 4 and 12 with loss o f one 
of the two, or normal for 4 
and 12
4257.1 One chromosome 
Large signal for 12
Normal for 12
4257.2 Three chromosomes 
Doublets for 4 ,12 ,17
Normal for 4,12 and 17
4257.3 Two chromosomes Normal for 4 and 12
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Doublets for 4,12
4292.7 Two chromosomes 
Doublets for 12,17
Normal for 12 and 17
4292.9 Two chromosomes 
Doublets for 4,17
Normal for 4 and 17
4264.1 Two chromosomes 
Doublet for 4 
Two doublets for 17
Disomy for 17 
No PB result
4264.2 One chromosome 
Doublet for 12
Normal for 12
4264.3 Two chromosomes 
Doublets for 4 ,12
Normal for 4 and 12
4264.4 Three chromosomes 
Two separate signals for 4 
Doublet for 12 and 17
Premature division of 
chromatids for 4, normal for 
12 and 17
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Table 4.6: FISH results for corresponding 1st PBs, investigated for chromosomes 4,
12, and 17
PB/patient no. Chromosomes scored and further 
observations
PB characterisation
3892.1 PB Two chromosomes 
Large signal for 12 
Large signal for 17
Normal for 12 and 17
41813 PB Two chromosomes 
Two separate signals for 4 
Large signal for 17
Separation o f sister 
chromatids for 4, normal for 
17
4181.4 PB One chromosome 
Doublet for 4
Normal for 4
4184.2 Two chromosomes 
Doublet for 12 
Two separate signals for 17
Separation of sister 
chromatids for 17, normal 
for 12
1243.6 PB 
oocyte and PB 
chromosomes 
were mixed
Three chromosomes 
Doublet for 4 or one signal for 4 
Doublet for 12 or one signal for 12 
Two separate signals for 17
Premature division of 
chromatids for 17 and either 
for 4 and 12 with loss o f one 
of the two, or normal for 4 
and 12
Triple-colour FISH efficiency on lymphocytes: 95%
i
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4.4 Second hybridisation round
The second hybridisation round comprised the assessment of chromosomes 13 and 21. 
Further examination of the status of chromosome 16 was also attempted. Investigation of 
all oocytes and PBs that yielded results after the first hybridisation round was attempted. 
In total, 85 oocytes, some including PBs, donated from 47 patients underwent this second 
hybridisation round. FISH analysis was feasible for 29 oocytes and 8 corresponding 1st 
PBs, while the remaining 56 cells were lost.
Two probe combinations were employed, the first using the commercial 
(Vysis/Abbott,UK) (3-satellite probe for chromosome 16 labelled in SA, while the second 
one involved the application of two commercial (Vysis/Abbott, UK) locus-specific 
probes for chromosome 13 labelled in SG, and chromosome 21 labelled in SO. Probe 
details are shown in Table 2.5. As far as the oocytes and PBs were concerned, no further 
treatment took place. Removal of the first round probes took place as described in 2.2.6.5 
and denaturation followed. Hybridisation time was 12 hours.
4.4.1 FISH with the centromeric probe for chromosome 16
This probe was applied to examine the chromosome complement of the oocytes that had 
failed to show any signals during the first hybridisation round, that took place with the 
centromeric probes for chromosomes 12, 16 and 18. That failure was attributed to 
inadequate hybridisation time. Fifteen oocytes were to be analysed during this second 
hybridisation round. Upon visualisation at the fluorescent microscope, it was observed 
that all cells had been lost.
Thus, no results were obtained during this hybridisation round. All oocytes had been 
stained with DAPI twice, once in order to locate them prior to FISH, and once to identify 
them after the first hybridisation round. Both times they were exposed to fluorescent light 
for a prolonged period. The above could explain why all oocytes were lost after the 
second hybridisation round.
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4.4.2 FISH with the locus-specific probes for chromosomes 13 and 21
Analysis of seventy cells originating from 39 patients was attempted in this hybridisation 
round. The probes applied both mapped on regions of the long arms of chromosomes 13 
and 21. Therefore, their signals would always appear as doublets showing slight 
separation, corresponding to each of the two sister chromatids comprising the 
chromosomes. A total of 29 oocytes and 8 1st PBs yielded results after this round, leading 
in this way to the investigation of eggs from 22 patients. The remaining cells could not be 
detected after FISH.
Nine oocytes (1005.2, 1084.2, 1084.6, 3967.3, 1033.4, 1147.1,4081.1, 1243.6, 4257.1) 
showed the expected doublets for chromosomes 13 and 21, and were characterised as 
being normal. Five oocytes (3782.1, 3967.9, 3839., 1, 3887.6, Hutchinson-1) showed a 
double signal for 13 and no signals for 21 and six oocytes (3982., 1 3892.5, 1001.5, 
4176.5, 4297.7, 5coll(t)) had the expected complement for 21, but no chromosome 13. 
Loss of chromosomes was attributed either to the spreading of the cells or the FISH 
procedure. Signals for both chromosomes were scored in three 1st PBs (1084.6PB, 
3967.9PB, 3892.5PB), one (3967.3PB) was identified as having the expected double 
signal for 13, but no signal for 21 and one (3982.1PB) consisting of chromosome 21, but 
having lost chromosome 13. All the above cells came from fifteen patients.
Premature division of chromatids was observed for both chromosomes, but was more 
frequent for chromosome 21 in this small sample of cells. Thus, four oocytes (1001.5,
4181.3, 4184.2, 4257.1) and two PBs (4184.1 PB, 1243.6 PB) were scored as having 
undergone premature division of chromosome 21 into its two sister chromatids. 
Predivision of chromatids for chromosome 13 was observed in two oocytes (4257.3, and 
3969.3) only.
FISH analysis of oocyte 1084.4 revealed two double SG signals corresponding to two 
chromosomes 13. The oocyte had probably lost chromosome 21 during processing. The 
corresponding PB was also available, but did not show any signals for either chromosome 
probably indicating whole chromosome non-disjunction for 13. Technical chromosome 
loss may have affected chromosome 21. An extra copy of chromosome 13 was scored for
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Fig.4.5: Second hybridisation round- Locus-specific probes for 
13 and 21
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was characterised as normal haploid for both 
LSI 21 probe-2 Iq22.13-q22.2 (SO) chromosomes 13 and 21. Two sligtly separated
green signals were scored for 13, whilst a red 
doublet was visiblefor 21.
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(iii) FISH analysis of PB 4181.4.
(ii) FISH analysis of oocyte 1084.4. The cell was characterised as normal
An extra copy of chromosome 13 was haploid for both chromosomes 13 and
observed in this cell (2 green doublets). 21. A green doublet was scored for 13
Chromosome 21 was missing. and a red for 21.
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oocyte 3969.3. Both copies of this chromosome had prematurely divided into their sister 
chromatids. The cell had a normal complement for chromosome 21. The corresponding 
1st PB was identified with the oocyte. The latter had two double signals, each one 
demonstrating the presence of one chromosome 13 and one chromosome 21. Thus, the 
PB was characterised as normal for both chromosomes. These observations led to the 
conclusion that this patient could have been a germinal mosaic for trisomy 13 with the 
extra chromosome ending up in the oocyte.
These results are summarised in Tables 4.7, and 4.8. Signal patterns for a normal oocyte, 
an oocyte disomic for 13 and a PB normal for 13 and 21 are shown in fig.4.5. 
Cytogenetic analysis of all oocytes and PBs using the ISCN nomenclature is given in 
Appendix C.
In summary, seven patients appeared to have abnormalities after oocyte analysis during 
this second hybridisation round. A case of whole chromosome non-disjunction was 
detected for one oocyte that contained an extra copy of 13, whilst its corresponding PB 
did not have any signals for this chromosome. Evidence of germinal mosaicism for a 
trisomic cell line was also obvious after this FISH analysis in one patient. Extra copies 
were observed for chromosome 13, but not for chromosome 21, as would be expected, 
considering the preferential involvement of smaller chromosomes in oocyte aneuploidy 
(Cupisti et al.,, 2003, Sandalinas et al, 2002). The latter could be attributed to the 
relatively high chromosome loss (60%) experienced during this hybridisation round. 
Effectively only a few oocytes were available for analysis and most of them were either 
considered to be normal for chromosome 21, or had lost it altogether.
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Table 4.7: FISH results for metaphase II oocytes investigated for chromosomes 13 and
21
Oocyte/patient
no.
Chromosomes scored and further 
observations
Oocyte characterisation
5coll(t) One chromosome 
Double signal for 21
Normal for 21
3782.1 One chromosome 
Double signal for 13
Normal for 13
1005.2 Two chromosomes 
Double signals for 13 and 21
Normal for 13 and 21
1084.2 Two chromosomes 
Double signals for 13 and 21
Normal for 13 and 21
1084.4 One chromosome 
Two double signals for 
chromosome 13
Disomic for 13
1084.6 Two chromosomes 
Double signals for 13 and 21
Normal for 13 and 21
3892.1 Two chromosomes 
Double signals for 13 and 21
Normal for 13 and 21
3967.3 Two chromosomes 
Double signals for 13 and 21
Normal for 13 and 21
3969.3 Two chromosomes 
Four separated signals for 13 
Double signal for 21
Premature division of 
chromatids for 13 and 
disomic for 13, normal for 
21
3967.9 One chromosome 
Double signal for 13
Normal for 13
3892.5 One chromosome 
Double signal for 21
Normal for 21
1033.4 Two chromosomes Normal for 13 and 21
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Double signals for 13 and 21
3839.1 One chromosome 
Double signal for 13
Normal for 13
3887.6 One chromosome 
Double signal for 13
Normal for 13
1001.5 One chromosome 
Single signal for 21
Premature division of 21, 
loss of other chromatid
H-l One chromosome 
Double signal for 13
Normal for 13
1147.1 Two chromosomes 
Double signals for 13 and 21
Normal for 13 and 21
4081.1 Two chromosomes 
Double signals for 13 and 21
Normal for 13 and 21
4176.5 One chromosome 
Double signal for 21
Normal for 21
4181.3 Two chromosomes. Double signal 
for 13. Two separate signals for 21
Premature division of 
sister chromatids for 21, 
normal for 13
4181.4 No signals -
4184.2 Two chromosomes 
Double signal for 13 
Two separate signals for 21
Premature division of 
sister chromatids for 21
1243.6 Two chromosomes 
Double signals for 13 and 21
Normal for 13 and 21
4257.1 One chromosome 
Two separate signals for 21
Premature division of 
sister chromatids for 21
4257.2 Two chromosomes 
Double signals for 13 and 21
Normal for 13 and 21
4257.3 Two chromosomes 
Two separate signals for 13
Premature division of 
sister chromatids for 13,
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Double signal for 21 normal for 21
4292.7 One chromosome 
Double signal for 21
Normal for 21
Table 4.8: FISH results for corresponding 1st PBs investigated for chromosomes 13 and
21
PB/patlent
no.
Chromosomes scored and further 
observations
PB characterisation
1084.4 PB No signals -
1084.6 PB Two chromosomes 
Double signals for 13 and 21
Normal for 13 and 21
3892.1 PB Two chromosomes 
Double signals for 13 and 21
Normal for 13 and 21
3967.3 PB One chromosome 
Two separate signals for 21
Division of sister 
chromatids for 21
3969.3 PB Two chromosomes 
Double signals for 13 and 21
Normal for 13 and 21
3892.5 PB Two chromosomes 
Double signal for 13 and 21
Normal for 13 and 21
4181.4 PB Two chromosomes 
Double signal for 13 
Two separate signals for 21
Division of sister 
chromatids for 21, normal 
for 21
1243.6 PB Two chromosomes 
Double signal for 13 
Two separate signals for 21
Division of sister 
chromatids for 21, normal 
for 13
Two-colour FISH efficiency on lymphocytes: 90%
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4.5 Third hybridisation round
During this hybridisation step the status of chromosome 22 was assessed. Analysis was 
attempted for the 29 oocytes and 8 corresponding 1st PBs that yielded results during the 
second hybridisation round. Out of these, signals were visible for seven oocytes and two 
PBs. The remaining were lost after FISH. Eggs from 22 patients were investigated in this 
final part of the study.
The probe used for chromosome 22 investigation was commercial (Vysis/Abbott, UK), 
locus-specific and was labelled in SG. Details are seen in Table 2.5. Similar to the second 
hybridisation round, no further pre-treatment of the cells took place. They were denatured 
after removal of the probes for chromosomes 13 and 21 and were left to hybridise for 12 
hours.
4.5.1 FISH with the locus-specific probe for chromosome 22
The probe employed for the investigation of chromosome 22, hybridised to the long 
arms, leading to the observation of slightly separated signals on oocytes, as for the locus- 
specific probes for chromosomes 13 and 21.
Analysis of seven oocytes from seven different patients was feasible with the application 
of this probe. The oocytes/patients examined were: 5coll(t), 1084.4, 3839.1, 4176.5,
4181.4, 1243.6, and 4292.6. All appeared to have a normal constitution for chromosome 
22. Neither premature division of chromatids or extra copies of this chromosome were 
detected in any of these cells.
Corresponding 1st PBs were investigated for two oocytes, 1243.6 and 4181.4. In the first 
case, the 1243.6 PB appeared to be a mirror image of the corresponding oocyte, being 
normal for chromosome 22. However, premature separation of chromatids was evident 
for this chromosome. In the case of the 4181.4 PB, three distinct and separate signals 
were observed upon visualisation of the cell under the fluorescent microscope. The latter 
meant that there was an extra chromatid 22 in the PB, in addition to the prematurely 
separated chromosome 22. This observation, combined with the fact that the actual 
oocyte was scored as normal for chromosome 22, led to the conclusion that this patient 
was possibly a germinal mosaic for trisomy 22, with the extra chromosome 22 ending up
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Fig.4.6: T h ird  hybrid isation  round- Locus-specific p robe  fo r
chrom osom e 22
LSI 22 probe- 22ql 1.2 (SG)
\  x  + * *
t
(i><v
(i) FISH analysis of oocyte 4176.5. The 
cell was scored to have the normal 
complement for chromosome 22. The 
expected green doublet was observed.
(ii)
chromatid 22
N v to
(iii)
(iii) FISH analysis of PB 4181.4.
The cell was identified to contain
(ii) FISH analysis of oocyte 4181.4. The expected an extra chromatid 22, as a single
green doublet was osberved for chromosome 22. The green signal was visible in addition 
latter meant that this cell was normal for 22. to the expected doublet. Signal sepa­
ration was attributed to PB dgeneration.
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in the 1st PB, and then separating to its sister chromatids either prematurely, or due to 
rapid PB degeneration. One of the two chromatids could have been lost during 
processing.
Tables 4.9 and 4.10 demonstrate all the above observations. FISH analysis of a 
normal oocyte for chromosome 22 and of the oocyte and corresponding 1st PB from 
patient 4181.4 are illustrated in fig.4.6. Detailed cytogenetic analysis of all oocytes 
and PBs with the ISCN nomenclature is given in Appendix C.
The chromosome loss rate after this final hybridisation round was calculated to be 
76%. Consequently, the size of the studied sample was very small for more 
abnormalities to be identified. The morphology of the chromosomes from the oocytes 
and PBs that remained after the third round of FISH appeared to be much poorer 
compared to their morphology after the first round of FISH. The latter was a result of 
the repeated staining of the chromosomal DNA with DAPI in combination to the 
extended exposure to fluorescent light. Oocytes and PBs, which appeared to be more 
degenerate after the second round of FISH, were not detected after the third round.
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Table 4.9: FISH results for metaphase II oocytes, investigated for chromosome 22
Oocyte/patient no. Observations Oocyte characterisation
5coll(t) Double signal for 22 Normal for 22
1084.4 Double signal for 22 Normal for 22
3839.1 Double signal for 22 Normal for 22
1243.6 Double signal for 22 Normal for 22
4292.7 Double signal for 22 Normal for 22
4176.5 Double signal for 22 Normal for 22
4181.4 Double signal for 22 Normal for 22
Table 4.10: FISH results for corresponding 1st PBs investigated for chromosome 22
PR/patient no. Observations PB characterisation
12436. PB Two separate signals for 22 Division of sister chromatids for 22
4181.4 PB Double signal for 22 
Single signal for 22
Extra chromatid 22
Single-colour FISH efficiency on lymphocytes: 85%
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4.6 Aneuploidy in human metaphase II oocytes and corresponding 1st 
polar bodies
Three consecutive hybridisation rounds took place for the analysis of 265 metaphase II 
oocytes and their corresponding 1st PBs, when these were available. Investigation of 
chromosomes 1,4, 12, 13, 17, 21, 22, and X, belonging to different groups occurred, 
in an attempt to establish how frequent each of these was present as an extra whole 
univalent or a single chromatid. Absence of chromosomes was not scored as an 
anomaly, as this loss could have resulted from overspreading or the FISH procedure. 
FISH analysis for chromosomes 1,4, 12, 17, and X (1st round) was feasible on 51 
oocytes and 11 PBs. Chromosomes 13 and 21 (2nd round) were examined in a total of 
29 oocytes and 8 PBs, whereas seven oocytes and 2 PBs yielded results for 
chromosome 22. All the remaining cells were lost either before the first hybridisation 
or during one of the subsequent rounds. Data on the chromosome status of the female 
gametes was obtained from thirty-three patients.
Hyperhaploid eggs were recorded for five patients (average age 32.2), with the 
anomalies scored affecting one chromosome only. In four cases one extra 
chromosome was observed in the oocyte. Chromosomes that presented as extra copies 
included 17 in two patients (4264,1209), and 13 in another two patients (1084, 3969). 
The fifth patient (4181) appeared to have an extra chromatid 22 in the 1st PB, with the 
corresponding oocyte being normal. These results are shown in Table 4.11.
The presence of germinal mosaicism was evident in two out of the five patients, 
whose eggs were scored as abnormal. More specifically, an oocyte and its 
corresponding 1st PB were investigated for patient 3969. An extra whole copy of 
chromosome 13 was scored in the oocyte, whereas the PB had a normal complement 
for this chromosome. An extra chromatid 22 was present in the 1st PB coming from 
patient 4181, while the corresponding oocyte had the expected double signal for this 
chromosome. The remaining two oocytes from this patient were lost during FISH and 
no further information on the complement of 22 could be obtained. It is possible that 
one or more of the primary oocytes from these two patients were trisomic for
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chromosomes 13 and 22 respectively, with the extra copy ending up in the oocyte for 
the first case and the 1 * PB for the second.
Balanced predivision of chromatids affected nearly all the chromosomes investigated. 
This phenomenon was first reported by Angell (1991) and is thought to take place 
prior to anaphase I. The separated chromatids run the risk of segregating randomly to 
either pole, during meiosis II. In this study, it was observed for 11 oocytes (4181.3,
4184.2, 4257.1,4257.3, 3416.11, 3969.3, 3969.4, 3967.9,1243.6, 4264.1,1001.5) and 
six PBs (968.1PB, 3967.9PB, 1243.6PB, 4181.3PB, 4181.4PB, 3967.3PB). As far as 
the PBs are concerned, this phenomenon could be the result of their rapid 
degeneration, during prolonged culture. The chromosome, which most frequently was 
identified as having precociously separated into its sister chromatids, was 21, with 
seven such events being scored. The latter could be attributed to the small size of this 
chromosome, which has an effect the formation of very few or no chiasmata during 
meiosis I in the female gamete (Antonarakis et al, 1993). The frequency with which 
each of the examined chromosomes was affected by premature division into its sister 
chromatids is demonstrated in Table 4.12.
Five abnormalities were identified in total, four of which involved additional 
chromosomes, and just one an additional chromatid. Anomalies were observed for 
chromosomes 13, 17, and 22, with a frequency ranging between 9-14.3%. The highest 
frequency corresponded to chromosome 22, which was the smallest presenting with 
an extra chromatid in one PB. No abnormalities were observed for the larger 
chromosomes 1,4, 12 and X. Similar results have been obtained from other studies 
from our group (Cupisti et al, 2003, Mahmood et al, 2000), which postulated the 
preferential involvement of smaller chromosomes in oocyte aneuploidy. Table 4.13 
demonstrates the frequency of hyperploidy found in oocytes and 1st PBs for all the 
chromosomes that were examined.
The number of oocytes and corresponding 1st PBs available for investigation in this 
part of the research project was very small, and the latter could explain why no 
abnormalities were observed for chromosome 21, which was one of the two smallest 
in the group. High cell loss was experienced during processing. Attributing factors
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included the actual spreading and FISH procedures, the staining of the oocyte DNA 
with DAPI or Giemsa, and the prolonged exposure to fluorescent light, which also 
affected chromosome quality. Even though many cells were lost, certain anomalies 
were scored for the ones that remained and went through all three rounds of FISH. 
The data obtained provided evidence for different mechanisms leading to maternal 
aneuploidy, which was the first hypothesis being tested. These include the classical 
non-disjunction of a whole univalent chromosome, the precocious separation of 
chromosomes into their sister chromatids prior to anaphase I with the potential risk of 
random segregation during meiosis II, the preferential involvement of smaller 
chromosomes in oocyte aneuploidy (second hypothesis being tested), and the presence 
of germinal mosaicism for a trisomic cell line, involving again smaller chromosomes. 
The effect of advanced maternal age could not be established because of the small 
sample size.
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Table 4.11: Patients with extra chromosomes/chromatids in one or more oocytes or PBs. Chromosomes investigated are indicated
Patient no. Age Infertility
cause
Egg* number/ 
status
Examined chromosomes 
1 4 12 13 17 21 22 X
Abnormalities observed
4264 35 Unknown 4 unfertilised * * * Extra chromosome 17 in oocyte 4264.1 
(no PB). Remaining oocytes normal for 
17
1209 33 MF 3 unfertilised/ 
3 immature
* * * Extra chromosome 17 in oocyte 1209.2 
(no PB)
1084 31 MF 3 unfertilised/ 
5 immature
* * * Extra chromosome 13 in oocyte 
1084.4; no PB result. 
Remaining oocytes normal
3969 31 MF 12 unfertilised * * Extra chromosome 13 in oocyte 
3969.3; PB normal. Remaining oocytes 
lostb
4181 31 Tubal 3 unfertilised * + * * Extra chromatid 22 in 1st PB 
(4181 APB), corresponding oocyte 
normal6
[ Indicated chromosomes examined. MF, male factor
a An egg consists of an oocyte and a first polar body, but each may be present alone without the other
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b Evidence of trisomic precursor cell and germinal mosaicism
Table 4.12: Patients showing precocious separation of chromosomes into their sister chromatids in oocytes and/or PBs.
Patient no. Oocyte no. PB no. Predivision of chromatids 
1 4 12 13 17 21 22 X
3416 3416.11 - *
968 - 968.1 PB *
3969 3969.3 - *
3969.4 - *
3967 3967.9 3967.9 PB ♦
- 3967.3 PB ♦
1243 1243.6 1243.6 PB * * * * (PB)
4181 4181.3 4181.3 PB *(PB) *
- 4181.4 PB ♦ *
1001 1001.5 - *
4184 4184.2 - *
4257 4257.1 - *
4257.3 - *
[ Chromosomes showing predivision to sister chromatids are indicated
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Table 4.13: Hyperploidy frequency identified in oocytes or 1st PBs per chromosome
Chromosome Eggs scored Whole chromosome Single chromatids % of abnormalities
1 5 0 0 0
4 22 0 0 0
12 28 0 0 0
13 22 2 0 9
17 29 2 0 7
21 21 0 0 0
22 7 0 1 14.3
X 10 0 0 0
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C h a p t e r  5- R e s u l t s  
The analysis of human metaphase n  oocvtes and 
corresponding polar bodies with CGH
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5.1 CGH investigation of human metaphase H oocytes and 
corresponding 1st PBs
The final part of the study involved the analysis of unfertilised human oocytes, arrested at 
metaphase II, and their corresponding 1st PBs with the application of Comparative 
Genomic Hybridisation (CGH). As mentioned, CGH enables the screening of an entire 
genome in a single hybridisation (Kallioniemi et al, 1992). Thus, the application of this 
technique for the analysis of oocytes and 1st PBs would provide data on the whole of the 
maternal genome. The aims of this part of the study were the following:
• To examine chromosomes not generally targeted in oocyte examination by FISH.
• To investigate how and whether chromosomes of larger size than 13 affect 
maternal aneuploidy.
• To accurately estimate hypohaploidy and hence the aneuploidy rate in the 
examined cells.
All investigated oocytes had either failed to fertilise after their exposure to sperm, either 
via IVF or ICSI or were immature and were not exposed to sperm. Three differently 
prepared groups of cells were examined:
Group 1: Oocyte and PB were separated after removal of the zona pellucida (ZP) using 
Acid Tyrode’s solution, and were suspended in lOOpl of sterile PBS. Removal of excess 
PBS was essential before further treatment of these cells. Thirteen oocytes and 13 PBs 
from this group underwent the CGH procedure, out of which 12 were pairs.
Group 2: Similar to the first group, oocytes and PBs were separated after treatment with 
Acid Tyrode’s, but each cell was suspended in approximately 2pl of sterile PBS. This 
difference in preparation occurred to avoid the risk of losing the cell during the initial 
removal of the excess PBS. CGH analysis was attempted for 12 oocytes and 14 PBs, nine 
of which were pairs.
Group 3: Pronase was employed for the removal of the ZP and the oocytes and their 
corresponding PBs were separated by agitation. Similar to the second group each cell was 
suspended in 2pl of sterile PBS, and overlaid with a drop of oil to prevent possible
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contamination by external DNA agents. CGH analysis of 15 oocytes and 17 PBs was 
attempted, 15 of which were pairs.
All mature unfertilised oocytes and especially those that underwent ICSI were considered 
to contain sperm DNA. Hence, analysis of a potential zygote occurred with CGH. In 
other words, data may have been obtained on both the maternal and the paternal genomes 
in some cases. PCR analysis to identify maternal and paternal polymorphisms would 
detect the presence of sperm. However, this did not take place, due to lack of time 
available for this study. The situation was different for the corresponding 1st PBs, as they 
were extruded during the first meiotic division, and sperm contamination was unlikely. 
Therefore, the results obtained from these cells were considered to represent solely the 
maternal genome. The rapid degeneration of first PBs was considered a potential source 
of DNA loss. For this reason, their morphology was always checked prior to them being 
placed in tubes.
The patients that took part in this study were assumed to be of normal karyotype (46 XX, 
46 XY), with maternal ages between 22 and 39 years (mean 31.9). Treatment for 
infertility took place for various reasons, including male factor, anovulation and 
polycystic ovary syndrome. All couples underwent treatment at the Assisted Conception 
Unit at Tayside University Hospitals, NHS Trust, Dundee, Scotland. All cells arrived in 
London frozen in a special container, and were stored at -80°C until they were processed.
5.2 Evaluation of the CGH protocol
Analysis of single cells with the application of CGH was achieved in three sequential 
stages, as suggested by Wells and colleagues (2002). More specifically, during the first 
stage the entire genome of the single cell (6-10pg) was amplified to provide enough DNA 
for subsequent investigations. The amplified samples were then fluorescently labelled, 
combined and hybridised onto target lymphocyte metaphases, coming from a normal 
male. Evaluation of the CGH protocol prior to its application on the oocytes and PBs 
occurred by carrying out seven different positive control experiments. These were the 
following:
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1. Normal female (46,XX) lymphocyte genomic DNA labelled in SG against normal 
male (46,XY) lymphocyte genomic DNA labelled in SR.
2. Fibroblast DNA trisomic for chromosome 13 labelled in SG against 46,XY genomic 
DNA labelled in SR.
3. Fibroblast DNA trisomic for chromosome 21 labelled in SG against 46,XX genomic 
DNA labelled in SR.
4. Fibroblast DNA trisomic for chromosome 22 labelled in SG against 46,XY genomic 
DNA labelled in SR.
5. Clump of buccal cells 46,XX labelled in SG against clump of buccal cells 46,XY 
labelled in SR.
6. Clump of buccal cells 46,XX labelled in SG against clump of buccal cells 46,XX 
labelled in SR.
7. Single fibroblast trisomic for chromosome 18 labelled in SG against 46,XY genomic 
DNA labelled in SR.
Initial amplification for all the above samples was achieved with the application of the 
Degenerate Oligonucleotide Primed (DOP) PCR. This reaction employed a semi­
degenerate primer that annealed at many sites throughout the genome. DOP-PCR was 
shown to provide a good coverage of the genome, allowing the subsequent amplification 
of approximately 223 loci, out of a total of 250 (Wells et al., 1999). Some preferential 
amplification of certain parts of the genome exists. In this study, evaluation of the DOP 
PCR, was achieved by firstly attempting the amplification of the above DNAs, which 
were all of low initial concentrations ranging from 1-800 ng/pl, and then of the clumps 
(3-5 cells) or single buccal cells, and fibroblasts. Stringent precautions against 
contamination took place for all experiments, as described in the Methods section.
The incorporation of fluorescent labels into the amplified products occurred 
enzymatically, with the use of a kit (Vysis/Abbot, UK). For all experiments, the DNAs 
requiring examination (test), were labelled in green, and were hybridised against DNA 
known to be normal (46,XX or 46,XY). The latter was considered to be the reference 
sample, and was labelled in red.
The above positive control experiments were set up to ensure firstly that small 
concentrations of DNA were accurately amplified, the nick translation was efficiently
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incorporating the fluorescent labels in the amplified products, and that the remainder of 
the protocol would result in target metaphases showing bright and clear signals for both 
test and reference DNAs. Moreover, these experiments enabled the assessment of the 
accuracy and sensitivity of the computer software employed for the analysis and 
interpretation of the captured images. All samples were of known karyotypes, prior to 
analysis. The aim was to check whether the interpretation of the analysed images would 
demonstrate the difference in fluorescence in the sex chromosomes when female samples 
were hybridised against male, and also the trisomies of the different chromosomes, in the 
analysis of the fibroblast DNAs. Description of the results obtained from these positive 
control experiments will take place in the following sections.
5.2.1 CGH analysis of 46JCX genomic DNA against 46.XY genomic DNA
The DNA concentration of both samples was lOOOpg/pl. This experiment was carried out 
to assess the ability of the DOP PCR to amplify DNA of a low concentration and to 
demonstrate the fluorescence pattern observed when a normal female DNA sample was 
hybridised against a normal male DNA sample. During CGH analysis of DNAs of a 
normal diploid karyotype, it was essential that the autosome regions showed minimal or 
no deviation from 1. The ratio profile obtained for chromosome X could be considered as 
the positive internal control for the assessment of the dynamic range of the particular 
hybridisation (Karhu et al., 1997).
Amplified products were initially analysed by agarose gel electrophoresis. Visualisation 
of the gel showed bright smears of sizes between 300-1500bp in length for both samples. 
Smears of such sizes were observed by Wells and colleagues (1999) and Voullaire and 
colleagues (1999), in their attempt to assess the efficiency of the DOP-PCR. No smear 
was seen for the contamination control PCR sample, consisting of all the reaction 
components, apart from DNA. These observations led to the conclusion that the DOP- 
PCR had effectively amplified both samples, without any contamination being present. 
Incorporation of fluorescent tags followed, with the female genomic DNA being labelled 
in green, and the male in red. Both samples were subsequently combined and hybridised 
onto normal male target metaphases. Examination of these metaphases under the
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Fig. 5.1: Positive control experiment: CGH analysis o f 46,XX genomic 
DNA against 46,XY genomic DNA
Fig.5.1a: Normal 46,XY metaphase
chromosomes hybridised with 46,XX 
genomic DNA {green) and 46,XY genomic 
DNA {red).
?! Iii i i i  ii IsiEu
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Fig.5.1b: Normal 46,XY metaphase
chromosomes classified according to their 
banding patterns. All 23 autosomes had an 
even orange/yellow colouration due to the 
combination of the green and red
fluorochromes. Chromosome X was
excessively green, as an extra copy was 
present in the green 46,XX DNA, whilst 
chromosome Y was excessively red, as it was 
present in the red 46,XY DNA.
Fig.5.1c: Interpretation of the positive control CGH experiment described in section 5.2.1. 
No difference in fluorescence intensities was detected for any of the 23 autosomes, as they 
were present in equal numbers in the “test” (46,XX- green) and “reference” (46,XY- red). 
DNAs. Excess green fluorescence and the expected deviation of the ratio profile towards the 
right threshold (more than 1.20) was detected for the X chromosome, indicating its presence 
in two copies in the green “test” DNA. Excess red fluorescence and the expected deviation 
of the ratio profile towards the left threshold (less than 0.80) was identified for the Y 
chromosome, indicating its presence in the “reference” DNA and its absence from the “test” 
DNA.
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fluorescent microscope revealed that both the green and the red fluorochromes gave 
intense and clear signals, without any background. Combination of both led to an even 
orange coloration on all the chromosomes, apart from the X and Y. More specifically, 
chromosome X was excessively green, whereas chromosome Y was excessively red. This 
was expected, as the female sample containing two chromosomes X was labelled in 
green, whereas the male sample with an X and a Y was labelled in red.
Five metaphases were analysed and 188 chromosomes were included in the 
interpretation. As was expected, almost no deviation from 1 was observed for the ratio 
profiles of all autosomes. Some regions of the karyotype, including the centromeres of 
chromosomes 13, 14, 15, 21 and 22 and the short arm telomeres of chromosomes 2, 10 
and 12 showed deviations from 1. These were attributed to known hybridisation artefacts 
and were not included in the analysis of the images. Excess green fluorescence was 
consistently observed on the X chromosome (Xp22.3-q28), leading to a deviation of the 
ratio profile towards the right threshold (more than 1.2). The latter was expected, as the 
“test” sample came from a female. Consistent excess red fluorescence was observed for 
the Y chromosome (Ypl 1.3-ql2), resulting to a deviation of the ratio profile towards the 
left threshold (less than 0.8). This was also expected, as the “reference” DNA came from 
a male. Thus, confirmation of both karyotypes was achieved. A metaphase showing the 
fluorescent signals on the chromosomes can be seen in fig. 5.1a and b, whereas the 
interpretation of this experiment is shown in fig. 5.1c.
5.2.2 CGH analysis of fibroblast DNA trisomic for chromosome 13 against 46JCY 
genomic DNA
The concentration of both DNA samples was of the range of 80ng/pl. The karyotype of 
the test fibroblast DNA was 47,XY, +13. This experiment was carried out to assess 
whether the CGH was sensitive enough to identify the trisomy for chromosome 13 in the 
test sample. In addition, it would serve as a reference for the detection of comparable 
abnormalities in oocytes and/or PBs.
Both test and reference DNAs were amplified with the use of the DOP-PCR. Agarose gel 
analysis demonstrated smears of similar intensities and fragment sizes with those
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Fig. 5.2: Positive control experim ent: C G H  analysis o f 47,XY+13
fibroblast DNA against 46,XY genom ic DNA
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Fig.5.2a: Normal 46,XY metaphase 
chromosomes hybridised with 
47,XY,+ 13 fibroblast DNA {green) 
and 46,XY genomic DNA {red).
Fig.5.2b: Normal 46,XY metaphase
chromosomes classified according to their 
banding patterns. Chromosome 13 was 
excessively green, the latter indicating the 
presence of the extra copy for 13 in the test 
sample (47,XY,+ 13). Both test and reference 
DNAs were XY. Hence no difference in 
fluorescence was seen for the sex 
chromosomes.
Fig. 5.1c: Interpretation of the positive control CGH experiment described in section
5.2.2. The ratio profile for chromosome 13 deviated towards the right threshold (more 
than 1.20), the latter indicating the presence of an extra copy of this chromosome in 
the green test DNA compared to the red reference DNA. No other deviations of ratio 
profiles were observed either for the autosomes or the sex chromosomes. Accurate 
identification of the karyotype of the test sample as 47,XY,+13 was achieved.
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observed for the previous experiment. The trisomic fibroblast DNA was considered to be 
the test and was labelled in green, whereas the reference normal male DNA was labelled 
in red. Both test and reference DNAs were combined and hybridised onto target male 
metaphases.
Visualisation of the slide under the fluorescent microscope revealed that both 
fluorochromes gave clear and even signals on the chromosomes. The green fluorescently 
labelled fibroblast DNA was relatively more intense, compared to the red, resulting in the 
chromosomes having a slightly more green rather than orange colouration. Chromosome 
13 was easily distinguished, as it was even greener, due to the trisomy of the test sample. 
There was no fluorescence difference in the sex chromosomes.
Analysis took place on ten metaphases and 362 chromosomes were included in the 
interpretation. Hybridisation artefacts were observed for the long arm telomeres of 
chromosomes 1, 9, 12, 15, 16, and Y, and for the short arm telomeres of chromosomes X 
and 14. These were anticipated and were not included in the analysis. The ratio profiles 
for all autosomes apart from 13 did not deviate from 1, as expected. Chromosome 13 was 
consistently excessively green (regions: 13pl2-q34). Its ratio profile deviated to the right 
(more than 1.2). This demonstrated the trisomy in the test sample. There was no 
fluorescence difference in the sex chromosomes, as both test and reference DNAs were 
male. Hence, the karyotype of the test sample was correctly identified as male trisomy 
13. A metaphase demonstrating the fluorescent signals on the chromosomes is shown in 
fig. 5.2a and b, whereas the interpretation of this experiment is demonstrated in fig. 5.2c.
5.23 CGH analysis of fibroblast DNA trisomic for chromosome 21 against 46«XX 
genomic DNA
The concentration of the fibroblast DNA sample was 70ng/pl, whereas that of the female 
genomic DNA was 200ng/pl. The karyotype of the test fibroblast DNA was 47,XY, +21. 
This experiment was performed to evaluate CGH sensitivity for the detection of the 
trisomy for the smaller chromosome 21 in the test sample. It would serve as a reference
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Fig. 5.3: Positive control experim ent: C G H  analysis o f 47,XY+21
fib rob last DNA against 46,XX genom ic DNA
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Fig.5.3a: Normal 46,XY metaphase
chromosomes hybridised with 47,XY,+21 
fibroblast DNA {green) and 46,XX 
genomic DNA {red).
Fig. 5.3b: Normal 46,XY metaphase 
chromosomes classified according to their 
banding patterns. Chromosome 21 was 
excessively green, the latter indicating the 
presence of the extra copy for 21 in the 
test sample (47,XY,+21). Chromosome X 
was excessively red, indicating the 
presence of this chromosome in 2 copies 
in the female red reference DNA, while 
chromosome Y was excessively green, as 
the green test was XY.
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Fig. 53c: Interpretation of the positive control CGH experiment described in 
section 5.2.3. The ratio profile for chromosome 21 deviated towards the right 
threshold (more than 1.20), the latter indicating the presence of an extra copy of this 
chromosome in the green test DNA compared to the red reference DNA. A 
deviation of the ratio profile of chromosome X towards the left threshold (less than 
0.80) and of chromosome Y towards the right threshold (more than 1.20) indicates 
that the reference DNA was XX, while the test DNA was XY. Accurate 
identification of the karyotype of the test sample as 47,XY,+21 was achieved.
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for the identification of similar abnormalities in oocytes and/or PBs.
Analysis of the amplified products with agarose gel electrophoresis revealed smears 
similar to those observed for the previous experiments, and as above, the fibroblast DNA 
was labelled in green, while the female genomic DNA was labelled in red.
Visualisation of the target metaphase chromosomes, under the fluorescent microscope 
showed that they had a clear, intense and even orange coloration. Both the green and the 
red fluorochromes were very bright, and did not give any background. Chromosome 21 
was distinct from the others, as it was visibly greener, due to the trisomy in the test 
sample (regions 21pl3-q22). Deviation of its ratio profile towards the right threshold 
(more than 1.2) was also observed. Chromosome X was relatively more red (regions 
Xp22.3-q28), as the reference DNA was female. The latter resulted in the ratio profile of 
this chromosome deviating towards the left threshold (less than 0.8). Chromosome Y, on 
the other hand, appeared green (regions Ypl 1.3-ql2) with its ratio profile also deviating 
to the right. The above confirmed the karyotype of the test sample, as male trisomy 21. 
Analysis was carried out on 15 metaphases and 593 chromosomes were included in the 
interpretation. Hybridisation artefacts were not observed for this experiment. The latter 
was attributed to the good quality of the hybridisation for both the test and reference 
DNA probes. A metaphase showing the fluorescent signals on the chromosomes can be 
seen in fig. 5.3a and b, whereas the interpretation of this experiment is shown in fig. 5.3c.
5.2.4 CGH analysis of fibroblast DNA trisomic for chromosome 22 against 46.XY 
genomic DNA
The concentration of the fibroblast DNA sample was lOOng/pl and the karyotype was 
47,XY, +22. The male genomic DNA had a concentration of 200ng/pl. This experiment 
would also serve as a reference for the oocyte and PB CGH results. DOP- PCR 
amplification and agarose gel analysis resulted in smears of similar intensities and 
fragment sizes as those observed for the previous experiments. During the nick
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Fig. 5.4: Positive con tro l experim ent: C G H  analysis o f 47,XY+22
fib rob last DNA against 46,XY genom ic DNA
Fig.5.4a: Normal 46,XY metaphase 
chromosomes hybridised with 
47,XY,+22 fibroblast DNA {green) 
and 46,XY genomic DNA {red).
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Fig. 5.4b: Normal 46,XY metaphase 
chromosomes classified according 
to their banding patterns. 
Chromosome 22 was excessively 
green, the latter indicating the 
presence of the extra copy for 22 in 
the test sample (47,XY,+22). Both 
test and reference DNAs were XY. 
Hence no difference in fluorescence 
was seen for the sex chromosomes.
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Fig. 5.4c: Interpretation of the positive control CGH experiment described in 
section 5.2.4. The ratio profile for chromosome 22 deviated towards the right 
threshold (more than 1.20), the latter indicating the presence of an extra copy 
of this chromosome in the green test DNA compared to the red reference DNA. 
No other deviations of ratio profiles were observed either for the autosomes or 
the sex chromosomes. Accurate identification of the karyotype of the test 
sample as 47,XY,+22 was achieved.
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translation of both samples, the fibroblast DNA was labelled in green, whilst the male 
genomic DNA was labelled in red.
Observation of the slide revealed that both green and red fluorochromes were clearly 
visible, but not as bright as in previous experiments. Chromosome 22 was identified 
easily, as it was greener, compared to the rest of the autosomes, which were orange, 
while there was no difference in the fluorescent intensities of the sex chromosomes, as 
both test and reference DNAs were male.
Analysis occurred in eleven metaphases and 387 chromosomes were included in the 
interpretation. Hybridisation artefacts were observed for the short arm telomeres of 
chromosomes 13, 14, and 17, the centromere of 9, and the long arm telomeres of 
chromosomes 12, 18, 20, X and Y. These were excluded from the analysis. Chromosome 
22 was consistently greener (regions: 22pl3-ql3). Its ratio profile deviated to the right 
(more than 1.2). There was no fluorescence difference on the sex chromosomes, as both 
test and reference samples were male. Thus, the karyotype of the test DNA was 
confirmed as male trisomy 22. A metaphase showing the fluorescent signals on the 
chromosomes is illustrated in fig. 5.4a and b, whereas the interpretation of this 
experiment can be seen in fig. 5.4c.
5.2.5 CGH analysis of 46AX buccal cell clump against 46«XY buccal cell clump
All the above experiments confirmed that the CGH protocol was functional at the 
genomic DNA level, and was sensitive enough to detect trisomies for chromosomes 
ranging in size, and the difference in the sex chromosomes when sex mismatched test and 
reference DNAs co-hybridised. The same protocol was then employed for the analysis of 
much lower concentrations of DNA, to test its efficiency in the examination of cell 
clumps and single cells. Clumps of buccal cells consisted of 3-5 cells. Hence DNA 
concentrations were estimated to be between 18-30pg of starting material. This 
experiment would also provide an initial indication of the fluorescence pattern that would 
be obtained when either an oocyte or a PB were hybridised against male DNA. Agarose 
gel analysis of the DOP-amplified products demonstrated that the obtained smears did not 
vary in either brightness, or fragment sizes from the smears given by the
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Fig. 5.5: Positive control experim ent: C G H  analysis o f 46,XX buccal cell
clum p DNA against 46,XY buccal cell clum p DNA
Fig.5.5a: Normal 46,XY
metaphase chromosomes 
hybridised with 46,XX buccal 
cell DNA {green) and 46,XY 
buccal cell DNA {red).
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Fig.5.5b: Normal 46,XY metaphase
chromosomes classified according to their 
banding patterns. Chromosome X was 
excessively green, as the “test” sample was 
female, whilst chromosome Y was 
excessively red, as the “reference” sample 
was male.
Fig.5.5c: Interpretation of the positive control CGH experiment described in section 
5.2.5. No difference in fluorescence intensities was detected for any of the 23 
autosomes, as they were present in equal numbers in the “test” (46,XX- green) and 
“reference” (46,XY- red). DNAs. The fluorescence pattern and the shifts of the ratio 
profiles observed for the sex chromosomes were identical to those observed when 
46,XX genomic DNA (green) was hybridised against 46,XY genomic DNA (red), as 
described in fig. 5.1c.
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genomic DNA. The observation of smears led to the conclusion that the DOP PCR had 
the ability to effectively amplify clumps of cells. The remainder of the CGH protocol was 
identical to the one followed for the genomic DNA samples. Hence, enzymatic 
incorporation of fluorescent labels took place, resulting in the labelling of the female 
clump in green (“test”), and the male clump in red (“reference”). Combination of both 
and their hybridisation on normal male metaphase target slides followed.
Upon visualisation of the hybridisation area under the fluorescent microscope it was 
observed that all chromosomes had a very bright and even orange colouration, resulting 
from the combination of the red and green fluorochromes. The X and Y chromosomes 
were clearly distinguished, due to their difference in intensities between the red and the 
green. The above demonstrated that the nick translation and remainder of the CGH 
protocol were successful.
Analysis of 13 metaphases took place, and 457 chromosomes were included in the 
interpretation. Hybridisation artefacts were observed for the long arm telomere of 
chromosome 15. The ratio profiles for all autosomes did not deviate from 1, as was 
expected because both test and reference DNAs were normal. Excess green fluorescence 
was observed on almost the whole of chromosome X (Xp22.3-q27), leading to a 
deviation of its ratio profile to the right (more than 1.2). This demonstrated that the test 
DNA was of a female karyotype. Excess red fluorescence was observed for the Y 
chromosome (regions: Ypl 1.2-Yql2). Its ratio profile deviated to the left (less than 0.8). 
This showed that the reference DNA was of male karyotype. Thus, both karyotypes were 
confirmed. A metaphase showing the fluorescent signals on the chromosomes is 
illustrated in fig. 5.5a and b, whereas the interpretation of this experiment can be seen in 
fig. 5.5c.
5.2.6 CGH analysis of 46AX buccal cell clump against 46JCX buccal cell clump
The previous experiment established that the CGH protocol was applicable at the single 
cell level. Co-hybridisation of two clumps of female buccal cells would indicate how the 
fluorescent pattern for a normal oocyte or PB would be if they hybridised against female 
DNA. Similar to the above, DOP-PCR was carried out for the amplification of the buccal 
cell DNA. One clump of cells was labelled in green and the other in red and
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Fig. 5.6: Positive control experim ent: C G H  analysis o f 46,XX buccal cell
clum p DNA against 46,XX buccal cell c lum p DNA
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Fig.5.6a: Normal 46,XY
metaphase chromosomes
hybridised with 46,XX buccal cell 
DNA {green) and 46,XX buccal 
cell DNA (red).
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Fig.5.6b: Normal 46,XY metaphase
chromosomes classified according to their 
banding patterns. All 23 autosomes and 
chromosome X had even fluorescence intensities 
due to the combination of the green and red 
fluorochromes. No fluorescence was visible for 
the Y chromosome, as there was no DNA present 
either in test or the reference samples.
Fig.5.6c: Interpretation of the positive control CGH experiment described in 
section 5.2.6. No difference in fluorescence intensities was detected for any of 
the 23 autosomes and the X chromosome, as they were present in equal numbers 
in the “test” (46,XX- green) and “reference” (46,XX- red) samples.
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co-hybridisation took place on male metaphases as before. Since there was no male 
DNA, it was expected that the Y chromosome would not show any fluorescence, whereas 
no difference in fluorescence intensity would be observed for the X chromosome.
Observation of the slide revealed that all chromosomes had a bright and even colouration, 
resulting from the combination of the red and green fluorochromes. The Y chromosome 
was visible with the DAP1 filter only, as there was no hybridising DNA, whilst the X 
chromosome had equal amounts of both red and green, as expected.
Analysis was carried out on eight metaphases, and 275 chromosomes were included in 
the interpretation. Hybridisation artefacts were visible for the centromeres of 
chromosomes 14 and 15 and the long arm of chromosome Y. No deviation from 1 was 
observed for the ratio profiles of all autosomes and the X chromosome. Thus, the 46,XX 
karyotype was confirmed. Fig. 5.6a and b demonstrates the appearance of the fluorescent 
signals on a metaphase, whereas the interpretation of this experiment is shown in fig. 
5.6c.
5.2.7 CGH analysis of a single fibroblast cell trfsomic for chromosome 18 against 
46JCY genomic DNA
The karyotype of the fibroblast cell was 47,XX, +18. The concentration of the genomic 
DNA was of the range of lOOOpg/pl. This experiment took place to investigate whether 
the CGH profiles would show notable fluctuations, due to the difference of the initial 
DNA concentrations (6pg versus lOOOpg) of the two samples. In addition, it would serve 
as a reference for the identification of similar abnormalities in oocytes and/or PBs.
Both samples were amplified with the use of the DOP-PCR, resulting in smears very 
similar to those observed previously. The fibroblast was labelled in green, whereas the 
male genomic DNA was labelled in red. Their combination and hybridisation occurred as 
previously described.
Upon visualisation of the target metaphases, it was obvious that both the red and the 
green fluorochromes were equally intense and clear, giving an even orange coloration
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Fig. 5.7: Positive control experim ent: C G H  analysis o f 47,XX+18
fibroblast cell DNA against 46,XY genom ic DNA
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Fig.5.7a: Normal 46,XY metaphase 
chromosomes hybridised with 
47,XX,+18 fibroblast cell DNA (green) 
and 46,XY genomic DNA (red).
Fig. 5.7b: Normal 46,XY metaphase
chromosomes classified according to their 
banding patterns. Chromosome 18 was 
excessively green, the latter indicating the 
trisomy of this chromosome in the test 
DNA. Chromosome X was also excessively 
green, indicating the female karyotype of 
the test DNA, while chromosome Y was 
excessively red, as the reference DNA was 
XY.
Fig. 5.7c: Interpretation of the positive control CGH experiment described in section 5.2.7. 
The deviation of the ratio profile for chromosomes 18 and X towards the right threshold 
(more than 1.20) demonstrated that the test DNA was female and trisomic for chromosome 
18. The male karyotype of the reference DNA was obvious due to the deviation of the ratio 
profile of chromosome Y towards the left threshold (less than 0.8), which also demonstrated 
its absence from the test DNA. Accurate identification of the karyotype of the test sample as 
47,XX,+18 was achieved.
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throughout the chromosomes. Chromosome 18 was easily distinguished, as it was 
relatively more green than red (regions 18pll.3-q23). Its ratio profile deviated towards 
the right threshold (more than 1.2), demonstrating the trisomy of this chromosome in the 
test sample. A similar green colouration was visible for chromosome X (regions 
Xp22.30q28), leading to its ratio profile deviating to the right and the identification of the 
female karyotype in the test sample. Chromosome Y was easily scored as well, due to its 
excessive red colouration (regions Ypl 1.2-ql2). Its ratio profile deviated to the left (less 
than 0.8). This showed that the reference DNA was of male karyotype. Thus, the 
karyotype of the test sample was confirmed as female trisomy 18.
Analysis took place on 13 metaphases and 510 chromosomes were included in the 
interpretation. Hybridisation artefacts were observed for the centromere and short arm 
telomere of chromosome 9, and the centromere of chromosome 13. A metaphase showing 
the fluorescent signals on the chromosomes can be seen in fig. 5.7a and b. The 
interpretation of this experiment can be seen in fig. 5.7c.
Optimisation of the CGH protocol was essential during the positive control experiments 
described above, especially at the single cell level. The latter meant that some of these 
experiments took place more than once, in order for the desired results to be obtained. 
Various modifications in the initial CGH protocol occurred. Thus, the extension 
temperature in the DOP-PCR conditions was decreased from the 72°C that was initially 
used to 68°C. This temperature was considered to be optimal for the highest performance 
of the Super Taq Plus™ Enzyme. Moreover, the incubation time for the labelling of the 
CGH probes varied between 1-2 hours, depending on the sizes of the generated DNA 
fragments. Ideally these should be between 500bp- 1Kb. During initial CGH experiments, 
the target metaphase chromosomes were pre-treated with the application of Proteinase K 
(PK), in order for the surrounding cytoplasm to be removed. The latter was achieved by 
incubating the slides in PK buffer for 10 minutes at 37°C. This slide pre-treatment was 
omitted in subsequent experiments, as it was determined to be too aggressive and to 
affect chromosome morphology, and hence the quality of hybridisation of die CGH 
probes.
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5.3 CGH analysis of human metaphase H oocytes
CGH analysis was attempted for 40 human oocytes that were arrested at the metaphase II 
stage of meiosis. Eleven cells yielded results, coming from nine patients. Out of these, 
two oocytes belonged to the first group, four to the second group, and five to the third 
group with reference to the method of preparation. Different types of reference DNA 
were used, against which these cells hybridised. Oocytes were initially co-hybridised 
with 46,XY genomic DNA or clumps of buccal cells. However, the analysis and 
interpretation of an oocyte (1243.2-green) that was not exposed to sperm and was 
hybridised against a 46,XY clump of buccal cells (red) did not result in the expected 
fluorescence difference on the sex chromosomes (excess green on the X, excess red on 
the Y), indicating the possible contamination of the cell with male DNA, most likely 
from the technician responsible for cell isolation. It was perceived that the use of female 
DNA as reference would have allowed the contamination to be more readily detected, as 
the Y chromosome would have appeared to be green. In addition, the use of 46,XX DNA 
as reference would enable the detection of X chromosome hyperhaploidy. The latter was 
not feasible when 46,XY DNA was used as reference, as the test DNA came from female 
sources, and the X would always appear overrepresented relative the 46,XY control DNA 
as CGH is not capable of accurately distinguishing chromosome excess (e.g. trisomy 
versus tetrasomy). For these reasons, the majority of oocytes were hybridised against 
46,XX DNA, either genomic or derived from cell clumps. In the latter case, clumps were 
preferred to single cells, in order to avoid the possibility of an anucleate or degenerate 
buccal cell, not yielding any results.
All oocytes, clumps of buccal cells, and genomic DNA were initially amplified with the 
use of the DOP-PCR. Agarose gel analysis revealed smears of DNA fragments whose 
sizes were between 300-1500bp, as previously. The smears obtained for the oocytes were 
usually not as bright (i.e. less DNA was present) compared to those from die clumps or 
the genomic DNA. This observation was attributed to the fact that fewer copies of the 
genome were present in oocytes than in clumps or genomic DNA samples and that the 
quality of the oocyte DNA may have been inferior due to prolonged in vitro culture. 
However, the sizes of the amplified fragments from the oocytes, demonstrated that their
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Oocyte and PB DOP-PCR Amplification
Fig.5.8: Agarose gel analysis demonstrating the DOP-PCR 
amplification of oocyte and PB 1134.3, and two buccal cell clumps
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|Oocyte Polar Body Buccal Buccal
Fig.5.8: Agarose gel analysis demonstrating the DOP-PCR amplification 
of oocyte no. 1134.3, its corresponding 1st PB and two clumps of buccal 
cells, which were used as reference DNA against which the oocyte and 
PB were hybridised. Both the amplified products from the oocyte and its 
corresponding PB produced smears of similar intensities and fragment 
sizes with the two clumps of buccal cells. Fragment sizes were between 
300-1500bp in length for all samples. The intensity of the smears that 
were produced from the amplified oocytes and/or PBs varied, being 
usually fainter compared to those observed for the buccal cell clumps.
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DNA was adequately amplified with the use of the DOP-PCR. A gel showing the smears 
representing an oocyte, a PB, and two clumps of buccal cells can be seen in fig. 5.8. 
Oocytes were considered to behave in the same way as a diploid female cell. Out of the 
eleven oocytes analysed with CGH, eight were considered to be normal 23,X. These were 
the following: oocyte no. 1141.2 from the first group, oocytes 1172.2, 1173.1, 1243.2, 
1174.1 from the second group, and oocytes 4412.6, 1355.4 and 4405.3 from the third 
group. Fertilisation was attempted with ICSI for five of them (1141.2, 1172.2, 1173.1, 
1174.1, 1355.4) and with 1VF for the remaining two, whilst oocyte 1243.2 was immature 
at the time of retrieval and was not exposed to sperm.
Oocytes 1141.2, 1172.2, 1173.1, 1174.1, 1243.2 were all hybridised against normal male 
DNA. After visualisation of the target metaphase areas under the fluorescent microscope, 
it was observed that the red fluorescence being emitted from the reference DNA was 
almost always intense, clear and even on the chromosomes, without giving any 
background. The green fluorescence corresponding to the oocyte DNA was almost 
always much fainter and background was frequently observed. The latter was attributed 
to the DNA quality of the oocytes. Analysis was carried out on 7-12 metaphases each 
time.
In the case of oocyte 1174.1, which was exposed to sperm via ICSI, and hybridised 
against a clump of 46,XY buccal cells, the interpretation of the captured images did not 
detect any marked fluorescence difference on the sex chromosomes, and no obvious 
deviation of their ratio profiles from 1. This observation led to the conclusion that this 
oocyte was penetrated with Y-bearing sperm. The karyotype of the actual oocyte was 
considered to be normal 23,X.
For the remaining four oocytes that co-hybridised with 46,XY DNA, interpretation of the 
captured metaphase images would demonstrate autosomes with ratio profiles not 
deviating from 1, and difference in the fluorescence intensities on the sex chromosomes. 
Hence, chromosome X was consistently excessively green (areas: Xp22.3-Xq27) leading 
to a deviation of its ratio profile towards the right threshold (more than 1.2). This showed 
that the test DNA was of a female karyotype.
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Fig. 5.9: C G H  analysis o f oocyte no. 1173.1, 23,X against 46,XY buccal
cell clum p DNA
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Fig.5.9b: Normal 46,XY metaphase
chromosomes classified according to their 
banding patterns. All 23 autosomes had an 
even orange colour resulting from the 
combination of the green oocyte DNA and 
the red buccal clump DNA. We considered 
that a haploid oocyte behaved as a diploid 
female cell. Thus, chromosome X was 
excessively green indicating the female test 
DNA, whilst chromosome Y was 
excessively red, due to the male reference 
DNA.
Fig.5.9c: Interpretation of the CGH experiment for oocyte 1173.1. The oocyte was 
characterised as normal haploid (23,X), as no difference in fluorescence intensities 
was detected for any of the 23 autosomes, meaning that they were present in equal 
numbers in the “test” (green) and “reference” (red) DNAs. The fluorescence pattern 
and the shifts of the ratio profiles observed for the sex chromosomes were identical 
to those observed when sex mismatched DNAs are hybridised against each other, as 
described in fig.5.1 and fig.5.5.
Fig.5.9a: Normal 46,XY metaphase 
chromosomes hybridised with DNA 
from oocyte 1173.1 {green) and 46,XY 
buccal cell DNA {red).
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Chromosome Y was excessively red (areas: Ypll.l-ql2). Its ratio profile deviated 
towards the left threshold (less than 0.8), demonstrating the male karyotype of the 
reference DNA. All these oocytes, apart from oocyte 1243.2, were injected with sperm. 
Thus, it was considered that the fluorescence difference observed cm the sex 
chromosomes was attributed to the fact that the sperm was carrying an X chromosome as 
well. In all cases the oocytes were considered to be normal 23,X. A metaphase showing 
the appearance of the fluorescent signals on the chromosomes for oocyte 1173.1 is shown 
in fig.5.9a and b, whereas its corresponding interpretation is illustrated in fig.5.9c.
Oocytes 4412.6, 1355.4, and 4405.3 were all hybridised against 46,XX clumps of buccal 
cells. Observation of the hybridisation target areas led to similar findings to the above, 
i.e., the clumps of buccal cells always gave bright and clear red fluorescent signals, 
whereas fainter green signals were visible for the oocyte DNA, combined with some 
background green fluorescence. Chromosome Y did not show any fluorescent signals, in 
all cases apart from one (oocyte no. 4405.3). The fluorescent signal absence for 
chromosome Y was expected and was also demonstrated during the analysis of the 
positive control experiment, involving the co-hybridisation of 46,XX buccal cells, 
labelled in red and green.
Analysis and interpretation of the metaphase images for oocytes 4412.6, and 1355.4 gave 
very similar results. All autosomes and the X chromosome showed an orange colouration 
from the combination of the red and the green fluorochromes. The latter was interpreted 
as no deviation of ratio profiles from 1. In all these cases, the karyotype of the test oocyte 
was considered to be normal 23,X, possibly having been penetrated with an X-bearing 
sperm.
The situation was different for oocyte 4405.3. Fertilisation of this cell was attempted via 
IVF. Interpretation of the metaphase images did not show any deviation from 1 for any of 
the autosomes. A very small part towards the bottom of the long arm of chromosome X 
(Xq25-q27) showed excess green. This was considered to be attributable to hybridisation 
artefacts that often affect telomeric regions, and was excluded from the analysis. Excess 
red fluorescence, was observed for the whole of chromosome Y (Ypl 1.3-ql2), leading to 
a deviation of the ratio towards the left threshold (less than 0.8). The latter was 
unexpected, as the reference DNA used for
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Fig. 5.10: CG H  analysis of oocyte no. 1355.4, 23,X against 46,XX buccal
cell clum p DNA
Fig.5.10a: Normal 46,XY
metaphase chromosomes
hybridised with DNA from 
oocyte 1355.4 {green) and 46,XX 
buccal cell DNA {red).
Fig.5.10b: Normal 46,XY metaphase 
chromosomes classified according to 
their banding patterns. Even 
fluorescence intensities were observed 
for all 23 autosomes and the X 
chromosome, as both the test oocyte 
DNA and the reference DNA were 
female.
Fig.5.10c: Interpretation of the CGH experiment for oocyte 1355.4. The oocyte 
was characterised as normal haploid (23,X), as no difference in fluorescence 
intensities was detected for any of the 23 autosomes, meaning that they were 
present in equal numbers in the “test” (green) and “reference” (red) DNAs. No 
shift was observed for the ratio profile of chromosome X, as the latter was also 
present in equal amounts in both test and reference (46,XX) DNAs. The 
fluorescence pattern for the sex chromosomes in this experiment was similar to 
the one described in fig.5.6, when a 46,XX buccal cell clump (green) was 
hybridised against another 46,XX buccal cell clump (red).
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this experiment was 46,XX. It was very likely that the clump of buccal cells was 
contaminated. The oocyte was considered to be normal 23,X. A metaphase demonstrating 
the appearance of the fluorescent signals for oocyte 1355.4 is shown in fig.5.10a and b. 
Its corresponding interpretation can be seen in fig.5.10c.
Details of the above observations for all the oocytes that were characterised as normal are 
shown in Table 5.1.
Abnormalities were observed for oocytes 1134.3, 4412.4 and 4412.5, the first belonging 
to the first group, whilst the other two the third one. As was mentioned in the previous 
chapter, non-disjunction of whole chromosomes and premature separation of a 
chromosome into its sister chromatids prior to anaphase I, can both lead to aneuploidy in 
oocytes. Distinction between extra or missing chromosomes and chromatids was not 
feasible in most cases due to the relative detection insensitivity of the CGH and the 
suboptimal condition of the oocyte DNA. In addition, the abnormalities observed in 
oocytes 4412.4 and 4412.5 described below could have been due to sperm presence. 
Confirmation that such abnormalities were the result of non-disjunction would only occur 
if the reciprocal loss or gain were scored in the corresponding 1st PB. This occurred for 
the oocyte no. 4412.5 and will be discussed in the following section. Oocyte 1134.3 was 
at the germinal vesicle stage when collected, was not injected due to its immaturity and 
was left to mature to metaphase II in vitro.
Oocyte 1134.3 was hybridised against a clump of 46,XY buccal cells. Upon visualisation 
of the target metaphase chromosomes the following were observed: the red fluorochrome 
corresponding to the reference DNA was very intense and even on the chromosomes. The 
green fluorescence for the oocyte DNA was even on the chromosomes as well, but 
fainter. No difference in fluorescence could be seen for the sex chromosomes, which was 
not expected. Analysis of 12 metaphases took place, and 412 chromosomes were 
included in the interpretation. Chromosome 13 appeared to be excessively green (areas: 
13pl3-q21). Its ratio profile deviated towards the right threshold (more than 1.2). This 
indicated the presence of extra chromosomal material for 13 in the test DNA. In the 
positive control experiment involving the CGH analysis of fibroblast DNA that was 
trisomic for chromosome 13, the areas of the chromosome that showed the excess green 
were 13pl2-q34. Comparison with the results obtained for this oocyte confirmed the
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Fig.5.11: C G H  analysis o f oocyte no .l 134.3 against 46,XY buccal cell
clum p DNA
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Fig.5.11a: Normal 46,XY
metaphase chromosomes 
hybridised with DNA from 
oocyte 1134.3 {green) and 
46,XY buccal cell DNA {red).
Fig.5.11b: Normal 46,XY metaphase 
chromosomes classified according to 
their banding patterns. Chromosome 13 
appeared to be excessively green, 
compared to the rest of the autosomes, 
the latter indicating the presence of 
extra DNA for this chromosome in the 
test sample.
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Fig.5.11c: Interpretation of the CGH experiment for oocyte 1134.3. The 
ratio profile of chromosome 13 deviated towards the right threshold (more 
than 1.20), demonstrating the presence of extra DNA material for this 
chromosome in the green oocyte sample. CGH analysis of the corresponding 
PB did not demonstrate the expected reciprocal loss of chromosome 13. It is 
possible that the extra DNA for 13 was due to the presence of an additional 
chromatid in the oocyte, with the CGH software not detecting its loss in the 
corresponding PB. Another possibility was that this patient was a germinal 
mosaic for trisomy 13, with the extra copy ending up in the oocyte. The 
oocyte was not exposed to sperm, as it was immature at the time of 
collection. Hence the karyotype of this oocyte was thought to be either 
24,X,+13 or 23X,+1/2 13cht.
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presence of the extra DNA for this chromosome in the cell. CGH analysis of the 
corresponding 1st PB revealed that the latter had a normal 23,X karyotype as will be 
described in the following section. Thus, the presence of the extra chromosome 13 in 
oocyte 1134.3 could be attributed to the fact that the patient was a germinal mosaic for 
trisomy 13. Another possibility could be that the oocyte contained an extra chromatid 13. 
In this case, the CGH analysis may have had insufficient sensitivity to detect the loss of 
the chromatid 13 in the corresponding PB. It has been shown that CGH is less efficient in 
detecting chromosome loss than chromosome gain (Malmgrem et al, 2002; D. Wells 
personal communication). As far as the remaining autosomes and the sex chromosomes 
were concerned, there was no difference in fluorescence intensities between the two 
fluorochromes, and ratio profiles did not deviate from 1. Since the reference DNA was 
male and the oocyte uninjected, it was concluded that the cell was contaminated by the 
male handler during its tubing. Thus, CGH analysis of the test DNA demonstrated that 
the karyotype of this oocyte was 24,X,+13 or 23,X,+i/2l3cht in the case of an extra 
chromatid. Appearance of fluorescent signals on a metaphase is shown in fig.5.1 la and b, 
whereas the interpretation of this oocyte is illustrated in fig.5.1 lc.
Fertilisation was attempted with IVF for oocyte 4412.4. The reference DNA used was a 
clump of 46,XX buccal cells. Observation of the slide under the fluorescent microscope 
showed chromosomes that had an even orange colouration, with the green fluorochrome 
corresponding to the oocyte DNA being relatively more faint compared to the red 
fluorochrome for the reference DNA. Analysis was carried out on seven metaphases and 
224 chromosomes were included in the interpretation. Excess green fluorescence was 
observed for chromosome 13 (areas: 13ql4-q32). The ratio profile for this chromosome 
deviated towards the right threshold (more than 1.2), indicating the presence of extra 
chromosomal material for 13 in the test DNA. Excess red fluorescence was scored for 
chromosome 22 (areas: 22pl3-pll.l, 22qll.2-ql3), leading to a deviation towards the 
left threshold (less than 0.8) This deviation indicated that the test DNA was missing 
chromosomal material for 22. Comparison with the positive control experiment involving 
the CGH analysis of fibroblast DNA, trisomic for 22 showed the presence of excess 
green fluorescence on the exact same regions of this chromosome, and confirmed the 
results for the oocyte.
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Fig.5.12: C G H  analysis o f oocyte no. 4412.4 against 46,XX buccal cell
clum p DNA
_
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Fig.5.12a: Normal 46,XY
metaphase chromosomes 
hybridised with DNA from 
oocyte 4412.4 (green) and 
46,XX buccal cell DNA (red).
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Fig.5.12b: Normal 46,XY metaphase
chromosomes classified according to their 
banding patterns. Chromosome 13 
appeared to be excessively green, whilst 
chromosome 22 was excessively red, 
compared to the rest of the autosomes. 
These differences in fluorescence 
intensities demonstrated that the test 
oocyte sample contained extra DNA 
material for 13 and was also missing DNA 
material for 22.
Fig.5.12c: Interpretation of the CGH experiment for oocyte 4412.4. The ratio 
profile of chromosome 13 deviated towards the right threshold (more than 
1.20), whereas the ratio profile for chromosome 22 deviated towards the left 
(less than 0.80). These shifts demonstrated the presence of extra DNA 
material for 13 and the absence for 22 in the oocyte sample. CGH analysis of 
the corresponding PB did not demonstrate the reciprocal loss and gain for 
these chromosomes. Sperm contamination was evident, as chromosome Y 
was excessively green, and the reference DNA used in this experiment was 
46,XX. It was possible that these abnormalities could have been caused by an 
aneuploid sperm. Another possibility was that the abnormalities observed 
were caused by single chromatids. In the case that these anomalies were of 
maternal origin, then the karyotype of the oocyte was considered to be either 
23,X,+13,-22 or 23,X,+1/2 13cht,-i/2 22cht.
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Chromosome Y was consistently excessively green (areas: Ypl 1.2-ql2), with its ratio 
profile deviating to the right. This observation made the presence of sperm DNA in the 
oocyte evident. CGH analysis of its corresponding 1st PB showed the latter to be normal 
23,X. The abnormalities observed in this cell could either be attributed to the sperm, and 
thus, oocyte 4412.4 had a normal 23,X karyotype and the sperm had a 23, Y+13,-22 
karyotype, or they were all caused by meiotic errors taking place in the oocyte. The fact 
that the reciprocal gain and loss were not detected in the corresponding 1st PB argues for 
an origin in the sperm. However, it is also possible that the CGH failed to detect the 
imbalance in the corresponding 1st PB due to poor hybridisation. In the case that these 
chromosome abnormalities were of maternal origin, the karyotype of the oocyte would be 
either 23,X,+13,-22 if whole chromosomes were involved or 23,X,+1/2l3cht,-1/222cht if 
single chromatids were participating. A metaphase from the CGH of this oocyte is seen in 
fig.5.12a and b, while the interpretation for this experiment is shown in fig.5.12c.
Analysis took place on nine metaphases and 352 chromosomes were included in the interpretation 
for oocyte 4412.5. Excess red fluorescence was observed for chromosome X (areas: Xp21-Xq28). 
This was accompanied by a shift o f  the ratio profile for this chromosome towards the left 
threshold (less than 0.8), indicating the loss o f  this chromosome from the test sample. A slight 
shift towards the right threshold (more than 1.2) was observed for the ratio profile o f chromosome 
21. Some hybridisation artefacts were observed on chromosome 9 (p and q telomeres, and 
heterochromatic region), at the bottom part o f  chromosome Y (Y qll.2 -q l2 ) and a small part o f 
the short arm o f chromosome 2. These well described CGH artefacts were excluded from the 
interpretation. The above observations led to the conclusion that oocyte 4412.5 was missing 
chromosome X and could contain extra chromosome material for 21, possibly an extra chromatid. 
The corresponding PB was also investigated with CGH and the reciprocal gain o f DNA for 
chromosome X and loss o f DNA for chromosome 21 were both identified, as discussed in the 
following section. Hence, the karyotype o f oocyte 4412.5 according to the obtained CGH results 
was 22,-X,(possibly +l/221cht). A metaphase demonstrating the hybridisation signals for this 
oocyte is shown in fig. 5.13a and b, whilst the interpretation for this experiment can be seen in 
fig.5.13c. Oocyte 4412.6 coming from the same patient was characterised to be normal haploid 
23,X. The patient that donated these oocytes was
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Fig.5.13: CGH analysis o f oocyte no. 4412.5 against 46,XX buccal cell
clump DNA
Fig.5.13a: Normal 46,XY
metaphase chromosomes hybridised 
with DNA from oocyte 4412.5 
{green) and 46,XX buccal cell DNA
{red).
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Fig.5.13b: Normal 46,XY metaphase 
chromosomes classified according to their 
banding patterns. Chromosome X 
appeared to be excessively red. The latter 
indicated that the test oocyte sample was 
missing DNA for this chromosome.
Fig.5.13c: Interpretation of the CGH experiment for oocyte 4412.5. The ratio 
profile of chromosome X deviated towards the left (less than 0.80). This shift 
demonstrated the absence of this chromosome in the oocyte sample. A slight shift 
of the ratio profile for 21 towards the right (more than 1.20) was also seen, 
indicating the possible presence of extra DNA for this chromosome in the test 
sample. The reciprocal gain of X and loss of chromosome 21 was evident from the 
CGH analysis of the corresponding PB (see fig.5.16). These anomalies were most 
likely of maternal origin, as they were confirmed in the corresponding PB. The 
karyotype of the oocyte was 22,-X, possibly +1/2 21cht.
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treated for infertility due to polycystic ovary syndrome. Such patients frequently 
produce oocytes with multiple chromosome anomalies (Sengoku et al, 1997; Clyde et 
al, 2001). So it was very likely that the abnormalities observed in the oocyte no.
4412.5 were of maternal origin. Details of the observations from the CGH analysis of 
the oocytes are summarised in Table 5.1.
Amplified DNA from the oocytes that did not yield results after they underwent CGH 
was analysed by agarose gel electrophoresis. Out of the 29 samples analysed, only 
two oocytes gave very faint smears, demonstrating that there was amplification of 
their DNA. The fact that the CGH did not work for these samples could be attributed 
to very poor DNA quality. None of the other samples gave smears. It was very likely 
that these oocytes were either lost or lysed at a stage during their processing.
In summary, CGH results were obtained for 11 oocytes out of a total of 40, for which 
analysis was attempted. Nine patients were investigated. From these 11 oocytes eight 
could be characterised as normal 23,X. Abnormalities were identified for three 
oocytes coming from two different patients. In two of the three cases the reciprocal 
abnormalities were not detected in corresponding 1st PBs. Hence, in the case of oocyte 
1134.3 it is either possible that the extra chromosome 13 originated from a primary 
oocyte, trisomic for 13, or that the CGH did not detect the missing 13 in the 
corresponding PB. The situation is different for oocyte 4412.4, which showed 
anomalies for chromosomes 13 and 22. Sperm penetration was identified for this cell. 
However, it is unlikely for a sperm to be carrying so many chromosome 
abnormalities. Reciprocal losses and gains were identified in the oocyte 4412.5 and its 
corresponding 1st PB. This oocyte came from the same patient that had also donated 
oocyte 4412.4. CGH analysis and interpretation revealed that this cell was missing 
chromosome X and could possibly contain extra DNA for chromosome 21. The 
reciprocal gain of chromosome X was identified in the corresponding 1st PB that was 
also identified to be missing chromosome 21. Hence in this case, the abnormalities 
scored in the oocyte were most likely due to meiotic non-disjunction taking place in 
the female.
Confirmation that the above chromosome abnormalities were of maternal origin also 
comes from the fact, that the female patient that donated these cells was being treated
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for infertility due to polycystic ovary syndrome. Such patients could tend to produce 
gametes carrying multiple chromosome abnormalities (Sengoku et al., 1997).
Table 5.1: CGH analysis of human metaphase II oocytes
Oocyte/patient no. ART method Reference DNA CGH Interpretation
1141.2 ICSI 46,XY clump of 
buccal cells
23,X
1134.3 Uninjected 46,XY clump of 
buccal cells
24,X+13 or 23,X+i/2 
13cht
1172.2 ICSI 46,XY clump of 
buccal cells
23,X
1173.1 ICSI 46,XY clump of 
buccal cells
23,X
1174.1 ICSI 46,XY clump of 
buccal cells
23,X
1243.2 Uninjected 46,XY clump of 
buccal cells
23,X
1355.4 ICSI 46,XX clump of 
buccal cells
23,X
4412.4 IVF 46,XX clump of 
buccal cells
23,X+13,-22 or 
23,X+i/2 13cht, - 1/2 
22cht
4412.5 IVF 46,XX clump of 
buccal cells
22 -X , or 22,-X +1/2 
21cht
4412.6 IVF 46,XX clump of 
buccal cells
23,X
4405.3 IVF 46,XX clump of 
buccal cells
23,X
i
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5.4 CGH analysis of 1st Polar Bodies
A total of 45 first PBs underwent CGH analysis, 37 of which had their corresponding 
oocyte also investigated. Results were obtained for 15 PBs, three belonging to group 1, 
four belonging to group 2, and eight belonging to group 3, from fourteen different 
patients. It was thought that sperm contamination was unlikely for the PBs, and thus the 
obtained CGH results were representative of the maternal genome only. The reference 
DNA used was as for the oocytes, i.e. genomic or clumps of buccals of 46,XY or 46,XX 
DNA. All PBs and reference DNAs were amplified with the use of the DOP-PCR as 
previously described. Agarose gel analysis demonstrated the same difference in smear 
intensities between PBs and reference DNAs, as that observed for the oocyte DNA. 
Average fragment sizes were in the range of 1500bp.
Similar to the oocytes, the PBs were also considered to behave as diploid female cells. 
Eleven PBs were characterised as being normal 23,X after their CGH analysis. These 
were the following: 1141.2PB, 1134.3PB, 4047.3PB from the first group, 1173.1, 
4125.1PB, 1243.1PB, 4069.1PB from the second group, and 4412.4PB, 4412.6PB, 
1355.5PB, 4405.3PB from the third group.
Normal 46,XY DNA in the form of clumps of buccal cells was used as reference during 
the CGH analysis of 1173.1PB, 1134.3PB, 4047.3PB and 4125.1PB. Upon visualisation 
of the hybridisation target areas under the fluorescent microscope, the metaphase 
chromosomes were seen to have a uniform orange colour from the combination of the red 
and green fluorochromes. As before, the red fluorescence emitted from the reference 
DNA was very intense and sharp, without any background. The green fluorescence, 
corresponding to the PB was much brighter and clearer compared to that observed for the 
oocyte DNA. Chromosomes X and Y could easily be distinguished as the former was 
more green and the latter more red, demonstrating the difference in DNA quantities 
between the test and reference DNAs for these chromosomes.
Analysis was carried out on 15 metaphases for all four PBs. Interpretation of the images 
showed no marked fluorescence difference between test and reference DNAs in any of 
the autosomes for all these. Their ratio profiles did not deviate from 1.
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Fig. 5.14: CG H  analysis of PB no. 4125.1, 23,X against 46,XY buccal cell
clum p DNA
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Fig.5.14a: Normal 46, XY
metaphase chromosomes
hybridised with DNA from PB 
no. 4125.1 {green) and 46,XY 
buccal cell DNA {red).
Fig.5.14b: Normal 46,XY metaphase 
chromosomes classified according to 
their banding patterns. As with the 
oocytes, we considered that PBs behaved 
as diploid female cells. Chromosome X 
was excessively green indicating the 
female test DNA, whilst chromosome Y 
was excessively red, due to the male 
reference DNA.
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Fig.5.14c: Interpretation of the CGH experiment for PB 4125.1. This PB was 
characterised as normal haploid (23,X), as no difference in fluorescence 
intensities was detected for any of the 23 autosomes, meaning that they were 
present in equal numbers in the “test” (green) and “reference” (red) DNAs. The 
fluorescence pattern and the shifts of the ratio profiles observed for the sex 
chromosomes were identical to those observed when sex mismatched DNAs are 
hybridised against each other, as described in fig.5.1, 5.5 and 5.9.
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Chromosome X was consistently excessively more green (areas: Xp22.1-Xq27), with its 
ratio profile deviating towards the right threshold (more than 1.2). Chromosome Y was 
more red (areas Ypll.2-ql2), with its ratio profile deviating towards the left threshold 
(less than 0.8). The above showed that the karyotype of all four PBs was normal 23,X. A 
metaphase showing the appearance of the fluorescent signals obtained for 4125.1PB can 
be seen in fig.5.14a and b. Its corresponding interpretation is shown in fig.5.14c.
In the case of 1134.3PB, CGH results were obtained for its corresponding oocyte, which 
appeared to be carrying extra chromosome material for 13. The reciprocal loss of 13 was 
not observed in the 1st PB. This could either be attributed to this patient being a germinal 
mosaic for trisomy 13, or to inability of the CGH software to identify a missing 
chromatid for 13 in the PB, as mentioned in the previous section.
Normal 46,XX DNA either genomic or in the form of buccal cell clumps was used as 
reference for the 1141.2PB, 1243.1PB, 4069.1PB, 4412.4PB, 4412.6PB, 1355.5PB and 
4405.3PB. The appearance of fluorescent signals on the target metaphase chromosomes 
was as previously for both reference and test DNA, with the only difference being that no 
fluorescence was visible for the Y chromosome. The latter was expected, as neither the 
test nor the reference DNAs were male. Analysis was carried out on 7-15 metaphases. 
Hybridisation artefacts were sometimes visible for the centromeres and/or telomeres of 
chromosomes 1, 2, 5, 6, 7, 8, 9, 13, 15, 21, and 22. These were excluded from the 
analysis. Interpretation of the metaphase images demonstrated that the ratio profiles of all 
autosomes and the X chromosome did not deviate from 1. In the case of 4412.6PB excess 
green fluorescence was consistently observed on the Y chromosome, leading to a 
deviation to the right. The latter indicated the presence of male DNA contamination in 
this PB, most likely from the handler. The karyotype of all the above analysed PBs was 
considered to be normal 23,X. Normal reciprocal results were obtained for the following 
pairs of cells: 1141.2 oocyte and PB, 1173.1 oocyte and PB, 4405.3 oocyte and PB, and
4412.6 oocyte and PB. All were characterised as haploid 23,X. A metaphase from 4412.6 
PB is shown in fig.5.15a and b, whereas its interpretation can be seen in fig.5.15c. Details 
of the observations made in all the above PBs are summarised in Table 5.2.
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Fig. 5.15: CG H  analysis of PB no. 4412.6, 23,X against 46,XX buccal cell
clum p DNA
Fig.5.15a: Normal 46,XY
metaphase chromosomes hybridised 
with DNA from PB no. 4412.6 
(green) and 46,XX buccal cell DNA 
(red).
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Fig.5.15b: Normal 46,XY metaphase 
chrom osomes classified according to 
their banding patterns. Even 
fluorescence intensity was observed for 
all 23 autosomes and the X chromosome, 
as both the test PB DNA and the 
reference DNA were female. No 
fluorescence was visible for 
chrom osom e Y, due to its absence from 
both samples.
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Fig.5.15c: Interpretation o f  the CGH experiment for PB 4412.6. The PB was 
characterised as normal haploid (23,X), as no difference in fluorescence intensities 
was detected for any o f  the 23 autosomes and chromosome X. These were present 
in equal numbers in the “test” (green) and “reference” (red) DNAs. The 
fluorescence pattern for the sex chrom osomes in this experiment is similar to the 
one described in fig.5.6 and 5.10.
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Fig.5.16: C G H  analysis o f PB no. 4412.5 against 46,XX buccal cell
clum p DNA
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Fig.5.16a: Norm al 46,XY m etaphase 
chrom osom es hybridised with DNA 
from PB 4412.5 (green) and 46,XX 
buccal cell DNA (red).
Fig.5.16b: Norm al 46,XY m etaphase 
chrom osom es classified according to 
their banding patterns. Chrom osom e X 
appeared to be excessively green and 
chrom osom e 21 excessively red. The 
latter indicated that the test PB sample 
contained extra DNA material for X 
and was m issing DNA material for 21.
Fig.5.16c: Interpretation o f  the CGH experim ent for PB 4412.5. The ratio profile 
o f  chrom osome X deviated towards the right threshold (m ore than 1.20). This shift 
demonstrated the presence o f  extra chrom osom al m aterial in the PB sample. A 
shift o f  the ratio profile for 21 towards the left (less than 0.80) was observed as 
well, indicating the absence o f  chrom osomal material for 21 in the te s t  The 
reciprocal loss o f  X and possible gain o f  chrom osom e 21 were evident from the 
CGH analysis o f  the corresponding oocyte (see fig.5.13). Contam ination by the 
male handler was seen in this PB. These anom alies w ere o f  maternal origin, as 
they were confirmed in the corresponding oocyte. The karyotype o f  this PB was 
23,X ,+X ,-21 (or -1/2 21 cht).
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Chromosome abnormalities were scored in four PBs: 1143.4PB, 1254.6PB, 4412.5PB 
and 1355.1PB. Similar to the oocytes, anomalies involving extra or missing 
chromosomes could not usually be distinguished from those that involved single 
chromatids.
The most pronounced case was again that of patient 4412, who was suffering from 
polycystic ovaries. CGH analysis was carried out on four PBs (4412.1PB, 4412.4PB, 
4412.5PB, and 4412.6PB) from this patient, out of which three yielded results.
The 4412.5PB was hybridised against a clump of 46,XX buccal cells. Analysis took place 
on eight metaphases, and 292 chromosomes were included in the interpretation. Excess 
red fluorescence was observed on chromosome 21 (areas: 21pl2-pll.2, 21qll.l-q22). 
The ratio profile of this chromosome deviated towards the left threshold (less than 0.8), 
something, which demonstrated that the PB was missing DNA material for 21. The latter 
was confirmed by comparing the fluorescence pattern with the positive control 
experiment involving the CGH analysis of fibroblast DNA trisomic for chromosome 21. 
Excess green was observed on the exact same areas of this chromosome. Chromosome X 
was excessively green, as well (areas: Xp22.3-p22, Xp21-pll.2, Xq21, Xq27). The 
deviation of its ratio profile towards the right threshold, demonstrated that the 4412.5PB 
consisted of extra chromosomal material for X. Excess green was also observed for 
chromosome Y (areas Yql 1.1-12), indicating the presence of male DNA contamination, 
possibly from the handler, as it was unlikely for the actual PB cell to be penetrated by 
sperm. The reciprocal loss of DNA for chromosome X was detected in the corresponding 
oocyte, but not the gain of DNA for chromosome 21, as described in the previous section. 
According to these observations, it is possible that this PB contained an extra whole 
chromosome X and was missing a single chromatid 21, its karyotype being 24,X,+X,- 
V-il 1 cht. The appearance of the fluorescent signals on a metaphase coming from the CGH 
analysis of this PB can be seen in fig.5.16a and b, whereas the interpretation results are 
shown in fig.5.16c.
In total three oocytes and four PBs from patient 4412 were investigated, and 
abnormalities were seen for two oocytes and one PB, the latter corresponding to one
270
PB CGH Results
Fig.5.17: C G H  analysis o f PB no. 1143.4 against 46*XY buccal cell
c lum p DNA
9
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Fig.5.17a: Normal 46, XY
metaphase chromosomes hybridised 
with DNA from PB 1143.4 {green) 
and 46,XY buccal cell DNA {red).
Fig.5.17b: Normal 46,XY metaphase 
chromosomes classified according to 
their banding patterns. Chromosome 8 
appeared to be excessively green. The 
’’cated that the test PB 
sample contained extra DNA material 
for this cfimmr«f>me
Fig.5.17c: Interpretation of the CGH experiment for PB 1143.4. The ratio profile of 
chromosome 8 deviated towards the right threshold (more than 1.20). This shift 
demonstrated the presence of extra chromosomal material in the PB sav?pL. The 
fluorescence pattern and the shifts of the ratio profiles towards the right threshold for
UiK ie X and toward* the left threshold for chromosome Y were seen 
previously when sex mismatched DNAs co-hybridised. The karyotype of this PB was 
thought to be 24,X,+8. The corresponding oocyte was not investigated.
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of the two oocytes. Different chromosomes were involved, including 13 and X, which 
appeared to be present in extra copies, and the smaller 21 and 22, which appeared to be 
missing. One oocyte and PB pair (4412.6) appeared to be normal haploid, 23,X. The 
maternal age was 22 years.
The PB no. 1143.4 was hybridised against 46,XY genomic DNA. Analysis took place on 
15 metaphases and 544 chromosomes were included in the interpretation. Hybridisation 
artefacts were observed for the centromeres of chromosomes 1, 5, 7, 9, 13,14,15,16, 17, 
18, 19, 20, 21, and 22. These were not included in the analysis. Chromosome 8 appeared 
to be consistently excessively green (areas 8p22-q24.1), with its ratio profile deviating 
towards the right threshold (more than 1.2). The latter indicated the presence of extra 
chromosome material for 8 in this PB. The sex chromosomes showed the expected 
fluorescence pattern, obtained when a female test DNA was hybridised against male 
reference DNA. Thus, the X chromosome was greener (areas: Xp22.2-q27), and its ratio 
profile deviated to the right, whereas the Y chromosome was more red (areas: Y p ll.l- 
ql2), with its ratio profile deviating towards the left. Hence, the karyotype of this PB was 
considered to be 24,X,+8. No results were obtained from the corresponding oocyte. The 
reason of infertility treatment for this patient was due to severe asthenoligospermia of the 
male partner. The maternal age was 32 years. A metaphase from the CGH analysis is 
shown in fig.5.17a and b and the interpretation in fig.5.17c.
PB no. 1254.6 was hybridised against a clump of 46,XX buccal cells. Nine metaphases 
were analysed, and 338 chromosomes were included in the interpretation. The ratio 
profiles of chromosomes 4 and 5 deviated towards the right threshold (more than 1.2), as 
they were both excessively green (areas: 4pl5.3-pl2, 4ql3-q26, 4q28-q31.3, 5pl4-pl2, 
5qll.2-q23, 5q31-q33). Excess green was also observed for a part of the long arm of 
chromosome 12 (12ql4-q24.1). The above indicated that the PB consisted of extra DNA 
for chromosomes 4 and 5 and possibly for chromosome 12. No fluorescence difference 
was visible for chromosome X, as both test and reference DNA were female. This cell 
was identified to be 26,X,+4,+5,+12. The corresponding oocyte was not investigated, 
while the maternal age of this patient was 39 years. Figures 5.18a and b and 5.18c 
demonstrate the fluorescent signals of a metaphase and the interpretation results obtained 
for this PB respectively.
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Fig.5.18: C G H  analysis o f PB no. 1254.6 against 46,XX buccal cell
clum p DNA
EDliB
Fig.5.18a: Normal 46,XY
metaphase chromosomes
hybridised with DNA from PB 
1254.6 {green) and 46,XX buccal 
cell DNA {red).
Fig.5.18b: Normal 46,XY metaphase 
chromosomes classified according to 
their banding patterns. Chromosomes 
4, 5, and the long arm of 12 appeared 
to be excessively green, compared to 
the rest of the autosomes. The latter 
indicated that the test PB sample 
contained extra DNA material for these 
chromosomes. Only chromosomes 4 
and 12 are shown in this metaphase.
Fig.5.18c: Interpretation of the CGH experiment for PB 1254.6. The ratio 
profile of chromosomes 4, 5 and 12ql4-q24.1 deviated towards the right 
threshold (more than 1.20). The shifts demonstrated the presence of extra 
DNA material for these chromosomes in the PB sample. As far as 
chromosome 12 was concerned, we considered that extra DNA was present 
for the whole chromosome and that the software did not identify it in its 
entirety. The karyotype of this PB was thought to be 26,X,+4,+5,+12. The 
corresponding oocyte was not investigated.
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Fig.5.19: C G H  analysis o f PB no. 1355.1 against 46,XX buccal cell
clum p DNA
Fig.5.19a: Normal 46,XY metaphase 
chromosomes hybridised with DNA 
from PB 1355.1 (green) and 46,XX 
buccal cell DNA (red).
■ II II
B IB ■l■al
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Fig.5.19b: Normal 46,XY
metaphase chromosomes classified 
according to their banding
patterns. Chromosome 9 was 
observed to be excessively green. 
The latter indicated that the test PB 
sample contained extra DNA 
material for this chromosome.
Fig.5.19c: Interpretation of the CGH experiment for PB 1355.1. The ratio profile 
of chromosome 9 deviated towards the right threshold (more than 1.20), the shift 
demonstrating the presence of extra chromosomal material in this PB sample. 
The karyotype of this PB was thought to be 24,X,+9. The corresponding oocyte 
underwent CGH as well, but it failed to yield any results. Hence the possible 
reciprocal loss of chromosome 9 in the oocyte was not confirmed.
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A clump of 46,XX buccal cells was used as reference DNA for the CGH investigation of 
1355.1PB. Analysis was carried out on seven metaphases and 254 chromosomes were 
included in the interpretation. The ratio profiles for all the autosomes apart from 
chromosome 9, and for chromosome X did not deviate from 1. No fluorescence was 
observed for chromosome Y, which was expected, as both test and reference DNAs were 
female. Chromosome 9 showed excess green fluorescence (areas: 9p23-p21, 9pl2-ql2, 
9q21-q33), with its ratio profile deviating towards the right threshold. This observation 
led to the conclusion that this PB contained extra chromosomal material for 9. Its 
karyotype was 24,X,+9. There were no results obtained from the corresponding oocyte, 
due to CGH failure. However, oocyte 1355.4 and the 1355.5PB coming from the same 
patient, were characterised as being normal 23,X. The latter could indicate possible 
germinal mosaicism for trisomy 9 for this patient. The couple were being treated for 
unexplained infertility, and the maternal age was 32. Fig.5.19a and b show the 
appearance of the fluorescent signals of a metaphase, while fig.5.19c illustrates the 
interpretation of this PB.
Details of all the abnormalities scored in these PBs are shown in Table 5.2.
Similar to the oocytes, all the DOP-PCR products from the 30 PBs that failed to yield 
results with CGH were analysed on agarose gels. Only one of these cells was shown to 
give a very faint smear after amplification with the DOP-PCR. Failure of CGH for this 
cell was attributed to inferior DNA quality. The remaining cells did not show smears, 
which meant that they were either lost or lysed during processing, or the DNA degraded 
due to prolonged storage in the -80°C.
In summary, fifteen PBs yielded results and four of those were considered to be 
abnormal, corresponding to four different patients. All analysed PBs were thought to be 
representing solely the maternal genome. Male contamination was detected for one cell 
and was attributed to the handler. The obtained results provide preliminary data 
concerning the effect of polycystic ovary syndrome on maternal meiosis and identified 
the presence of possible germinal mosaicism for a trisomic cell line for two patients, 
although chromatid errors are also possible. Two PBs appeared to have abnormalities
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affecting at least two different chromosomes. Extra copies of larger chromosomes, 
including 4, 5, 8, 9, and 12 were identified. Abnormalities of these chromosomes have 
not as yet been observed during FISH studies of PBs, even if the actual chromosomes are 
being investigated (e.g. Cupisti et al., 2003). One PB was also identified to be missing 
chromosomal material for 21. Both the above observations illustrate the ability of CGH in 
detecting abnormalities of chromosomes that would not generally be targeted for 
examination during similar FISH studies, and in reliably identifying missing chromosome 
material as well.
Table 5.2: CGH analysis of corresponding 1st PBs
PB/patient no. ART method Reference DNA CGH interpretation
1141.2PB ICSI 46,XX genomic DNA 23,X
1134.3PB Uninjected 46,XY genomic DNA 23,X
1173.1 PB ICSI 46,XY genomic DNA 23,X
4047.3PB IVF 46,XY buccal cell clump 23,X
4125.1PB IVF 46,XY buccal cell clump 23,X
1143.4PB ICSI 46,XY buccal cell clump 24,X+8
1243.1PB Uninjected 46,XX buccal cell clump 23,X
4069.1PB IVF 46,XX genomic DNA 23,X
4412.4PB IVF 46,XX buccal cell clump 23,X
4412.5PB IVF 46,XX buccal cell clump 24,X, +X,- XA 21cht
4412.6 PB IVF 46,XX buccal cell clump 23,X
1355.1PB ICSI 46,XX buccal cell clump 24,X,+9
1355.5PB ICSI 46,XX buccal cell clump 23,X
1254.6PB Uninjected 46,XX buccal cell clump 26,X,+4,+5,+12
4405.3PB IVF 46,XX buccal cell clump 23,X
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5.5 Aneuploidy in human metaphase II oocytes and corresponding 1st 
polar bodies analysed by CGH
Comparative genomic hybridisation was employed for the study of 40 oocytes and 45 
polar bodies. The majority of the oocytes had failed to fertilise after their exposure to 
sperm either via IVF or ICSI, and they were all arrested at metaphase II, having 
extruded the 1st PB. Out of the 45 PBs examined, 37 corresponded to oocytes. CGH 
was applied in an attempt:
1. To gain information for the entire maternal genome.
2. To investigate the involvement of larger autosomes in meiotic errors leading to 
female aneuploidy.
3. To establish the possible hypohaploidy rate for all chromosomes. The latter 
was not feasible with the application of FISH as artefactual loss of 
chromosomes could occur due to the spreading procedure.
Seven different positive control experiments were carried out prior to the application 
of CGH on oocytes and PBs. These took place for the following reasons:
1. To demonstrated that the protocol used was able to amplify minute amounts of 
DNA.
2. The analysis and interpretation were sensitive enough to detect trisomies of 
chromosomes ranging in size.
3. To be used as reference in cases where comparable results were obtained from 
the CGH analysis of the oocytes and PBs.
Oocytes and PBs were categorised into three groups, according to the way they were 
prepared. In total results were obtained from 26 cells (11 oocytes and 15 PBs). From 
these, 6 belonged to the first group, 8 to the second group, and 12 to the third group. 
Fourteen different patients were investigated. Five of these were treated via IVF, six 
via ICSI, while for three no ART procedure took place, as the oocytes were immature 
at the time of retrieval. As far as the oocytes were concerned, we considered that the 
presence of sperm DNA to be likely. Thus, the CGH results yielded from these cells 
were thought to demonstrate the karyotypes of both the paternal and the maternal
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genomes (i.e. a potential zygote genome). This was not the case for the CGH analysis 
of 1st PBs. The latter were considered to be free of sperm and the data obtained from 
them was representing the maternal genome only. During analysis and interpretation 
of CGH metaphase images it was not always feasible to distinguish between extra or 
missing chromosomes or chromatids.
Nine oocytes and eleven PBs were identified to contain a normal number of 
chromosomes. Out of these four were corresponding: 1141.2 oocyte+PB, 1173.1 
oocyte+PB, 4405.3 oocyte+PB, and 4412.6 oocyte+PB. For the remaining, results 
were obtained either for the PB with CGH having failed for the oocyte (4125.1PB, 
4069.1PB, 4047.3PB, 1355.5PB), or the opposite (1172.2, 1174.1, 1243.2, 1174.1, 
1355.4). The corresponding oocyte was not investigated for 1243.1PB and 1254.6PB. 
PBs 1134.3PB and 4412.4PB were characterised as being normal 23,X with anomalies 
being scored in the corresponding oocytes.
Abnormalities in the form of chromosome gains were identified in oocytes 1134.3 and 
4412.4, and the following PBs: 4412.5PB, 1143.4PB, 1254.6PB,and 1355.1PB. 
Losses were detected for oocyte 4412.4, 4412.5 and 4412.5PB. Reciprocal gains and 
losses were seen in one pair of corresponding cells only, with oocyte 4412.5 having 
lost DNA material for chromosome X and 4412.5PB having gained DNA material for 
the same chromosome. The inability to identify reciprocal gains and losses in the case 
of the remaining 2 abnormal oocytes, was attributed either due to germinal mosaicism 
for a trisomic cell line resulting to the extra chromosome copy ending up in the 
oocyte, or due to the actual female cell having been penetrated by an abnormal sperm. 
As far as the PBs were concerned, 1143.4PB, and 1254.6PB did not have their oocytes 
analysed. No result was obtained for the oocyte 1355.1, whose PB appeared to contain 
extra chromosomal material for 9. Data was obtained for another oocyte and another 
PB originating from the same patient. Both these were normal. The possibility of the 
CGH technique being unable to detect the expected abnormalities in the 
corresponding cells was always considered.
Oocyte 4412.4, and two PBs: 4412.5PB, and 1254.6PB appeared to have anomalies 
affecting more than one chromosomes. Interpretation of the CGH results obtained for
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oocyte 4412.4 led to the conclusion that the cell contained extra chromosome material 
for 13 and was missing 22. The PB no.4412.5 from the same patient contained extra 
chromosome material for X and was missing 21. Detection of extra DNA for 
chromosomes 4, 5, and 12 was observed after the interpretation of the CGH results for 
the 1254.6PB.
Abnormalities were observed for several chromosomes. Gains of the larger autosomes 
4, 5, 8, 9,12, and X were evident in four PBs. Since the PBs were thought to represent 
solely the maternal genome, it was very likely that these gains were true and were not 
an artefact of the hybridisation process. Extra copies for these autosomes have not 
been reported in any oocyte and PB FISH study so far. Meiotic errors affecting larger 
autosomes were evident in three other CGH studies, one carried out on first PBs and 
the other two on embryonic blastomeres (Wells et ah, 2002; Wells and Delhanty, 
2000; Voullaire et ah, 2000), and one study that applied SKY on fresh non­
inseminated oocytes (Sandalinas et ah, 2002). Gains of chromosome 13 were 
identified in two oocytes, whereas one oocyte and one PB were detected to be missing 
chromosomes 22 and 21 respectively. These chromosomes have been shown in the 
FISH study described in the previous section, and in others from our group (Mahmood 
et ah, 2000, Cupisti et ah, 2003) to be frequently involved in meiotic errors leading to 
maternal aneuploidy. The abnormalities observed for all the oocytes and 
corresponding 1st PBs, along with patient details are summarised in Table 5.3.
A total of five patients were recognised to be carrying chromosome anomalies in one 
or more of their examined cells. Maternal ages varied between 22-39 (mean 25). 
Patient no. 4412 was the youngest in the group, and the one whose cells appeared to 
be the most abnormal. Four oocytes and their corresponding PBs were investigated 
and only one pair (4412.6 oocyte+PB) was characterised to be fully normal 23,X. The 
remaining cells appeared to have gains and losses for different chromosomes, some 
consisting of more than one abnormality. This patient was being treated due to 
polycystic ovary syndrome. It has been postulated that polycystic ovaries could lead to 
oocytes with multiple abnormalities (Clyde et ah, 2001). This could explain the 
observations made in the oocytes and PBs from this patient. Multiple abnormalities 
were also observed in the 1254.6PB. This patient was the oldest in the group, 39 years
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of age, and the reason for infertility treatment was unknown. A case of possible 
germinal mosaicism for trisomy 13 was detected. Patient 1134 was 32 years old and 
was being treated for male factor infertility.
Out of a total of 85 cells (oocytes and PBs) for which CGH analysis was attempted, 
results were obtained for 26 cells (30.6%). Seven of those appeared to have 
abnormalities for one or more chromosomes, resulting to an aneuploidy rate of nearly 
27%. If patient 4412 is excluded from this group, then the aneuploidy rate becomes 
15.4%.
In summary, although the sample size o f oocytes and PBs analysed with CGH was 
relatively small, chromosome anomalies were observed, even for larger autosomes. 
Non-disjunction of chromosomes was identified, along with the possibility of 
germinal mosaicism for a trisomic cell line. We were not able to distinguish with 
certainty aneuploidy associated with premature division of chromosomes into their 
sister chromatids, due to the relative insensitivity of the single cell CGH and the 
suboptimal condition of the oocyte and PB DNA. Chromosome loss was identified in 
two different cases. The majority of the abnormalities were observed for the younger 
patients in the group. The above show the advantage of CGH over FISH, in its ability 
to detect anomalies for chromosomes other than the ones commonly expected to be 
involved in maternal aneuploidy. Estimation of hypohaploidy, and which 
chromosomes could be affected is feasible, but a larger sample would be essential for 
definite conclusions to be drawn.
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Table 5.3: Summary of CGH analysis of human metaphase II oocytes and their corresponding 1st PBs. Patient details and ART method are 
indicated
Patient no. Maternal
age
Reason for infertility treatment ART method Oocyte no. Oocyte CGH result PB no. PB CGH result
1141 31 Not known ICSI 1141.2 23,X 1141.2PB 23,X
1134 32 Azoospermia Uninjected 1134.3
GV
24,X+13 or 23,X,+1/2 
13cht
1134.3PB 23,X
1172 38 Vas reversal failure ICSI 1172.2 23,X 1172.2PB CGH failure
1173 30 Azoospermia ICSI 1173.1 23,X 1173.1PB 23,X
1174 33 Asthenooligospermia ICSI 1174.1 23,X 1174.1PB CGH failure
1243 31 Male factor Uninjected 1243.1
1243.2
Not investigated 
23,X
1243.1PB
1243.2PB
23,X 
CGH failure
1355 32 Unexplained ICSI 1355.1
1355.4
1355.5
CGH failure 
23,X 
CGH failure
1355.1PB
1355.4PB
1355.5PB
24,X,+9 
CGH failure 
23,X
4412 22 Polycystic ovaries IVF 4412.1
4412.4
4412.5
4412.6
CGH failure
23,X,+13,-22 or 23,X,+1/2 
13cht,- »/2 22cht
22,-X, possibly +1/2 21cht 
23,X
4412.1PB
4412.4PB
4412.5PB
4412.6PB
CGH failure 
23,X
24,X,+X, - 1/2 
21cht
23,X
4405 37 Bicomuate uterus, recurrent 
miscarriages
IVF 4405.3 23,X 4405.3PB 23,X
4047 35 Unexplained IVF 4047.3 CGH failure 4047.3PB 23,X
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Patient no. Maternal
age
Reason for infertility treatment ART method Oocyte no. Oocyte CGH result PB no. PB CGH result
4125 30 Anovulation IVF 4125.1 CGH failure 4125.1PB 23,X
1143 32 Asthenooligospermia ICSI 1143.4 Not investigated 1143.4PB 24,X,+8
4069 28 Idiopathic IVF 4069.1 CGH failure 4069.1PB 23,X
1254 39 Male factor Uninjected 1254.6 Not investigated 1254.6PB 26,X,+4,+5,+12
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Chapter 6 
Discussion
Discussion
6.1 The application of PGD for the detection of chromosomal 
abnormalities
The main aim of Preimplantation Genetic Diagnosis (PGD) is to ensure the initiation 
of a healthy pregnancy (Munne and Wells, 2002). The first application of PGD took 
place in 1989, and involved the sex selection of embryos generated by couples who 
were at risk of transmitting an X-linked recessive disorder (Handyside et cd., 1990). 
Since then this procedure has progressed rapidly and is currently being offered at more 
than fifty centres all over the world (ESHRE PGD Consortium, 2002). Data collected 
on the obstetric and neonatal outcome of pregnancies achieved after PGD did not 
demonstrate any increase in major congenital malformations, compared to 
spontaneous pregnancies, or those that ensued after IVF or ICSI (ESHRE PGD 
Consortium, 2000; 2002). The latter confirmed the safety and efficacy of this 
procedure. Effectively, PGD was developed as a very early form of prenatal diagnosis. 
It is advantageous over prenatal diagnosis, as it avoids the physical and psychological 
trauma that could be caused by the termination of an affected pregnancy.
Patients requesting PGD fall into two large categories: those that are at risk of 
transmitting a single gene disorder to their offspring, and those that are carriers of a 
chromosome abnormality (Delhanty, 1998). The patients of the second group can be 
further subdivided into those that are carriers of a structural chromosome abnormality 
(usually reciprocal or Robertsonian translocation), and those whose karyotype is 
normal, but are unable either to establish or maintain a pregnancy, including women 
over the age of 35. Pregnancy loss in such cases is most likely attributed to one or 
more numerical abnormalities. The identification of both structural and numerical 
abnormalities in single embryonic blastomeres is accomplished with the application of 
FISH. Different strategies are used for the diagnosis of structural and numerical 
chromosome abnormalities.
The frequency of balanced translocations in the neonatal population has been 
estimated to be between 1 and 2 per 1,000 (Nielsen and Silessen, 1975; Hamerton et 
al, 1975, Jacobs et al., 1974). Half of these are Robertsonian, and the remaining
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reciprocal translocations (Jacobs, 1977). Reciprocal translocations were also 
identified in 0.6% of infertile couples, 3.2% of couples with over 10 failed IVF 
attempts, 9.2% of fertile couples that suffered more than three sequential first- 
trimester miscarriages (Stem et al, 1999), and 2-3.2% of males needing ICSI (Testart 
et al., 1996; Meschede et al, 1998; Van der Ven et al., 1998). The scope of PGD for 
such couples is to decrease the rate of spontaneous abortions, and reduce the risk of an 
imbalanced conception (Munne and Wells, 2002). Several factors including the 
chromosomes involved, the position of the breakpoints and the sex of the 
translocation carrier affect the risk of conceiving an unbalanced baby (Goldman and 
Hulten, 1993; Faraut et al., 2000). The application of FISH for the diagnosis of 
reciprocal and Robertsonian translocations differs, due to the different nature of these 
two structural chromosome abnormalities.
Reciprocal translocations can theoretically take place between any two chromosomes 
at any position. Thus, each case is considered to be unique, with the exception of the 
most common reciprocal translocation t(ll;22). Two FISH approaches have been 
established for the detection of such abnormalities in interphase blastomeres. The 
strategy employed currently at the UCL centre for PGD uses two probes that flank the 
breakpoint on one of the two chromosomes involved in the translocation, with a third 
probe mapping at any position on the other chromosome. This FISH approach has the 
ability to detect the products of all unbalanced segregation patterns, but it cannot 
distinguish between a normal and a balanced chromosome complement. It was 
initially developed by Conn and colleagues (1999). It has been widely applied in most 
PGD centres including those at Guy’s and St Thomas’, Brussels Free University, the 
Karolinska Hospital group in Stockholm, and the St. Barnabas group in the USA. The 
availability of commercial subtelomeric probes has increased the number of couples 
being treated in the past few years, compared to previously, when laboratory-prepared 
probes had to be used, making the development of FISH protocols more time 
consuming (Conn et al., 1998). However, subtelomeric probes have lower efficiency 
of hybridisation, especially if they are compared with repetitive probes (Simopoulou 
et al, 2003). Thus, we prefer to use two centromeric and one locus-specific probe for 
the PGD of reciprocal translocations, if the chromosomes involved and the position of 
the breakpoints permit it.
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The “flanking” probe strategy has been applied for the PGD of the two reciprocal 
translocations in this study. In case A, 46,XY,t(5;19)(pl2;pl2) it was not possible to 
use a centromeric probe, due to cross-hybridisation. Thus a commercial dual locus- 
specific probe was utilised for chromosome 5 and a YAC locus-specific probe was 
used to detect chromosome 19, as at that time a commercial subtelomere was not 
available for this chromosome. The FISH protocol took a long time to optimise, as 
several problems involving culturing and DNA extraction of the YAC probe had to be 
overcome. In the end the DNA for this probe was sufficient for the analysis of the 
biopsied blastomeres only.
In case B, 46XX,t(ll;22)(q23.3;qll.2), a commercial dual locus-specific probe was 
used for chromosome 22, and a commercial centromeric probe was used for 
chromosome 11. The latter probe emitted an orange-yellow fluorescence that was 
produced by the combination of red and green centromeric probes. This couple 
underwent two cycles of PGD, with an embryo transfer following the second cycle. 
During this cycle, failure of hybridisation was observed for the green centromeric 
probe for chromosome 11. The latter was attributed to the batch of the probes, as is 
discussed in 3.2.2. After careful consideration involving the colour and size difference 
between the locus-specific and centromere probes, two embryos were identified as 
normal or balanced and were transferred, leading to a normal live birth. The same 
probe combination was applied by Van Assche and colleagues (1999) in a PGD case 
involving a male carrier of this translocation.
Our group (Simopoulou et al, 2003) described the application o f the “flanking” probe 
FISH strategy for the PGD of six different reciprocal translocations. Embryo transfers 
took place in all of them. A biochemical pregnancy and two clinical pregnancies were 
achieved for three different cases, the latter two leading to normal live births. A 
modification of the “flanking probe” approach involved the use of two probes 
proximal to the breakpoints and two distal (Murine et al, 1998a). The application of 
four probes instead of three could eliminate the risk o f misdiagnosis due to the failure 
of hybridisation of one of the probes, but has to be balanced against the reduced 
efficiency of hybridisation with the increasing number of probes.
The second FISH approach for the PGD of reciprocal translocations was developed by 
Muime and colleagues (1998a) and involved die use of probes that spanned on the
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breakpoints of a translocation. More specifically, such probes would give two distinct 
signals when hybridised to normal chromosomes. Their hybridisation on the 
derivative chromosomes would appear as an association of the colours that these 
probes were labelled with (Munne et al, 1998a). This approach had the advantage that 
it was able to distinguish between normal and balanced products. It was applied for 
the PGD of a reciprocal translocation, 46,XY,t(3;4)(p24;pl 5). Spanning probes were 
developed from YAC clones, labelled in green for chromosome 3 and red for 
chromosome 4, and were also combined with a centromeric probe for chromosome 3, 
labelled in aqua. The couple underwent two PGD cycles, and identification of normal, 
balanced and unbalanced embryos was achieved during FISH analysis of biopsied 
blastomeres in both. Results were confirmed by re-analysis of the spare embryos 
(Munne et al., 1998a). The disadvantage o f this FISH strategy was that it was entirely 
patient-specific, and thus time consuming and not cost-effective.
Willadsen and colleagues (1999) and Verlinsky and Evsikov (1999) described the 
injection of human blastomeres or second polar bodies in cow eggs or mouse zygotes, 
with the aim of obtaining metaphase chromosomes from them. Both approaches have 
been used in the diagnosis of reciprocal translocations, leading to the birth of 
chromosomally balanced children (Willadsen et al., 1999; Evsikov et al., 2000). There 
is however, a high risk of chromosome loss when spreading a single metaphase.
PGD of reciprocal translocations was also carried out on metaphase chromosomes 
obtained from first polar bodies, fixed six hours after oocyte retrieval and analysed 
with whole chromosome paints combined with telomere probes (Durban et al., 1998; 
Munne et al, 1998d Munne et al, 1998e). Full chromosome analysis of first polar 
bodies with the aid of spectral imaging was described by Marquez and colleagues 
(1998) for the diagnosis of reciprocal translocations in female carriers. The 
requirement of a well spread metaphase plate with clear chromosomes, the high risk 
of chromosome loss when spreading a single metaphase, the artefactual precocious 
separation of chromatids due to PB degeneration in culture, and the signal 
morphology could all lead to misdiagnosis using this PGD approach. Another event 
that could lead to a possible misdiagnosis is the occurrence of an interstitial crossover 
followed by segregation of balanced and imbalanced sets of chromosomes during the
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second meiotic division (Munne, 2002). All the above made this strategy difficult to 
use on a regular basis.
Another group of patients requiring PGD to achieve a healthy pregnancy is that of 
balanced carriers of Robertsonian translocations. Such translocations are formed by 
the fusion of two acrocentric chromosomes. Male carriers sometimes display low 
sperm counts (Wells and Delhanty, 2001). This was the case for both male carriers of 
Robertsonian translocations in this study. Compared with the PGD strategies 
employed for the detection of unbalanced products from reciprocal translocations, the 
FISH protocols applied during PGD for Robertsonian translocations are much 
simpler. Thus, such cases can be diagnosed with die use of a minimum of two locus- 
specific and/or telomeric probes, each one hybridising to the acrocentric chromosomes 
that are involved in this rearrangement. When chromosome 21 is involved, it is 
preferable to use three probes, i.e. two hybridising on 21 and the third on the long arm 
of the other chromosome. In this way, chromosome 21 that is more likely to produce a 
viable trisomy could be detected with certainty and misdiagnosis due to hybridisation 
failure and/or signal overlap could be avoided.
The dual labelling of chromosome 21 was applied for the PGD of case D in this study. 
The male partner was a balanced carrier o f a Robertsonian translocation, his karyotype 
being 45 ,XY,der( 13 ;21 )(q 10;q 10). The probes used for this case included a locus- 
specific probe for the long arm of chromosome 13, a locus-specific probe for the long 
arm of chromosome 21, and telomeric probe for 21q. These probes were used in both 
PGD cycles, during which the telomere probe for 21 appeared to be much fainter, 
compared with the two locus-specific probes. It also frequently failed to hybridise. 
The latter was attributed to the quality o f this probe, as it was supplied by a different 
company than the one that provided the locus-specific probes. This had as an effect 
the diagnosis to be carried out based on the signals visible for the locus-specific probe 
for chromosome 21 for some blastomeres. Dual-coloured FISH was used for the 
diagnosis of case £. The carrier o f the Robertsonian translocation was again the male 
partner, whose karyotype was 45,XY,der(13;14XqlO;qlO).
A comparable approach was used by Conn and colleagues (1998), who carried out 
five PGD cycles for two couples, whose karyotype was 45,XY,der(13;14)(qlO;qlO)
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and 45,XX,der( 13;21)(ql0;ql0). As this study took place when commercial locus- 
specific probes were not widely available for every chromosome, it used probes that 
were prepared from YAC clones, but the FISH strategy was exactly the same with the 
one used for this study.
Durban and co-workers (2001) described an alternative FISH approach for the 
detection of Robertsonian translocations in female carriers. In this study, PGD to aid 
four female Robertsonian translocation carriers to initiate a normal pregnancy, was 
carried out by biopsying die first polar body, and using a combination of locus- 
specific probes, subtelomere probes and whole chromosome paints. The group 
claimed a diagnosis success rate varying between 80-100% with the use of first polar 
bodies. However, this approach has many disadvantages, as described above.
Two phenotypically and karyotypically normal couples were referred to the UCL 
centre for PGD for possible gonadal mosaicism for trisomy 21. The couple in case F 
had two ectopic pregnancies, and a Down’s syndrome pregnancy which were all 
terminated, leading to inability to conceive naturally. The couple in case G had given 
birth to two children with Down’s syndrome and had a termination of a trisomy 21 
pregnancy. Chronologically couple G was referred first, but they decided against 
treatment due to family reasons. The initial FISH protocol that would be used for 
couple G involved the investigation of chromosome 21 only, with the use of a band- 
specific and a telomeric probe both hybridising to the long arm of this chromosome. A 
different approach was applied during the PGD of couple F. Hence, only one locus- 
specific probe was applied for the detection o f chromosome 21, and an extra locus- 
specific probe was added for identifying chromosome 13. This modification occurred, 
as the telomere probe for chromosome 21 was not very efficient, giving relatively 
faint signals, combined with a high rate of hybridisation failure. The extra probe for 
chromosome 13 acted as a positive control for the FISH procedure, and also enabled 
the investigation of an extra chromosome, that tends to cause abnormalities. The ages 
of the female partners from these couples at the time of PGD referral were 39 for 
couple F and 37 for couple G.
No gametes, either oocytes or sperm, were available from couple F, during two PGD 
cycles. Thus, it was not feasible to directly investigate the possible presence of 
gonadal mosaicism for trisomy 21 in any o f the two partners. There was no evidence
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of mosaicism for trisomy 21 for this couple, upon examination of lymphocyte 
interphase nuclei from both partners.
Two locus-specific probes hybridising to different positions on the long arm of 
chromosome 21 were used by Conn and colleagues (1999) during the PGD of a couple 
that had a normal child, a child affected with Down’s syndrome, and two other 
trisomy 21 conceptions. Polymerase chain reaction (PCR) analysis of DNA 
polymorphisms had previously revealed that the origin of the extra chromosome 21 
was maternal. Confirmation that the female partner was a gonadal mosaic for trisomy 
21 came from analysis of four unfertilised oocytes, three of which showed 
hyperhaploidy for chromosome 21, with one having a normal haploid complement 
(Conn etal., 1999).
Embryo transfers took place for all five patients during nine PGD cycles. Data for 
couples A and D are also analysed in a larger report that has recently been published 
by our group (Simopoulou et al, 2003), describing the outcome of 11 PGD cycles for 
8 patients carrying six reciprocal translocations, one Robertsonian translocation and 
one intrachromosomal between arm insertion. Combination of this data with the 
outcome of the rest of the PGD cases outlined in this thesis leads to seventeen PGD 
cycles for the diagnosis of chromosome abnormalities, carried out over six years. 
Embryo transfers took place during all these cycles resulting to five pregnancies, one 
biochemical and four clinical, and the birth of four healthy infants. Table 6.1 
demonstrates the above. In addition, one couple underwent a further cycle of 
treatment, leading to an ongoing twin pregnancy. Thus, in total, five of the eleven 
couples treated had a positive outcome.
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Table 6.1: Summary of the outcome of 17 cycles of PGD for 11 couples carrying a chromosome abnormality (Cases H-M from Simopoulou et 
al, 2003)
Patients and karyotypes Cycles Oocytes
retrieved
Oocytes
fertilised
Embryos
biopsied
Normal/
balanced
Abnormal* Embryos
transferred
Outcome
A: 46,X Y,t(5; 19)(p 12;p 12) 1 20 15 13 1(8.3%) 12(91.7%) 1 No pregnancy
B :46,XX,t( 11 ;22)(q23.3 ;q 11.2) 2 26 14 11 2(18.2%) 11(84.6%) 2 Normal live birth
D: 45,XY,der( 13;21 )(q 10; 10) 2 22 17 15 6(40%) 9(60%) 6 No pregnancy
E: 45,XY,der(13;14)(qlO;qlO) 2 25 21 17 6(35.3%) 10(58.8%) 5 No pregnancy4
F: 46,XX, 46,XY, possible 
gonadal mosaicism for trisomy 
21
2 43 37 33 10(30.3%) 27(72.3%) 7 No pregnancy
H: 46,XX,t(5;ll)(q34;q25) 3 34 29 22 8(36.4%) 18(69.2%) 7 Normal live birth
I: 46,XX,t(l ;2)(q42.1 ;p23) 1 16 11 11 2(20%) 8(80%) 2 No pregnancy
J: 46,XX,t(16;17)(pl3.3;pl 1.1) 1 8 8 7 4(50%) 4(50%) 3 Biochemical
pregnancy
K: 46,XX,INS(7)(p22 q32 
q31.1)
1 16 16 11 7(70%) 3(30%) 2 Normal live birth
L: 46,XX,t(8;12)(qll.2;ql2) 1 21 17 13 2(15%) 11(85%) 1 Normal live birth
M: 46,XY,t(l ;18)(p32;q23) 1 16 14 12 1(8.3%) 11(91.7%) 1
frozen/thawed
Balanced embryo 
frozen as 
blastocyst
Total 17 247 199 165 49(29.7%) 124(75.2%) 37
♦The percentage of normal/abnormal embryos is based on the em )ryos that have been analysed (including biopsied embryos but a so embryos not suitable for biopsy spread
and FISH-ed on day 4 or 5) and provided results for embryo classification. Embryos were considered abnormal when they consisted of an unbalanced chromosome
constitution either due to abnormal meiotic segregation or due to post-zygotic errors. +Twin pregnancy now ongoing.
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6.2 Analysis of preimplantation embryos from nine cycles for the 
PGD of chromosome abnormalities
This part of the study involved the investigation of embryos from carriers of either 
structural or numerical chromosome abnormalities with application of FISH.
PGD was carried out for two different reciprocal translocations. In case A, the male 
partner was the carrier of the rearrangement, which involved chromosomes 5 and 19. 
This couple had experienced years of infertility, attributed to the severe oligospermia 
of the male partner. In case B, the female partner was the carrier o f the translocation, 
that had taken place between chromosomes 11 and 22. Unlike other such 
rearrangements that are usually unique in the population, the t(l lq;22q) translocation 
is frequently observed in humans. Four pregnancies were established for this couple, 
in the year preceding PGD treatment, but had all spontaneously aborted.
One PGD cycle was carried out for case A. All generated embryos were normally 
developing and of very good morphology. FISH investigation of all biopsied 
blastomeres and non-transferred embryos revealed that the majority of them were 
chaotic having literally almost every cell with a different chromosome complement. 
This observation affirms that good embryonic morphology cannot predict 
chromosome constitution. The generation of such highly abnormal embryos was 
attributed to extensive mitotic non-disjunction. The latter in combination with 
chromosome breakage, which was observed for one embryo from another reciprocal 
translocation patient (46,XXt(5;l I)(q35;q25)), as described in the larger report 
published by our group (Simopoulou et al, 2003) are two of the main factors leading 
to post-zygotic mosaicism. Chromosome breakage was evident in the analysis of 
blastomeres from three embryos that were examined with the application of CGH in 
two studies carried out by our group and a group in Australia (Wells and Delhanty, 
2000; Voullaire et al, 2000). Wells and Delhanty (2000) observed reciprocal losses 
and gains of parts of chromosomes 1, 2, and 7 in pairs of blastomeres from two 
different embryos. Breakpoints mapped to fragile chromosomal sites that are prone to 
breakage, which could take place due to depletion of nutrients from the culture
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medium. Both groups postulated that such chromosome rearrangements could be the 
cause of significant imbalance, which in turn affects embryo viability (Wells and 
Delhanty, 2000; Voullaire et al, 2000). The two different sets of embryos investigated 
in both studies had fertilised normally and were of good morphology, similar to the 
ones generated by the couple in case A.
One embryo was identified as normal or balanced and was transferred, but no clinical 
pregnancy ensued. The unavailability of the YAC probe, along with the high 
frequency of chaotic embryos made it impossible to determine the most common 
segregations for this translocation in the non-transferred embryos. Sperm analysis 
revealed that the alternate segregation was the most frequently occurring (54.3%), 
followed by adjacent-1 (18.4%), adjacent-2 (10.8%), and 3:1 disjunction (16.5%). 
Escudero and co-workers (2003) in their investigation of sperm from eleven reciprocal 
translocation carriers made a similar observation. They postulated that translocations 
with breakpoints near the centromeres of chromosomes, as was the case with the 
patient in this study, tend to form close configurations in meiosis I, leading to mainly 
2:2 segregations (Escudero et al, 2003).
Two cycles were carried out for the couple in case B. Fifteen embryos were generated 
during both cycles and their morphology was generally poor. No embryo transfer took 
place in the first IVF attempt due to the unexpected low fertilisation rate and the 
chaotic nature of the three embryos that were analysed. ICSI was used for the second 
PGD cycle, two embryos were identified as normal or balanced, and were transferred 
leading to the birth of a normal male baby. Re-analysis of all embryos from both 
cycles involved the investigation of chromosomes 11 and 22, but also of 15, 16, and 
18 for the spare embryos of the first cycle, and 18, X, and Y for those o f the second 
cycle. Five embryos were classified as chaotic, while the rest as mosaic aneuploid, 
mosaic balanced aneuploid, and mosaic balanced chaotic. One embryo was 
characterised as uniformly abnormal, but information was obtained only from the 
biopsied blastomeres, as the rest of the embryo was lost after the FISH procedure. The 
segregation patterns of the chromosomes participating in the translocation were 
established for five embryos and were: 2:2 alternate with a frequency of 40%, 3:1 
interchange with a frequency of 40% as well, and 2:2 adjacent-1 with a frequency of 
20%. Mitotic non-disjunction was also observed, sometimes in combination with one 
of the standard segregations. Cytogenetic investigation of livebom unbalanced
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offspring of both male and female carriers of the t(llq;22q) demonstrated that the 
majority are the products of tertiary trisomy for der(22) due to 3:1 non-disjunction 
(Iselius et al., 1983). This was not observed in this study, as the 3:1 disjunction 
resulted in oocytes monosomic for either chromosome 11 or chromosome 22. 
Armstrong and colleagues (2000) analysed sperm from a male carrier of this 
translocation, and identified all types o f segregation at metaphase II nuclei. They 
suggested that it was very likely that embryos carrying the unbalanced 2:2 
translocation spontaneously miscarry early on during the pregnancy, while the ones 
trisomic for der(22) could survive at least until they are bom (Armstrong et al., 2000).
PGD was carried out for two cases of Robertsonian translocations, dei(13;21) and 
der(13;14). In these cases, the carriers of the rearrangements were the male partners, 
who were both infertile. Each of the two couples had two cycles o f PGD, during 
which twelve embryos were identified as balanced, and eleven of those were 
transferred. Analysis of the non-transferred embryos involved the investigation of the 
chromosomes forming the translocations, for the diagnosis to be confirmed. Their 
chromosome constitution was further examined scoring for chromosomes 4,15,18, X 
and Y, when embryo morphology permitted it. As previously, all the spare embryos 
were highly abnormal, with three being mosaic diploid, two being mosaic aneuploid 
and thirteen being entirely chaotic. Embryo morphology and development were again 
inferior. Both these could have been attributing factors for the inability of these two 
couples to establish a clinical pregnancy. Similar observations were made by Conn 
and colleagues (1998) in their investigation of 45 preimplantation embryos generated 
by two carriers of different Robertsonian translocations, 45 ,XY,der( 13; 14)(q 10;q 10) 
and 45,XX,der(13;21XqlO;qlO) during five PGD cycles. Six embryos (13%) were 
identified as balanced for both couples, and were transferred, but no clinical 
pregnancy was established. All the remaining embryos were highly abnormal, 36% 
being aneuploid or aneuploid mosaic, and 51% chaotic. The high frequency of 
abnormal embryos generated by carriers o f Robertsonian translocations noted in this 
study and that of Conn et a l (1998) suggests that there could be two distinct causative 
factors leading to the reduced fertility observed for such patients: the aneuploid 
segregation of the parental Robertsonian translocation, combined with a post-zygotic
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factor that has as an effect the unregulated distribution of chromosomes in early 
cleavage stages in a significantly high number of embryos.
Determination of the segregations of the chromosomes involved in the translocation 
occurred directly by sperm analysis in case D, and indirectly according to the 
chromosome constitution of the embryos in case E. The most common segregation 
pattern in both cases was the alternate with a frequency o f 85.7% in case D and 91.6% 
in case E. Adjacent-1 followed with a frequency of 14.3% in case D and 8.3% in case 
E. Post-zygotic errors including mitotic non-disjunction and chromosome loss 
attributed to the formation of the highly abnormal non-transferred embryos. Gametic 
analysis of male carriers of Robertsonian translocations has shown that a very large 
number of spermatozoa are either normal or balanced. Ogawa and colleagues (2000) 
and Escudero and colleagues (2000) in their studies of male Robertsonian 
translocation carrier sperm detected normal/balanced cells with frequencies ranging 
from 75-87% in each of the patients they examined. Comparable rates were seen in 
this study.
Couple F was referred to our centre for PGD because o f the suspicion that one of the 
two partners was a gonadal mosaic for trisomy 21. Two PGD cycles were carried out 
and ten normal embryos were identified, seven o f which were transferred. This patient 
did not manage to achieve a pregnancy in any of these cycles. Examination of 
chromosomes 13 and 21 occurred for the non-transferred embryos from both cycles, 
whereas the ones generated during the second attempt were also investigated for 
chromosomes 15, 18, and 22. Out of these, one was identified as normal for all the 
chromosomes. Biopsy of one cell had taken place for this embryo, but no result was 
obtained during diagnosis. Hence it was excluded from transfer. The remaining were 
as follows: seven uniformly abnormal or inconclusive, seven mosaic diploid, five 
mosaic aneuploid, and eight chaotic. These abnormalities were in their majority 
products of post-zygotic errors, namely mitotic non-disjunction, chromosome loss 
and/or gain. Meiotic errors were observed for two different embryos. Chromosome 21 
was affected in one of them, whilst both chromosomes 13 and 21 were affected in the 
other, as discussed in 3.4.3. The chromosome abnormalities observed in the non- 
transferred embryos generated in the two PGD cycles were of different types. More 
specifically, in the first PGD cycle almost all spare embryos consisted of chaotic
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chromosome constitutions, whereas during the second PGD cycle the observed 
abnormalities were the result of meiotic errors and mitotic non-disjunction. The 
inability of this couple to achieve a clinical pregnancy, even though they produced a 
relatively high number of balanced embryos, could be attributed to the advanced 
maternal age (39 during both treatment cycles) that could have led to both the meiotic 
chromosome abnormalities but also to the high incidence of mosaicism observed 
during both cycles. It has been generally accepted that mosaicism observed during the 
cleavage stage of embryo development and caused by post-zygotic m ors does not 
increase with advancing maternal age (Munne and Cohen 1998). Recently the group at 
St Barnabas evaluated 1235 cleavage stage embryos derived from routine IVF patients 
by applying FISH for the detection of chromosomes 13, 18, 21, X, and Y (Munne et 
al., 2002b). They determined that aneuploid mosaicism due to mitotic non-disjunction 
tends to be more frequent in embryos coming from women of advanced age. In an 
attempt to explain this phenomenon, they suggested that older oocytes could contain 
damaged stored mRNA and other components that are critical during the first 
cleavage divisions, up until the activation of the embryonic genome. Hence, 
depending on the degree of this damage, these components could lead to either 
meiotic or post-zygotic errors, seen as mitotic aneuploid mosaicism in the embryo 
(Munne et al, 2002). This could have been the case for this patient, as the number of 
mosaic aneuploid embryos generated in both cycles was almost equal to the chaotic 
ones.
A total o f 94 embryos were chromosomally investigated throughout this part of the 
study, and only twenty-five of them were classified as balanced. The remaining sixty- 
nine were either uniformly abnormal, mosaic diploid, or mosaic aneuploid. The 
majority however, of all generated embryos were classified as chaotic. Other studies 
have shown that embryos from some carriers o f reciprocal and Robertsonian 
translocations are in the majority mosaic and chaotic. More specifically, Iwarsson and 
co-workers (2000) examined 64 biopsied and normally developing preimplantation 
embryos derived from four Robertsonian and three reciprocal translocation carriers. 
Out of these 64 embryos 17 were balanced, whereas 47 (73%) were mosaic for the 
chromosomes involved in the translocation (Iwarsson et al., 2000). Similar 
observations were made by our group (Simopoulou et al. 2003) in the study of 
embryos coming from eight patients, all being carriers of a chromosome
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rearrangement, as already described. Post-zygotic errors leading to mosaicism and 
chaos were detected in 75% of the non-transferred embryos investigated (Simopoulou 
et al., 2003). Analysis of embryos from patients with structural chromosome 
abnormalities has also taken place with the application of CGH (Malmgrem et al, 
2002). This study involved the examination of 94 blastomeres from 28 embryos that 
were generated by 13 couples. Mosaicism affected the chromosomes involved in the 
rearrangement, but also other chromosomes, and all embryos investigated were either 
mosaic or chaotic. The group noticed that some patients were more prone to produce 
chaotic embryos, compared to others (Malmgrem et al, 2002). The latter was also 
shown by Delhanty and colleagues (1997), and is confirmed by the data obtained in 
this study.
It has also been suggested that translocations may behave in a certain way during 
meiosis, predisposing only to a small proportion of embryos with a normal or 
balanced karyotype, and thus only a few or even no embryos available for transfer 
(Conn et al, 1999). Additionally, several groups have carried out research in the 
possible interchromosomal effect and its association with structural rearrangements. 
The latter is defined as the effect a chromosomal rearrangement could have on the 
meiotic behaviour of chromosomes that are not involved (Pellestor et al, 2001). FISH 
has been applied for the analysis of sperm of two male reciprocal translocation 
carriers, t(l;13) and t(3;19) (Oliver-Bonet et al., 2002). Chromosomes 6, 18, 21, X 
and Y were scored in both cases and a possible interchromosomal effect was seen only 
for the second translocation carrier whose sperm demonstrated high rates of disomy 
21 (Oliver-Bonet et al., 2002). Different results were obtained from a larger study of 
172 embryos from 28 carriers of both reciprocal and Robertsonian translocations, and 
being examined for chromosomes 13, 16, 18, 21, 22 and some for X, Y and 1 
(Gianaroli et al, 2002a). The group observed a higher incidence of aneuploidy for 
other chromosomes than those involved in the rearrangement in the case of the 
Robertsonian translocation carriers, but not for the ones belonging to the reciprocal 
group (Gianaroli et al., 2002a). Comparable findings were seen for the embryos of the 
two Robertsonian translocation carriers in this study, but the sample size was too 
small to draw definite conclusions. Moreover, infertile males in general show 
increased rates of sperm aneuploidy so this fact may give a spurious 
interchromosomal effect.
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The high rate of mosaic and chaotic embryos detected in this and other similar studies, 
is the outcome of many different factors. More specifically, during the first embryonic 
cleavage divisions, cell cycle checkpoints that normally regulate mitosis are either 
absent or function with reduced efficiency (Delhanty and Handyside, 1995). Ibis 
factor most likely affects the normal chromosome segregation in the embryos 
(Delhanty and Handyside, 1995). In addition, the different drug regimes given to 
women in order for their stimulation to be achieved, along with the embryo culture 
conditions could influence chromosome division at this early stage of development 
(Munne et al., 1997). Another factor affecting embryo survival could be the 5-10 
minute incubation of the embryos in Ca2+Mg2+ free medium, which disrupts the gap 
cell junctions of the embryo, to allow the blastomeres to be acquired easier during the 
biopsy. In our centre we have increased the size of the medium droplet and the biopsy 
occurs as soon as the embryo is placed in it. Hence, the 10-minute incubation in the 
Ca2+Mg2+ free medium is avoided, and the repair of the cellular gap junctions that 
enable embryo compaction to proceed may be faster.
6 3  Conclusions
The main objective of this part of the study was firstly to develop robust and reliable 
FISH protocols for their implementation in the PGD of seven carriers of three 
different types of chromosomal abnormality, and secondly to examine the non­
transferred embryos generated from these couples, to determine the various 
segregation modes and the frequencies of meiotic and mitotic errors. PGD strategies 
were devised for all seven patients, and were applied clinically in five cases. Even 
though the number of embryos investigated was relatively small, the results obtained 
are significant, as they contribute extra information on the preferential segregation 
patterns for both reciprocal and Robertsonian translocations and the chromosome 
constitution of embryos generated by such patients. Moreover, examination of 
embryos from patient F revealed that the repeated implantation failure was attributed 
to the high rate of post-zygotic errors observed in these embryos, rather than to the 
possible gonadal mosaicism. This patient could be another example of the advanced 
maternal age effect on mitotic aneuploid mosaicism, which was also demonstrated by
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Munne and colleagues (2002), as discussed in the previous section. Effectively this 
patient is expected to go through a third PGD cycle, but this time her embryos will be 
investigated for six autosomes, 13, 15, 16, 18, 21, and 22. These chromosomes are 
examined in our centre during aneuploidy screening cases for which only one cell is 
biopsied per embryo. In the case of patient F, however, two cells will be biopsied, as 
previously, as her main problem is the generation of highly mosaic embryos. 
Investigation of six chromosomes instead of the two that were targeted in the previous 
cycles should lead to the identification of the most suitable embryo(s) to transfer.
The value of PGD to aid carriers of structural chromosomal abnormalities to achieve a 
normal pregnancy is demonstrated by the birth of a normal male baby in the case of 
the carrier of t(l lq;22q), that had suffered four early spontaneous miscarriages prior 
to treatment, but also in the larger study by our group (Simopoulou et al, 2003) in 
which clinical pregnancies followed three of the eight PGD cycles, two being 
established after the first treatment.
FISH as a diagnostic tool for the detection of chromosome abnormalities in embryos 
is a very efficient technique. It has, however certain limitations. Technical problems 
include the decrease in efficiency with the addition of extra probes, signal overlaps 
that could lead to misdiagnosis and loss of nuclei during the procedure, the latter 
being frequently experienced during this study. All these must always be assessed 
during the development of the proposed PGD strategy. FISH is mostly hampered by 
embryo mosaicism that could lead to misdiagnosing an abnormal embryo as normal, 
especially in cases when only one blastomere is being biopsied. The single cell biopsy 
is being followed by several PGD groups, including the Guy’s and St Thomas’ centre. 
This group advocates that biopsy of two cells significantly reduces the embryo mass, 
decreasing in this way the potential for implantation (Pickering et al, 2003). There is 
more than one example both in this and the larger study carried out by our group 
(Simopoulou et al, 2003), during which one of the nuclei was lost and a result was 
obtained from the other. In addition, re-analysis of the non-transferred embryos 
generated from this group of patients revealed that chromosomally balanced and 
abnormal cells could co-exist in the same embryo. The latter confirms our view that in 
cases of patients who are carriers of chromosomal abnormality diagnosis should be 
carried out on two blastomeres, rather than one.
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The data obtained from this study demonstrates and confirms the observation that the 
generation of chaotic embryos is both patient-specific and a prognostic factor for the 
establishment of a clinical pregnancy (Delhanty et al., 1997). The only couple that 
managed to achieve a pregnancy during the study was in case B. The female partner 
was able to start but not maintain pregnancies in the past. This combined with the fact 
that out of the five couples investigated, this couple had produced the second lowest 
number of chaotic embryos, meant that there was a higher chance for them to achieve 
a pregnancy with the right embryo. The latter happened after their second PGD 
attempt.
Counselling of prospective patients for the PGD of chromosome abnormalities should 
emphasise the fact that multiple attempts could be necessary for a pregnancy to be 
established. It should also stress the fact of embryo mosaicism and the possibility of 
not identifying an embryo suitable for transfer from the first attempt. Even if no such 
embryo is identified should such couples go ahead, the data obtained from the FISH 
examination should be discussed to provide such patients with the ability of making 
an informed choice as to how to proceed after treatment
FISH has an extra limitation in that it is unable to target all 23 chromosomes. Recently 
the use of multiplex fluorescent PCR and DNA fingerprinting has been applied for the 
detection of chromosomes 13, 18, 21, X and Y, as an alternative to FISH for the 
detection of aneuploidy in single embryonic blastomeres (Findlay et al., 2002; Katz et 
al, 2002). Single-cell PCR has generally been hampered by ADO, which tends to 
affect 10% of amplifications (D. Wells, personal communication). The use of multiple 
markers per chromosome, however, increases single-cell multiplex PCR accuracy, and 
could be used to identify a larger number of chromosomes in a single amplification, 
compared to the number being diagnosed by FISH (A. Handyside, personal 
communication). CGH is at the moment the only technique with the ability to screen 
the entire genome of a single cell, and during the past two years has been applied 
clinically to screen embryonic blastomeres (Wilton et al, 2001) and first polar bodies 
(Wells et al, 2002). The disadvantages of this technique in its clinical application 
include the fact that it is vary laborious and requires good knowledge of both 
molecular and cytogenetic methods (Munne and Wells, 2002). Another drawback is
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the time required for a result to be obtained. Current applications to blastomeres 
involve the freezing of the embryos (Wilton et al, 2001). Modifications of the 
protocol leading to reduction in hybridisation time would possibly enable its wider 
application for the detection of both structural and numerical chromosome 
abnormalities.
In conclusion, PGD can be a very useful tool for couples that have experienced either 
years of infertility, multiple spontaneous abortions, or continuous implantation 
failures as a result of a chromosomal abnormality. As PGD is still relatively new and 
complicated, because it involves the combination of reproductive medicine and 
science, good communication between all the participants in the same centre and 
worldwide is essential (Vandervost et al, 2000). The latter is accomplished by the 
ESHRE PGD Consortium. Reproductive medicine and science are currently evolving 
very rapidly. This means that PGD will hopefully become more accurate and more 
effective to aid childless couples to become parents.
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6.4 FISH analysis of human metaphase H oocytes and corresponding
first PBs
Out of all types of chromosome anomaly, constitutional aneuploidy is considered to be 
the most significant clinically, occurring in at least 5% of recognised pregnancies. 
Genetic investigations on human gametes and embryos have demonstrated that errors 
during female meiosis I are the main cause of numerical abnormalities. During the second 
part of this study, FISH was employed in three consecutive rounds for the analysis of 
unfertilised meiosis II oocytes and their corresponding first PBs when these were 
available. The probes used were specific for chromosomes of differing sizes representing 
all groups apart from F. The aim was to gain information concerning the segregation 
patterns in these cells that came from women undergoing assisted conception, in an 
attempt to answer questions related to mechanisms leading to maternal aneuploidy.
A total of 265 oocytes, some consisting of PBs as well, were considered suitable for this 
FISH investigation. These came from 168 patients with an average maternal age of 32.5 
years. The collaborating centres were two: the Assisted Conception Unit at the University 
College London Hospitals Trust, and the Assisted Conception Unit at Tayside University 
Hospitals NHS Trust, in Dundee, Scotland.
Ten chromosomes were examined including 1, 4, 12, 13, 16, 17, 18, 21, 22, and X. Both 
centromeric and locus-specific probes were used for their investigation. Strict scoring 
criteria were adopted for the identification of anomalies in these cells. More specifically, 
we were scoring as abnormal, oocytes and/or PBs that showed extra signals, representing 
the gain of a whole chromosome or chromatid. Absence of signals was not scored, as the 
latter could not be distinguished from chromosome loss during the spreading process or 
hybridisation failure. An oocyte and/or PB was characterised as having undergone 
premature division of chromatids, when two or more chromatid diameters were 
separating the two signals. In these cases the cell was not considered to be abnormal per 
se, but to have an increased potential to cause an aneuploid conception due to random 
segregation at anaphase II, following fertilisation. These scoring criteria were employed
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by Mahmood and colleagues (2000) and Cupisti and colleagues (2003) in earlier 
investigations by our group.
6.4.1 Processing of oocvtes and PBs
Two different techniques were employed in order for the fixation of the eggs (oocyte + 
PB) on slides to be achieved. The majority of cells were fixed using the method 
suggested by Tarkowski (1966) with modifications, as described by Mahmood et al. 
(2000). Some eggs were fixed according to a different protocol based on the gradual 
fixation method suggested by Kamiguchi and colleagues (1993). As mentioned in the 
Results section, this study was hampered by the high material loss rate. This was the 
main reason of the application of the two spreading methods. Effectively, applying these 
two methods made no difference to the frequency of cell loss, chromosome numbers and 
morphology, and the ability of oocytes to remain on slides during the three consecutive 
rounds of FISH. Moreover, the gradual fixation method led to chromosome preparations 
that were surrounded by cytoplasm, making the scoring of signals very difficult.
The Tarkowski spreading protocol has been applied in several similar studies including 
those by Cupisti et al. (2003), Durban et al. (1998), Munne et al. (1995), and Pellestor et 
al. (1993) with or without modifications. Durban and colleagues (1998) in their study of 
first PBs reported on a very low rate of chromosome loss, due to the use of a fixative that 
consisted of equal amounts of ethanol and acetic acid, leading to its slower evaporation. 
The gradual fixation method was applied by Pellestor and colleagues (2003) in their 
investigation of unfertilised oocytes with the use of R-banding. The application of this 
method enabled them to score for both extra and missing chromosomal material in these 
cells (Pellestor et al., 2003). A completely different protocol was employed by Martini 
and co-workers (2000). In this study the oocytes were spread on slides with the use of 
Tween/HCL in a way comparable with the one used for blastomere/embryo spreading. 
The latter resulted in the formation of “fragments” that had lost their chromosome shape 
and could easily be removed together with the cytoplasm. Corresponding PBs were not 
examined, as they could not be distinguished from the oocytes.
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In the current study identification of cells initially took place by staining them with DAPI 
and locating them under fluorescence. This step was replaced by staining the oocytes and 
PBs with Giemsa, as it was thought that the DAPI and the prolonged exposure to 
fluorescent light affected their DNA leading to poorer chromosome morphology and 
frequent loss of material after the first round of FISH. The staining of the cells was 
abandoned altogether towards the end of this study, as it was observed that the Giemsa 
was also affecting chromosome quality and leading to an even higher rate of chromosome 
loss. Different treatments were also applied in order to reduce this, including ageing the 
cells at room temperature for 2-4 weeks, leaving them overnight in an incubator at 37°C 
or at 65°C, as suggested by Sandalinas et al. (2002), or a combination of both, storing 
them at either 4°C or -20°C prior to the first, second or third round of FISH, and 
spreading them on charged slides. From the eggs that were lost others were relatively 
new, i.e. spread during the year of examination, and others were very old and had been 
stored at 4°C or -20°C for years. Thus, there was not a standard pattern that could explain 
the reason as to why these cells were being lost with such high frequency.
The results obtained from the FISH investigation of unfertilised oocytes and their 
corresponding first PBs will be discussed in the following section.
6.4,2 Aneuploidy detection in human metaphase II oocvtes and first PBs
FISH analysis was attempted for 265 meiosis II oocytes, some of them also consisting of 
their corresponding first PBs. Of these, 51 oocytes and 11 PBs yielded results after the 
first round of FISH, 27 oocytes and 8 PBs after the second round of FISH, whereas 7 
oocytes and 2 PBs were examined in the final FISH round. The remaining cells were all 
lost, leading to a decrease in the sample size for this part of the study. Information was 
obtained for 31 patients, whose average age was 32.5 years with the youngest being 22 
and the oldest 44. It has been demonstrated by population data that in an unselected group 
of women of average age of about 33 years it would be expected that approximately 8% 
of their oocytes would consist of either extra or missing chromosome material, and the 
groups mostly affected would be D, E, and G and also chromosome X due to their small 
size and the fewer chiasmata formed between the two homologues (Zenzes and Casper,
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1992). Added to chromosomes belonging to these groups we also chose to examine larger 
chromosomes, belonging to groups A, and C, to check whether they were prone to 
undergo non-disjunction during the first female meiosis.
Extra chromosomes were scored for four oocytes and one PB all from different patients. 
The youngest patient in this group was 31 and the oldest 35, leading to an average age of
32.2 years. The latter is below the age at which an increase in aneuploid conceptions 
becomes marked. This implies that some of the mechanisms leading to maternal 
aneuploidy could be age-independent, especially in the infertile population. Two patients 
had oocytes containing an extra copy of 17, two had oocytes hyperhaploid for 
chromosome 13 and one patient had one PB with an extra chromatid 22. Surprisingly no 
abnormalities were scored for chromosome 21. The latter was attributed to the small size 
of the sample, and the frequent absence of this chromosome from the oocytes and PBs 
investigated. The estimated hyperhaploidy rate was 9.8%.
No abnormalities were scored for the larger chromosomes 1, 12, and X. The latter was 
not unexpected for 1 and 12, as many similar studies, including these by our group, have 
demonstrated the preferential involvement of the smaller chromosomes and chromosome 
X in oocyte aneuploidy (Cupisti et al, 2003; Pellestor et al, 2003; Sandalinas et al, 2002; 
Mahmood et al, 2000; Dailey et al, 1996).
The results from this study were partially included in the report by Cupisti and colleagues
(2003). In that report a total of 236 eggs from 124 patients were successfully examined 
for chromosomes 1, 9, 12, 13,16, 18,21, and X. The abnormality rate (hyperploidy only) 
in this study was 4%, and smaller chromosomes were preferentially affected to a 
statistically significant extent (see Appendix C). Both extra whole chromosome and 
single chromatid anomalies were identified, among the fourteen hyperhaploidies that 
were scored. Table 6.2 summarises the frequency of anomalies found in eggs per 
chromosome investigated. From this study it was also postulated that aneuploidy could be 
affected by age independent mechanisms as the average age of patients with 
abnormalities was almost identical to that of the normal group (Cupisti et al, 2003).
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Table 6.2: Frequency of anomalies (hyperploidy) found in oocytes or 1st polar bodies per 
chromosome, (from Cupisti et al, 2003).
Chromosome Eggs* scored Whole
chromosome
anomalies
Single chromatid 
anomalies
% of
anomalies
1 83 0 0 0
9 84 0 0 0
12 62 0 0 0
13 95 3 0 3.2
16 97 1 1 2.1
18 95 1 1 2.1
21 96 2 4 7.0
X 105 0 1 1.1
aAn egg consists of an oocyte and a first polar body, but may each may be present alone 
without the other
Anahory and colleagues (2003) investigated 104 unfertilised oocytes and 56 first PBs, by 
applying a combination of centromeric or locus-specific probes and whole chromosome 
paints for chromosomes 9, 13, 16, 18, 21, and X, in sequential FISH rounds. The 
aneuploidy rate (hyperploidy plus hypohaploidy) was higher than the one found in the 
study of Cupisti and colleagues (2003), and was estimated to be 11.5%. Abnormalities 
affected chromosomes 9, 16, 18, 21, and X, and ten oocytes were identified as having 
either extra whole chromosomes or single chromatids. The authors claimed that this FISH 
approach was advantageous, as it enabled the detection of whole chromosomes, rather 
than the visualisation of two dots, seen with the application of single probes (Anahory et 
al, 2003). The spreading method used for this study was based on the Tarkowski 
protocol. However, the authors did not take into account the artifactual chromosome loss 
and were scoring both for extra but also for absent chromosomes.
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Ninety-three first PBs were examined for chromosomes 13, 16, 18, 21, and 22 by Munne 
and co-workers (2000c). This study was carried out in the context of PGD for aneuploidy 
screening, so the patients were in the older age group. Similarly to the findings of our 
study, and the two mentioned above, abnormalities affecting all these chromosomes were 
detected, with the aneuploidy rate being higher compared to the studies above, at 33.3%. 
As with the Anahory investigation, the authors of this report were scoring for extra and 
missing chromosomes, not taking into consideration the possibility of artifactual loss 
during the spreading process.
An even higher aneuploidy rate of 47.5% was reported in the study of first PBs and 54 
corresponding meiosis II oocytes, carried out by Pujol et al. (2003a). The aim of this 
investigation was the validation of PB analysis for prediction of aneuploidy in the oocyte. 
The chromosomes investigated belonged mostly to groups D, E, and G, including 13, 15, 
16, 17, 18, 21, 22 and X. The only representatives of groups A-C that were examined 
were chromosomes 1 and X. Comparison of the observations made for the PBs and their 
oocytes led to the conclusion that 28.5% of the results obtained were artifactual. They did 
not identify a difference in the frequency with which the various chromosomes were 
involved in aneuploidy (Pujol et al., 2003a). The latter contradicts the findings presented 
in all the other studies, including the one described in this project that all show the 
preferential involvement of the small chromosomes in maternal aneuploidy. This and the 
very high aneuploidy rate could be explained by the fact that almost all the oocyte/PB 
pairs they examined were obtained at the germinal vesicle stage of oogenesis and were 
left to mature in vitro. This, however, is not discussed in the report.
Germinal or gonadal mosaicism has been determined as one of the mechanisms leading 
to female aneuploidy (Cozzi et al., 1999; Mahmood et al., 2000; Delhanty, 2001; Cupisti 
et al., 2003). This mechanism was evident in this study as well, and was observed for two 
out of the five patients whose oocytes or PBs were considered to be abnormal. In the first 
case germinal mosaicism for trisomy 13 was evident, by the scoring of an extra copy of 
this chromosome in one oocyte, whilst the corresponding PB had a normal complement. 
In the second case the first PB consisted of an extra chromatid for chromosome 22, with 
the corresponding oocyte having the normal single copy of this chromosome. In both
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cases the cells consisted of about 23 chromosomes, so it was highly unlikely for all of 
them to have lost the extra copy of the chromosome in question. Such an event could take 
place in an otherwise karyotypically normal individual. In cases such as these it is 
possible for the trisomic germ cell line to undergo secondary non-disjunction (Cozzi et 
al., 1999). There have been two reports by our group on evidence for gonadal mosaicism 
obtained by the analysis of oocytes by FISH. In one case a couple requested PGD for 
recurrent trisomy 21 conceptions, and FISH analysis of their preimplantation embryos 
along with unfertilised oocytes and their PBs revealed that the female partner was a 
gonadal mosaic for this trisomy (Cozzi et al., 1999). In another report two patients were 
identified to be gonadal or germinal mosaics for trisomies 13 and 21. Both cases were 
unsuspected and were detected during an oocyte and PB study, very similar to the one 
described here (Mahmood et al., 2000). Gonadal mosaicism is thought to be associated 
with confined placental mosaicism (CPM), as the primordial germ cells and the chorionic 
stroma originate from the same progenitor cells (Buehr, 1997). Stavropoulos and 
colleagues (1998) demonstrated the above by identifying a case of a conceptus that had 
CPM for trisomy 16 and was also a gonadal mosaic for this abnormality. Since CPM 
affects at least 1% of pregnancies, investigated by chorionic villus sampling (CVS), it is 
likely that gonadal mosaicism is more frequent than is assumed. Evidence for germinal 
mosaicism was also identified in the Pujol et al., (2003a) study. Hence, three PBs from 
the same patient were detected to have extra whole chromosomes, whereas the 
corresponding oocytes were characterised as normal, haploid. Chromosomes 13, 15, 16, 
17, and 22 were affected. The authors attributed these abnormalities to unique, multiple 
or successive segregation errors that could have taken place during the mitotic divisions 
of the precursor oogonia, rather than in the presence of a trisomic germ cell line (Pujol et 
al., 2003a).
Balanced predivision of chromatids was noted for nearly all the examined chromosomes, 
with chromosome 21 being observed to be more frequently involved. This phenomenon 
was initially described by Angell (1991) and involves the premature separation of 
chromatids prior to anaphase I. The chromatids are then are at risk of segregating 
randomly during meiosis II and possibly leading to the formation of a trisomic
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conception. For this reason, the observation of this balanced predivision was not 
considered as an abnormality, as these chromatids still had the potential to segregate 
normally, leading in this way to an oocyte that had the expected chromosome 
complement. Several studies have proposed that this balanced predivision of 
chromosomes to their sister chromatids was an artifact attributed to prolonged culture 
conditions of the cells and not a true event that could potentially result to female 
aneuploidy (Munne et al, 1995, Dailey et al., 1996). This hypothesis was abandoned 
after the findings of a further study by the same group on 47 fresh oocytes that were 
produced from 13 fertile donors (Sandalinas et al, 2002). These oocytes were analysed 
by SKY, and 12 were identified to contain chromosomes that had undergone balanced 
predivision to their sister chromatids. It was concluded that the premature separation of 
oocyte chromosomes is one of the factors involved in female aneuploidy. This is 
confirmed by the fact that half of all anomalies detected by FISH analysis of oocytes 
affect single chromatids. The group also identified a direct association of advancing 
maternal age and increased frequency of chromatid predivision (Sandalinas et al, 2002). 
The situation is different for the PBs, that undergo rapid degeneration once in culture. In 
this case the balanced premature separation of chromosomes could be the result of this 
rapid degeneration, rather than being a true event. The latter was observed by Clyde and 
colleagues (2001) in their study of one oocyte and its corresponding first PB by M-FISH. 
More specifically, once cytokinesis in the PB was complete, degeneration of the cell 
began. This was observed after having cultured the PB for approximately 6 hours. 
Balanced predivision was also noted for two other PBs from the same patient, that were 
fixed on slides in less than six hours (Clyde et al, 2001).
The observations made in the current study concerning predivision are most likely a 
combination of both artifactual and true events, especially in the case of oocytes. In 
general, the latter were left in culture 24-48 hours before being fixed. In cases of inferior 
chromosome morphology, balanced predivision was attributed to cellular degeneration. If 
chromosome quality was good, then this event was considered more likely to be true.
An observation that was made in the SKY study by Sandalinas et al (2002) was that the 
balanced predivision affected chromosomes belonging to groups E-G more frequently,
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compared to the larger ones. This was also noted in this study, with chromosome 21 
having separated into its sister chromatids in six oocytes. Chromosomes 12, 13, 17, and 
22 were scored as prematurely separated in two oocytes each, whereas the larger 
chromosome 4 underwent premature division in two oocytes and one PB, the latter most 
likely being due to the cell’s degeneration. Such observations in combination with the 
fact that smaller chromosomes are more prone to non-disjunction during the first female 
meiotic division are all attributed to the number of chiasmata that are formed during 
meiotic recombination. The smaller the chromosome, the fewer the number of crossing- 
over events. Chiasmata are crucial for the correct segregation of homologues during 
meiosis (Tease et al., 2002). Several studies have been carried out in an attempt to 
elucidate the patterns of female recombination that could potentially lead to 
malsegregation of chromosomes (Robinson et al, 1993; Sherman et al., 1994; Fisher et 
al, 1995; Hassold et al., 1995; Lamb et al., 1996; Nicolaidis and Petersen, 1998; Brown 
et al, 2000). All these came to the common conclusion that variations in recombination 
patterns such as failure of crossing-over, reduction in crossing over frequency combined 
with formation of distal chiasmata, or an increase in crossing-over frequency combined 
with the formation of proximal chiasmata, all act as risk factors contributing to non­
disjunction. Tease and colleagues (2002) used an immunocytological approach to 
investigate the chromosome recombination patterns in human fetal oocytes. They found 
that only one distal crossover is formed between the two homologues for chromosome 
21. The latter could explain the observation of the frequent balanced predivision for this 
chromosome, made in this study.
The effect of maternal age in oocyte aneuploidy was not investigated in this study due to 
the small sample size. The negative influence of advanced maternal age on female 
meiosis has been demonstrated, however, by various other studies on unfertilised oocytes 
and first PBs. The first was that of Dailey et al. (1996). The group examined 383 oocytes 
from 107 patients with an average maternal age of 36.2 years, for chromosomes X, 13, 
18, and 21. They reported an increase in non-disjunction of bivalent chromosomes from 
1.5% in women 25-34 years of age to 24.2% in women of 40 years or older. Hence the 
association of advanced maternal age with chromosome malsegragtion was obvious 
(Dailey et al., 1996). A patient with an extra whole chromosome 18 and an extra
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chromatid for 21 in the same oocyte was identified in the study of Mahmood and 
colleagues (2000). This patient was 38 years old and the oldest in the group. The 
presence of two different anomalies in a single cell clearly demonstrates the adverse 
effects of maternal ageing in the chromosome complement of oocytes (Mahmood et al., 
2000). Pellestor and colleagues (2003) carried out a much larger study of 3,042 
unfertilised oocytes from women aged between 19-46. The cells were examined with R- 
banding. They identified that maternal age is directly correlated with both whole 
chromosome non-disjunction, but also with abnormal single chromatid events and 
concluded that multiple factors are related in this maternal age effect, both environmental 
and intrinsic (Pellestor et al., 2003).
Throughout this study no extra copies were scored for the larger chromosomes 1, 4, 12, 
and X. Absence of these chromosomes was attributed to technical loss. Data from 
cleavage stage embryos analysed both with FISH and CGH have shown monosomies for 
such chromosomes (Harper et al., 1995; Voullaire et al., 2000; Wells and Delhanty, 
2000). Events such as these could be the result of a different mechanism, namely 
anaphase lag, which seems to affect larger chromosomes (Harper et al, 1995; Voullaire 
et al, 2000; Wells and Delhanty, 2000).
The estimation of the true aneuploidy rate in studies that are examining female gametes 
either karyotypically or via FISH methods occurs by doubling the hyperhaploidy rate to 
account for the hypohaploids that result from the true chromosome loss. Zenzes and 
Casper (1992) reported on the hyperhaploid rates from 11 karyotyping studies of 1120 
oocytes. The average rate from the combination of these studies was 6.6%. More 
recently Pellestor and colleagues (2002) carried out a larger karyotyping study on 1397 
oocytes and identified a hyperhaploidy rate of 4.1%. Moreover, the average rates from 
FISH studies range between 4-11%, scoring, however, only for extra chromosomes. 
There have been reports of much higher aneuploidy rates, namely 45.2 % (Verlinsky et 
al, 2001) and 44% (Martini et al, 2000). In the first case the group applied FISH on the 
1st and 2nd PBs with aim of predicting the chromosome complement of the corresponding 
oocytes in the context of PGD for aneuploidy. The authors were scoring for both extra
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and missing chromosome material, without accounting for the artifactual loss of 
chromosomes due to processing. In addition, they aimed to identify and transfer 
chromosomally balanced embryos, so as for the success rate of IVF in older women to be 
improved. Hence, any oocyte that was suspected of an abnormality was excluded 
(Verlinsky et al., 1999; 2001). In the second case (Martini et al., 2000) the high 
aneuploidy rate is most likely due to the way the oocytes were processed. They were 
treated with pronase to remove corresponding PBs and were spread in a way that grossly 
affected their morphology. Removal of the PB had as an effect the inability to investigate 
the corresponding cell and confirm possible abnormalities.
Hyperhaploidy can be reliably demonstrated with the application of FISH and other 
related techniques, such as SKY, and this is evident from the results obtained in this and 
other similar studies. The estimation of hypohaploidy, however, requires a molecular 
cytogenetic technique that would ensure no artifactual loss of genetic material. 
Comparative Genomic Hybridisation is a DNA based method that enables the screening 
of an entire genome being achieved in a single hybridisation step. CGH has been 
developed by our group for the analysis of blastomeres coming from cleavage stage 
embryos (Wells and Delhanty, 2000) and also of first PBs during a clinical PGD case 
(Wells et al., 2002). This method was employed in this study in an attempt to examine all 
23 chromosomes in meiosis II oocytes and corresponding first PBs to investigate 
maternal aneuploidy and its causal factors further.
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6.5 CGH analysis of human metaphase n  oocytes and corresponding 
first PBs
During the last stage of this study, CGH was employed to screen all 23 chromosomes of 
unfertilised oocytes and their corresponding first PBs. This molecular cytogenetic 
technique would enable the examination of chromosomes that were not targeted during 
the previous FISH study, and would possibly provide data on hypohaploidy, as well.
Investigation was attempted for 85 cells (40 oocytes, and 45 PBs), and 37 of these were 
pairs. All the patients that donated their cells for this part of the study were undergoing 
infertility treatment at the Assisted Conception Unit at Tayside University Hospitals, 
NHS Trust, Dundee, Scotland. Maternal ages ranged between 22 and 39 years (mean 
31.9). These couples were mostly being treated due to male factor infertility. Problems 
with the female partner were evident in three cases, including one patient with polycystic 
ovary syndrome (PCOS), one with anovulation, and one with idiopathic infertility.
Prior to its application for the examination of oocytes and PBs, CGH was evaluated on 
genomic, and trisomic fibroblast DNA, and on normal and abnormal single cells. This 
evaluation, along with the technical problems experienced during the development of an 
accurate and reliable protocol for the analysis of minute DNA amounts will be discussed 
below.
6.5.1 Technical aspects of CGH
The CGH protocol used for the analysis of all oocytes and PBs was as described by Wells 
and colleagues (2002) with certain modifications. Three sequential stages were involved. 
These included the initial DNA amplification with the DOP-PCR, the enzymatic 
incorporation of the fluorescent labels, followed by hybridisation onto normal male 
metaphases. Evaluation of these stages took place by carrying out seven positive control 
experiments:
1. Normal female genomic DNA against normal male genomic DNA
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2. Fibroblast DNA trisomic for 13 against normal male genomic DNA
3. Fibroblast DNA trisomic for 21 against normal female genomic DNA
4. Fibroblast DNA trisomic for 22 against normal male genomic DNA
5. DNA from a clump of three normal female buccal cells against DNA from a clump of 
three normal male buccal cells
6. DNA from a clump of three normal female buccal cells against DNA from a clump of 
three normal female buccal cells
7. DNA from a single fibroblast cell trisomic for 18 against normal male genomic DNA
Genomic and fibroblast DNAs were of relatively low concentrations and these along with 
that from the clumps (3-5 cells) and single cells were all amplified with the use of a 
whole genome amplification (WGA) reaction, namely DOP-PCR. The primer employed 
in this reaction is capable of annealing to a huge number of sites scattered throughout the 
genome, leading to efficient amplification of more than 85% of loci (Wells et al, 1999). 
Its application for these samples led to the generation of DNA fragments between 300- 
1500bp in size, and concentrations of approximately 800-1000ng. These were more than 
sufficient for the further processing of all samples. Evaluation of the remainder of the 
CGH protocol, in the context of nick translation efficiency and assessment of the 
accuracy and sensitivity of the computer software employed for the experiment analysis 
and interpretation for DNA samples with the same or different concentration was also 
feasible. Karyotypes were accurately assessed in every case, with all trisomies correctly 
identified. These seven experiments were also used as reference when comparable results 
were obtained from the CGH analysis of the oocytes and PBs.
Wells and colleagues (1999) were the first to describe the application of CGH to single 
fibroblasts, buccal cells, and amniocytes. They tested four different WGA approaches, 
including DOP-PCR, tagged PCR (T-PCR), primer extension preamplification (PEP), and 
Alu-PCR for the amplification of these cells. The DOP-PCR was the method that 
provided the most efficient coverage of the genome, and generated the highest DNA 
quantity that was sufficient for the CGH analysis of these cells (Wells et al., 1999). This 
approach was different from the one applied in this study, as the fluorescent labels for
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both test and reference DNAs were incorporated during amplification, instead of by nick 
translation. The authors of that report were the first to demonstrate the detection of 
aneuploidy with CGH analysis of cells amplified by DOP-PCR (Wells et al, 1999).
A similar study was carried out by Voullaire and colleagues (1999). They also applied the 
DOP-PCR for the amplification of single fibroblasts that were trisomic for 13, 18, or 21. 
Genomic DNA that was also amplified by the DOP-PCR was used as reference. The 
fragment sizes of the amplified products were comparable to the ones generated in this 
investigation, i.e. their size varied between 300-2000bp. They also applied the nick 
translation procedure for the labelling of the PCR products. Analysis and interpretation of 
the obtained results verified the ability of the CGH to detect trisomies of even small 
chromosomes, such as 21 at the single cell level with the resolution being of the order of 
40Mb (Voullaire et al, 1999). The latter was seen in this study as well, as fibroblast 
samples trisomic for the smaller chromosomes 18, 21 and 22 were analysed and these 
trisomies were identified with the same resolution.
An alternative WGA protocol was described by Klein and colleagues (1999) called 
“Ligation-Mediated” PCR. During this WGA method, the single cell DNA was initially 
digested after cell lysis, with the use of the Msel restriction endonuclease. The digestion 
lasted approximately three hours. Subsequently, two primers were used that were left to 
anneal and amplify the digested single cell DNA overnight. The authors claimed that this 
approach enabled the faithful amplification of the genome. This was its advantage over 
the DOP-PCR, which preferentially over-amplified certain parts of the genome (Wells et 
al, 1999). However, “Ligation-Mediated” PCR required a longer period of time for the 
amplification to be complete, whereas the amplified products were generated within 6 
hours with the application of the DOP-PCR. The utilisation of CGH at the single cell 
level was evaluated not only for research purposes but also with the aim of applying this 
technique clinically for the analysis of gametes and blastomeres from embryos. Such 
applications necessitated the design of a protocol that would yield results within the time 
frame of an embryo transfer, i.e. by day 5 the latest. Hence, the WGA approach described 
by Klein and colleagues (1999) was not appropriate, as it was both time consuming and 
had the additional restriction endonuclease digestion step, increasing in this way both the
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complexity of the WGA protocol, and the possibility of contamination to enter the 
reaction.
Three groups of differently prepared oocytes and PBs were investigated with CGH 
throughout this part of the study, as is described in section 5.1. Results were obtained for 
all three groups, with the CGH being most successful for the cells belonging to the third 
category (single cells suspend in approximately 2pi of sterile PBS and overlaid with oil), 
and least for the cells belonging to the first category (single cells suspended in 100pi of 
sterile PBS). The latter were stored in the -80°C for approximately four months prior to 
their analysis. It was suspected that the combination of the high amount of PBS in which 
the cells were suspended and their prolonged storage in the -80°C could have adversely 
affected the DNA amplification. The high PBS volume necessitated centrifugation and 
removal of excess fluid prior to the DOP-PCR. This could have increased the risk of cell 
loss. In addition, the long storage of the cells could have resulted in DNA degradation, 
leading to poor amplification and fragment sizes that were too small for CGH, especially 
after nick translation, which introduces further DNA strand breaks. Many cells were 
known to have been lost or lysed during their processing, and consequently the low 
amplification success rate was not unexpected (26 cells demonstrated the expected 
smears from a total of 85 for which CGH was attempted). The amplified products from 
all cells were analysed by agarose gel electrophoresis, and smears were visible for three 
cells out of those that had not yielded results with CGH. In these three cases failure was 
attributed to inferior DNA quality and possible degradation, due to prolonged storage 
time. Absence of the characteristic smears for the rest of the failed cells suggested their 
loss during processing. All the above observations led to the conclusion that CGH would 
be most successful on cells that were suspended in a small amount of PBS, overlaid with 
oil and being stored in the -80°C for a relatively short period of time, i.e. two months or 
less.
Difficulties arose in the interpretation of the captured images as well. More specifically, 
the majority of the oocytes used in this study had been exposed to sperm either via IVF or 
ICSI. So the presence of sperm DNA was possible for the IVF oocytes and almost a
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certainty for the ICSI ones. Hence, we considered that the CGH analysis was probably 
carried out on both the maternal and the paternal genomes. In the cases of the PBs, the 
presence of sperm was very unlikely, as these cells were already extruded prior to 
fertilisation, and thus represented solely the maternal genome. It was postulated that for 
the purposes of analysis the DNA from haploid oocytes and PBs would behave as diploid 
female DNA, and thus when a whole chromosome was missing this would correspond to 
a nullisomy in the diploid state, whereas absence of a single chromatid would correspond 
to a monosomy. Another problem encountered during interpretation was the relative 
insensitivity of the CGH software to detect abnormalities caused by single chromatids in 
DNA from single haploid cells, especially those involving their possible absence from the 
complement.
Despite the technical problems encountered during the CGH analysis of such cells, data 
was collected for 11 oocytes and 15 first PBs. Among these, several were characterised as 
abnormal, and chromosomes that are not typically targeted with FISH were seen to show 
anomalies. This demonstrated the value of CGH in its ability to screen entire 
chromosome complements.
6.5.2 Chromosome abnormalities in oocvtes and PBs investigated with CGH
The second and main aim of this project involved the extended investigation into the 
mechanisms causing female aneuploidy by examining unfertilised oocytes and their 
corresponding first PBs. CGH was selected to conclude this investigation, due to its 
capability to examine all 23 chromosomes and identify most gains and losses of DNA. A 
normal haploid chromosome complement was detected for 8 oocytes and 10 PBs, four of 
which were corresponding, whereas CGH failure was observed for 5 PBs and 6 oocytes. 
Eggs (oocytes and PBs) were donated from fourteen patients, with a mean maternal age 
of 31.9 (22-39) years. This was slightly lower compared to the average maternal age of 
the patients that participated to the FISH part of the study.
The reference DNA, with which the test DNA samples were compared, was initially from 
a normal male (46,XY), but this changed, as the study proceeded to DNA from a normal
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female (46,XX). This modification occurred for three reasons: firstly, the use of female 
DNA would act as an internal control in cases that the examined cells were contaminated 
with male DNA from the handler, secondly it would enable the detection of chromosome 
X hyperhaploidy in the test sample, and thirdly it would possibly aid in the distinction 
between loss of whole chromosomes and single chromatids. The argument for this was 
that neither the reference DNA nor the test DNA, especially in the cases of PBs, 
contained Y chromosome material. Hence, if the CGH analysis detected a chromosome 
for which DNA was missing in the test, comparison between the fluorescence intensity of 
the green fluorochrome on the chromosome in question and the Y chromosome, would 
most likely identify whether this loss was attributed to a whole chromosome or a single 
chromatid. More specifically, if there was no green visible and the chromosome in 
question was very faint, similar to the bottom part the Y chromosome then loss of a 
whole chromosome would have taken place (nullisomy in the diploid state). If however, 
there were some green fluorescence visible for that chromosome, then the loss would be 
attributed to a single chromatid (monosomy in the diploid state).
In practice, it was observed that the CGH software used was more sensitive in detecting 
the presence of extra chromosomal material rather than its absence. This was also noted 
by other groups that were using this version of software to carry out their CGH analysis 
(Malmgrem et al, 2002; D. Wells, personal communication).
During analysis and interpretation of the captured images in some cases, the presence of 
hybridisation artefacts was observed for the heterochromatic regions, and both the short 
and long arm telomeres of certain chromosomes, including 1, 9, 16, and Y and the 
satellite regions of the acrocentric chromosomes. These were caused due to the extreme 
suppression of these regions by the Cot-1 DNA and any low level fluorescence at these 
sites was attributable to background. Consequently, these regions were not considered 
during interpretation. In addition, in cases where abnormal results were obtained for 
chromosomes 19 and 22, they were interpreted with caution, due to the fact that these 
chromosomes are also known to be prone to labelling artefacts. Other CGH studies have 
reported on the observation of artefacts on these chromosome regions, such as Lomax 
and colleagues (2000), Tabet and colleagues (2001), and Wilton and colleagues (2001).
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Chromosome abnormalities in the form of both gains and losses were detected for seven 
cells, three oocytes and four PBs. Of these one oocyte and two PBs were carrying 
abnormalities affecting more than one chromosome. Gains were identified for 
chromosomes 4, 5, 8, 9, 12, 13, and X and losses for chromosomes X, 21 and 22. These 
cells were donated from five patients, whose ages ranged between 22-39, with an average 
maternal age of 25 years.
The most interesting case was that of patient 4412, who was the youngest of the group 
(22 years of age) and the one with the most abnormal cells. Four oocytes and their 
corresponding PBs were examined. Of these, one oocyte and two PBs consisted of the 
normal haploid chromosome complement, whilst three cells (two oocytes and one PB) 
were characterised as abnormal. The anomalies scored involved the presence of extra 
DNA material for chromosome 13 and absence of DNA material for chromosome 22 in 
the first oocyte and the corresponding PB characterised as normal, and the absence of 
DNA material for chromosome X and possibly the presence of extra DNA material for 
chromosome 21 in the second oocyte, with its corresponding PB consisting of the 
reciprocal extra DNA for chromosome X and missing DNA for chromosome 21. The fact 
that the reciprocal loss and gain of DNA material was not detected in one oocyte-PB pair 
could be explained, due to the relative inability of the CGH to fully detect anomalies, or 
as a consequence of aneuploidy originating in the sperm.
This patient was undergoing fertility treatment due to PCOS. The observation of these 
highly abnormal cells in combination with the very young age of this patient led to the 
hypothesis that one of the causal factors for these aneuploid cells were the polycystic 
ovaries. Two other reports described patients with PCOS and aneuploid gametes. More 
specifically, Sengoku and colleagues (1997) examined 74 oocytes from PCOS patients in 
their investigation of an association of the poor fertilisation rate of oocytes coming from 
such patients and their chromosome complement. Aneuploidy was detected in ten 
oocytes, and four appeared to be diploid (Sengoku et al., 1997). More recently, Clyde and 
colleagues (2001) analysed one oocyte and its corresponding PB, from a 33-year old 
PCOS patient, with the application of M-FISH. They identified three extra chromatids for 
chromosomes 15, 19, and 22 in the oocyte, with their reciprocal loss from the PB. These
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abnormalities were the result of premature division of chromosomes into their sister 
chromatids, as discussed in the previous section.
The observations made in these studies, along with the data presented in this thesis 
suggest that PCOS patients could be at a relatively higher risk of producing aneuploid 
oocytes, but further examination of gametes generated from such patients is necessary to 
confirm this hypothesis. Production of highly aneuploid oocytes from polycystic ovaries 
could be attributed to the abnormal folliculogenesis that is observed in these patients. The 
follicles of PCOS patients arrest at a diameter of 5-8 mm, which is much earlier than a 
mature follicle is expected to ovulate (Webber et al., 2003). The latter is the result of the 
increased concentrations of the tonic luteinizing hormone (LH) that are observed at this 
stage leading to the generation of oocytes of inferior quality, with poor fertilisation 
potential (Stanger et al, 1985; Howels et al, 1986; Regan et al, 1990).
The fact that the CGH software used for analysis was possibly incapable of detecting 
abnormalities caused by the loss of single chromatids was also evident during the 
analysis of oocyte 1134.3 and its corresponding PB. In this case, the oocyte was at the 
germinal vesicle stage at the time of egg collection, was not exposed to sperm and was 
left to mature in vitro. Its analysis resulted in the identification of extra chromosome 
material for 13. The reciprocal loss was not detected in the corresponding PB. The latter 
could either be attributed to the presence of an extra chromatid for 13 in the oocyte 
combined with the incapability of the software to recognise the missing chromatid in the 
PB, or to the fact that this patient was a germinal mosaic for trisomy 13, with the extra 
chromosome segregating in the oocyte.
Gains of larger chromosomes, namely 4, 5, 8, 9, 12, and X were detected in three PBs. 
The PB no. 1254.6 was characterised as highly abnormal, as it presented with gains of 
three chromosomes. Chromosomes 4, 12 and X were also investigated during the FISH 
part of this study, both in PBs and oocytes, but no anomalies were scored for them. As 
mentioned above, PBs were considered to be free of sperm, representing solely the 
maternal genome. Thus, these gains were regarded as being true observations, and were 
not attributed to artefacts of the hybridisation process. Molecular cytogenetic studies of
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the female gametes, including the one described here have demonstrated the preferential 
involvement of chromosomes smaller in size than 13 in oocyte aneuploidy. Extra copies 
of chromosomes belonging to larger groups were also scored, but were not as frequent.
CGH was clinically applied for the analysis of 12 PBs from one patient, in the context of 
PGD for aneuploidy screening (Wells et al, 2002). During this investigation, results were 
obtained for 10 cells and only one of them was identified as consisting of the normal 
haploid chromosome complement. Both gains and losses of chromosomes were detected 
in the 9 aneuploid PBs, with smaller chromosomes 14, 16, 20, 21, and 22 being more 
frequently involved. Among the abnormal PBs two were described to be carrying 
anomalies of larger autosomes, one consisting of an extra copy of chromosome 2, and the 
other missing chromosome 5. Further investigation occurred by FISH analysis of 
blastomeres from the resulting embryos with probes targeting the chromosomes that 
came up as abnormal with CGH. Almost all abnormalities observed in the PBs were 
confirmed by FISH in the embryos, one of them being classified as trisomic for 
chromosome 5, due to a meiotic error. The oocyte corresponding to the PB with the extra 
chromosome 2 had failed to fertilise, and this result was not confirmed by FISH (Wells et 
al, 2002).
Extra or missing copies of larger autosomes were scored in the examination of 47 fresh 
unfertilised oocytes, carried out by Sandalinas and colleagues (2002). These cells were 
assessed with the application of SKY, which enabled the detection of all 23 chromosomes 
and the scoring of both extra and missing copies. Meiotic errors were more frequently 
seen to be affecting the smaller chromosomes 14, 16, 17, 18, 19, 20, 21, and 22. 
However, five cells consisted of extra or missing whole chromosomes and/or chromatids, 
including 6, 8, 9, and 12 (Sandalinas et al, 2002).
Pellestor and colleagues (2002) applied the R-banding method for the analysis of 1397 
unfertilised meiosis II oocytes. Among these, five cells were carrying extra copies of 3,6, 
9, 11, and 12, either in the form of whole chromosomes or single chromatids. Similar to 
the highly abnormal PBs observed in this study, Pellestor’s investigation detected cells 
with multiple anomalies, with up to 10 chromosomes being affected. Since this was a
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karyotyping study exact assignment for a chromosome was not always feasible (Pellestor 
et al, 2002), and the identification of chromosome loss was not reliable.
Meiotic errors affecting larger autosomes were also observed during the CGH analysis of 
preimplantation embryos. Wells and Delhanty (2000) used this method in the 
examination of 64 blastomeres from 12 cleavage-stage embryos. High levels of 
mosaicism were detected, caused mainly due to post-zygotic errors. In addition, one third 
of the examined embryos were classified as aneuploid due to meiotic errors, with 
chromosomes 1, 21 and X being affected (Wells and Delhanty, 2000). A similar CGH 
investigation was carried out on 126 blastomeres from embryos derived from patients 
with repeated implantation failure (Voullaire et al, 2002). Errors of meiotic origin led to 
the presence of extra copies of chromosomes 11, 13, 16, and 21 and absence of 
chromosomes 8, 9, 10, 14, 15, 16, 21 and X, observed in a total of 12 embryos. From 
these, eight were generated from patients of advanced maternal age (Voullaire et al, 
2002).
From all the above it can be concluded, that larger autosomes can malsegregate during 
meiosis, but this phenomenon is not as common as the one involving the non-disjunction 
of the smaller chromosomes.
Theoretically, the application of CGH for the extended investigation of unfertilised 
meiosis II oocytes and their corresponding first PBs gives a more comprehensive rate of 
aneuploidy, as both the presence and the absence of chromosomes can be scored. The 
aneuploidy rate derived from the data obtained during this part of the study was estimated 
to be approximately 27%. This is relatively high, but results from a small sample size 
such as this, are easily skewed by the inclusion of unusual data from individual samples. 
For example, if patient 4412 were excluded from the group, on the basis that the 
abnormalities scored in her eggs were attributable to the PCOS, then the aneuploidy rate 
becomes 15.4%. The latter is still higher compared to the 9.8% hyperhaploidy rate that 
was the result of the FISH analysis of oocytes and PBs. However, this is expected as the 
application of FISH allowed the examination of 10 chromosomes only and was also 
hampered by the inability to score for missing chromosomes due to the artifactual 
chromosome loss. Voullaire and colleagues (2002) in their CGH investigation of
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preimplantation embryos found that the incidence of meiotic aneuploidy in that group 
was about 10%. A similar rate was calculated in the R-banding study of Pellestor et al. 
(2002), whereas in the FISH study of Cupisti et al. (2003) the hyperhaploidy rate was 
estimated to be 4%. Doubling to include hypothetical corresponding hypohaploidy would 
give a rate of 8% not significantly different from the 10% experienced by others. 
Considering the young average age of the patients participating in this study, our data on 
the aneuploidy rate do not seem exceedingly high.
In summary, the CGH part of this project should be viewed as a pilot study. Much has 
been learned of the difficulties involved when this technique is employed for the analysis 
of minute amounts of DNA. The main problem that needs to be overcome so as for a 
method such as CGH to find a possible wider clinical application for the analysis of cells 
such as PBs is the current inability to distinguish between chromosome and chromatid 
abnormalities and also the difficulty in consistently identifying reciprocal gains and 
losses in oocyte and PB pairs. An alternative approach would be to combine FISH and 
CGH. Hence, and since PBs tend to be more fragile and degenerate rapidly, they could be 
analysed with CGH, whilst the corresponding oocytes could be placed on slides and 
analysed via FISH. In this way it should be possible to target specifically abnormalities 
detected with the CGH and examine whether they were genuine. A similar study was 
carried out recently by Gutierrez-Mateo and colleagues (2004) who also used CGH for 
the analysis of oocytes and their corresponding 1st PBs. Thirty unfertilised oocytes and 
their PBs, along with seven single 1st PBs were examined in this way. The aneuploidy 
rate was of the range of 48%, which is much higher compared to the one estimated from 
the results of this study. The latter could be attributed to the fact that all the examined 
cells in the Guiterrez-Mateo study were at the MI stage at the time of retrieval and were 
left to mature in vitro, whereas the majority of the oocytes investigated in the study 
described in this thesis were at the Mil stage when collected. Even so, the results 
obtained in this project clearly demonstrate the potential of CGH to detect a wider range 
of anomalies, compared to similar FISH studies.
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6.6 Conclusions
Karyotyping and FISH studies of preimplantation embryos and unfertilised meiosis II 
oocytes have demonstrated that errors taking place during the first meiotic division in 
females are the main cause of constitutional numerical chromosome abnormalities. This 
has been backed up by earlier molecular studies investigating various chromosome 
polymorphisms of fetal material from spontaneous abortions (Hassold et al, 1984). The 
main mechanisms proposed are two: the first involves the malsegregation of whole 
univalent chromosomes (Griffin, 1996), and the second the predivision of sister 
chromatids prior to meiotic anaphase I (Angell et al, 1991; 1994). Smaller autosome 
aneuploidies have been particularly associated with advancing maternal age, while absent 
or aberrant genetic recombination has previously been identified as a generally 
predisposing factor (Dailey et al 1996). The research objective of the second part of this 
project was the extensive investigation into the mechanisms leading to female aneuploidy 
of specific chromosomes in IVF patients, the majority of whom were below the age of 35 
years. This was attempted by employing two different methods, FISH and CGH for the 
analysis of meiosis II oocytes and their corresponding PBs when these were available.
Both methods were hampered by several technical difficulties, which led to the collection 
of data for only a small fraction of cells for which analysis was attempted. FISH as a 
technique was much simpler and results were obtained within 24 hours. However, out of 
the 265 eggs that was the starting number for this part of the study, results on almost all 
10 chromosomes investigated were obtained from only 7 oocytes and 2 PBs. Partial 
results were obtained from 51 oocytes, while the remaining cells were all lost during the 
sequential FISH rounds. In addition, both the spreading methods used clearly led to the 
loss of individual chromosomes. Hence, during the FISH part of the study, only 
abnormalities due to extra copies of chromosomes and/or single chromatids were scored.
CGH is a DNA-based method, and its advantage over FISH is that it enables the 
screening of all 23 chromosomes, providing in this way information on chromosomes 
that are not targeted by FISH, and also giving an idea about the hypohaploidy rate, as the
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cells are placed intact in tubes. In practice, however, the development of a CGH protocol 
that would yield reliable results when applied on cells such as oocytes and PBs took 
longer than expected, the actual technique was very labor intensive, and required 
knowledge of both molecular and cytogenetic methods. In addition, the software used for 
the interpretation of the captured images was sometimes (depending on the quality of the 
hybridisation and the analysis of the captured images) not sensitive enough to pick up 
absence of chromosomal material, especially in cases of single chromatids. This in 
combination with the suboptimal quality of the examined cells were most likely the 
reasons why reciprocal losses and gains of DNA were detected for only one oocyte-PB 
pair, out of the seventeen investigated.
One of the main problems with CGH, especially in its potential to be clinically applied, is 
the required hybridisation time. Wilton and colleagues (2001) were the first group to 
apply CGH for the clinical diagnosis of aneuploidy, and the protocol they used had a 
hybridisation time of 72 hours, which was longer than the timeframe of an embryo 
transfer. Hence all embryos were cryopreserved. This cryopreservation could be very 
damaging to the biopsied embryos. This was observed in a subsequent CGH study by the 
same group (Wilton et al, 2003), in which only 54% of the embryos survived with half 
of their cells undamaged (Munne and Wells, 2003). The hybridisation time used in this 
study was also for 72 hours, but a similar CGH protocol has been shown to yield results 
after 25-30 hours (Wells et al, 2002). The latter was not investigated here due to lack of 
time.
Even though the sizes of the final sample for both the FISH and the CGH parts of this 
study were smaller than expected, some conclusions could be drawn from the obtained 
results. Hence, combination of both the FISH and CGH observations made from the 
analysis of unfertilised meiosis II oocytes and their corresponding PBs revealed several 
mechanisms leading to maternal aneuploidy. In particular, the classical model of non­
disjunction of whole chromosomes leading to them being present as extra copies, or 
absent from the oocytes was observed and was the most common in both studies. 
Moreover, the precocious separation of chromatids prior to anaphase I with their 
subsequent random segregation was also evident from the FISH results. Evidence for the
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presence of gonadal or germinal mosaicism for a trisomic cell line was seen in three 
different patients out of a total of 49 assessed, two participating in the FISH study, and 
possibly one in the CGH investigation. The latter could mean that this phenomenon tends 
to be more frequent than expected, at least in this infertile population. The preferential 
involvement of the smaller autosomes was also observed, especially from data obtained 
by FISH analysis. However, involvement of larger autosomes was also evident from the 
CGH results. Several cells, either oocytes or PBs were also identified to be carrying 
multiple abnormalities.
This was the first study during which the combination of FISH and CGH was applied for 
the extensive investigation of different groups of female gametes. Its significance lies 
firstly to the fact that it enabled the identification of the involvement of chromosomes 
ranging in size in oocyte aneuploidy. Added to this, it also allowed the comprehensive 
analysis of six cells (oocytes and PBs) coming from a very young patient with PCOS, and 
the identification of three highly abnormal ones, versus three cells with a normal 
chromosome complement. The most important finding was that the average age of the 
patients with abnormalities was much lower than 35. This implies that some of the 
mechanisms of aneuploidy described above could be acting in an age-independent 
manner in this group of younger IVF patients and may be influenced by their infertile 
aetiology. Further CGH examination of oocytes and their corresponding 1st PBs is 
however required to confirm the observations made in this work. Such information could 
be crucial in the counseling of infertile couples, and the treatment options that should be 
offered to them in order for the successful beginning of a clinical pregnancy to be 
achieved. Infertile patients found to be at high risk of producing aneuploid gametes may 
benefit from Preimplantation Genetic Screening (PGS) for chromosome abnormalities. 
Such methods have been reported to improve implantation rates and lower the incidence 
of spontaneous abortions and trisomic pregnancies in certain subgroups of IVF patients 
(advanced maternal age, 3 or more failed IVF attempts, repeated spontaneous pregnancy 
loss) (Gianaroli et al., 1997a,b; Munne et al. 2002a).
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6.7 Future work
During the final part of this study, CGH was evaluated and modified in order to enable 
the investigation of chromosomes in oocytes and their corresponding first PBs. This 
protocol has been shown to work reliably on the DNA from these cells, but also on 
blastomere DNA from preimplantation embryos. The next step is to evaluate the 
modified CGH protocol and its potential in clinical application for PGD. Selection of 
embryos after CGH analysis has been shown to lead to improved IVF success rates, as 
well as a reduction in the incidence of spontaneous abortions and aneuploid syndromes in 
high risk patients (Wilton et al, 2003). The preferred approach would be to carry out 
CGH on the first PB, which would be removed prior to fertilisation. In this way, 
cryopreservation of embryos should be avoided.
Prior to its clinical application, this approach will be validated by the separation of the 
oocyte and its corresponding PB. PBs will be placed in tubes and will be analysed by 
CGH, whereas the corresponding oocytes will be spread on slides and will be analysed by 
FISH. In these cases, probes for chromosomes investigated during the current study will 
be combined with others shown by the CGH analysis of the PBs to be abnormal. In this 
way, data will be collected both about the significance of the effects of the different 
mechanisms of aneuploidy established in this study, the accuracy of CGH versus FISH, 
and the frequency of aneuploidy for each of the examined chromosomes. It is hoped that 
the use of oocytes matured in vitro (I VM) will improve the success rate of both types of 
analysis, as it will be possible to obtain oocytes and 1st PBs without them running the risk 
of degenerating due to extended time in culture, and avoiding in this way the adverse 
effects on chromosome morphology and DNA quality. The downside of using IVM 
oocytes, is that they may not be representative of mature eggs, as far as the frequency of 
chromosome abnormalities is concerned.
Modifications of the current CGH protocol, involving both the WGA method and the 
hybridisation time will be attempted in order to further improve its accuracy. An
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alternative WGA approach to the DOP-PCR procedure is a method termed multiple 
displacement amplification (MDA). This method uses a (p29 DNA polymerase and 
random exonuclease-resistant primers, whilst DNA amplification takes place at 30°C 
(Dean et al., 2002). It has been shown that MDA provides a highly uniform 
representation of the genome, with the amplification bias being less than 3-fold among 
eight chromosomal loci, compared to the 4-6-fold observed with the application of the 
DOP-PCR (Dean et al., 2002). As far as the reduction time in hybridisation is concerned, 
the current protocol will be evaluated to examine whether it could yield analysable results 
after 25-30 hours, as was shown by Wells and colleagues (2002). The use of DNA 
microarrays to act as hybridisation templates, instead of the target metaphase 
chromosomes that have been used so far could further reduce the period of hybridisation, 
and improve the analysis of the obtained results, increasing the simplicity of 
interpretation by avoiding the need to karyotype metaphase chromosomes.
Once the above validation is complete and the CGH protocol is considered reliable and 
robust, it will be possible for it to be applied clinically, in cases of patients that have a 
previous history of trisomic conceptions, repeated miscarriages or repeated IVF failure. 
The clinical application will involve the analysis of first PBs with CGH, followed 
initially by selective FISH analysis of blastomeres from embryos derived from the 
corresponding oocytes. The latter procedure is already being carried out at the UCL 
Centre for PGD. Theoretically, the combination of the two molecular cytogenetic 
methods will enable the selection of embryos that have a normal chromosome 
complement, increasing the probability of a clinical pregnancy and the birth of a healthy 
baby. A similar approach is currently being carried out by Verlinsky and colleagues at the 
Reproductive Genetics Institute, in Chicago USA. Preliminary results have not shown a 
decline in embryo viability, despite the additional manipulation (Y.Verlinsky, ISPD 
Conference, 2004). Further data on the effect of a double biopsy (PB plus blastomere) on 
embryonic survival were provided in a recent study carried out by Magli and colleagues
(2004). They evaluated implantation rates among three groups of embryos (1st- PB biopsy 
only, 2nd - PB and blastomere biopsy, 3rd -  blastomere biopsy only) generated from 
patients that were undergoing PGS. Chromosomes X, Y, 13, 15, 16, 18, 21, and 22 were
328
Discussion
examined by two sequential FISH rounds. The authors of this report concluded that the 
implantation rates did not vary significantly among the three embryo groups, being 15% 
for the first, 26% for the second, and 25% for the third, demonstrating in this way that a 
combined PB-blastomere biopsy does not seem to adversely affect embryo viability 
(Magli et al. 2004).
329
Bibliography
Chapter 7 
Bibliography
330
Bibliography
7.1 Publications Arising from Thesis
7.1.1 Articles
1. Cupisti S., Conn C.M., Fragouli E., Whalley K., Mills J.A., Faed Delhanty 
J.D.A. (2003). Sequential FISH analysis of oocytes and polar bodies reveals 
aneuploidy mechanisms. Prenat. Diagn. 23: 663-668
2. Simopoulou M., Harper J.C., Fragouli E., Mantzouratou A., Speyer B.E., Serhal P., 
Ranieri D.M., Doshi A., Henderson J., Rodeck C.H., Delhanty J.D.A. (2003). 
Preimplantation genetic diagnosis of chromosome abnormalities: implications from 
the outcome for couples with chromosomal rearrangements. Prenat. Diagn. 23: 652- 
662
7.1.2 Abstracts
1. J.D.A. Delhanty, R. Mahmood, C.M. Conn, S. Cupisti, E. Fragouli, K. Whalley, 
J.A. Mills, M.J.W. Faed (2002). Mechanisms of maternal aneuploidy: FISH analysis 
of human oocytes and polar bodies. Reproductive Biomedicine Online, 4 (SuppL 2), 
19
2. E. Fragouli, C.M Conn, S. Cupisti, K. Whalley, J.A Mills, M.J.W. Faed, J.D.A. 
Delhanty (2002). FISH analysis of human oocytes and polar bodies demonstrates 
different mechanisms of maternal aneuploidy. Genetical Research, 81, 6
3. Fragouli E., Conn C.M, Cupisti S., Wells D., Whalley K., Mills J.A., Faed M.J.W., 
Delhanty J.D.A. (2003). Molecular cytogenetic investigations of aneuploidy 
mechanisms in oogenesis. Human Reproduction, 18 (Suppl. 1), xviiil85
4. E. Fragouli, C.M. Conn, S. Cupisti, D. Wells, K. Whalley, J.A. Mills, M.J.W. Faed, 
J.D.A. Delhanty (2004). Molecular cytogenetic investigations of aneuploidy: FISH 
and CGH analysis of human oocytes and polar bodies. ISPD Abstract Book, 29
5. J. Delhanty, E. Fragouli, D. Wells, C. Conn, K. Whalley, J. Mills, M. Faed (2004). 
Investigation of aneuploidy mechanisms by FISH and CGH analysis of oocytes and 
polar bodies. Chromosome Research, 12 (Suppl. 1), 34
331
Bibliography
7.2 References
1. Abrieu A., Kahana J.A., Wood K.W., Cleveland D.W. (2000). CENP-E as an essential 
component of the mitotic checkpoint in vitro. Cell. 102:817-26.
2. Albertson D.G., Ylstra B., Segraves R., Collins C., Dairkee S.H., Kowbel D., Kuo W.L., 
Gray J.W., Pinkel D. (2000). Quantitative mapping of amplicon structure by array CGH 
identifies CYP24 as a candidate oncogene. Nat. Genet. 25: 144-1146
3. Allshire R. (2004). Guardian spirit blesses meiosis. Nature 427: 495-497
4. Amiel A., Bouaron N., Kidron D., Sharony R., Gaber E., Fejgin M.D. (2002). CGH in the 
detection of confined placental mosaicism (CPM) in placentas of abnormal pregnancies. 
Prenat. Diagn. 22: 752-758
5. Anahory T., Andreo B., Regnier-Vigoroux G., Soulie J.P., Baudouin M., Demaille J., 
Pellestor F. (2003). Sequential multiple probe fluorescence in-situ hybridization analysis of 
human oocytes and polar bodies by combining centromeric labelling and whole chromosome 
painting. Mol. Hum. Reprod. 9: 577-585
6. Angell R.R. (1989). Chromosome abnormalities in human preimplantation embryos. In: 
Development of Preimplantation Embryos and Their Environment, New York: Alan R. Liss,: 
181-187
7. Angell R.R. (1991). Predivision in human oocytes at meiosis I: a mechanism for trisomy 
formation in man. Hum. Genet. 86: 383-387
8. Angell R. (1995). Mechanism of chromosome nondisjunction in human oocytes. 
Prog. Clin. Biol. Res. 393: 13-26.
9. Angell R. (1997). First-meiotic-division nondisjunction in human oocytes. 
Am. J. Hum. Genet. 61: 23-32.
10. Angell R., Xian J., Keith J., Ledger W., Baird D.T. (1994). First meiotic division 
abnormalities in human oocytes: Mechanism of trisomy formation. Cytogen. Cell Genet. 65: 
194-202
11. Antonarakis S.E., Avramopoulos D., Blouin J-L., Talbot C.C. Jr, Schinzel A.A. (1993). 
Mitotic errors in somatic cells cause trisomy 21 in about 4.5% of cases and are not associated 
with advanced maternal age. Nat. Genet. 3: 146-150
12. Antczak M., Van Blerkom J. (1997). Oocyte influences on early development: the 
regulatory proteins leptin and STAT3 are polarized in mouse and human oocytes and 
differentially distributed within the cells of the preimplantation stage embryo. Mol. Hum. 
Reprod. 3: 1067-1086
332
Bibliography
13. Anver R., Reubinoff B.E., Simon A., Zentner B.S., Friedman A., Mitrani Rosenbaum S., 
Laufer N. (1996). Management of rhesus isoimmunization by preimplantation genetic 
diagnosis. Mol. Hum. Reprod. 2: 60-62
14. Ao A., Wells D., Handyside A.H., Winston R.M., Delhanty J.D. (1998). Preimplantation 
genetic diagnosis of inherited cancer: familial adenomatous polyposis coli. J. Assist. Reprod. 
Genet. 15: 140-144
15. Araki K., Naito K., Haraguchi S., Suzuki R., Yokoyama M., Inoue M., Aizawa S., 
Toyoda Y., Sato E. (1996). Meiotic abnormalities of c-mos knockout mouse oocytes: 
activation after first meiosis or entrance into third meiotic metaphase. Biol. Reprod. 5: 1315- 
1324.
16. Archidiacono N., Antonacci R., Marzella R., Finelli P., Lonoce A., Rocchi M. (1995). 
Comparative mapping of human alphoid sequences in great apes using fluorescent in situ 
hybridisation. Genomics 25: 477-484
17. Armstrong S.J., Goldman A.S.H., Speed R.M., Hulten M.A. (2000). Meiotic studies of a 
human male carrier of the common translocation t(ll;22), suggests postzygotic selection 
rather than preferential 3:1 MI segregation as the cause of the livebom offspring with an 
unbalanced translocation. Am. J. Hum. Genet. 67: 601-609
18. Bahce M., Cohen J., Munne S. (1999). Preimplantation Genetic Diagnosis of Aneuploidy: 
Were we looking at the Wrong Chromosomes? J. Assist. Reprod. Genet. 16: 176-181
19. Bahce M., Escudero T., Sandalinas M., Morrison L., Legator M., Munne S. (2000). 
Improvements of preimplantation diagnosis of aneuploidy by using microwave hybridisation, 
cell recycling, and monocolor labelling of probes. Mol. Hum. Reprod. 6: 849-854
20. Baldini A., Rocchi M., Archidiacono M., Miller O.J., Miller J.A. (1990). A human alpha 
satellite DNA subset specific for chromosome 12. Am. J. Hum. Genet. 46: 784-788
21. Bauman H., Morelia K., White D., Dembski M., Bailou P.S., Kim H., Lai C., Tartaglia 
L.A. (1996). The full-length leptin receptor has signalling capabilities of interleukin 6-type 
cytokine receptors. Proc. Natl. Acad. Sci. USA 93: 8374-8378
22. Berridge M.J. (1993). Inositol trisphosphate and calcium signalling. Nature. 361:315-
325.
23. Bielanska M., Tan S.L., Ao A. (2003). Chromosomal information derived from single 
blastomeres isolated from cleavage-stage embryos and cultured in vitro. Fertil. Steril. 79: 
1304-1311
24. Blaszczyk A., Tang Y.X., Dietz H.C., Adler A., Berkeley A.S., Krey L.C., Grifo J.A..
(1998). Preimplantation genetic diagnosis of human embryos for Marfan's syndrome. J. 
Assist. Reprod. Genet. 15: 281-284
333
Bibliography
25. Boada M., Carrera M., De la Iglesia C., Sandalinas M., Barri P.N., Veiga A. (1998). 
Successful use of laser for human embryo biopsy in preimplantation genetic diagnosis: report 
of two cases. J. Assist. Reprod. Genet. 15: 302-307
26. Bond D.J., Chandley A.C. (1983). Aneuploidy. Oxford Monographs on Medical 
Genetics. Oxford University Press, Oxford
27. Bonde J.P.E., Ernst E., Jenson T.K., Hjollund N.H.I., Kolstad H., Hemikson T.B.,
Scheike T., Giwercman A., Olsen J., Skakkebak N.E. (1998). Relation between semen quality 
and fertility: a population based study of 430 first-pregnancy planners. Lancet 352:1172-117
28. Bonduelle M., Liebaers I., Deketelaere V., Dedre M.P., Camus M., Devroey P., Van 
Steirteghem A. (2002). Neonatal data on a cohort of 2889 infants bom after ICSI (1991-1999) 
and of2995 infants bom after IVF (1983-1999). Hum. Reprod. 17: 671-694
29. Boue A., Galliano P. (1984). Collaborative study of the segregation of inherited 
chromosome structural rearrangements in 1356 prenatal diagnosis. Prenat. Diagn. 4: 45-67
30. Braude P., Bolton V., Moore S. (1988). Human gene expression first occurs between the 
four- and eight-cell stages of preimplantation development. Nature 333: 459-461
31. Brown A.S., Feingold E., Broman K.W., Sherman S.L. (2000). Genome-wide variation in 
recombination in female meiosis: a risk factor for non-disjunction of chromosome 21. Hum. 
Mol. Genet. 9: 515-523
32. Bryndorf T., Kirchoff M., Rose H., Maahr J., Gerdes T., Karhu R., Kallioniemi A., 
Christensen B., Lundsteen C., Phillip J. (1995). Comparative genomic hyrbridization in 
clinical cytogenetics. Am. J. Hum. Genet. 57: 1211-1220
M. Hftnrihr M. (1997). The primordial germ cells of mammals: some current perspectives. 
Exp. Cell Res. 232: 194-207
34. Cai W.W., Mao J.H., Chow C.W., Damani S., Balmian A. Bradley A. (2002). Genome- 
wide detection of chromosomal imbalances in tumours using BAC micorarrays. Nat. 
Biotechn. 20: 393-396
35. Choi J.M., Chung P., Veeck L., Mielnik A., Palermo G., Schelegel P.N. (2004). AZF 
microdeletions of the Y chromosome and in vitro outcome. Fertil. Steril. 81: 337-341
36. Cieslak J., Ivakhnenko V., Wolf G., Sheleg S., Verlinsky Y. (1999). Three-dimensional 
partial zona dissection for preimplantation genetic diagnosis and assisted hatching. Fertil. 
Steril. 71: 308-313
37. Clarke H.J., Masui Y. (1983). The induction of reversible and irreversible chromosome 
decondensation by protein synthesis inhibition during meiotic maturation of mouse oocytes. 
Dev. Biol. 97: 291-301
334
Bibliography
38. Clouston H.J., Fenwick J., Webb A.L., Herbert M., Murdoch A., Wolstenholme J. (1997). 
Detection of mosaic and non-mosaic chromosome abnormalities in 6- to 8-day-old human 
blastocysts. Hum. Genet. 101: 30-36
39. Clouston H.J., Herbert M., Fenwick J., Murdoch A., Wolstenholme J. (2000). 
Cytogenetic analysis of human blastocysts. Prenat. Diagn. 22: 1143-1152
40. Clyde J.M., Gosden R.G., Rutherford A.G., Picton H.M. (2001). Demonstration of a 
mechanism in human oocytes using multifluor fluorescence in situ hybridisation. Fertil. 
Steril. 76: 837-840
41. Cohen-Fix O. (2000). Sister chromatid separation: falling apart at the seams. Curr. Biol. 
10: R816-R819
42. Colledge W.H., Carlton M.B., Udy G.B., Evans M.J. (1994). Disruption of c-mos causes 
parthenogenetic development of unfertilized mouse eggs. Nature 370: 65-68.
43. Conn C.M., Cozzi J., Harper J.C., Winston R.M.L., Delhanty J.D.A. (1999). 
Preimplantation genetic diagnosis for couples at high risk of Down syndrome pregnancy 
owing to parental translocation or mosaicism. J.Med.Genet. 36: 45-50
44. Conn C.M., Harper J.C., Winston R.M.L., Delhanty J.D.A. (1998). Infertile couples with 
Robertsonian translocations: preimplantation genetic analysis of embryos reveals chaotic 
cleavage divisions. Hum. Genet. 102: 117-123
45. Cooke H.J., Hindley J. (1979). Cloning of human satellite HI DNA: different components 
are on different chromosomes. Nucleic Acids Res. 25: 3177-3197
46. Coonen E., Derhaag J.G., Dumoulin J.C.M., van Wissen L.C.P., Bras M., Janssen M., 
Evers J.L.H., Geraedts J.P.M. (2004). Anaphase lagging mainly explains chromosomal 
mosaicism in human preimplantation embryos. Hum. Reprod. 19: 316-324
47. Coonen E., Dumoulin J.C.M., Ramackers F.C.S., Hopman A.H.N. (1994). Optimal 
preparation of preimplantation embryo interphase nuclei for analysis by fluorescence in-situ 
hybridization. Hum. Reprod. 9: 533-537
48. Coonen E., Martini E., Dumoulin J.C.M., Hollanders-Crombach H.T.M., de Die- 
Smulders C., Geraedts J.P.M., Hopman A.H.N., Evers J.L.H. (2000). Preimplantation genetic 
diagnosis of a reciprocal translocation t(3;l lXq27.3;q24.3) in siblings. Mol. Hum. Reprod. 6: 
199-206
49. Coronado R., Morrissette J., Sukhareva M., Vaughan D.M. (1994). Structure and function 
of ryanodine receptors. Am. J. Physiol. 266: C1485-1504.
50. Cozzi J., Conn C.M., Harper J., Winston R.M.L., Rindl M., Famdon P.A., Delhanty 
J.D.A. (1999). A trisomic cell line and precocious chromatid segregation leads to recurrent 
trisomy 21 conception. Hum. Genet. 104: 23-28
336
Bibliography
51. Cserhalmi-Friedman P.B., Tang Y., Adler A., Krey L., Grifo J.A., Christiano A.M. 
(2000). Preimplantation genetic diagnosis in two families at risk for recurrence of Herlitz 
junctional epidermolysis bullosa. Exp. Dermatol. 9: 290-297
52. Cupisti S., Conn C.M., Fragouli E., Whalley K., Mills J.A., Faed M.J.W., Delhanty 
J.D.A. (2003). Sequential FISH analysis of oocytes and polar bodies reveals aneuploidy 
mechanisms. Prenat. Diagn. 23: 663-668
53. DAiuto L., Antonacci R., Marzella R., Archidiacono N., Rocchi M. (1993). Cloning and 
comparative mapping of a human chromosome 4-specific alpha satellite DNA sequence. 
Genomics. 18:230-235.
54. Dailey T., Dale B., Cohen J., Munne S. (1996). Association between nondisjunction and 
maternal age in meiosis-II human oocytes. Am. J. Hum. Genet. 59: 176-184
55. Daniel A. (2002). Distortion of female meiotic segregation and reduced male fertility in 
human Robertsonian translocations: Consistent with the centromere model of co-evolving 
centromere DNA/centromeric histone (CENP-A). Am. J. Med. Genet. Il l:  450-452
56. Daniely M., Aviram-Goldring A., Barkai G., Goldman B. (1998). Detection of 
chromosomal aberration in fetuses arising from recurrent spontaneous abortion by 
comparative genomic hybridization. Hum. Reprod. 13: 805-809
57. Daniely M., Barkai G., Goldman B., Aviram-Goldring A. (1999). Structural unbalanced 
chromosome rearrangements resolved by comparative genomic hybridization. Cytogen. Cell 
Genet. 86: 51-55
58. Dawson K., Conaghan J., Ostera G.R., Winston R.M.L., Hardy K. (1995). Delaying 
transfer to the third day post-insemination to select non-arrested embryos increases 
development to the fetal heart stage. Hum. Reprod. 10: 177-182
59. Dean F.B., Hosono S., Fang L., Xiaohong W., Fawad Faruqi A., Bray-Ward P., Sun Z., 
Zong Q., Du Y., Du J., Driscoll M., Song W., Kingsmore F., Egholm M., Lasken R.S. (2002). 
Comprehensive human genome amplification using multiple displacement amplification. 
PNAS 99: 5261-5266
60. Delhanty J.D.A. (1994). Preimplantation diagnosis. Prenat. Diagn. 14:1217-1227
61. Delhanty J.D.A. (1998). Preimplantation Diagnosis: Basic Science and Clinical Practice. 
Cogn. Anom. 38: 361-366
62. Delhanty J.D.A. (2001). Preimplantation genetics: an explanation for poor human 
fertility? Ann. Hum. Genet. 65: 331-338
63. Delhanty J.D., Griffin D.K., Handyside A.H., Harper J., Atkinson G.H., Pieters M.H., 
Winston R.M. (1993). Detection of aneuploidy and chromosomal mosaicism in human 
embryos during preimplantation sex determination by fluorescent in situ hybridisation, 
(FISH). Hum. Mol. Genet. 2:1183-1185.
336
Bibliography
64. Delhanty J.D.A., Handyside A.H. (1995). The origin of genetic defects in the human and 
their detection in the preimplantation embryo. Hum. Reprod. Update 1: 201-215
65. Delhanty J.D.A., Harper J.C., Ao A., Handyside A.H., Winston R.M.L. (1997). 
Multicolour FISH detects frequent chromosomal mosaicism and chaotic division in normal 
preimplantation embryos from fertile patients. Hum. Genet. 99: 755-760
66. Devilee P., Cremer T., Slagboom P., Bakker E., Scholl H.P., Hager H.D., Stevenson A.F., 
Comelisse C.J., Pearson P.L. (1986). Two subsets of human alphoid repetitive DNA show 
distinct preferential localization in the pericentric regions of chromosomes 13, 18, and 21. 
Cytogenet. Cell Genet. 41: 193-201
67. De Vos A., Sermon K., Van de Velde H., Joris H., Vandervorst M., Lissens W., De Paepe 
A., Liebaers I., Van Steirteghem A. (2000). Two pregnancies after preimplantation genetic 
diagnosis for osteogenesis imperfecta type I and type IV. Hum. Genet. 106: 605-613
68. De Vos A., Sermon K., Van de Velde H., Joris H., Vandervorst M., Lissens W., Mortier 
G., De Sutter P., Lofgren A., Van Broeckhoven C., Liebaers I., Van Steirteghem A. (1998). 
Pregnancy after preimplantation genetic diagnosis for Charcot-Marie-Tooth disease type 1A. 
Mol. Hum. Reprod. 4: 978-984
69. Downs S. (1995). The influence of glucose, cumulus cells, and metabolic coupling on 
ATP levels and meiotic control in the isolated mouse oocyte. Dev. Biol. 167: 502-512 
Dozortsev D.I., McGinnis K.T. (2001). An improved fixation technique for fluorescence in- 
situ hybridization for preimplantation genetic diagnosis. Fertil. Steril. 76: 186-188
70. Dreesen J.C., Bras M., de Die-Smulders C., Dumoulin J.C., Cobben J.M., Evers J.L., 
Smeets H.J., Geraedts J.P. (1998). Preimplantation genetic diagnosis of spinal muscular 
atrophy. Mol. Hum. Reprod. 4:881-885
71. Duesberry N.S., Choi T., Brown K.D. Wood K.W., Resau J., Fukasawa K., Cleveland
D.W., Vande Woude G.F. (1997). CENP-E is an essential kinetochore motor in maturing 
oocytes and is masked during mos-dependent, cell cycle arrest at metaphase n. Proc. Natl. 
Acad. Sci. USA 94: 143-169
72. Dumoulin J.C., Bras M., Coonen E., Dreesen J., Geraedts J.P., Evers J.L. (1998). Effect 
of Ca2+/Mg2+- free medium on the biopsy procedure for preimplantation genetic diagnosis 
and further development of human embiyos. Hum. Reprod. 13: 2880-2883
73. Durban M., Benet J., Boada M., Fernandez E., Calafell J.M., Lailla J.M., Sanchez-Garcia 
J.F., Pujol A., Egozcue J., Navarro J. (2001). PGD in female carriers of balanced 
Robertsonian and reciprocal translocations by first polar body analysis. Hum. Reprod. Upd. 
7: 591-602
74. Durban M., Benet J., Egozcue J., Navarro J.(1998). Chromosome studies in first polar 
bodies from hamster and human oocytes. Hum Reprod. 3: 583-587
337
Bibliography
75. Edwards R.G., Beard H.K. (1997). Oocyte polarity and cell determination in early 
mammalian embryos. Mol. Hum. Reprod. 3: 863-905
76. Edwards R.G., Beard H.K. (1999). Blastocyst stage transfer: pitfalls and benefits. Hum. 
Reprod. 14: 1-6
77. Edwards R.G., Brody S.A. (1995). Principles and practice of assisted human 
reproduction. W.B. Saunders Co, Philadelphia, USA
78. Escudero T., Abdelhadi I., Sandalinas M., Munne S. (2003). Predictive value of sperm 
fluorescence in situ hybridisation analysis on the outcome of preimplantation genetic 
diagnosis for translocations. Fertil. Steril. 79: 1528-1534
79. Escudero T., Lee M., Carrel D., Blanco J., Munne S. (2000). Analysis of chromosome 
abnormalities in sperm and embryos from two 45,XY,t(13;14XqlO;qlO) carriers. Prenat. 
Diagn. 20: 599-602
80. Escudero T., Lee M., Stevens J., Sandalinas M., Munne S. (2001). Preimplantation 
genetic diagnosis of pericentric inversions. Prenat. Diagn. 21: 760-766
81. ESHRE PGD Consortium Steering Committee. (2002). ESHRE Preimplantation Genetic 
Diagnosis Consortium: data collection in (May 2001). Hum Reprod. 17: 233-46.
82. ESHRE PGD Consortium Steering Committee (2000). ESHRE Preimplantation Genetic 
Diagnosis (PGD) Consortium: data collection II (May 2000). Hum. Reprod. 15: 2673-2683
83. Estop A.M., Cieply K.M., Aston C.E. (1997). The meiotic segregation pattern of a 
reciprocal translocation t(10;12Xq26.1;pl3.3) by fluorescence in situ hybridization sperm 
analysis. Eur. J. Hum. Genet. 5: 78-82
84. Estop A.M., Cieply K.M., Munne S., Feingold E. (1999). Multicolor fluorescence in situ 
hybridization analysis of the spermatozoa of a male heterozygous for a reciprocal 
translocation t(l l;22Xq23;qll). Hum. Genet. 104: 412-417.
85. Evsikov S., Cieslak M.L.T., Verlinsky Y. (2000). Effect of chromosomal translocations 
on the development of preimplantation human embryos in vitro. Fertil. Steril. 74: 672-677
86. Evsikov S., Verlinsky Y. (1998). Mosaicism in the inner cell mass of human blastocysts. 
Hum. Reprod. 13: 3151-3155
87. Faraut T., Mermet M-A., Demongeot J., Cohen O. (2000). Co-operation of selection and 
meiotic mechanisms in the production of imbalances in reciprocal translocations. Cytogen. 
Cell Genet. 88: 15-21
88. Ferraretti A.P., Magli M.C., Kopcow L., Gianaroli L. (2004). Prognostic role of 
preimplantation genetic diagnosis for aneuploidy in assisted reproductive technology 
outcome. Hum. Reprod. 19: 694-699
338
Bibliography
89. Findlay I., Mathews P.L., Mulcahy B.K., Mitchelson K. (2002). Using MF-PCR to 
diagnose multiple defects from single cells: implications for PGD. Mol. Cell. Endocrionol. 
183 Suppl. 1: S5-12
90. Fisher J.M., Harvey J.F., Morton N.E., Jacobs P.A. (1995). Trisomy 18: studies of the 
parent and cell division of origin and the effect of aberrant recombination on nondisjunction . 
Am. J. Hum. Genet. 56: 669-675
91. Foresta C., Ferlin A., Garolla A., Moro E., Pistorello P., Barbaux S., Rossato M. (1998). 
High frequency of well-defined Y-chromosome deletions in idiopathic Sertolli cell-only 
syndrome. Hum. Reprod. 13: 202-207
92. Fonts A., Weghuis D.O., Smeets D., Fodstad O., Mykelbost O., Geurts van Kessel A.
(1995). Comparative genomic hybridization analysis of human sarcomas: II Identification of 
novel amplicons at 6p and 17p in osteosarcomas. Genes Chrom. Cancer 14: 15-21
93. Frengen E., Weichenhan D., Zhao B., Osoegawa K., van Geel M., de Jong P.J. (1999). A 
modular positive selection bacterial artificial chromosome vector with multiple cloning sites. 
Genomics 58: 250-253
94. Fridstrom M., Ahrlund-Richter L., Iwarsson E., Malmgrem H., Inzunza J., Rosenlund B., 
Sjoblom P., Nordenskjold M., Blennow E., Hovatta O. (2001). Clinical outcome of treatment 
cycles using preimplantation genetic diagnosis for structural chromosome abnormalities. 
Prenat. Diagn. 21: 781-787
95. Funderburk S.J., Spence M.A., Sparkes R.S. (1977). Mental retardation associated with 
“balanced” chromosome rearrangements. Am. J. Hum.Genet. 29: 136-141
96. Furuno N., Nishizawa M., Okazaki K., Tanaka H, Iwashita J, Nakajo N, Ogawa Y, Sagata 
N. (1994). Suppression of DNA replication via Mos function during meiotic division in 
Xenopus oocytes. EMBO J. 13: 2399-2410
97. Gardner R.J.M., Sutherland G.R. (1996). Chromosome Abnormalities and Genetic 
Counselling. 2nd edn. Oxford: Oxford University Press
98. Ghaffari S.R., Boyd E., Tolmie J.L., Crow Y.J., Trainer A.H., Connor J.M. (1998). A new 
strategy for ciyptic telomeric translocation screening in patients with idiopathic mental 
retardation. J. Med. Genet. 35: 225-233
99. Gianaroli L., Magli M.C., Ferrraretti. A.P., Fiorentino A., Garrisi J., Munne S. (1997a). 
Preimplantation genetic diagnosis increases the implantation rate in human in vitro 
fertilization by avoiding the transfer of chromosomally abnormal embryos. Fertil. Steril. 68: 
1128-1131
100. Gianaroli L., Magli M.C., Munne S., Fiorentino A., Montanaro N., Ferraretti A.P. 
(1997b). Will preimplantation genetic diagnosis assist patients with a poor prognosis to 
achieve pregnancy? Hum. Reprod. 12: 1762-1767
339
Bibliography
101. Gianaroli L., Magli M.C., Ferrraretti. A.P., Munne S., Balicchia B., Escudero T., Crippa 
A. (2002a). Possible interchromosomal effect in embryos generated by gametes from 
translocation carriers. Hum. Reprod. 17: 3201-3207
102. Gianaroli L., Magli M.C., Ferrraretti. A.P., Tabanelli C., Trombetta C., Boudjema E. 
(2002b). The role of preimplantation diagnosis for aneuploidies. Reprod. Biomed. Online 4: 
31-36
103. Gibbons W.E., Gitlin S.A., Lanzendorf S.E., Kaufrnann R.A., Slotnick R.N., Hodgen 
G.D. (1995). Preimplantation genetic diagnosis for Tay-Sachs disease: successful pregnancy 
after pre-embryo biopsy and gene amplification by polymerase chain 
reaction.Fertil.Steril.63:723-8.
104. Goldman A.S.H., Hulten M.A. (1993). Meiotic analysis by FISH of a human male 
46,XY,t(15;20Xqll.2;qll.2) translocation heterozygote: quadrivalent configuration, 
orientation and first meiotic segregation. Chromosoma 102: 102-111
105. Goossens V., Sermon K., Lissens W., Vandervorst M., Vanderfaeillie A., De Rijcke M., 
De Vos A., Henderix P., Van de Velde H., Van Steirteghem A., Liebaers I. (2000). Clinical 
application of preimplantation genetic diagnosis for cystic fibrosis. Prenat. Diagn- 20: 571- 
581
106. Gordon K.B., Thomson C.T., Char D.H., O’Brien J.M., Kroll S., Ghazvini S., Gray J.W. 
(1994). Comparative genomic hybridization in the detection of DNA copy number 
abnormalities in uveal melanoma. Cancer Res. 54: 4764-4768
107. Gordon J.W., Talansky B.E. (1986). Assisted fertilization by zona drilling: a mouse 
model for the correction of oligospermia. J. Exp. Zool. 239: 347-354
108. Goud P.T., Goud A.P., Van Oostveldt P., Dhont M. (1999). Presence and dynamic 
redistribution of type I inositol 1,4,5-trisphosphate receptors in human oocytes and embryos 
during in-vitro maturation, fertilization and early cleavage divisions. 
Mol Hum Reprod. 5: 441-451.
109. Granot I., Dekel N. (1998). Cell-to-cell communication on the ovarian follicle: 
developmental and hormonal regulation of the expression of connexin43. Hum. Reprod. 13: 
85-97
110. Greig G.M., England S.B., Bedford H.M., Willard H.F. (1989). Chromosome-specific 
alpha satellite DNA from the centromere of human chromosome 16. Am. J. Hum.Genet. 45: 
862-872
111. Griffin D.K. (1996). The incidence, origin, and etiology of aneuploidy. Int. Rev. Cytol. 
167: 263-296
112. Griffin D.K., Handyside A.H., Harper J.C., Wilton L., Atkison G., Soussis I., Wells D., 
Kontogianni E., Tarin J., Geber S., Ao A., Winston R.M.L., Delhanty J.D.A. (1994). Clinical
340
Bibliography
experience with preimplantation diagnosis of sex by fluorescent in situ hybridisation. J. 
Assist. Reprod. Genet. 11: 132-143
113. Guiterrez-Mateo C., Wells D., Benet J., Sanchez-Garcia J.F., Bermudez M.G., Belil I., 
Egozcue J., Munne S., Navarro J. (2004). Reliability of comparative genomic hybridization to 
detect chromosome abnormalities in first polar bodies and metaphase II oocytes. Hum. 
Reprod. 19:2118-2125
114. Hamerton J.L., Canning N., Roy M., Smith S. (1975). A cytogenetic survey of 14,069 
newborn infants. Clin. Genet. 8: 223-243
HQS. ffiandyside A.H. (1998). Clinical evaluation of preimplantation genetic diagnosis. 
Prenat. Diagn. 18: 1345-1348
116. Handyside A.H., Delhanty J.D.A. (1997). Preimplantation genetic diagnosis: strategies 
and surprises. TIG 13: 270-275
117. Handyside A.H., Kontogianni E.H., Hardy K., Winston R.M.L. (1990). Pregnancies 
from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. 
Nature 5: 707-714
118. Handyside A.H., Lesko J.G., Tarin J.J., Winston R.M., Hughes M.R. (1992). Birth of a 
normal girl after in vitro fertilisation and preimplantation diagnosis testing for cystic fibrosis. 
N. Engl. Med. J. 327: 905-909
119. Handyside A.H., Pattinson J.K., Penketh R.J., Delhanty J.D., Winston R.M., Tuddenham
E.G. (1989). Biopsy of human preimplantation embryos and sexing by DNA amplification. 
Lancet 1: 347-349
120. Hardy K., Martin K.L., Leese H.J., Winston R.M., Handyside A.H. (1990). Human 
preimplantation development in vitro is not adversely affected by biopsy at the 8-cell stage. 
Hum Reprod. 5: 708-714.
121. Hardy K., Warner A., Winston R.M., Becker D.L. (1996). Expression of intercellular 
junctions during preimplantation development of the human embryo. Mol Hum Reprod. 2: 
621-632.
122. Harper J.C., Bui T-H. (2002). Pre-implantation genetic diagnosis. Best Practice & 
Research Clin. Obs. Gyanec. 16: 659-670
123. Harper J.C., Coonen E., Handyside A.H., Winston R.M.L., Hopman A.H.N., Delhanty 
J.D.A. (1995). Mosaicism of autosomes and sex chromosomes in morphologically normal, 
monospermic preimplantation embryos. Prenat. Diagn. 15:41-49
124. Harper J.C., Coonen E., Raemakers F.C.S., Delhanty J.D.A, Handyside A.H., Winston 
R.M.L., Hopman A.H.N. (1994). Identification of the sex of human preimplantation embryos 
in two hours using an improved spreading method and fluorescent in situ (FISH) using 
directly labelled probes. Hum. Reprod. 9: 721-724
341
Bibliography
125. Harper J.C., Delhanty J.D.A. (2000). Preimplantation Genetic Diagnosis. Curr. Opin. 
Obstetr. Gynecol. 12: 67-72
126. Harper J.C., Wells D. (1999). Recent advances and future developments in PGD. Prenat. 
Diagn. 19: 1193-1199
127. Hassold T.J. (1998). Nondisjunction in the human male. Curr. Top. Dev. Biol. 37: 383- 
406
128. Hassold T.J., Abruzzo M., Adkins K., Griffin D., Merrill M., Millie E., Saker D., Shen 
J., Zaragoza M. (1996). Human aneuploidy: incidence, origin and etiology. Environ. Mol. 
Mutag. 28: 167-175
129. Hassold T.J., Chen N., Funkhouser J., Jooss T., Manuel B., Matsuura J., Matsuyama A., 
Wilson C., Yamane J.A., Jacobs P.A. (1980). A cytogenetic study of 1000 spontaneous 
abortions. Ann. Hum. Genet.: 151-178
130. Hassold T., Chiu D., Yamane J.A. (1984). Parental origin of autosomal trisomies. Ann. 
Hum. Genet. 48: 129-144
131. Hassold T., Jacobs P.A. (1984). Trisomy in man. Annu. Rev. Genet. 18:69-97
132. Hassold T., Merril M., Adkins K., Freeman S., Sherman S. (1995). Recombination and 
maternal age-dependent nondisjunction: molecular studies of trisomy 16. Am. J. Hum. Genet. 
57: 876-874
133. Hassold T.J., Sherman S.L., Pettay D., Page D.C., Jacobs P.A. (1991). XY chromosome 
nondisjunction in man is associated with diminished recombination in the pseudoautosomal 
region. Am. J. Hum. Genet. 49: 253-260
134. Heikinhheimo O., Gibbons W.E. (1998). The molecular mechanisms of oocyte 
maturation and early embryonic development are unveiling new insights into reproductive 
medicine. Mol. Hum. Reprod. 4: 745-756
135. Heikinheimo O., Lanzendorf S.E., Baka S.G., Gibbons W.E. (1995). Cell cycle genes c- 
mos and cyclin-Bl are expressed in a specific pattern in human oocytes mid pre-implantation 
embryos. Hum. Reprod. 10: 699-707
136. Heng H.H.Q., Spyropoulos B., Moens P.B. (1997). Fish technology in chromosome and 
genome research. Bioessays 19: 75-84
137. Henikoff S., Ahmad K., Malik H.S. (2001). The centromere paradox; stable inheritance 
with rapidly evolving DNA. Science 293: 1098-1102
138. Hennebicq S., Pelletier R., Bergues U., Rousseaux S. (2001). Risk of trisomy 21 in 
offspring of patients with Klinefelter’s syndrome. The Lancet 357: 2104-2105
139. Hook E.B., Hamerton J.L. (1977). The frequency of chromosome abnormalities detected 
in consecutive newborn studies: differences between studies and results by sex and severity
342
Bibliography
of phenotypic involvement. In Hook E.B., Porter L.I.I. (Eds). Population Cytogenetics, New 
York, Academic Press: 66-79
140. Hopman A.H.N., Raemakers F.C.S., Raap A.K., Beck J.L.M., Devilee P., Ploeg van der 
M., Voojiis G.P. (1988). In situ hybridisation as a tool to study numerical chromosome 
aberrations in solid bladder tumours. Histochemistry 89: 307-316
141. Houliston E., Maro B. (1989). Posttranslational modification of distinct microtubule 
subpopulations during cell polarization and differentiation in the mouse preimplantation 
embryo. J. Cell Biol. 108: 543-551
142. Howels C.M., Macnamee M.C., Edwards R.G. (1986). Effect of high tonic levels of 
luteinizing hormone on outcome of in-vitro ferilization. Lancet 92: 385-390
143. Hunt P.A., Hassold T.J. (2002). Sex matters in meiosis. Science 296: 2181-2183
144. Hu D.G., Webb G., Hussey N. (2004). Aneuploidy detection in single cells using DNA 
array-based comparative genomic hybridization. Mol. Hum. Reprod. 10: 283-289
145. Inzunza J., Iwarsson E., Fridstrom M., Rosenlund B., Sjoblom P., Hillensjo T., Blennow
E., Jones B., Nordenskjold M., Ahrlund-Richter L. (1998). Application of single-needle 
blastomere biopsy in human preimplantation genetic diagnosis. Prenat. Diagn. 18:1381-1388
146. Ioulianos A., Wells D., Harper J.C., Delhanty J.D. (2000). A successful strategy for 
preimplantation diagnosis of medium-chain acyl-CoA dehydrogenase (MCAD) 
deficiency.Prenat.Diagn.20:593-598
147. ISCN (1995). An International System for Human Cytogenetic Nomenclature, Mitelman
F. (ed.) S. Karger, Basel, 1995.
148. Iselius L., Lindsten J., Fraccaro M., Bastard C., Botelli A.M., TH, Caufin D., Dalpra L., 
Delendi N. (1983). The llq;22q translocation: A collaborative study of 20 new cases and 
analysis of 110 families. Hum. Genet. 64: 343-355
149. Iwarsson E., Ahrlund-Richter L., Inzunza J., Fridstrom M., Rosenlund B., Hillensjo T., 
Sjoblom P., Nordenskjold M., Blennow E. (1998a). Preimplantation genetic diagnosis of Di 
George syndrome. Mol. Hum. Reprod. 4: 871-875
150. Iwarsson E., Ahrlund-Richter L., Inzunza J., Rosenlund B., Fridstrom M., Hillensjo T., 
Sjoblom P., Nordenskjold M., Blennow E. (1998b). Preimplantation genetic diagnosis of a 
large pericentric inversion of chromosome 5. Mol. Hum. Reprod. 4: 719-723
151. Iwarsson E., Malmgrem H., Inzunza J., Ahrlund-Richter L. Sjoblom P., Rosenlund B., 
Fridstrom M., Hovatta O., Nordenskjold M., Blennow E. (2000). Highly abnormal cleavage 
divisions in preimplantation embryos from translocation carriers. Prenat. Diagn. 20: 1038- 
1047
152. Jacobs P.A. (1977). Epidemiology of chromosome abnormalities in man. Am. J. 
Epidemiol. 105: 180-191
343
Bibliography
153. Jacobs P.A., Hassold T.J. (1980). The origin of chromosome abnormalities in 
spontaneous abortion. In Human Embryonic and Fetal Death. Porter I.H., and Hook E.B. eds. 
Academic Press, New York: 289-298
154. Jacobs P.A., Melville M., Ratcliffe S. (1974). A cytogenetic survey of 11,680 newborn 
infants. Ann Hum. Genet. 37: 359-376
156. Jalbert P., Sele B., Jalbert H. (1980). Reciprocal translocations: a way to predict the 
mode of imbalanced segregation by pachytene-diagram drawing. Hum. Genet. 55: 209-222
157. Jamieson M.E., Coutts J.R.T., Connor J.M. (1994). The chromosome constitution of 
human preimplantation embryos fertilised in vitro. Hum. Reprod. 9: 709-715
158. Jones T. (2004). Turning it on and off: M-phase promoting factor during meiotic 
maturation and fertilization. Mol. Hum. Reprod. 10: 1-5
159. Kahraman S., Bahce M., Samli H., Imirzalioglu N., Yakisn K., Cengiz G., Donmez E. 
(2000). Healthy births and ongoing pregnancies obtained by preimplantation genetic 
diagnosis in patients with advanced maternal age and recurrent implantation failure. Hum. 
Reprod. 15: 2003-2007
160. Kajii T., Niikawa N. (1977). Origin of triploidy and tetraploidy in man: 11 cases with 
chromosome markers. Cytogen. Cell. Genet. 18: 109-125
161. Kallioniemi A., Kallioniemi O.P., Piper J., Tanner M., Stokke T., Chen L., Smith H.S., 
Pinkel D., Gray J.W., Waldman F.M. (1994). Detection and mapping of amplified DNA 
sequences in breast cancer by comparative genomic hybridization. Proc. Natl. Acad. Sci. 
USA 91: 2156-2160
162. Kallioniemi A., Kallioniemi O.P., Sudar M.R., Rutovitz D., Gray J.W., Waldman F., 
Pinkel D. (1992). Comparative genomic hybridisation for molecular cytogenetic analysis of 
solid tumours. Science 258: 818-821
163. Kalousek D.K. (1990). Confined placental mosaicism. Pediatr. Pathol. 10: 69-77
164. Kalousek D.K., Barrett I., McGillivray B.C. (1989). Placental mosaicism and 
intrauterine survival of trisomies 13 and 18. Am. J. Hum. Genet. 44: 338-343
165. Kalousek D.K., Dill F.J. (1983). Chromosomal mosaicism confined to the placenta in 
human conceptions. Science 221: 665-667
166. Kalousek D.K., Langlois S., Barrett I., Yam I., Wilson D.R., Howard-Peebles P.N., 
Johnson M.P., Giorgiutti E. (1993). Uniparental disomy for chromosome 16 in humans. Am. 
J. Hum. Genet. 52: 8-16
167. Kamiguchi Y., Rosenbusch B., Sterzik K., Mikamo K. (1993). Chromosomal analysis of 
unfertilized human oocytes prepared by gradual fixation-air drying method. Hum. Genet. 90: 
533-54
344
Bibliography
168. Kanavakis E.,Vrettou V., Palmer G., Tzetis M., Mastrominas M., Traeger-Synodinos 
J.(1999). Preimplantation genetic diagnosis in 10 couples at risk for transmitting |3- 
thalassaemia major: clinical experience including the initiation of six singleton pregnancies. 
Prenat. Diagn. 19: 1217-1222
169. Karhu R., Kahkonen M., Kuukasjarvi T., Pennanen S., Tirkonnen M., Kallioniemi O.
(1997). Quality control of CGH: impact of metaphase chromosomes and the dynamic range 
of hybridisation. Cytometry 28: 198-205
170. Karikoski R., Aine R., Heinonen P.K. (1993). Abnormal embiyogenesis in the etiology 
of ectopic pregnancy. Gynecol. Obstet. Invest. 36: 158-162.
171. Kirchhoff M., Gerdes T., Naahr J., Rose H., Bentz M., Dohner H., Lundsteen C. (1999). 
Deletions below 10 megabasepairs are detected in comparative genomic hybridization by 
standard reference intervals. Genes Chrom. Cancer. 25: 410-413
172. Katz M.G., Trounson A.O., Cram D.S. (2002). DNA fingerprinting of sister blastomeres 
from human IVF embryos. Hum. Reprod. 17: 752-759
173. Kirchhoff M., Rose H., Lundsteen C. (2001). High resolution comparative genomic 
hybridization in clinical cytogenetics. J. Med. Genet. 38: 740-744
174. Klein C.A., Schmidt-Kittler O., Schardt J.A., Pantel K., Speicher M.R., Rietmuller G.
(1999). Comparative genomic hybridisation, loss of heterozygosity, and DNA sequence 
analysis of single cells. Proc. Natl. Acad. Sci. 96: 4494-4499
175. Klinger K., Landes G., Shook D., Harvey R., Lopez L., Locke P., Lemer T., 
Osathanondh R., Leverone B., Houseal T. (1992). Rapid detection of chromosome 
aneuploidies in uncultured amniocytes by using fluorescence in situ hybridisation (FISH). 
Am. J. Hum. Genet. 51: 55-65
176. Knight S.J.L., Flint J. (2000). Perfect endings: a review of subtelomeric probes and their 
use in clinical diagnosis. J. Med. Genet. 37: 401- 409
177. Kola I., Wilton L. (1991). Preimplantation embryo biopsy: detection of trisomy in a 
single cell biopsied from a 4-cell mouse embryo. Mol. Reprod. Develop. 29: 16-21
178. Krzyminska J., Weber M., de Pennart H., Winston N.J., Maro B. (1993). The metaphase 
II arrest in mouse oocytes is controlled through microtubule-dependent destruction of cyclin 
B in the presence of CSF. EMBO J. 12: 3773-3778
179. Kuliev A., Rechitsky S., Verlinsky O., Ivakhnenko V., Evsikov S., Wolf G., 
Angastiniotis M., Georghiou D., Kukharenko V., Strom C., Verlinsky Y. (1998). 
Preimplantation genetic diagnosis of thalassemias. J. Assist. Repr. Genet. 15: 219-225
180. Kuo H-C., Ogilvie C.M., Handyside A.H. (1998). Chromosomal mosaicism in cleavage 
stage human embryos and the accuracy of single-cell genetic analysis. 
J. Assist.Reprod.Genet. 15:219-225
345
Bibliography
181. Kupker W., Schwinger E., Hiort O., Ludwig M., Nikolettos N., Schlegel P., Diedrich K.
(1999). Genetics of'male subfertility: consequences for the clinical work-up. Hum. Reprod. 
14: 24-37
182. Lahiri D.K., Numberger J.I.Jr. (1991). A rapid non-enzymatic method for the 
preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 19:5444
183. Lamb N., Feingold E., Savage A., Avramopoulos D., Freeman S., Gu Y., Hallberg A., 
Hersey J., Karadima G., Pettay D., Saker D., Shen J., Taft L., Mikkelsen M., Petersen M., 
Hassold T., Sherman S. (1997). Characterisation of susceptible chiasma configurations that 
increase the risk for maternal nondisjunction of chromosome 21. Hum. Mol. Genet. 6: 1391- 
1399
184. Lamb N.E., Freeman S.B., Savage-Austin A., Pettay D., Taft L., Hersey J., Gu Y., Shen 
J., May K.M., Avramopoulos D., Petersen M.B., Hallberg A., Mikkelsen M., Hassold T.J., 
Sherman S.L. (1996). Susceptible chiasmate configurations of chromosome 21 predispose to 
non-disjunction in both maternal meiosis I and meiosis EL Nat. Genet. 14: 400-405
185. Larsen W.J. (1997). Human Embiyology (2nd edition). Churchil Livingstone, New York
186. Latham K.E. (1999). Mechanisms and control of embryonic genome activation in 
mammalian embryos. Int. Rev Cytol.l93:71-124.
187. Lee S.H., Kwak I.P., Cha K.E., Park S.E., Kim N.K., Cha K.Y. (1998).Preimplantation 
diagnosis of non-deletion Duchenne muscular dystrophy (DMD) by linkage polymerase chain 
reaction analysis. Mol. Hum. Reprod. 4: 345-349
188. LeMaire-Adkins R., Radke K., Hunt P.A. (1997). Lack of checkpoint control at the 
metaphase/anaphase transition: a mechanism of meiotic nondisjunction in mammalian 
females. J. Cell. Biol. 29: 1611-1619
189. Levin N.A., Brzoska P.M., Wamock M.L., Gray J.W., Christman M.F. (1995). 
Identification of novel regions of altered DNA copy number in small cell lung tumours. 
Genes Chrom. Cancer 13: 175-185
190. Lilford R., Jones A.M., Bishop D.T., Thornton J., Mueller R. (1994). Case control study 
of whether subfertility in men is familial. B.M.J. 309: 570-573
191. Litscher E.S., Juntunen K., Seppo A., Penttila L., Niemela R., Renkonen O., Wassarman 
P.M. (1995). Oligosaccharide constructs with defined structures that inhibit binding of mouse 
sperm to unfertilized eggs in vitro. Biochemistry 34: 4662-4669.
192. Liu J., Lissens W., Van Broeckhoven C., Lofgren A., Camus M., Liebaers I., Van 
Steirteghem A. (1995). Normal pregnancy after preimplantation DNA diagnosis of a 
dystrophin gene deletion. Prenat. Diagn. 15:351-358
346
Bibliography
193. Liu L., Czerwiec E., Keefe D.L. (2004). Effect of ploidy and parental genome 
composition on expression of Oct-4 protein in mouse embryos. Gene Expr. Patterns 4: 433- 
441
194. Liu P., Siciliano J., Seong D., Craig J., Zhao Y., de Jong P.J., Siciliano M.J. (1993). 
Dual Alu polymerase chain reaction primers and conditions for isolation of human 
chromosome painting probes from hybrid cells. Cancer Genet. Cytogent. 65: 93-99
195. Lomax B., Tang S., Separovic E., Phillips D., Hillard E., Thomson T., Kalousek D.K
(2000). Comparative genomic hybridization in comparison with flow cytometry improves 
results of cytogenetic analysis of spontaneous abortions. Am. J. Hum. Genet. 66: 1516-1521
196. Ma K., Inglis J.D., Sharkey A., Bickmore W.A., Hill R.E., Prosser E.J., Speed R.M., 
Thomson E.J., Jobling M., Taylor K. (1993). A Y chromosome gene family with RNA- 
binding protein homology: candidates for the azoospermia factor AZF controlling human 
spermatogenesis. Cell 75: 1287-1295
197. Magli M.C., Gianaroli L., Ferraretti A.P. (2001a). Chromosomal abnormalities in 
embryos. Mol. Cell. Endocrin. 183: S29-S34
198. Magli M.C., Gianaroli L., Ferrareti A.P., Toshci M., Esposito F., Fasolino C.M. (2004). 
The combination of polar body and embryo biopsy does not affect embryo viability. Hum. 
Reprod. 19: 1163-1169
199. Magli M.C., Sandalinas M., Escudero T., Morrison L., Ferraretti A.P., Gianaroli L., 
Munne S. (2001b). Double locus analysis of chromosome 21 for preimplantation genetic 
diagnosis of aneuploidy. Prenat. Diagn. 21: 1080-1085
200. Mahmood R., Brierley C.H. Faed M.J.W., Mills J.A., Delhanty J.D.A. (2000). 
Mechanism of maternal aneuploidy: FISH analysis of oocytes and polar bodies in patients 
undergoing assisted conception. Hum. Genet. 106: 620-626
201. Malmgrem H., Sahlen S., Inzunza J., Aho M., Rosenlund B., Fridstrom M., Hovatta O., 
Ahrlund-Richter L., Nordenskjold M., Blennow E. (2002). Single cell CGH analysis reveals a 
high degree of mosaicism in human embryos from patients with balanced structural 
chromosome aberrations. Mol. Hum. Reprod. 8: 502-510
202. Malter H.E., Cohen J. (1989). Partial zona dissection of the human oocyte: a non- 
traumatic method using micromanipulation to assist zona pellucida penetration. Fertil. Steril. 
51: 139-148
203. Marquez C., Cohen J., Munne S. (1998). Chromosome identification on human oocytes 
and polar bodies by spectral karyotyping. Cytogen Cell Genet. 81: 254-258
204. Martini E., Flaherty S., Swann N.J., Matthews C.D., Ramaekers F.C.S., Geraedts J.P.M.
(2000). FISH analysis of six chromosomes in unfertilized human oocytes after polar body 
removal. J. Assist. Reprod. Genet. 17: 276-283
347
Bibliography
205. Martin R.H. (1988). Cytogenetic analysis of sperm from a male heterozygous for a 
13;14 Robertsonian translocation. Hum. Genet. 80: 357-361
206. Mattioli M., Galeati G., Bacci M., Barboni B. (1991). Changes in maturation-promoting 
activity in the cytoplasm of pig oocytes throughout maturation. Mol. Reprod. Dev. 30: 119- 
125
207. Meschede D., Lemcke B., Exeler J.R., De Geyter Ch., Behre H.M., Nieschlag E., Horst 
J. (1998). Chromosome abnormalities in 447 couples undergoing intracytoplasmic sperm 
injection: prevalence, types, sex distribution and reproductive relevance. Hum .Reprpod. 13: 
576-582
208. Midro A.T., Stengel-Rutowski S., Stene J. (1992). Experiences with risk estimates for 
carriers of chromosomal reciprocal translocations. Clin. Genet. 41: 113-122
209. Montag M., van der Ven K., Delacretaz G., Rink K., van der Ven H. (1998). Laser- 
assisted microdissection of the zona pellucida facilitates polar body biopsy. Fertil. Steril. 
539-542
210. Moore K.L. (1988). The Developing Human, Clinically Orientated Embryology. (Fourth 
Ed) W.B. Saunders Company
211. Morel F., Roux C., Bresson J.-L. (2001). FISH analysis of the chromosomal status of 
spermatozoa from three men with 45, XY der(13;14XqlO;qlO) karyotype. Mol. Hum. 
Reprod. 7: 483-488
212. Morton N.E. (1991). Parameters of the human genome. Proc. Natl. Acad. Sci. USA 88: 
7474-7476
213. Mottla G.L., Adelman M.R., Hall J.L., GindoffP.R., Stillman R.J., Johnson K.E. (1995). 
Lineage tracing demonstrates that blastomeres of early cleavage-stage human pre-embryos 
contribute to both trophectoderm and inner cell mass. Hum. Reprod. 10: 384-391
214. Muggleton-Harris A.L., Glazier A.M., Pickering S.J. (1993). Biopsy of the human 
blastocyst and polymerase chain reaction (PCR) amplification of the B-globin gene and a 
dinucleotide repeat motif from 2-6 trophectoderm cells. Hum. Reprod. 8: 2197-2205
215. Munne S. (2002). Preimplantation genetic diagnosis of numerical and structural 
chromosome abnormalities. Reprod. BioMed. Online 4: 183-196
216. Munne S., Cohen J. (1998). Chromosome abnormalities in human embiyos. Hum. 
Reprod. Update 4: 842-855
217. Munne S., Cohen J., Sable D. (2002a). Preimplantation genetic diagnosis for advanced 
maternal age and other indications. Fertil. Steril. 78: 234-236
218. Munne S., Dailey T., Filkenstein M., Weier H.U.G. (1996). Reduction in signal overlap 
results in increased FISH efficiency: implications for preimplantation genetic diagnosis. J. 
Assist. Reprod. Genet. 13: 149-156
348
Bibliography
219. Munne S., Dailey T., Sultan K.M., Grifo J., Cohen J. (1995). The use of first polar 
bodies for preimplantation diagnosis of aneuploidy. Hum. Reprod. 10: 1014-1020
220. Munne S., Escudero T. Sandalinas M. Sable D. Cohen J (2000b). Gamete segregation in 
female carriers of Robertsonian translocations. Cytogen. Cell. Genet. 90: 303-308
221. Munne S., Fung J., Cassel M., Marquez C., Weier H.U.G. (1998a). Preimplantation 
genetic diagnosis of translocations: case-specific probes for interphase cell analysis. Hum. 
Genet. 102: 663-674
222. Munne S., Lee A., Rosenwaks Z., Grifo J., Cohen J. (1993). Diagnosis of major 
aneuploidies in human preimplantation embryos. Hum. Reprod. 8: 2185-2191
223. Munne S., Magli C., Adler A. (1997). Treatment-related chromosome abnormalities in 
human embryos. Hum. Reprod. 12: 780-784
224. Munne S., Magli C., Bahce M., Fung J., Legator M., Morrison L., Cohen J., Gianaroli L. 
(1998b). Preimplantation diagnosis of the aneuploidies most commonly found in spontaneous 
abortions and live births, XY, 13, 14, 15, 16, 18,21,22. Prenat. Diagn. 18: 1459-1466
225. Munne S., Marquez C., Magli C., Morton P., Morrison L. (1998c). Scoring criteria for 
preimplantation genetic diagnosis of numerical abnormalities for chromosomes X, Y, 13, 16, 
18, and 21. Mol. Hum. Reprod. 4: 863-870
226. Munne S., Morrison L., Fung J. Marquez C., Weier U., Bahce M., Sable Grundefeld L., 
Schoolcraft B., Scott R., Cohen J. (1998d). Spontaneous abortions are reduced after pre­
conception diagnosis of translocations. J. Assist. Reprod. Genet. 15: 290-296
227. Munne S., Sandalinas M., Escudero T., Fung J., Gianaroli L., Cohen J., and the Saint 
Barnabas Medical Center PGD Network. (2000c). Outcome of preimplantation genetic 
diagnosis of translocations. Fertil. Steril. 73 : 1209-1218
228. Munne S., Sandalinas M., Escudero T., Marquez C., Cohen J. (2002b). Chromosome 
mosaicism in cleavage stage human embryos: evidence of a maternal age effect. Reprod. 
Biomed. Online: 223-232
229. Munne S., Scott R., Sable D., Cohen J. (1998e). First pregnancies after preconception 
diagnosis of translocations of maternal origin. Fertil. Steril. 69: 675-681
230. Munne S., Sepulveda S., Balmaceda J., Fernandez E., Fabres C., Mackenna A., Lopez 
T., Crosby J.A., Zegers-Hochshild F. (2000c). Selection of the most common chromosome 
abnormalities in oocytes prior to ICSI. Prenat. Diagn. 20: 582-586
231. Munne S., Weier H.U. (1996). Reduction in signal overlap results in increased FISH 
efficiency: implications for preimplantation genetic diagnosis. 
J Assist Reprod Genet. 13: 149-56.
232. Munne S., Wells D. (2002). Preimplantation genetic diagnosis. Curr. Opinin. Obs. 
Gynaec. 14: 239-244
349
Bibliography
233. Munne S., Wells D. (2003). Questions concerning the suitability of comparative 
genomic hybridization for preimplantation genetic diagnosis. Fertil. Steril. 80: 871-872
234. Mutton D., Alberman E., Hook E.B.(1996). Cytogenetic and epidemiological findings in 
Down syndrome, England and Wales 1989 to 1993. National Down Syndrome Cytogenetic 
Register and the Association of Clinical Cytogeneticists. J Med Genet. 33 : 387-394.
235. Nakano Y., Shirakawa H., Mitsuhashi N., Kuwabara Y., Miyazaki S. (1997). 
Spatiotemporal dynamics of intracellular calcium in the mouse egg injected with a 
spermatozoon. Mol Hum Reprod. 1997 12:1087-1093.
236. Navidii W., Amheim N. (1991). Using PCR in preimplantation genetic diagnosis. Hum. 
Reprod. 6:836-849
237. Nicolaidis P., Petersen M.B. (1998). Origin and mechanisms of non-disjunction in 
human autosomal trisomies. Hum. Reprod. 13: 313-319
238. Niebuhr E. (1974). Triploidy in man: cytogenetic and clinical aspects. Hum. Genet. 21: 
103-125
239. Nielsen J., Sillesen I. (1975). Incidence of chromosome aberrations among 11,148 
newborn children. Hum. Genet. 30: 1-12
240. NiikawaN., Kajii T. (1974). A triploid human abortus due to dispermy. Hum. Genet. 24: 
261-264
241. Nijs M., Camus H., Van Steiteghem A.C. (1988). Evaluation of different biopsy 
methods of blastomeres from 2-cell embiyos. Hum. Reprod. 3: 999-1003
242. Ogawa S., Araki S., Araki Y., Ohno M., Sato I. (2000). Chromosome analysis of human 
spermatozoa from an oligoasthenozoospermic carrier for a 13; 14 Robertsonian translocation 
by their injection into mouse oocytes. Hum. Reprod. 15:1136-1139
243. Ogilvie C.M., Scriven P.N. (2002). Meiotic outcomes in reciprocal translocation carriers 
ascertained in 3-day human embiyos. Eur. J. Hum. Genet. 10: 801-806
244. Oliver-Bonet M., Navarro J., Carrera M., Egozcue J., Benet J. (2002). Aneuploid and 
unbalanced sperm in two translocation carriers: evaluation of the genetic risk. Mol. Hum. 
Reprod. 8: 958-963
245. Papadopoulos G., Templeton A.A., Fisk N., Randall J. (1989). The frequency of 
chromosome anomalies in human preimplantation embryos after IVF. Hum. Reprod. 4: 91-98
246. Pellestor F., Andreo B., Amal F., Humaeu C., Demaille J. (2002). Mechanisms of non­
disjunction in human female meiosis: the co-existence of two modes of malsegregation 
evidenced by the karyotyping of 1397 in-vitro unfertilized oocytes. Hum. Reprod. 17: 2134- 
2145
350
Bibliography
247. Pellestor F., Andreo B., Amal F., Humaeu C., Demaille J. (2003). Maternal ageing and 
chromosomal abnormalities: new data drawn from in vitro unfertilized human oocytes. Hum. 
Genet. 112: 195-203
248. Pellestor F., Dufour M.C., Amal F., Humeau C. (1993). A simplified method for R 
banding of human oocyte chromosomes. Hum. Reprod. 8: 604-608
249. Pellestor F., Imbert I., Andreo B., Lefort G. (2001). Study of the occurrence of 
interchromosomal effect in spermatozoa of chromosomal rearrangement carriers by 
fluorescence in-situ hybridization and primed in-situ labelling techniques. Hum. Reprod. 16: 
1155-1164
250. Pellicer A., Rubio C., Vidal F., Minguez Y., Gimenez C., Egozcue J., Remohi J., Simon 
C. (1999). In vitro fertilisation plus preimplantation genetic diagnosis in patients with 
recurrent miscarriage: an analysis of chromosome abnormalities in human preimplantation 
embryos. Fertil. Steril. 6: 1033-1039
251. Pergament E., Confino E., Zhang J.X., Roscetti L., Chen P.X., Wellman D. (2000). 
Recurrent triploidy of maternal origin. Prenat. Diagn. 20: 561-563
252. Pickering S., Polidoropoulos N., Caller J., Scriven P., Mackie Oglivie C., Braude P., and 
the PGD study group, (2003). Strategies and outcomes of the first 100 cycles of 
preimplantation genetic diagnosis at the Guy’s and St. Thomas Center. Fertil. Steril. 79: 81- 
90
253. Pierce K.E., Michalopoulos J., Kiessling A.A., Seibel M.M., Zilberstein M. (1997). 
Priemplantation development of mouse and human embryos biopsied at cleavage stage using 
a modified displacement technique. Hum. Reprod. 12: 351-356
254. Piyiamongkol W., Harper J.C., Sherlock J.K., Doshi A., Serhal P.F., Delhanty J.D.A., 
Wells D. (2001). A successful strategy for preimplantation genetic diagnosis of myotonic 
dystrophy using multiplex fluorescent PCR. Prenat. Diagn. 21: 223-232
255. Plachot M., Junca A.-M., Mandelbaum J., Grouchy J., de., Salat-Baroux J., Cohen J. 
(1987). Chromosome investigations in early life. II. Human preimplantation embryos. Hum. 
Reprod. 2: 29-35
256. Pollack J.R., Sorlie T., Perou C.M., Rees C.A., Jeffrey S.S., Lonning P.E., Tibshirani R., 
Botstein D., Borresen-Dale A.L., Brown P.O. (2002). Microarray analysis reveals a major 
direct role of DNA copy number alteration in the transcriptional program of human breast 
tumours. Proc. Natl. Acad. Sci. USA 99: 12963-12968
257. Pryor J.L., Kent-First M., Muallem A., Van Bergen A.H., Nolten W.E., Meisner L., 
Roberts KP. (1997). Microdeletions in the Y chromosome of infertile men. N. Engl. Med. J 
336: 534-539
351
Bibliography
258. Pujol A. Boiso I., Benet J., Veiga A., Durban M., Campillo M., Egozcue J., Navarro J. 
(2003a). Analysis of nine chromosomes probes in first polar bodies and metaphase II oocytes 
for the detection of aneuploidies. Eur. J. Hum. Genet. 11: 325-336
259. Pujol A., Durban M., Benet J., Boiso I., Calfell J.M., Egozcue J., Navarro J. (2003b). 
Multiple aneuploidies in the oocytes of balanced translocation carriers:a preimplantation 
genetic diagnosis study using first polar body. Reprod. 126: 701-711
260. Ranieri D.M., Quinn F., Maklouf A., Khadum I., Ghutmi W., McCarrigle H., Davies M., 
Serhal P. (1998). Simultaneous evaluation of basal follicle-stimulating hormone and 17(3- 
estradiol response to gonadotropin-releasing hormone analogue stimulation: an improved 
predictor of ovarian reserve. Fertil. Steril. 70: 227-233
261. Ray P.F., Handyside A.H. (1996). Increasing the denaturation temperature during the 
first cycles of amplification reduces allele dropout from single cells for preimplantation 
genetic diagnosis. Mol. Hum. Reprod. 2: 213-218
262. Ray P.F., Harper J.C., Ao A., Taylor D.M., Winston R.M.L, Hughes M., Handyside 
A.H. (1999). Successful preimplantation genetic diagnosis for sex linked Lesch-Nyhan 
syndrome using specific diagnosis Prenat. Diagn. 19: 1237-1241
263. Regan L., Owen E.J., Jacobs H.S. (1990). Hypersecretion of luteinizing hormone, 
infertility and miscarriage. Lancet 336: 1141-1144
264. Reijo R., Lee T., Salo P., Alagapaan R., Brown L.G., Rosenberg M., Rozen S., Jaffe T., 
Straus D., Hovatta O., de la Chapelle A., Silber S., Page D.C. (1995). Diverse spermatogenic 
defects in humans caused by Y chromosome deletions encompassing a novel RNA-binding 
protein gene. Nat. Genet. 10: 383-393
265. Ried T., Petersen I., Holtgreve-Grez H., Speicher M.R., Schrock E., du Manoir S., 
Cremer T. (1994). Mapping of multiple DNA gains and losses in primary small cell lung 
carcinomas by comparative genomic hybridization. Cancer Res. 54: 1801-1806
266. Robinson W.P., Barrett I.J., Bernard L., Telenius A., Bemasconi F., Wilson R.D., Best 
R.G., Howard-Peebles P.N., Langlois S., Kalousek D.K. (1997). Meiotic origin of trisomy in 
confined placental mosaicism is correlated with presence of fetal uniparental disomy, high 
levels of trisomy in trophoblast, and increased risk of fetal intrauterine growth restriction.. 
Am. J. Hum. Genet. 1997 Apr;60(4):917-27.
267. Robinson W.P., Bemasconi F., Mutirangura A., Ledbetter D.H., Langlois S., Malcolm 
S., Morris M.A., Schinzel A.A. (1993). Nondisjunction of chromosome 15: origin and 
recombination. Am. J. Hum. Genet. 53: 740-751
268. Rodrigo L., Rubio C., Mateu E., Simon C., Remohi J., Pellicer A., Gil-Salom M. (2004). 
Analysis of chromosomal abnormalities in testicular and epididymal spermatozoa from 
azoospermic ICSI patients by fluorescence in-situ hybridization. Hum. Reprod. 19: 118-123
362
Bibliography
269. Romana S., Tachdjan G., Druart L., Cohen D., Berger R., Cherif D. (1993). A simple 
method for prenatal diagnosis of trisomy 21 on uncultured amniocytes. Eur. J. Hum.Genet. 1: 
245-251
270. Ruangvutilert P., Delhanty J.D.A., Rodeck C.H., Harper J.C. (2000a). Relative 
efficiency of FISH on metaphase and interphase nuclei from non-mosaic trisomic or triploid 
fibroblast cultures. Prenat. Diagn. 20: 159-162
271. Ruangvutilert P., Delhanty J.D., Serhal P., Simopoulou M., Rodeck C.H., Harper J.C. 
(2000b). FISH analysis on day 5 post-insemination of human arrested and blastocyst stage 
embryos. Prenat Diagn. 20: 552-560.
272. SagataN. (1997). What does Mos do in oocytes and somatic cells. BioEssays 19: 13-21
273. Sandalinas M., Marquez C., Munne S. (2002). Spectral karyotyping of fresh, non­
inseminated oocytes. Mol. Hum. Reprod. 8: 580-585
274. Sandalinas S., Sadowy S., Alikani M., Calderon G., Cohen J., Munne S. (2001). 
Developmental ability of chromosomally abnormal human embiyos to develop to the 
blastocyst stage. Hum. Reprod. 16: 1954-1958
275. Sathananthan A.H. (1998). Paternal centrosomal dynamics in early human development 
and infertility. J. Assist. Reprod. Genet. 15: 129-139
276. Schrock E., Manoir S. du, Veldman T., Schoell, Widberg J., Ferguson-Smith M.A., Nin 
Y., Ledbetter D., Bar-Am I.., Soenksen D., Garini Y., Ried T. (1996). Multicolor spectral 
karyotyping of human chromosomes. Science 273: 494-497
277. Schrock E., Thiel G., Lozanova T., du Manoir S., Meffert M.C., Jauch A., Speicher 
M.R., Numberg P., Vogel S., Janisch W., et al. (1994). Comparative genomic hybridization 
of human malignant gliomas reveals multiple amplification sites and nonrandom 
chromosomal gains and losses. Am J Pathol. 144:1203-18.
278. Scriven P.N., Handyside A.H., Ogilvie C.M. (1998). Chromosome translocations: 
segregation modes and strategies for preimplantation genetic diagnosis. Prenat. Diagn. 18: 
1437-1449
279. Scriven P.N., Flinter F.A., Braude P.R., Ogilvie C.M. (2001). Robertsonian 
translocations- reproductive risks and indications for preimplantation genetic diagnosis. 
Hum. Reprod. 16: 2267-2273
280. Sengoku K., Tamate K., Takuma N., Yoshida T., Goishi K., Ishikawa M. (1997). The 
chromosomal normality of unfertilized oocytes from patients with polycystic ovarian 
syndrome. Hum. Reprod. 12: 474-477
281. Sermon K., De Vos A., Van de Velde H., Seneca S., Lissens W., Joris H., Vandervorst 
M., Van Steirteghem A., Liebaers I. (1998a). Fluorescent PCR and automated fragment
353
Bibliography
analysis for the clinical application of preimplantation genetic diagnosis of myotonic 
dystrophy (Steinert's disease). Mol. Hum. Reprod. 4: 791-796
282. Sermon K., Goossens V., Seneca S., Lissens W., De Vos A., Vandervorst M., Van 
Steirteghem A., Liebaers I. (1998b). Preimplantation diagnosis for Huntington's disease 
(HD): clinical application and analysis of the HD expansion in affected embryos. Prenat. 
Diagn. 18: 1427-1436
283. Sermon K., Lissens W., Messiaen L., Bonduelle M., Vandervorst M., Van Steirteghem 
A., Liebaers I. (1999a). Preimplantation genetic diagnosis of Marfan syndrome with the use 
of fluorescent polymerase chain reaction and the Automated Laser Fluorescence DNA 
Sequencer. Fertil. Steril. 71: 163-166
284. Sermon K., Seneca S., Vanderfaeillie A., Lissens W., Joris H., Vandervorst M., Van 
Steirteghem A., Liebaers I. (1999b). Preimplantation diagnosis for fragile X syndrome based 
on the detection of the non-expanded paternal and maternal CGG. Prenat. Diagn. 19: 1223- 
1230
285. Sherman S.L., Petersen M.B., Freeman S.B., Hersey J., Pettay D., Taft L., Frantzen M., 
Mikkelsen M., Hassold T.J. (1994). Non-disjunction of chromosome 21 in maternal meiosis 
I. Evidence of a maternal age-dependent mechanism involving reduced recombination. Hum 
Mol. Genet. 3: 1529-1535
286. Sherman S.L., Takaesu N., Freeman S.B. (1991). Trisomy 21: association between 
reduced recombination and non-disjunction. Am. J. Hum. Genet. 49: 608-620
287. Simopoulou M., Harper J.C., Fragouli E., Mantzouratou A., Speyer B.E., Serhal P., 
Ranieri D.M., Doshi A., Henderson J., Rodeck C.H., Delhanty J.D.A. (2003). 
Preimplantation genetic diagnosis of chromosome abnormalities: implications from the 
outcome for couples with chromosomal rearrangements. Prenat. Diagn. 23: 652-662
288. Solinas-Toldo S., Wallrapp C., Muller-Pillasch F., Bentz M., Gress T., Lichter P.
(1996). Mapping of chromosomal imbalances in pancreatic carcinoma by comparative 
genomic hybridization. Cancer Res. 56: 3803-3807
289. Soussis J., Harper J.C., Handyside A.H., Winston R.M.L. (1996a). Obstetric outcome of 
pregnancies resulting from preimplantation diagnosis of inherited disease. Br. J. Obstetr. 
Gynecol. 103: 784-788
290. Soussis J., Harper J.C., Kontogianni E., Paraschos T., Packham D., Handyside A.H., 
Winston R.M.L. (1996b). Pregnancies resulting from embiyos biopsied for preimplantation 
diagnosis of genetic disease. Biochemical and ultrasonic studies in the first trimester of 
pregnancy. J. Assist. Reprod. Genet. 13: 254-257
291. Spandidos D.A., Koumantakis E., Sifakis S., Sourvinos G. (1998). Microsatellite 
mutations in spontaneously aborted embryos. Fertil. Steril. 70: 892-895
354
Bibliography
292. Speicher M.R., Gwyn Ballard S.,Ward D.C. (1996). Karyotyping human chromosomes 
by combinatorial multi-fluor FISH. Nat. Genet. 12: 368-375.
293. Speicher M.R., Howe C., Crotty P., du Manoir S., Costa J., Ward D.C. (1995). 
Comparative genomic hybridization detects novel deletions mid amplifications in head and 
neck squamous cell carcinomas. Cancer Res. 55: 1010-1013
294. Spriggs E.L., Rademaker A.W., Martin R.H. (1996). Aneuploidy in human sperm: The 
use of multicolor FISH to test various theories of nondisjunction. Am. J. Hum. Genet. 58: 
356-362
295. Staessen C., Van Asshe E., Joris H., Bonduelle M., Vandervorst M., Liebaers I., Van 
Steirteghem A. (1999). Clinical experience of sex determination by fluorescent in-situ 
hybridisation for preimplantation genetic diagnosis. Mol. Hum. Reprod. 5: 382-398
296. Stanger J.D., Yovich J.L. (1985). Reduced in-vitro fertilization of human oocytes from 
patients with raised basal luteinizing hormone levels during the follicular phase. Br. J. 
Obstet. Gyanecol. 92: 385-393
297. Stavropoulos D.J., Bick D., Kalousek D. (1998). Molecular cytogenetic detection of 
confined gonadal mosaicism in a conceptus with trisomy 16 placental mosaicism. Am. J. 
Hum. Genet. 63: 1912-1914
298. Stem C., Pertle M., Norris H., Hale L., Baker H.W.G. (1999). Chromosome 
translocations in couples with in vitro fertilisation implantation failure. Hum. Reprod. 14: 
2097-2101
299. Steuerwald N., Cohen J., Herrera R.J., Sandalinas M., Brenner C.A. (2001). Association 
between spindle assembly checkpoints expression and maternal age in human oocytes. Mol. 
Hum. Reprod. 7: 49-55
300. Strom C., Rechitsky C. Cieslak J. (1997). Preimplantation diagnosis of single gene 
disorders by two-step oocyte analysis. J. Assist. Reprod. Genet. 14: 469
301. Strom C.M., Rechitsky S., Wolf G., Cieslak J., Kuliev A., Verlinsky Y. (1998). 
Preimplantation diagnosis of autosomal dominant retinitis pigmentosum using two 
simultaneous single cell assays for a point mutation in the rhodopsin gene. Mol. Hum. 
Reprod. 4:351-355
302. Strom C.M., Strom S., Levine E., Ginsberg N., Barton J., Verlinsky Y. (2000). Obstetric 
outcomes in 102 pregnancies after preimplantation genetic diagnosis. Am. J. Obs. Gynec. 
182: 1629-1632
303. Tabet A.C., Aboura A., Dauge M.C., Audibert F., Coulomb A., Batallan A., Coutourier- 
Turpin M.H., Feldman G., Tachdjian G. (2001). Cytogenetic analysis of trophoblasts by 
comparative genomic hybridization in embryo-fetal development anomalies. Prenat. Diagn. 
21:613-618
355
Bibliography
304. Tarin J.J., Handyside A.H. (1993). Embryo biopsy strategies for preimplantation 
diagnosis. Fertil. Steril. 59: 943-952
305. Tarkowski A.K. (1966). An air drying method for chromosome preparation from mouse 
eggs. Cytogenetics 5: 394-400
306. Tarkowski A.K., Wroblewska J. (1967). Development of blastomeres of mouse eggs 
isolated at the 4- and 8-cell stage. J. Embryol. Exp. Morphol. 18: 155-180
307. Taylor D.M, Ray P.F., Ao A., Winston R.M.., Handyside A.H. (1997). Paternal 
transcripts for glucose-6-phosphate dehydrogenase and adenosine deaminase are first 
detectable in the human preimplantation embryo at the three- to four-cell stage. Mol Reprod 
Dev. 48: 442-8
308. Tease C., Hartshome G.M., Hulten M.A. (2002). Patterns of meiotic recombination in 
human fetal oocytes. Am. J. Hum. Genet. 70: 1469-1479
309. Telenius H., Carter N.P., Bebb C.E., Nordenskjold M., Ponder B.A., Tunnacliffe 
A.(1992). Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a 
single degenerate primer. Genomics. 13:718-25.
310. Tesarik J., Mendoza C., Greco E. (2002). Paternal effects acting during the first cell 
cycle of human preimplantation development after ICSI. Hum. Reprod. 17: 184-189
311. Testart J., Gautier E., Brami C. Rolet F., Sebdon E., Thebault A. (1996). 
Intracytoplasmic sperm injection in infertile patients with structural chromosome 
abnormalities. Hum. Reprod. 11: 2609-2612
312. Tharapel A.T., Tharapel S.A., Bannerman R.M. (1985). Recurrent pregnancy losses and 
parental chromosome abnormalities: a review. Br. J. Obstet. Gynecol. 92: 899-914
313. Therman A.T., Susman M. (1993). Reciprocal translocations. In: Human Chromosomes, 
Structure, Behavior and Effects 3rd edn. Spinger-Verlag: 273-287
314. Tomkins D.J., Roux A.F., Wayne J., Freeman V.C.P., Cox D.W., Whelan D.T. (1996). 
Maternal uniparental isodisomy of human chromosome 14 associated with paternal t(13; 14) 
and precocious puberty. Eur. J. Hum. Genet. 4: 153-159
315. Toth A., Kirsten P., Rabitsch K.P., Galova M., Schleiffer A., Buonomo S.B.C., Nasmyth 
K. (2000). Functional genomics identifies monopolin: a kinetochore protein required for 
segregation of homologs during meiosis-I. Cell 103: 1155-1168
316. Vaissee C., Halaas J., Horvath C., Darnel J.E. Jr., Stoffel M., Friedman J. (1996). Leptin 
activation of STAT3 in the hypothalamus of wild type and ob/ob mice. Nat. Genet. 14: 95-97
317. Van Assche E., Staessen C., Vegetti W., Bonduelle M., Vandervorst M., Van 
Steirteghem A., Liebaers I. (1999). Preimplantation genetic diagnosis and sperm analysis by 
fluorescence in-situ hybridisation for the most common reciprocal translocation t(ll;22). 
Mol. Hum. Reprod. 5: 682-690
366
Bibliography
318. Van Heemst D., Heyting C. (2000). Sister chromatid cohesion and recombination in 
meiosis. Chromosoma 109: 10-26
319. Van Hummelen P., Manchester D., Lowe X., Wyrobek (1997) Meiotic segregation, 
recombination and gamete aneuploidy assessed in a t(l;10Xp22.1;q22.3) reciprocal 
translocation carrier by three and four-probe multicolor FISH in sperm. Am. J. Hum. Genet. 
61:651-659
320. Van de Velde H., De Vos A., Sermon K., Staessen C., De Rycke M., Van Assche E., 
Lissens W., Vandervorst M., Van Ranst H., Liebaers I., Van Steirteghem A. (2000). Embryo 
implantation after biopsy of one or two cells from cleavage-stage embryos with a view to 
preimplantation genetic diagnosis. Prenat. Diagn. 20: 1030-1037
321. Van de Velde H., Sermon K., De Vos A., Lissens W., Joris H., Vandervorst M., Van 
Steirteghem A., Liebaers I. (1999). Fluorescent PCR and automated fragment analysis in 
preimplantation genetic diagnosis for 21-hydroxylase deficiency in congenital 
adrenalhyperplasia.Mol.Hum.Reprod.5:691-696
322. Van der Ven K., Peschkla B., Montag M. Lange R., Schwanitz G., Van der Ven H.H.
(1998). Increased frequency of congenital chromosomal aberrations in female partners of 
couples undergoing intracytoplasmic sperm injection. Hum. Reprod. 13: 48-54
323. Vandervorst M., Staessen C., Sermon K., De Vos A., Van de Velde H., Van Assche E., 
Bonduelle M., Vanderfaellie A., Lissens W., Toumaye H., Devroey P., Van Steirteghem A., 
Liebaers I. (2000). The Brussels’ experience of more than 5 years of clinical preimplantation 
genetic diagnosis. Hum. Reprod. 6: 364-373
324. Van Steirteghem A., Nagy Z., Joris H., Liu J., Staessen C., Smitz J., Wisanto A., 
Devroey P.(1993). High fertilisation and implantation rates after intracytoplasmic sperm 
injection. Hum. Reprod. 8: 1061-1066
325. Veiga A., Sandalinas M., Benkhalifa M., Boada M., Carrera M., Santalo J., Barri P.N., 
Menezo Y. (1997). Laser blastocyst biopsy for preimplantation genetic diagnosis in the 
human. Zygote 5: 351-354
326. Vellila E. (2002). Blastomere fixation techniques and risk of misdiagnosis for 
preimplantation genetic diagnosis of aneuploidy. Reprod. Biomed. Online 4: 210-217
327. Vendrely R. (1955). The deoxyribonucleic acid content of the nucleus. In: Chargaff E., 
Davidson J.N. editors. The Nucleic Acids, Chemistry and Biology. Vol. II New York, 
Academic Press: 155-180
328. Verlhac M.H., Lefebvre C., Kubiak J.Z., Umbhauer M., Rassinier P., Colledge W., 
Maro B. (2000). Mos activates MAP kinase in mouse oocytes through two opposite 
pathways. EMBO J. 19: 6065-6074
357
Bibliography
329. Verlinsky Y., Cieslak J., Ivakhnenko V., Evsikov S., Wolf G., White M., Lifchez A., 
Kaplan B., Moise J., Valle J., Ginsberg N., Strom C., Kuliev A. (1998). Preimplantation 
diagnosis of common aneuploidies by the first- and second-polar body FISH analysis. J. 
Assist. Reprod. Genet. 15: 285-289
330. Verlinsky Y., Cieslak V., Freidine M., Ivakhnenko V., Wolf G., Kovalinskaya L., White 
M., Lifchez A., Kaplan B., Moise J., Ginsberg N., Strom C., Kuliev A. (1995). Pregnancies 
following pre-conception diagnosis of common aneuploidies by fluorescent in situ 
hybridization. Mol. Hum. Reprod. 10: 1923-1927
331. Verlinsky Y., Cieslak J., Ivakhnenko V., Evsikov S., Wolf G., White M., Lifchez A., 
Kaplan B., Moise J., Valle J., Ginsberg N., Strom C., Kuliev A. (1999). Prevention of age- 
related aneuploidies by polar body testing of oocytes. J. Assist. Reprod. Genet. 16: 165-169
332. Verlinsky Y., Cieslak J., Ivakhnenko V., Evsikov S., Wolf G., White M., Lifchez A., 
Kaplan B., Moise J., Valle J., Ginsberg N., Strom C., Kuliev A. (2001). Chromosomal 
abnormalities in the first and second polar body. Mol. Cell Endocrinol. 183: S47-S49
333. Verlinsky Y., Cieslak J., Ivakhnenko V., Lifchez A., Strom C., Kuliev A. (1996). Birth 
of healthy children after preimplantation genetic diagnosis by polar body fluorescent in situ 
hybridization analysis. Preimplantation Genetics Group. Fertil. Steril. 66: 126-129
334. Verlinsky Y., Evsikov S. (1999). A simplified and efficient method for obtaining 
metaphase chromosomes from individual human blastomeres. Fertil. Steril. 72: 1127-1133
335. Verlinsky Y., Rechitsky S., Evsikov S., White M., Cieslak J., Lifchez A., Valle J., 
Moise J., Strom C.M. (1992). Preconception and preimplantation diagnosis for cystic 
fibrosis. Prenat. Diagn. 12: 103-110
336. Viville S., Pergament D. (1998). Results of a survey of the legal status and attitudes 
towards preimplantation genetic diagnosis conducted in 13 different countries. 
Prenat Diagn. 18: 1374-1380.
337. Vogt P.H., Edelmann A., Kirsch S., Henegariu O., Hirschmann P., Kiesewetter F, Kohn 
FM, Schill WB, Farah S, Ramos C, Hartmann M, Hartschuh W, Meschede D, Behre HM, 
Castel A, Nieschlag E, Weidner W, Grone HJ, Jung A, Engel W, Haidl G. (1996). Human Y 
chromosome azoospermia factors (AZF) mapped to different subregions in Yqll. Hum Mol 
Genet.5: 933-943.
338. Voullaire L., Slater H., Williamson R., Wilton L. (2000). Chromosome analysis of 
blastomeres from human embryos by using comparative genomic hybridisation. Hum. Genet. 
106:210-217
339. Voullaire L., Wilton L., McBain J., Callaghan T., Williamson R. (2002). Chromosome 
abnormalities identified by comparative genomic hybridization in embryos from women with 
repeated implantation failure. Mol. Hum. Reprod. 8: 1035-1041
368
Bibliography
340. Voullaire L., Wilton L. Slater H., Williamson R. (1999). Detection of aneuploidy in 
single cells by using comparative genomic hybridisation. Prenat. Diagn. 19: 846-851
341. Webber L.J., Stubbs S., Stark J., Trew G.H., Margara R., Hardy K., Franks S. (2003). 
Formation and early development of follicles in the polycystic ovary. The Lancet 362: 1017- 
1021
342. Ward B.E., Gersen S.L., Carelli M.P., McGuire N.M., Dackowski W.R., Weinstein M., 
Sandlin C., Warren R. Klinger K.W. (1993). Rapid prenatal diagnosis of chromosomal 
aneuploidies by fluorescence in situ hybridisation: clinical experience with 4,500 specimens. 
Am. J. Hum. Genet. 52: 854-865
343. Warren A.C., Chakravati A., Wong C., Slaugenhaupt S.A., Halloran S.L., Watkins P.C., 
Metaxotou C. (1987). Evidence for reduced recombination on the nondisjoined chromosomes 
21 in Down’s syndrome. Science 237: 652-654
344. Wassarman P.M. (1999). Mammalian fertilisation: molecular aspects of gamete 
adhesion, exocytosis, and fusion. Cell 96: 175-183
345. Wassarman P.M., Albertini D.F. (1993). The mammalian oocyte. In: Knobil E., Neil 
J.D. (eds) The Physiology of Reproduction (Second Ed) Raven Press, New York: 79-122
346. Wells D., Delhanty J.D.A. (2000). Comprehensive chromosomal analysis of human 
preimplantation embryos using whole genome amplification and single cell comparative 
genomic hybridisation. Mol. Hum. Reprod. 11: 1055-1062
347. Wells D., Delhanty J.D.A. (2001). Preimplantation genetic diagnosis: applications for 
molecular medicine. Trends in Mol. Medic. 17: 23-30
348. Wells D., Escudero T., Levy B., Hirschhom K., Delhanty J.D.A., Munne S. (2002). First 
clinical application of comparative genomic hybridisation and polar body testing for 
preimplantation genetic diagnosis of aneuploidy. Fertil. Steril. 78: 543-549
349. Wells D., Levy B. (2003). Cytogenetics in reproductive medicine: the contribution of 
comparative genomic hybridization (CGH). Bioessays 25: 289-300
350. Wells D., Sherlock J.K. (1998). Strategies for preimplantation genetic diagnosis of 
single gene disorders by DNA amplification. Prenat. Diagn- 18: 1389-1401
351. Wells D., Sherlock J.K., Handyside A.H., Delhanty J.D.A. (1999). Detailed 
chromosomal and molecular genetic analysis of single cells by whole genome amplification 
and comparative genomic hybridisation. Nucl. Acids Res. 27: 1214-1218
352. Willadsen S., Levron J., Munne S., Schimmel T., Marquez C., Scorr R., Cohen J.
(1999). Rapid visualization of metaphase chromosomes in single human blastomeres after 
fusion with in-vitro matured bovine eggs. Hum. Reprod. 14: 470-475
353. Willard H.F., Smith K.D., Sutherland J. (1983). Isolation and characterization of a major 
tandem repeat family from the human X chromosome. Nucleic Acids Res. 11: 2017-2033
359
Bibliography
354. Wilton L. (2002). Preimplantation genetic diagnosis for aneuploidy screening in early 
human embiyos: a review. Prenat. Diagn. 22: 512-518
355. Wilton L.J., Shaw J.M., Trounsen A.O. (1989). Successful single cell biopsy and 
cryopreservation of preimplantation mouse embiyos. Fertil. Steril. 51: 513-517
356. Wilton L., Voullaire L., Peta Sargeant R.M., Williamson R., McBain J. (2003). 
Preimplantation aneuploidy screening using comparative genomic hybridization or 
fluorescence in situ hybridization of embiyos from patients with recurrent implantation 
failure. Fertil. Steril. 80: 860-868
357. Wilton L., Williamson R., McBain J., Edgar D., Voullaire L. (2001). Birth of a healthy 
infant after preimplantation confirmation of euploidy by comparative genomic hybridization. 
N. Engl. Med. J. 345: 1537-1541
358. Wimmers M.S.E., van der Merve J.V. (1988). Chromosome studies on early human 
embryos fertilised in vitro. Hum. Reprod. 3: 894-900
359. Woodward B.J., Lenton E.A., Mac Neil S. (1993). Requirement of preimplantation 
human embryos for extracellular calmodulin for development. Hum. Reprod. 8:272-276.
360. Zenzes M.T., Casper R.F. (1992). Cytogenetics of human oocytes, zygotes and embryos 
after in vitro fertilisation. Hum. Genet. 88: 367-375
360
Appendices
Appendices
362
Appendices
A: Appendix to Materials and Methods 
1A Cell Culture Media
Media for bacteria and yeast culture were prepared with de-ionised double-distilled 
water, they were then autoclaved at 151bs psi 121°C for 30 minutes and stored at 
room temperature (15-25°C), under sterile conditions.
1A.1 Is cove’s 710% FCS/ GPS/ PHA- for peripheral lymphocyte culture.
Sterile Iscoves modified Dulbeccos medium; 10% v/v heat-inactivated fetal calf 
serum; lOpl/ml phytohaemagglutinin (PHA); 20pl/ml GPS. (GPS: 0.2M L-Glutamine, 
300mg/ml Penicillin, 500mg/ml Streptomycin monosulphate stored at -20°C).
1A.2 Roswell Park Memorial Institute (RPMO 1640 medium/ 15% FCS/ GPS/ 
NaHCOyPHA- for peripheral lymphocyte culture.
Sterile RPMI medium; 15% v/v heat inactivated fetal calf serum; 30pl/ml NaHCC>3; 
20 pl/ml phytohaemagglutinin (PHA); lOpl/ml GPS. (GPS: 0.2M L-Glutamine, 
300mg/ml Penicillin, 500mg/ml Streptomycin monosulphate stored at -20°C).
1A.3 Versene solution- for fibroblast FISH preparation, DNA extraction and 
single cell isolation.
0.02% (w/v) EDTA in lit of Hank’s medium 
1A.4 SP medium- for yeast culture.
7g/l Bacto yeast nitrogen base (without amino acids); 20g/l glucose; 55mg/l adenine 
and tyrosine. After autoclaving, 1% filter-sterilised casamino acid solution added.
1A.5 2xTY medium- for bacterial culture
16g/l Bacto tryptone; 10g/l Bacto yeast extract; 5g/l NaCl; lg/1 glucose 
1A.6 Medium for agar plates/stabs
1% w/v Bacto-agar added to the culture medium (SD or 2xTY) and autoclaved. For 
agar plates/stabs this was heated until liquefaction, cooled before addition of required 
antibiotic supplement and poured into sterile petri dishes or bijou’s straight away. The 
latter were left to dry under aseptic conditions.
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1A.7 Glycerol stocks
Three types were prepared, each containing different amounts of glycerol and yeast 
culture.
1. 250pl of yeast overnight culture; 650pl 100% sterile glycerol
2. 500pl of yeast overnight culture; 250|l x 1 100% sterile glycerol
3. 850pl of yeast overnight culture; 1 SOjliI 100% sterile glycerol
All were prepared in 1ml cryo-tubes. They were stored in the -20°C and then in the - 
80°C.
2A Solutions and buffers
De-ionised double distilled was used for the preparation of all the solutions and 
buffers. They were all stored at room temperature, unless stated otherwise.
2A.1 General solutions
2A.1.1 PBS: lOmM phosphate buffer; 2.7mM KC1; 137mM NaCl; pH 7.4
2A.1.2 20xSSC: 0.15M NaCl; 15mM Sodium citrate; pH 7
2A.1.3 lOxTBE: 90mM Tris-HCl pH 8; 90mM Boric acid; 2mM EDTA
2A. 1.4 TE: lOmM Tris-HCl, pH 8; O.lmM EDTA
2A.1.5 lOxTNE: lMTris: 1.5MNaCl; O.lmM EDTA
2A. 1.6 Fixation solution (fix): 3:1 Dried Methanol: Acetic Acid
2A.1.7 70% Acetic acid: 7ml Acetic acid, 3ml double distilled H2O
2A.2 Plasmid/Cosmid DNA maxiprep solutions
2A.2.1 Cell Resuspension Solution: 0.5M Glucose; 0.25M Tris-HCl, pH 8; 0.1M 
EDTA
2A.2.2 Cell Lvsis Solution: 0.2M NaOH; 1% SDS.
2A.2.3 Neutralisation Solution: 5M potassium acetate; 40% v/v glacial acetic acid 
2A.3 A/ifPCR reagents (Stored at -20°C)
2A.3.1 lOxPCR buffer (HT biotechnology Ltd): 0.1M Tris-HCl, pH 9; 0.5M KC1: 
15mM MgCh; 1% Triton X-100; 0.1% w/v gelatin.
2A.3.2 dNTP mix: 2mM each dATP, dCTP, dGTP, dTTP 
2A.3.3 Alu oligonucleotide primers:
ALU IF: GGA TTA CAG GCG TGA GCC A
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ALU 1R: GCC ACT GCA CTC CAG CCT G (Pharmacia) (Liu et al., 1993)
2A.4 PO P PCR reagents (Stored at -20°C)
2A.4.1 lOxPCR buffer (HT biotechnology Ltd): 0.1M Tris-HCl, pH 9; 0.5M KC1: 
15mM MgCb; 1% Triton X-100; 0.1% w/v gelatin.
2A.4.2 dNTP mix:
2A.4.3 POP oligonucleotide primer: CCGACTCGAGNNNNNNATGTGG (Oswel) 
(Telenius et al, 1992)
2A.5 Nick translation reagents (Stored at -20°C)
2A.5.1 dNTP mix: 0.2mM each dATP, dCTP, dGTP; O.lmM dTTP; O.lmM label- 
dUTP.
2A.5.2 lOx nick translation buffer: 0.5M Tris-HCl, pH 7.5; 0.1M MgSO/t; 1M DTT. 
2A.5.3 Nick translation enzyme: DNA polymerase I; DNase 1; 50% glycerol; 50mM 
Tris-HCl, pH 7.2; O.lmM DTT; 0.5 mg/ml nuclease-free BSA
2A.6 FISH solutions
2A.6.1 Pepsin buffer: 0.0IN HC1; O.lmg/ml pepsin.
2A.6.2 Paraformaldehyde buffer: lxPBS; 1% paraformaldehyde.
2A.6.3 LSI buffer for locus specific probes fVvsis):
2A.6.4 CEP buffer for repetitive sequence probes tYvsis):
2A.6.5 Hybridisation buffer for locus specific probes (lab-prepared VCOS MIX buffer: 
50% deionised formamide; 10%w/v dextran sulphate; 2xSSC pH 8. Stored at -20°C 
2A.6.6 Hybridisation buffer for repetitive sequence probed flab-prepared): 60% 
deionised formamide; 10%w/v dextran sulphate; 2xSSC pH 8. Stored at -20°C 
2A.6.7 SSCT: 4xSSC; 0.05% Tween 20
2A.6.8 Antifade medium: 1.25pg/ml 4’6-diamidino-2-phenylindole (DAPI) in 
Vectarshield mounting medium (Vector), Stored at 4°C, protected from light.
2A.7 CGH solutions
2A.7.1 Pronase for oocvte and PB separation: lOOme Pronase (Sigma), mixed with 
33ml PBS without Ca2+, Mg2+. Aliquots of 1ml prepared and stored at -20°C
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2A.7.2 Hybridisation buffer for CGH probes (lab-preparedVCOSMIX buffer: 50% 
deionised formamide; 10%w/v dextran sulphate; 2xSSC pH 8. Stored at -20°C 
2A.7.3 70% Formamide: 10ml double-distilled de-ionised H2O, 5ml 20x SSC, 35ml 
formamide
2A.7.4 SSC/Triton: 50ml 4x SSC, 50pl Triton (Sigma)
2A.8 Spreading solutions
2A.8.1 1% Tween 20: 1ml Tween 20 in 99ml of double distilled deionised H2O 
2A.8.2 IN HC1: 1ml of concentrated HC1 in 11ml of double distilled deionised H2O 
2A.8.3 Spreading solution for blastomeres and embryos: 1ml of 1% Tween, 0.1ml IN 
HC1, 8.9ml of double distilled deionised H2O.
2A.8.4 Fixative I for oocvte spreading: 5:1:4 Methanol: Acetic acid: H2O 
2A.8.5 Fixative II for oocvte spreading: as 2A.7.6
2A.8.6 Fixative solution I for oocvte spreading: Methanol- 10ml, Acetic acid- 2ml, 
H20- 8ml
2A.8.7 Fixative III for oocvte spreading: Methanol- 15ml, Acetic acid- 15ml, H2O- 
5 ml
2A.9 Solutions used for DNA extraction from blood
2A.9.1 TKM1 (low salt buffer): lOmM Tris-HCl pH 7.6, lOmM KC1, lOmM MgCl2, 
2mM EDTA
2A.9.2 TKM2 (high salt bufferl: lOmMTris-HCl pH 7.6, lOmM KC1, lOmM MgCl2, 
0.4 M NaCl, 2mM EDTA
2A.10 Lvsis buffer for fibroblast DNA extraction
1.21gr Tris, 0.19gr EDTA, 0.2gr SDS, 1.17gr NaCl in 100ml of double-distilled de­
ionised H20 . Solution autoclaved. 10mg/ 100ml of Proteinase K added after 
autoclaving.
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B: Appendix to Chapter 3. Cytogenetic analysis of embryonic 
blastomeres using the ISCN Nomenclature
Table 3.1 (ISCN): Case A, 46,XY,t(5;19)(pl2;pl2); FISH analysis o f embryos from 
one PGD cycle using the dual LSI EGRI locus-specific probe for chromosome 5 
(D5S721 5q31-SO, D5S23 5pl5.2-SG) and one locus-specific probe for chromosome 
19 (YAC19, 19q 13.2-orange) for the biopsied cells. Non-transferred embryos were 
FISHed with the LSI EGRI for chromosome 5 only.
Embryo FISH Analysis Result [No. of Blastomeresl
1
Biopsied Cell 
Remainder
nuc ish 5q31(D5S72xl), 19ql3.2 (YAC19 xl) [1] 
nuc ish 5q31 (D5S721xl), 5pl5.2 (D5S23x3) [1] 
nuc ish 5q31 (D5S721x2), 5pl5.2 (D5S231x2) [1] 
nuc ish 5q31 (D5S721xl), 5pl5.2 (D5S23x2) [1] 
nuc ish 5q31 (D5S721xl), 5pl5.2 (D5S231x 3) Til
2
Biopsied Cell 
Remainder
nuc ish 5q31 (D5S721x2), 5pl5.2 (D5S23x2), 19ql3.2 (YAC19 xl) 
[2]
nuc ish 5q31 (D5S721x2), 5pl5.2 (D5S23x2) [1] 
nuc ish 5q31 (D5S721x2), 5pl5.2 (D5S23x3) [1] 
nuc ish 5q31 (D5S721xl), 5pl5.2 (D5S23xl) [1] 
nuc ish 5q31 (D5S721x3), 5pl5.2 (D5S23x2) [1] 
nuc ish 5q31 (D5S721xl), 5pl5.2 (D5S23x2) [11
5
Remainder nuc ish 5q31 (D5S721 x2), 5pl5.2 (D5S23x4) [3] 
nuc ish 5q31 (D5S721x4), 5pl5.2 (D5S23x4) [1] 
nuc ish 5q31 (D5S721 x3), 5pl5.2 (D5S23x4) [1] 
nuc ish 5q31 (D5S721x2), 5pl5.2 (D5S23x3) m
7
Biopsied Cell 
Remainder
nuc ish 5q31 (D5S721x2), 5pl5.2 (D5S23x2), 19ql3.2 (YAC19x2) 
[2]
Transferred
8
Biopsied Cell 
Remainder
nuc ish 5q31 (D5S721xl), 5pl5.2 (D5S23x3) [1] 
nuc ish 5pl5.2 (D5S23x3) [1]
1 nucleus with no signals
nuc ish 5q31 (D5S721x2), 5pl5.2 (D5S23x3) [2]
nuc ish 5q31 (D5S721x3), 5pl5.2 (D5S23x3) \2]
9
Biopsied Cell 
Remainder
nuc ish 5q31 (D5S721xl), 5pl5.2 (D5S23xl), 19ql3.2 (YAC19xl) 
[1]
Lost
10
Biopsied Cell nuc ish 5q31 (D5S721xl), 5pl5.2 (D5S23x2), 19ql3.2 (YAC19xl)
[i] ............... _ ....
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10
Remainder
nuc ish 5q31 (D5S721x2), 5pl5.2 (D5S23x2), 19ql3.2 (YAC19xl) 
[1]
nuc ish 5q31 (D5S721x3), 5pl5.2 (D5S23x2) [2] 
nuc ish 5q31 (D5S721x3), 5pl5.2 (D5S23x4) [1] 
nuc ish 5q31 (D5S721x3), 5pl5.2 (D5S23x3) [11
11
Biopsied Cell 
Remainder
Lost
nuc ish 5q31 (D5S721x2), 5pl5.2 (D5S23x2) [4] 
nuc ish 5q31 (D5S721xl), 5pl5.2 (D5S23xl) [21
13
Biopsied Cell 
Remainder
nuc ish 5q31 (D5S721x4), 5pl5.2 (D5S23xl) [2] 
nuc ish 5q31 (D5S721xl), 5pl5.2 (D5S23xl) [1] 
nuc ish 5q31 (D5S721x2), 5pl5.2 (D5S23x2) [1] 
nuc ish 5q31 (D5S721x2), 5pl5.2 (D5S23xl) [1]
14
Biopsied Cell 
Remainder
nuc ish 5q31 (D5S721xl), 5pl5.2 (D5S23x2) [1] 
nuc ish 5q31 (D5S721xl), 5pl5.2 (D5S23xl)[l] 
nuc ish 5q31 (D5S721xl), 5pl5.2 (D5S23x2) [4] 
nuc ish 5q31 (D5S721x2), 5pl5.2 (D5S23xl) [1] 
nuc ish 5q31 (D5S721xl), 5pl5.2 (D5S23xl) [11
15
Biopsied Cell 
Remainder
Lost
nuc ish 5q31 (D5S721xl), 5pl5.2 (D5S23x3) [41
17
Biopsied Cell 
Remainder
Lost
nuc ish 5q31 (D5S721x3), 5pl5.2 (D5S231xl) [1] 
nuc ish 5q31 (D5S721x2), 5pl5.2 (D5S23xl) [51
18
Biopsied Cell 
Remainder
nuc ish 5q31 (D5S721x3), 5pl5.2 (D5S23x3) [1] 
nuc ish 5q31 (D5S721x2), 5pl5.2 (D5S23x3) [1] 
nuc ish 5q31 (D5S721x3), 5pl5.2 (D5S23x2) [1] 
nuc ish 5q31 (D5S721x3), 5pl5.2 (D5S23x3) [21
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Table 3.2 (ISCN): Case B, 46XX,t(l 1 ;22)(q23.3;ql 1.2); FISH analysis o f embryos 
from two PGD cycles using a centromeric probe for chromosome 11 (CEP 11, D11Z1 
orange),and the dual LSI VCFS locus-specific probe for chromosome 22 (D22S75 
22qll-SO, ARSA 22ql3-SG). Non-transferred embryos from the 1st PGD cycle were 
re-probed with the centromere probes for chromosomes 15 (D15Z3, SO), 16 (D16Z2 
SG), and 18 (D18Z1 SA). Non-transferred embryos from the 2nd PGD cycle were re­
probed with the centromere probes for chromosomes 18 (as 1st cycle), X  (DXZ1 SG), 
and Y (DYZ3 SO).
Embryo FISH Analysis Result fNo. of Blastomeres 1
171st cycle 
Biopsied 
Cell 
Remainder
Not biopsied
nuc ish 22qll (D22S75x2), 22ql3 (ARSAx2), 15qll.2 (D15Z3x2), 
16ql 1.1 (D16Z2x2) [1]
nuc ish 22qll (D22S75x2), 22ql3 (ARSAx2), 15qll.2 (D15Z3x2), 
18cen (D18Zlx2) HI
2/1st cycle 
Biopsied 
Cell 
Remainder
Not biopsied
nuc ish 22ql3 (ARSAxl) [1] 
nuc ish llc e n (D llZ lx l)  [1]
1071st cycle 
Biopsied 
Cell 
Remainder
nuc ish 1 lcen (D1 lZ lx l), 22ql 1 (D22S75x2), 22ql3 (ARSAx2) [1] 
nuc ish llcen (D llZ lx l), 22qll (D22S75x4), 22ql3 (ARSAx3), 
16ql 1.1 (D16Z2xl) [1]
nuc ish llcen  (D llZ lx l), 22qll (D22S75x2), 22ql3 (ARSAx3), 
16qll.l (D16Z2xl) [11
11/1st cycle 
Biopsied 
Cell
Remainder
nuc ish 22ql 1 (D22S75x4), 22ql3 (ARSAxl) [1]
nuc ish 22ql 1 (D22S75x2) [1]
nuc ish 22ql 1 (D22S75x2), 22ql3 (ARSAxl) [1J
nuc ish 22qll (D22S75x3), 22ql3 (ARSAxl), 16qll.l (D16Z2x2),
18cen (D18Zlxl) [1]
nuc ish 22ql 1 (D22S75x3), 22ql3 (ARSAxl), 15qll.2 
(D15Z3x2),16qll.l (D16Z2x2), 18cen(D18Zlx2) [1] 
nuc ish 22qll (D22S75x2), 22ql3 (ARSAxl), 15qll.2 
(D15Z3xl),16qll.l (D16Z2xl) [1]
nuc ish llcen (D llZ lx l), 22ql3 (ARSAxl), 15qll.2 
(D15Z3xl),16qll.l (D16Z2xl), 18cen(D18Zlx2) [1] 
nuc ish llcen  (D llZlx2), 22qll (D22S75x2), 15qll.2 (D15Z3xl) 
[1]
1271st cycle 
Biopsied 
Cell
Remainder
nuc ish 22ql 1 (D22S75x3/4) [1]
nuc ish 22ql 1 (D22S75xl), 22ql3 (ARSAx5)
nuc ish 22ql 1 (D22S75x2), 22ql3 (ARSAx2), 15qll.2
(D15Z3x2),16qll.l (D16Z2x3), 18cen(D18Zlx2) [1]
nuc ish 22qll (D22S75x2), 22ql3 (ARSAx2), 15qll.2
(D15Z3x2),16qll.l (D16Z2xl), 18cen(D18Zlx2) [1]
.
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172nd cycle 
Biopsied 
Cell 
Remainder
No result
nuc ish llcen (D llZ lx l), 22qll (D22S75x2), 22ql3 (ARSAx2), 
18cen (D18Zlx2), Xcen (DXZlx3)[l]
nuc ish llcen (D llZ lx l), 22qll (D22S75x2), 22ql3 (ARSAx2), 
18cen (D18Zlx2), Xcen (DXZlx3), Ycen (DYZ3x2)[l] 
nuc ish llcen  (D llZ lx l), 22qll (D22S75x3), 22ql3 (ARSAx3), 
18cen (D18Zlx2), Xcen (DXZlxl), Ycen (DYZ3x2) fll
2/2nd cycle 
Biopsied 
Cell 
Remainder
nuc ish 1 lcen (D1 1Z1x2), 22ql 1 (D22S75xl), 22ql3 (ARSAxl) [1] 
nuc ish 1 lcen (D1 1Z1x2), 22ql 1 (D22S75x3), 22ql3 (ARSAx2) [1] 
nuc ish 1 lcen (D1 1Z1x2), 22ql 1 (D22S75x2), 22ql3 (ARSAx2) Til
3/2“* cycle 
Biopsied 
Cell 
Remainder
nuc ish 1 lcen (D1 1Z1x2), 22ql 1 (D22S75x2), 22ql3 (ARSAx2) [1] 
Transferred
5/2"d cycle 
Biopsied 
Cell 
Remainder
nuc ish 22ql 1 (D22S75xl), 22ql3 (ARSAx3) [1]
nuc ish 1 lcen (D1 lZlx2), 22ql 1 (D22S75x3), 22ql3 (ARSAx2) [1]
nuc ish 1 lcen (D1 lZ lx l), 22ql 1 (D22S75xl), 22ql3 (ARSAxl) HI
672nd cycle 
Biopsied 
Cell 
Remainder
nuc ish 1 lcen (D1 1Z1x2), 22ql 1 (D22S75x2), 22ql3 (ARSAx2) [2] 
Transferred
7/2ml cycle 
Biopsied 
Cell 
Remainder
nuc ish 1 lcen (D1 1Z1x2), 22ql 1 (D22S75x2)[l] 
nuc ish 1 lcen (D1 lZ lx l), 22ql 1 (D22S75x2), 22ql3 (ARSAx2) [1] 
nuc ish llcen  (D1 1Z1x2), 22ql 1 (D22S75x2), 22ql3 (ARSAx2) [11
872“* cycle 
Biopsied 
Cell 
Remainder
nuc ish 22qll (D22S75x4), 22ql3 (ARSAx3) [2] 
Lost
9/2”“ cycle 
Biopsied 
Cell 
Remainder
No result
nuc ish 22qll (D22S75xl), 18cen (D18Zlxl), Xcen (DXZlxl), Ycen 
(DYZ3xl) [1]
nuc ish 22qll (D22S75x2), 22ql3 (ARSAxl), Xcen (DXZlxl), Ycen 
(DYZ3xl) [1]
nuc ish 22qll (D22S75x3), 22ql3 (ARSAxl), 18cen (D18Zlxl), 
Xcen (DXZlxl), Ycen (DYZ3xl) [1]
nuc ish llcen (D llZlx3), 22qll (D22S75x3), 22ql3 (ARSAxl), 
18cen (D18Zlx3), Xcen (DXZlx2), Ycen (DYZ3x3) fll
370
Appendices
Table 3.3 (ISCN): Case D, 45XY,t(13;21)(qlO;qlO); FISH analysis o f embryos from 
two PGD cycles using the locus-specific probe LSI13 for chromosome 13 (RBI SG), 
the locus-specific probe for chromosome 21(D21S529 SO), and the subtelomere probe 
for chromosome 21 (TEL21 orange). Non-transferred embryos from the 1st PGD cycle 
were re-probed with the centromere probes for chromosomes 18 (D18Z1), X  (DXZ1 
SG), andY  (DYZ3 SO).
Embryo FISH Analysis Result [No. of Blastomeres]
2/1st cycle 
Biopsied 
Cell 
Remainder
nuc ish 13ql4 (RBlx3), 21ql3.2 (D21S529x2), 21qter (TEL21qx2) [1] 
Lost
371st cycle 
Biopsied 
Cell 
Remainder
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2), 21qter (TEL21qx2) [1] 
Transferred
471st cycle 
Biopsied 
Cell 
Remainder
nuc ish 21ql3.2 (D21S529x3) [1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x3), 18cen (D18Zlx2),
Xcen (DXZlxl), Ycen (DYZ3xl) [1]
nuc ish 13ql4 (RBlxl), 21ql3.2 (D21S529xl) [1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x3) [1]
nuc ish 13ql4 (RBlxl), 21ql3.2 (D21S529xl), Ycen (DYZ3xl) [11
5/1st cycle 
Biopsied 
Cell 
Remainder
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2), 21qter (TEL21qx2) [2] 
Transferred
111st cycle 
Biopsied 
Cell 
Remainder
nuc ish 13ql4 (RBlx2), 21qter (TEL21qx2) [1] 
Transferred
9/1st cycle 
Biopsied 
Cell 
Remainder
Lost
Inconclusive
l/2"d cycle 
Biopsied 
Cell 
Remainder
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2), 21qter (TEL21qx2) [2] 
Transferred
2/2”“ cycle 
Biopsied 
Cell 
Remainder
nuc ish 13ql4 (RBlx3), 21ql3.2 (D21S529x2), 21qter(TEL21qxl) [1] 
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529xl) [1] 
nuc ish 13ql4 (RBlxl), 21ql3.2 (D21S529xl) D1
3/21”1 cycle 
Biopsied 
Cell 
Remainder
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529xl), 21qter (TEL21qxl) [1] 
nuc ish 13ql4 (RBlx3), 21ql3.2 (D21S529x2), 21qter (TEL21qx2) [1] 
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2), 21qter(TEL21qxl) [1] 
nuc ish 13ql4 (RBlx3), 21ql3.2 (D21S529x2) fll
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nuc ish 13ql4 (RBlx3), 21ql3.2 (D21S529xl) [1]
4/2"d cycle 
Biopsied 
Cell 
Remainder 
4/2nd cycle 
Remainder
nuc ish 13ql4 (RBlx3), 21ql3.2 (D21S529xl), 21qter (TEL21qxl) [1]
nuc ish 13ql4 (RBlxl) [2]
nuc ish 13ql4 (R B lxl), 21ql3.2 (D21S529xl) [1]
nuc ish 13ql4 (RBlx3), 21ql3.2 (D21S529xl), 21qter (TEL21qxl) [1]
5/2nd cycle 
Biopsied 
Cell 
Remainder
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2), 21qter (TEL21qx2) [1] 
Transferred
6/2nd cycle 
Biopsied 
Cell 
Remainder
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2), 21qter (TEL21qx2) [1] 
Transferred
112^ cycle 
Biopsied 
Cell 
Remainder
nuc ish 13ql4 (RBlx4), 21ql3.2 (D21S529x2), 21qter (TEL21qxl) [1]
nuc ish 13ql4 (RBlx4), 21ql3.2 (D21S529x2) [2]
nuc ish 13ql4 (RBlx3), 21ql3.2 (D21S529x2), 21qter (TEL21qxl) [1]
nuc ish 13ql4 (RBlx6), 21ql3.2 (D21S529x2) [1]
nuc ish 13ql4 (RBlxl), 21ql3.2 (D21S529x2), 21qter (TEL21qx2) [1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529xl), 21qter (TEL21qx3) [1]
8/2nd cycle 
Biopsied 
Cell 
Remainder
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x3), 21qter (TEL21qx2) [1] 
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529xl), 21qter (TEL21qx2) [1] 
nuc ish 13ql4 (RBlx5), 21ql3.2 (D21S529x3), 21qter (TEL21qxl) [2] 
nuc ish 13ql4 (RBlx3), 21ql3.2 (D21S529x2), 21qter (TEL21qx2) [1] 
nuc ish 13ql4 (RBlx3), 21ql3.2 (D21S529x3) \21
9/2nd cycle 
Biopsied 
Cell
Remainder
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2) [1]
nuc ish 13ql4 (RBlx4), 21ql3.2 (D21S529x3) [1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x3), 21qter (TEL21qxl) [1]
nuc ish 21ql3.2 (D21S529xl), 21qter (TEL21qxl) [1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2) [1]
nuc ish 13ql4 (RBlx2), 21qter (TEL21qx2) [1]
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Table 3.4(ISCN): Case E, 45XY,t(l3; 14)(ql0;ql0); FISH analysis o f embiyos from 
two PGD cycles using the locus-specific probe LSI 13 for chromosome 13 (RBI SG), 
and the TelVysion 14q subtelomere probe for chromosome 14 (D14S308 SO). Non­
transferred embryos from the 1st PGD cycle were re-probed with centromere probes 
for chromosomes 4 (D4Z1 SG), 15 (D15Z3 SO), and 18 (D18Z1 SA). Non-transferred 
embryos from the 2nd PGD cycle were re-probed with the centromere probes for 
chromosomes 18 (D18Z1 SA), X  (DXZ1 SG), and Y (DYZ3 SO).
Embryo FISH Analysis Result [No. of Blastomeres]
l / l st cycle 
Biopsied 
Cell 
Remainder
nuc ish 13ql4 (RBlx2), 14qter (D14S308xl) [1] 
nuc ish 13ql4 (RBlx2), 14qter (D14S308x2) [3] 
nuc ish 13ql4 (RBlx2) [4] 
nuc ish 13ql4 (RBlx2), 4cen (D4Zlx2) [1]
nuc ish 13ql4 (RBlx3), 14qter (D14S308x2), 15qll.2 (D15Z3xl), 
18cen (D18Zlx2) fl]
2/1st cycle 
Biopsied 
Cell 
Remainder
nuc ish 13ql4 (RBlx2), 14qter (D14S308x2) [1] 
Transferred
3/1^ cycle 
Biopsied 
Cell 
Remainder
nuc ish 13ql4 (RBlx2), 14qter (D14S308x2) [2] 
Transferred
4/1st cycle 
Biopsied 
Cell 
Remainder
nuc ish 13ql4 (RBlx2), 14qter (D14S308x2) [1]
nuc ish 13ql4 (RBlx2), 14qter (D14S308x2), 4cen (D4Zlx2), 15qll.2
(D15Z3x2), 18cen (D18Zlx2) [3]
nuc ish 13ql4 (RBlxl), 14qter (D14S308xl), 4cen (D4Zlxl), 18cen 
(D18Zlxl) [1]
nuc ish 13ql4 (RBlxl), 14qter (D14S308xl), 4cen (D4Zlxl), 15ql 1.2 
(D15Z3x2), 18cen (D18Zlx2) [1]
571st cycle 
Biopsied 
Cell 
Remainder
nuc ish 13ql4 (RBlx2), 14qter (D14S308x2) [1] 
Transferred
6/1* cycle 
Biopsied 
Cell 
Remainder
nuc ish 13ql4 (RBlx2), 14qter (D14S308x2) [1]
nuc ish 13ql4 (RBlx2), 14qter (D14S308x2), 4cen (D4Zlx2), 15ql 1.2
(D15Z3x2), 18cen (D18Zlx2) [1]
nuc ish 13ql4 (RBlx2), 14qter (D14S308xl), 4cen (D4Zlx2), 15qll.2 
(D15Z3xl), 18cen(D18Zlx3) [1}
111st cycle 
Biopsied 
Cell 
Remainder
nuc ish 13ql4 (RBlxl) [2]
nuc ish 13ql4 (RBlxl), 14qter (D14S308xl), 4cen (D4Zlx2), 15ql 1.2
(D15Z3x2), 18cen (D18Zlx2) [2]
nuc ish 13ql4 (RBlxl), 14qter (D14S308xl) fll
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7/181 cycle 
Remainder
nuc ish 13ql4 (RBlx3), 14qter (D14S308xl) [1]
nuc ish 13ql4 (RBlx3), 14qter (D14S308xl), 4cen (D4Zlxl), 15qll.2
(D15Z3xl) [1]
nuc ish 13ql4 (RBlx2), 14qter (D14S308x2), 4cen (D4Zlx2), 15qll.2 
(D15Z3x2), 18cen(D18Zlx2) [1]
nuc ish 13ql4 (RBlx2), 14qter (D14S308xI), 4cen (D4Zlx3), 
15qll.2(D15Z3x3), 18cen(D18Zlx3) [11
8/1st cycle 
Biopsied 
Cell 
Remainder
nuc ish 13ql4 (RBlx3), 14qter (D14S308x3) [2]
nuc ish 13ql4 (RBlx2), 14qter (D14S308x2) [2]
nuc ish 13ql4 (RBlx2), 14qter (D14S308x2), 15qll.2 (D15Z3xl) [1]
nuc ish 13ql4 (RBlxl), 14qter (D14S308xl), 15qll.2 (D15Z3xl) [1]
nuc ish 13ql4 (RBlxl), 14qter (D14S308xl), 4cen (D4Zlxl), 15ql 1.2
(D15Z3xl) [1]
nuc ish 4cen (D4Zlx2), 15ql 1.2 (D15Z3xl), 18cen (D18Zlxl) [2] 
nuc ish 13ql4 (RBlx3), 14qter (D14S308xl), 4cen (D4Zlx3), 15ql 1.2 
(D15Z3x2), 18cen (D18Zlx2) [1]
nuc ish 13ql4 (RBlx2), 14qter (D14S308xl), 4cen (D4Zlxl), 15qll.2 
(D15Z3xl), 18cen(D18Zlxl) [1]
nuc ish 13ql4 (RBlx2), 4cen (D4Zlx2), 15qll.2 (D15Z3xl), 18cen 
(D18Zlx2) [1]
nuc ish 13ql4 (RBlx3), 14qter (D14S308x2), 4cen (D4Zlx2), 15qll.2 
(D15Z3x2), 18cen (D18Zlx2) [11
l/2nd cycle 
Biopsied 
Cell 
Remainder
nuc ish 13ql4 (RBlxl), 14qter (D14S308xl) [1]
nuc ish 13ql4 (RBlx3), 14qter (D14S308x4), 18cen (D18Zlx2), Xcen
(DXZlx2), Ycen (DYZ3x2) [1]
nuc ish 13ql4 (RBlx2), 14qter (D14S308x2), 18cen (D18Zlx3), Xcen 
(DXZlx3), Ycen (DYZ3x2) [1]
nuc ish 13ql4 (RBlx2), 14qter (D14S308x4), 18cen (D18Zlxl), Xcen 
(DXZlx3), Ycen (DYZ3x2) [11
2/2“  cycle 
Biopsied 
Cell 
Remainder
nuc ish 13ql4 (RBlxl), 14qter(D14S308x2) [1] 
nuc ish 13ql4 (RBlxl), 14qter (D14S308x2) [1] 
nuc ish 13ql4 (RBlx2), 14qter (D14S308xl) [2] 
nuc ish 13ql4 (RBlx2), 14qter (D14S308x2) [1] 
nuc ish 13ql4 (RBlx3), 14qter (D14S308xl) [11
3/2"“ cycle 
Biopsied 
Cell 
Remainder
nuc ish 13ql4 (RBlx2), 14qter (D14S308x2) [1] 
Transferred
5/2nd cycle 
Biopsied 
Cell 
Remainder
nuc ish 13ql4 (RBlx2), 14qter (D14S308xl) [1] 
nuc ish 13ql4 (RBlx2), 14qter (D14S308x3) [1] 
nuc ish 13ql4 (RBlx2), 14qter (D14S308x2) [3] 
nuc ish 13ql4 (RBlx2), 14qter (D14S308xl) [1] 
nuc ish 13ql4 (RBlxl), 14qter (D14S308x2) [1]
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6/2nd cycle 
Biopsied 
Cell 
Remainder
nuc ish 13ql4 (RBlx2), 14qter (D14S308x2) [2] 
Transferred
7/2nd cycle 
Biopsied 
Cell 
Remainder
Lost
nuc ish 13ql4 (RBlxl), 14qter (D14S308xl) [1] 
nuc ish 13ql4 (RBlx2), 14qter (D14S308x2) Til
8/2nd cycle 
Biopsied 
Cell 
Remainder
nuc ish 13ql4 (RBlxl), 14qter (D14S308xl) [1] 
Lost
9/2nd cycle 
Biopsied 
Cell 
Remainder
nuc ish 13ql4 (RBlxl), 14qter (D14S308x3) [1]
nuc ish 13ql4 (RBlx2), 14qter (D14S308x3), 18cen (D18Zlx2), Xcen
(DXZlx2), Ycen (DYZ3xl) [2]
nuc ish 13ql4 (RBlxl), 14qter (D14S308x3), 18cen (D18Zlx2), Xcen 
(DXZlx2), Ycen (DYZ3xl) [1]
nuc ish 13ql4 (RBlx2), 14qter (D14S308x3), 18cen (D18Zlx2), Xcen 
(DXZlx4), Ycen (DYZ3x2) fH
Table 3.5(1SCN): Case F, possible gonadal mosaicism for trisomy 21; FISH analysis 
o f embryos from two PGD cycles using the locus-specific probe LSI13 for 
chromosome 13 (RBI SG), and the locus-specific probe for chromosome 21(D21S529 
SO). Non-transferred embryos from the 2nd PGD cycle were re-probed with 
centromere probes for chromosomes 15 (D15Z1 SO), and 18 (D18Z1 SA) and the 
locus-specific probe for chromosome 22 (bcr SG).
Embryo FISH Analysis Result [No. of Blastomeres]
111st cycle 
Biopsied Cell 
Remainder
Lost
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2) [5] 
nuc ish 13ql4(RBlx4),21ql3.2(D21S529x4)[7] 
nuc ish 13ql4 (RBlx3), 21ql3.2 (D21S529x2) \2\
271st cycle 
Biopsied Cell 
Remainder
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2) [1] 
Frozen
371st cycle 
Biopsied Cell 
Remainder
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2) [1] 
Frozen
471st cycle 
Biopsied Cell 
Remainder
No signals visible 
Inconclusive
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5/1 * cycle 
Biopsied Cell 
Remainder
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2) [2] 
Transferred
6/1st cycle 
Biopsied Cell 
Remainder
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2) [1] 
Frozen
7/1st cycle 
Biopsied Cell 
Remainder
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2) [2] 
Frozen
8/1* cycle 
Biopsied Cell 
Remainder
Lost
nuc ish 13ql4 (RBlx4), 21ql3.2 (D21S529x2) [2]
nuc ish 21ql3.2 (D21S529x2) [2]
nuc ish 21ql3.2 (D21S529xl) [2]
nuc ish 13ql4 (RBlx4), 21ql3.2 (D21S529x4) [3]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2) [1]
nuc ish 13ql4 (RBlx4), 21ql3.2 (D21S529x5) [11
9/1* cycle 
Biopsied Cell 
Remainder
Inconclusive
Frozen
10/1* cycle 
Biopsied Cell 
Remainder
Inconclusive, background 
Inconclusive
11/1* cycle 
Biopsied Cell 
Remainder
Not biopsied
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x4) [11
12/1* cycle 
Biopsied Cell 
Remainder
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x3) [11 
nuc ish 13ql4 (RBlx4), 21ql3.2 (D21S529x4) [21
13/1* cycle 
Biopsied Cell 
Remainder
nuc ish 13ql4 (RBlx4), 21ql3.2 (D21S529xl) [11 
Inconclusive
14/1* cycle 
Biopsied Cell 
Remainder
nuc ish 13ql4 (RBlx3), 21ql3.2 (D21S529x3) [1] 
nuc ish 21ql3.2 (D21S529x4) [31
15/1* cycle 
Biopsied Cell 
Remainder
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2) [1] 
Frozen
16/1* cycle 
Biopsied Cell 
Remainder
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2) [2] 
Transferred
17/1* cycle 
Biopsied Cell 
Remainder
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x3) [1] 
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x4) [1] 
nuc ish 13ql4 (RBlx4), 21ql3.2 (D21S529x4) [2] 
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2) [11
376
Appendices
18/Is'cycle 
Biopsied Cell 
Micronucleus 
Remainder
3PN/lst cycle 
Remainder
1/2“* cycle 
Remainder
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2) [1] 
nuc ish 21ql3.2 (D21S529xl) [1] 
nuc ish 13ql4 (RBlx4), 21ql3.2 (D21S529x3) [4] 
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2) [13] 
nuc ish 13ql4 (RBlx4), 21ql3.2 (D21S529x4) [8] 
nuc ish 13ql4 (RBlx8), 21ql3.2 (D21S529x4) [11
nuc ish 13ql4 (RBlx3), 21ql3.2 (D21S529x3) [11] 
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x3) [1] 
nuc ish 13ql4 (RBlx3), 21ql3.2 (D21S529x2) [1] 
nuc ish 13ql4 (RBlxl), 21ql3.2 (D21S529x3) [1] 
nuc ish 13ql4 (RBlx2),21ql3.2 (D21S529x2) [21
2/2”“ cycle 
Biopsied Cell 
Remainder
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2), 15cen (D15Zlx2), 
18cen (D18Zlx2), 22ql 1.2 (bcrx2) [2]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2), 15cen (D15Zlxl), 
18cen(D18Zlxl), 22qll.2 (bcrxl) [1]
nuc ish 13ql4 (RBlxl), 21ql3.2 (D21S529xl), lost after 2"“ round, 
[1]
nuc ish 15cen (D15Zlxl) [1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2), 15cen (D15Zlxl), 
18cen(D18Zlx2), 22qll.2 (bcrx2) P I_________________________
Lost
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2), 15cen (D15Zlx2), 
18cen (D18Zlx2), 22ql 1.2 (bcrx2) [61_________________________
3/2“* cycle 
Biopsied Cell
Remainder
nuc ish 21ql3.2 (D21S529x2), covered with cytoplasm [1] 
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2) [1] 
Transferred
4/2”“ cycle 
Biopsied Cell
Remainder
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2), 15cen (D15Zlx2), 
18cen (D18Zlx2), 22ql 1.2 (bcrx2) [1]
Transferred
5/2”“ cycle 
Biopsied Cell
Remainder
nuc ish 13ql4 (RBlxl), 21ql3.2 (D21S529x2) [1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2) [1]
nuc ish 13ql4 (RBlxl), 21ql3.2 (D21S529x2), 15cen (D15Zlxl),
18cen (D18Zlxl), 22qll.2 (bcrxl) [1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2), 15cen (D15Zlx2), 
18cen (D18Zlx2), 22qll.2 (bcix2) [1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2), 15cen (D15Zlx2), 
18cen (D18Zlx3), 22ql 1.2 (bcrx2) [1]
nuc is* 13ql4 (RBlxl), 21ql3.2 (D21S529xl), ), 15cen (D15Zlx2), 
18cen (D18Zlx3), 22qll.2 (bcrx2) [11_________________________
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6/2nd cycle 
Biopsied Cell
Remainder
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2) [1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x3) [1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2), 22qll.2 (bcrx3) [1]
nuc ish 13ql4 (RBlxl), 21ql3.2 (D21S529x2), 15cen (D15Zlx2),
18cen (D18Zlx2), 22qll.2 (bcrx2) [1]
nuc ish 13ql4 (RBlx3), 21ql3.2 (D21S529x3), lost after 2nd round 
[1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2), 15cen (D15Zlx2), 
18cen (D18Zlx2), 22qll.2 (bcrx2) [2]
nuc ish 13ql4 (RBlx3), 21ql3.2 (D21S529x2), lost after 2nd round 
[1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2), 15cen (D15Zlx2), 
18cen (D18Zlxl), 22ql 1.2 (bcrx2) [1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529xl), lost after 2nd round 
[1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2), 15cen (D15Zlx2), 
18cen (D18Zlx3), 22ql 1.2 (bcrx2) fl]
7/2“* cycle 
Biopsied Cell
Remainder
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2)[l]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529xl) [1]
nuc ish 13ql4 (RBlx3), 21ql3.2 (D21S529x2), 15cen (D15Zlxl),
18cen(D18Zlxl), 22qll.2 (bcrx2) [1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2), 15cen (D15Zlx2), 
18cen (D18Zlx2), 22ql 1.2 (bcrx3) [1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529xl), 15cen (D15Zlx2), 
18cen (D18Zlx2), 22ql 1.2 (bcrx2) [3]
nuc ish 13ql4 (RBlx3), 21ql3.2 (D21S529x2), 15cen (D15Zlx2), 
18cen (D18Zlx2), 22ql 1.2 (bcrx2) [1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2), lost after 20d round 
[1]
9/2nd cycle 
Biopsied Cell 
Remainder
nuc ish 13ql4 (RBlx3), 21ql3.2 (D21S529x2) [1]
nuc ish 13ql4 (RBlxl), 21ql3.2 (D21S529xl), 15cen (D15Zlx2),
18cen(D18Zlx2), 22qll.2 (bcrx2) [1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2), 15cen (D15Zlx2), 
18cen (D18Zlx2), 22ql 1.2 (bcrx2) [1]
nuc ish 13ql4 (RBlxl), 21ql3.2 (D21S529xl), 15cen (DISZlxl), 
18cen (D18Zlxl), 22ql 1.2 (bcrxl) [1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2), 15cen (D15Zlx3), 
18cen (D18Zlx2), 22qll.2 (bcrx2) [1]
nuc ish 13ql4 (RBlxl), 21ql3.2 (D21S529x2), 15cen (D15Zlx3), 
18cen(D18Zlx2), 22qll.2 (bcrx3) [1]
nuc ish 13ql4 (RBlxl), 21ql3.2 (D21S529x2), 15cen (D15Zlx2), 
18cen(D18Zlx5), 22qll.2 (bcrx2) [1]
10/2"d cycle 
Biopsied Cell
Remainder
No signals [1]
Lost [1]
Fragmented nuclei, no signals visible
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11/2“  cycle 
Biopsied Cell 
Remainder
nuc ish 21ql3.2 (D21S529xl) [1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2), 15cen (DI5Zlxl), 
18cen (D18Zlx2), 22qll.2 (bcrx2) [3]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529xl), 15cen (D15Zlx2), 
18cen (D18Zlx2), 22qll.2 (bcrx2) [1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2), 15cen (D15Zlx2), 
18cen (D18Zlx2), 22ql 1.2 (bcix3) [2]
nuc ish 13ql4 (RBlxl), 21ql3.2 (D21S529x2), 15cen (D15Zlx2), 
18cen (D18Zlx2), 22ql 1.2 (bcrx2) [1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2), 15cen (D15Zlx2), 
18cen (D18Zlx3), 22ql 1.2 (bcrxl) [1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2), lost after 2nd round 
[1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2), 15cen (D15Zlx2), 
18cen (D18Zlx2), 22ql 1.2 (bcrx2) f 11
12/2”“ cycle 
Biopsied Cell
Remainder
nuc ish 13ql4 (RBlx3), 21ql3.2 (D21S529x3) [1]
nuc ish 13ql4 (RBlx3), 21ql3.2 (D21S529x2) [1]
nuc ish 15cen (D15Zlx2), 18cen (D18Zlx2), 22ql 1.2 (bcrx3) [1]
nuc ish 13ql4 (RBlxl), 21ql3.2 (D21S529xl), 15cen (D15Zlxl),
18cen (D18Zlx2), 22qll.2 (bcrx3) [1]
nuc ish 15cen (D15Zlx3), 18cen (D18Zlxl) [1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529xl), 15cen (D15Zlxl),
18cen(D18Zlx2), 22qll.2  (bcrx3) [1]
nuc ish 13ql4 (RBlx3), 21ql3.2 (D21S529x3), 15cen (D15Zlx2), 
18cen (D18Zlx2), 22qll.2  (bcrx2) [1]
nuc ish 13ql4 (RBlx3), 21ql3.2 (D21S529x2), lost after 2nd round 
[1]
13/2”“ cycle 
Biopsied Cell
Remainder
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2) [1] 
No signals [1]
Lost
14/2nd cycle 
Biopsied Cell
Remainder
nuc ish 13ql4 (RBlx3), 21ql3.2 (D21S529xl) [1]
No signals [1]
nuc ish 13ql4 (RBlx3), 21ql3.2 (D21S529xl), lost after 2nd round 
[3]
nuc ish 13ql4 (RBlx3), 21ql3.2 (D21S529xl), 15cen (D15Zlx2), 
18cen (D18Zlx2), 22qll.2 (bcrx3) [1]
nuc ish 13ql4 (RBlx3), 21ql3.2 (D21S529xl), 15cen (D15Zlx2), 
18cen (D18Zlx2), 22ql 1.2 (bcrx2) [11
15/2"“ cycle 
Biopsied Cell
Remainder
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2), 15cen (D15Zlx2), 
18cen (D18Zlx2), 22ql 1.2 (bcrx2) [2]
Transferred
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16/2“* cycle 
Biopsied Cell
Remainder
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2) [1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529xl) [1]
nuc ish 13ql4 (RBlxl), 21ql3.2 (D21S529x2), 15cen (D15Zlx2),
18cen (D18Zlx2), 22qll.2 (bcrx3) [1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529xl), 15cen (D15Zlx2), 
18cen (D18Zlx2), 22qll.2 (bcrx2) [1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x3), IScen (D15Zlx3), 
18cen (D18Zlx2), 22ql 1.2 (bcrxl) [1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529x2), 15cen (D15Zlx3), 
18cen (D18Zlxl), 22ql 1.2 (bcrxl) [1]
nuc ish 13ql4 (RBlx3), 21ql3.2 (D21S529x2), 15cen (D 15Zlxl),), 
18cen (D18Zlx4), 22qll.2 (bcrxl) HI
19/2nd cycle 
Remainder nuc ish 13ql4 (RBlx5), 21ql3.2 (D21S529x3), 15cen (D15Zlx4), 
18cen(D18Zlxl), 22qll,2 (bcrxl) [11
20/2nd cycle 
(OPN) 
Biopsied Cell 
Remainder
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529xl) [1]
nuc ish 13ql4 (RBlx2), 21ql3.2 (D21S529xl), 18cen (D18Zlxl),
22qll.2(bcrxl) HI
21/2”“ cycle 
(3PN) 
Biopsied Cell 
R em ainder
Lost
nuc ish 13ql4 (RBlxl), 21ql3.2 (D21S529x2), 15cen (D15Zlx2), 
18cen (D18Zlx2), 22ql 1.2 (bcrxl) [1]
nuc ish 13ql4 (RBlx4), 21ql3.2 (D21S529x3), 15cen (D15Zlx2), 
18cen (D18Zlx3), 22ql 1.2 (bcrx3) [11
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C: Appendix to Chapter 4. Cytogenetic analysis of metaphase II 
oocytes and 1st PBs with the ISCN Nomenclature
Table 4.1 (ISCN): FISH analysis o f human metaphase II oocytes using the satellite III 
probe for chromosome l(lq l2 , SG), the centromeric probe for chromosome 12 
(D12Z1, orange), and the centromeric probe for chromosome X  (DXZ1, SO)
Oocyte/patient no. FISH Analysis Result
5coll(t) ish 12cen (D12Zlxl), Xcen (DXZlxl)
6col2(b) ish 12cen (D12Zlxl), Xcen (DXZlxl)
3782.1 ish.lql2 (xl), 12cen (D12Zlxl), Xcen (DXZlxl)
3783.2 ish lq l2  (xl), 12cen (D12Zlxl), Xcen (DXZlxl)
3855.1 ish Xcen (DXZlxl)
1009.4 ish 12cen(D12Zlxl), Xcen (DXZlxl)
971.3 ish lq l2  (xl), 12cen(D12Zlxl), Xcen (DXZlxl)
968.1 ish lq l2  (xl), Xcen (DXZlxl)
968.2 ish lq l2  (xl), Xcen (DXZlxl)
3416.11 ish Xcen (DXZlxlsep), Xcen (DXZlxlsep)
3416.12 ish Xcen (DXZlxl)
Table 4.2 (ISCN): FISH analysis o f  corresponding 1st PBs using the satellite III probe 
for chromosome l(lql2, SG), the centromeric probe for chromosome 12 (D12Z1, 
orange), and the centromeric probe for chromosome X  (DXZ1, SO)
PR/patient no. FISH Analysis Result
968.1 PB ish lq l2  (xl), 12cen (D12Zlxlsep), 12cen (D12Zllxlsep), Xcen 
(DXZlxl doublet)
3416.11 PB ish 12cen (D12Zlxl), Xcen (DXZlxl)
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Table 4.3 (ISCN): FISH analysis o f human metaphase II oocytes using the 
centromeric probe for chromosome 4 (D4Z1, SG), and the centromeric probe for 
chromosome 17 (D17Z1, SO)
Oocyte/patient no. FISH Analysis Result
3969.2 ish 17cen (D17Zlxl)
3969.3 No signals
3969.4 ish 4cen(D4Zlxlsep), 4cen(D4Zlxlsep), 17cen(D17Zlxl)
3967.3 No signals
3967.8 ish 17cen(D17Zlxl)
3967.9 ish 17cen (D17Zlxlsep), 17cen (D17Zlxlsep)
1084.4 ish 17cen(D17Zlxl)
1084.6 ish 17cen (D17Zlxl)
1084.8 ish 17cen (D17Zlxl)
Table 4.4 (ISCN): FISH analysis o f  corresponding 1st PBs using the centromeric 
probe for chromosome 4 (D4Z1, SG), and the centromeric probe for chromosome 17 
(D17Z1, SO)
PB/patient no. FISH Analysis Result
3969.4 PB No signals
3967.3 PB ish 17cen (D17Zlxl)
3967.9 PB ish 17cen (D17Zlxlsep), 17cen(D17Zlxlsep)
1084.8 PB ish 17cen (D17Zlxl)
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Table 4.5 (ISCN): FISH analysis o f human metaphase II oocytes using the 
centromeric probe for chromosome 4 (D4Z1, SG or SO), the centromeric probe for 
chromosome 12 (D12Z1, orange), and the centromeric probe for chromosome 17 
(D17Z1, SOorSG)
Oocyte/patient
no.
FISH Analysis Result
3892.1 ish 12cen (D12Zlxl), 17cen(D17Zlxl)
3892.2 ish 4cen (D4Zlxl), 12cen (D12Zlxl), 17cen(D17Zlxl)
3892.5 ish 12cen (D12Zlxl), 17cen(D17Zlxl)
1033.4 ish 12cen (D12Zlxl)
1118.5 ish 17cen (D17Zlxl)
1118.6 ish 17cen(D17Zlxl)
3847.1 ish 12cen (D12Zlxl)
1054.1 ish 4cen (D4Zlxl), 17cen (D17Zlxl)
3839.1 ish 12cen (D12Zlxl)
4077.1 ish 4cen (D4Zlxl), 17cen (D17Zlxl)
4091.2 ish 4cen (D4Zlxl)
1169.3 ish4cen (D4Zlxl), 17cen (D17Zlxl)
4130.6 ish4cen (D4Zlxl), 17cen (D17Zlxl)
1152.1 ish 4cen (D4Zlxl)
4176.5 ish 4cen (D4Zlxl), 12cen (D12Zlxl), 17cen(D17Zlxl)
4176.8 ish 4cen (D4Zlxl), 12cen (D12Zlxl), 17cen (D17Zlxl)
4181.1 ish 4cen (D4Zlxl), 12cen(D12Zlxl), 17cen(D17Zlxl)
4181.2 ish 4cen (D4Zlxl), 12cen (D12Zlxl), 17cen(D17Zlxl)
4181.3 ish4cen(D4Zlxl), 12cen (D12Zlxl), 17cen (D17Zlxl)
4181.4 ish4cen(D4Zlxl), 12cen (D12Zlxl), 17cen (D17Zlxl)
4184.2 ish 4cen (D 4Z lxl), 12cen (D12Zlxl), 17cen (D17Zlxl)
1209.2 ish4cen(D4Zlxl), 12cen (D12Zlxl), 17cen(D17Zlx2)
1243.6 ish 4cen (D4Zlxl), 12cen (D12Zlxl), 17cen (D17Zlxlsep), 
17cen (D17Zlxlsep) or
4cen (D4Zlxlsep), 12cen (D12Zlxlsep), 17cen (D17Zlxlsep), 
17cen (D17Zlxlsep)
4257.1 ish 12cen (D12Zlxl)
4257.2 ish 4cen (D4Zlxl), 12cen (D12Zlxl), 17cen (D17Zlxl)
4257.3 ish 4cen (D4Zlxl), 12cen (D12Zlxl)
4292.7 ish 12cen (D12Zlxl), 17cen (D17Zlxl)
4292.9 ish 4cen (D4Zlxl), 17cen(D17Zlxl)
4264.1 ish 4cen (D4Zlxl), 17cen (D17Zlx2 )
4264.2 ish 12cen (D12Zlxl)
4264.3 ish 4cen (D4Zlxl), 12cen (D12Zlxl)
4264.4 ish 4cen (D4Zlxlsep), 4cen (D4Zlxlsep), 12cen (D12Zlxl), 
17cen(D17Zlxl)
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Table 4.6 (ISCN): FISH analysis o f corresponding 1st PBs using the centromeric 
probe for chromosome 4 (D4Z1, SG or SO)), the centromeric probe for chromosome 
12 (D12Z1, orange), and the centromeric probe for chromosome 17 (D17Z1, SO or 
SG)
PB/patient no. FISH Analysis Result
3892.1 PB ish 12cen (D12Zlxl), 17cen(D17Zlxl)
4181.3 PB ish 4cen (D4Zlxlsep), 4cen (D4Zlxlsep), 17cen (D17Zlxl)
4181.4 PB ish 4cen (D4Zlxl)
4184.2 PB ish 12cen (D12Zlxl), 17cen (D17Zlxlsep), 17cen (D17Zlxlsep)
1243.6 PB ish 4cen (D4Zlxl), 12cen (D12Zlxl), 17cen (D17Zlxlsep), 17cen 
(D17Zlxlsep) or
ish 4cen (D4Zlxlsep), 12cen (D12Zlxlsep), \7cen (D17Zlxlsep), 
17cen (D17Zlxlsep)
Table 4.7 (ISCN): FISH analysis o f  human metaphase II oocytes using the locus- 
specific probe LSI13 for chromosome 13 (RBI SG), and the locus-specific probe 
LSI21 for chromosome 21 (D21S529 SO).
Oocyte/patient
no.
FISH Analysis Result
5coll(t) ish21ql3.2 (D21S529xl)
3782.1 ish 13ql4 (RBxl)
1005.2 ish 13ql4 (RBxl), 21ql3.2 (D21S529xl)
1084.2 ish 13ql4 (RBxl), 21ql3.2 (D21S529xl)
1084.4 ish 13ql4 (RBx2)
1084.6 ish 13ql4 (RBxl), 21ql3.2 (D21S529xl)
3892.1 ish 13ql4 (RBxl), 21ql3.2 (D21S529xl)
3967.3 ish 13ql4 (RBxl), 21ql3.2 (D21S529xl)
3967.9 ish 13ql4 (RBxl)
3969.3 ish 13q 14(RBx4sep), 21ql3.2 (D21S529xl)
3892.5 ish 21ql3.2 (D21S529xl)
1033.4 ish 13ql4 (RBxl), 21ql3.2 (D21S529xl)
3839.1 ish 13ql4 (RBxl)
3887.6 ish 13ql4 (RBxl)
1001.5 ish 21ql3.2 (D21S529xl)
H-l ish 13ql4 (RBxl)
1147.1 ish 13ql4 (RBxl), 21ql3.2 (D21S529xl)
4081.1 ish 13ql4 (RBxl), 21ql3.2 (D21S529xl)
4176.5 ish 2 lq 13.2 (D21S529xl)
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4181.3 ish 13ql4 (RBxl), 21ql3.2 (D21S529x2sep)
4181.4 No signals
4184.2 ish 13ql4 (RBxl), 21ql3.2 (D21S529x2sep)
1243.6 ish 13ql4 (RBxl), 21ql3.2 (D21S529xl)
4257.1 ish 21ql3.2 (D21S529x2sep)
4257.2 ish 13ql4 (RBxl), 21ql3.2 (D21S529xl)
4257.3 ish 13q 14(RBx2sep), 21ql3.2 (D21S529xl)
4292.7 ish21ql3.2 (D21S529xl)
Table 4.8 (ISCN): FISH analysis o f  corresponding 1st PBs using the locus-specific 
probe LSI 13 for chromosome 13 (RBI SG), and the locus-specific probe LSI21 for 
chromosome 21 (D21S529 SO).
PB/patient no. FISH Analysis Result
1084.4 PB No signals
1084.6 PB ish 13ql4 (RBxl double signal), 21ql3.2 (D21S529xl)
3892.1 PB ish 13ql4 (RBxl), 21ql3.2 (D21S529xl)
3967.3 PB ish 21ql3.2 (D21S529x2sep)
3969.3 PB ish 13ql4 (RBxl), 21ql3.2 (D21S529xl)
3892.5 PB ish 13ql4 (RBxl), 21ql3.2 (D21S529xl)
4181.4 PB ish 13ql4 (RBxl), 21ql3.2 (D21S529x2sep)
1243.6 PB ish 13ql4 (RBxl), 21ql3.2 (D21S529x2sep)
Table 4.9 (ISCN): FISH analysis o f  human metaphase II oocytes using the locus- 
specific probe LSI22 for chromosome 22 (bcr SG).
Oocyte/patient no. FISH Analysis Result
5coll(t) ish22qll.l (bcrxl)
1084.4 22ql 1.1 (bcrxl double signal)
3839.1 ish22qll.l (bcrxl)
1243.6 22qll.l (bcrxl double signal)
4292.7 ish22qll.l (bcrxl)
4176.5 ish 22ql 1.1 (bcrxl)
4181.4 ish 22ql 1.1 (bcrxl)
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Table 4.10 (ISCN): FISH analysis o f  corresponding 1st PBs using the locus-specific
probe LSI22 for chromosome 22 (bcr SG).
PB/patient no. FISH Analysis Result
1243.6 PB ish 22ql 1.1 (bcrx2 signals)
4181.4 PB ish22q ll.l (bcrxl), 22qll.l (bcrxlsep)
6.4.2 Aneuploidv detection in human metaphase II oocytes and first PBs/ 
Statistical analysis (as carried out for data presented in Cupisti et aL. 2003, and
in Table 6.21
The chi-squared test of independence for frequency in a 2 by 2 contingency table was 
used. The 2 by 2 contingency table is:
Small Not small Total
Anomalies present 13 1 14
No anomalies 370 333 703
Total 383 334 717
The null hypothesis is that the rates of anomalies in small and in non-small 
chromosomes are the same. The value of the chi-squared test statistic (with 1 degree 
of freedom) is 8.93, and the /?-value is 0.003.
As the p-value is quite small, there is strong evidence that the chromosome anomaly 
rates in the two groups differ from each other.
The odds of an anomaly in the smaller chromosomes is 11.7 times the odds of an 
anomaly in the larger chromosomes. It’s possible to attach a 95% confidence interval 
(Cl) to the ratio to give some idea of how precisely is being estimated. The 95% Cl for 
this ratio of odds from the data presented in Cupisti et aL,2003 and partly in this 
thesis, goes from of 1.5 to of 90.0.
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This interval does not contain 1 (the ratio obtained when the anomaly odds are the 
same in the two groups), but it does include a wide range of “plausible” values for the 
ratio of odds. This means the estimation of the magnitude of the difference in anomaly 
rates between the two groups cannot take place very precisely from this data set.
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